data_2n84_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n84 _Structure_validation_residue.Date_analyzed 2016-10-15 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 121.367 0.426 . . . . 62.43 112.537 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -23.2 31.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.651 2.234 . . . . 70.439999999999998 112.329 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 tpt 53.71 53.39 11.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.84 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 63.8 t -117.37 119.55 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.263 -0.426 . . . . 73.5 111.139 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.3 p -131.09 116.13 17.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 65.420000000000002 111.166 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.6 t -71.43 147.99 47.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 71.400000000000006 110.907 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.9 p -96.91 -19.16 19.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 64.310000000000002 111.148 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.72 20.81 73.21 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.705 -0.76 . . . . 74.329999999999998 112.479 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.29 141.44 29.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 74.310000000000002 110.932 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.87 153.36 34.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 70.230000000000004 110.95 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.6 p -67.13 -179.11 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 62.049999999999997 110.827 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -109.77 148.97 30.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 74.340000000000003 110.889 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.57 145.81 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 73.310000000000002 111.146 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.04 161.02 3.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 62.43 111.072 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.13 159.61 15.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.071 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.02 113.87 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 75.299999999999997 111.109 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -52.58 107.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 73.230000000000004 110.853 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -126.25 162.36 25.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 70.510000000000005 110.912 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.37 173.38 11.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 71.450000000000003 111.141 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.57 51.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 111.132 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -103.27 118.22 36.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 75.209999999999994 110.874 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.7 mt -99.46 106.74 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 75.340000000000003 111.094 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.42 161.85 26.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 74.439999999999998 111.113 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -140.5 86.61 12.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.537 0.684 . . . . 75.5 110.869 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 167.72 23.67 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.678 2.252 . . . . 75.230000000000004 112.326 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 167.76 23.47 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.7 2.267 . . . . 75.239999999999995 112.378 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 167.57 24.07 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.704 2.269 . . . . 75.209999999999994 112.35 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 173.72 10.51 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.709 2.273 . . . . 72.200000000000003 112.358 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.48 145.32 48.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 72.420000000000002 110.906 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.6 m -51.57 162.29 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 71.519999999999996 111.125 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.3 t -85.91 117.64 31.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.510000000000005 111.138 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -150.76 163.5 38.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 61.140000000000001 110.896 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.4 101.83 1.3 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.472 . . . . 72.140000000000001 110.894 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.8 175.66 7.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 111.126 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -54.1 -40.79 67.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 72.340000000000003 110.915 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.42 -26.54 31.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 71.25 111.107 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.53 78.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.420000000000002 111.065 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.21 -31.89 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 71.530000000000001 110.923 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -109.73 39.48 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 75.109999999999999 110.904 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.07 153.54 1.19 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.719 . . . . 75.129999999999995 110.893 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 177.47 5.53 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.663 2.242 . . . . 73.299999999999997 112.34 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -61.74 171.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 63.130000000000003 110.907 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -61.76 -44.9 96.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 72.299999999999997 110.858 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.86 -36.51 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 73.25 111.087 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.8 mt -70.34 -30.87 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 74.120000000000005 111.13 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.95 -10.33 58.61 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 74.230000000000004 112.474 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.0 t -104.08 -24.56 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 62.299999999999997 111.118 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.1 p -50.37 153.75 1.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 111.185 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.57 160.71 65.41 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.606 0.717 . . . . 72.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -36.08 11.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.642 2.228 . . . . 73.140000000000001 112.335 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.86 -24.25 23.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 63.100000000000001 111.153 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.49 -54.93 5.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.519999999999996 110.884 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -28.87 70.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 72.299999999999997 110.903 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -78.65 -29.4 45.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 70.219999999999999 110.907 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.8 -19.0 60.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 63.340000000000003 111.098 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -92.99 -14.58 27.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 71.409999999999997 110.908 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -85.79 -17.37 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 111.128 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 t -77.18 -7.94 56.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 65.239999999999995 110.846 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -114.04 -51.52 2.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 72.420000000000002 110.899 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -154.83 148.23 25.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 73.430000000000007 110.846 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -110.05 152.25 26.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 75.140000000000001 110.895 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.4 t -86.99 112.09 45.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.649 0.738 . . . . 73.019999999999996 110.856 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 63' ' ' TRP . 54.0 Cg_endo -69.73 169.6 18.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.735 2.29 . . . . 72.310000000000002 112.352 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 -41.67 3.95 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.654 2.236 . . . . 64.349999999999994 112.341 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.418 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 29.3 p-90 -71.62 -7.85 50.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 72.209999999999994 110.893 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.33 143.3 52.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 73.319999999999993 111.102 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 66.81 48.64 1.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 72.140000000000001 111.108 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.3 mt -146.32 65.99 10.87 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.625 0.726 . . . . 72.310000000000002 110.919 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 154.07 68.1 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 74.109999999999999 112.355 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.0 t -131.44 4.59 4.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 75.349999999999994 110.857 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.05 151.67 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 75.129999999999995 111.14 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.27 119.54 30.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 111.117 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 26.4 p -150.84 176.97 10.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 75.409999999999997 110.909 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -143.89 168.16 20.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 74.209999999999994 110.826 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -120.49 136.24 54.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 75.319999999999993 110.893 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.56 135.37 53.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 110.915 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 11.7 m -124.21 136.79 54.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.869 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.5 p -104.24 149.79 24.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.140000000000001 111.176 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -151.57 115.75 5.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 75.430000000000007 110.867 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 54.01 37.91 27.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 71.439999999999998 110.878 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.17 18.47 77.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 63.549999999999997 112.518 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.5 mt -108.63 108.6 61.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.648 0.737 . . . . 75.230000000000004 110.9 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 92.58 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.683 2.255 . . . . 71.230000000000004 112.299 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.4 mt -70.34 159.23 85.47 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.6 0.714 . . . . 71.319999999999993 110.96 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 117.88 5.35 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 71.140000000000001 112.3 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.99 146.86 54.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 62.530000000000001 111.08 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.1 mt -147.88 139.47 23.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 74.219999999999999 110.911 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.89 107.86 1.48 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 64.340000000000003 112.45 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.1 mt -80.07 71.14 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 73.409999999999997 110.941 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -111.49 6.3 20.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 72.219999999999999 110.885 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.23 -19.65 63.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 75.530000000000001 110.866 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -136.76 155.96 76.32 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.627 0.727 . . . . 74.340000000000003 110.907 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 -27.85 26.38 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 74.129999999999995 112.355 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -159.83 176.97 11.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.859 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -144.71 124.19 13.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 74.200000000000003 110.907 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.81 148.7 22.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 70.340000000000003 110.906 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -130.34 105.3 7.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.887 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.49 -157.85 17.05 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.725 -0.75 . . . . 72.310000000000002 112.46 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -102.69 -16.52 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 74.200000000000003 110.857 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -59.23 138.19 57.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.140000000000001 110.797 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -16.93 63.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 73.099999999999994 110.923 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.88 -25.8 10.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 74.219999999999999 111.134 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 90.2 m -58.9 157.76 9.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 71.540000000000006 110.88 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.27 -15.26 53.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 70.439999999999998 110.834 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -140.53 108.26 5.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 74.120000000000005 110.913 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 p -100.54 108.15 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 74.030000000000001 111.091 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.61 -169.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 71.25 110.905 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -137.24 107.35 6.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 74.219999999999999 110.868 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.6 146.8 11.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.616 0.722 . . . . 65.409999999999997 110.848 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -13.71 35.16 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.713 2.275 . . . . 74.010000000000005 112.385 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 p -99.09 -29.8 12.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.845 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 52.0 mt -76.35 121.36 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 70.310000000000002 111.105 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.88 170.64 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 61.420000000000002 110.881 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -33.94 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 75.439999999999998 110.889 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 m -145.69 81.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 73.329999999999998 111.11 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -65.62 -61.32 2.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 110.814 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -163.34 164.59 24.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 71.230000000000004 111.066 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 p -143.16 139.52 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 75.310000000000002 111.112 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 pp -111.76 147.39 35.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 74.530000000000001 110.871 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.4 t -137.66 132.85 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 74.349999999999994 111.179 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.87 99.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 71.230000000000004 110.911 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -74.17 104.0 4.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 71.299999999999997 110.885 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.96 -2.22 70.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 74.430000000000007 112.522 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.95 -38.8 5.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 73.019999999999996 112.467 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.86 5.82 19.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 75.230000000000004 110.925 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 51.64 57.82 6.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 75.109999999999999 110.873 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 30.7 p -173.38 136.96 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 73.129999999999995 110.86 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -56.94 128.93 39.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 73.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 p -106.92 108.02 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.491 . . . . 70.519999999999996 111.097 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.4 tt -102.62 134.24 46.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 75.5 110.944 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.6 mtm -129.48 133.9 47.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 71.400000000000006 110.855 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.38 132.56 34.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 71.519999999999996 110.846 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.07 -8.96 58.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 72.439999999999998 110.929 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.9 51.04 0.7 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 72.019999999999996 112.495 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 m -67.07 174.93 2.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 63.240000000000002 110.897 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 p -78.71 -70.69 0.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 75.409999999999997 111.141 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 135' ' ' ASN . 0.4 OUTLIER -49.18 -63.11 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 72.420000000000002 110.838 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 127.8 139.55 4.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.791 -0.719 . . . . 75.099999999999994 112.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.4 t -88.44 147.44 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 72.209999999999994 111.141 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.74 150.03 22.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 71.109999999999999 110.861 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -133.11 121.37 22.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 72.140000000000001 110.918 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 62.08 23.29 13.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.329999999999998 110.903 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.24 20.61 54.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 71.140000000000001 112.481 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -144.7 128.89 17.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 73.5 110.914 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 28.4 ptt-85 -60.75 136.79 58.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 72.340000000000003 110.896 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.48 178.71 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 74.239999999999995 111.114 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -170.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 110.92 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -172.53 2.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.140000000000001 110.905 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.33 39.69 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 63.549999999999997 110.894 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -139.71 154.9 71.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.644 0.735 . . . . 75.239999999999995 110.818 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 111.74 2.88 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.714 2.276 . . . . 71.430000000000007 112.336 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 17.6 mt -110.23 83.38 3.09 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.569 0.7 . . . . 74.010000000000005 110.916 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 119.91 6.78 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.721 2.281 . . . . 73.409999999999997 112.289 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -116.06 78.86 7.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.557 0.694 . . . . 75.049999999999997 111.153 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -173.93 0.82 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 74.319999999999993 112.332 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 m -64.01 144.46 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 75.040000000000006 111.137 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.41 -10.41 66.88 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 75.549999999999997 112.524 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.0 m -96.45 -175.38 3.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 74.310000000000002 110.86 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.8 m -138.89 166.12 25.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 63.329999999999998 110.828 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.2 mt -141.48 148.03 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 73.200000000000003 111.073 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.2 149.01 28.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 72.540000000000006 110.912 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -150.2 134.29 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 75.349999999999994 110.876 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 63.65 -158.03 40.76 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 73.409999999999997 112.49 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -97.22 15.16 23.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 73.030000000000001 110.891 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.9 p -64.53 156.78 28.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 72.540000000000006 110.856 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.5 t -91.25 -29.7 17.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.864 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.26 135.58 56.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 74.109999999999999 110.871 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.3 t -130.14 131.76 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.030000000000001 111.082 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -96.57 103.19 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 75.200000000000003 110.927 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -104.23 110.71 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 74.420000000000002 110.887 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.3 153.12 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.349999999999994 111.094 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -160.83 149.93 16.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 75.340000000000003 110.909 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.6 tp -84.33 136.82 33.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 75.519999999999996 110.905 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -110.37 177.68 19.67 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 35.210000000000001 112.498 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 167.78 23.43 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.27 . . . . 72.450000000000003 112.36 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 110.16 2.48 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.683 2.255 . . . . 65.340000000000003 112.318 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 92.3 p -71.98 -37.03 69.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 110.863 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.7 p -92.27 128.91 38.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 65.25 110.839 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 55.549999999999997 110.866 -179.814 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 CA-C-O 121.445 0.469 . . . . 72.239999999999995 112.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 160.39 49.87 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.732 2.288 . . . . 70.030000000000001 112.324 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpp -110.03 136.58 49.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.349999999999994 110.889 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.9 t -118.46 148.79 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 111.123 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.3 t -92.03 155.06 18.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 60.109999999999999 111.105 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -73.46 157.38 36.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 72.230000000000004 110.913 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -19.1 35.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 70.109999999999999 111.116 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.32 20.31 75.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 54.509999999999998 112.519 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.0 112.03 14.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.933 0.397 . . . . 71.420000000000002 110.918 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -137.44 136.86 38.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 73.420000000000002 110.888 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -95.66 156.33 16.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 64.409999999999997 110.88 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -127.66 123.52 35.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 73.099999999999994 110.883 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -133.98 139.86 47.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 111.125 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.92 116.97 3.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 111.112 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.38 149.29 29.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 71.409999999999997 111.11 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.36 90.83 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 64.239999999999995 111.08 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -141.11 134.27 29.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 71.230000000000004 110.883 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 pptp? -124.53 162.35 24.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 75.510000000000005 110.937 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.9 167.73 24.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 74.340000000000003 111.066 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.2 128.62 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 72.230000000000004 111.109 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -117.56 116.59 27.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 74.5 110.871 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.7 mt -84.15 127.68 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 75.430000000000007 111.123 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.51 -179.39 4.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 73.430000000000007 111.135 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 86.61 46.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.532 0.682 . . . . 73.340000000000003 110.852 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 167.78 23.49 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.677 2.251 . . . . 74.439999999999998 112.327 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 167.81 23.28 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.658 2.239 . . . . 72.319999999999993 112.335 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 167.55 24.07 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.683 2.255 . . . . 74.530000000000001 112.374 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 177.4 5.62 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.665 2.243 . . . . 72.109999999999999 112.346 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.04 120.82 15.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 73.109999999999999 110.898 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.3 m -56.07 170.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.432 . . . . 65.200000000000003 111.107 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.0 p -101.62 151.78 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 73.439999999999998 111.085 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -107.52 168.19 9.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.420000000000002 110.93 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 pp -51.74 135.17 29.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 110.977 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.32 169.01 10.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 72.120000000000005 111.166 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -60.96 -41.8 97.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 74.439999999999998 110.848 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.48 -16.55 34.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.510000000000005 111.12 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.92 -39.1 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 75.299999999999997 111.116 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -67.39 -12.51 60.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 73.5 110.929 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -73.32 -24.92 60.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 75.340000000000003 110.943 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.38 85.7 3.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.579 0.705 . . . . 52.149999999999999 110.895 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 158.26 57.62 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.249 . . . . 71.409999999999997 112.342 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -67.24 171.12 6.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 110.944 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -67.19 -38.29 85.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.839 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.7 pp -80.11 -32.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.421 . . . . 72.329999999999998 111.214 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.4 mt -78.79 -25.11 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 70.099999999999994 111.202 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.18 -17.13 65.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.706 -0.759 . . . . 74.019999999999996 112.491 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.51 -25.93 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.368 . . . . 74.230000000000004 111.146 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.9 p -89.91 153.62 20.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 111.068 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.14 160.47 57.44 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.591 0.71 . . . . 70.140000000000001 110.852 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -37.28 9.47 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.71 2.273 . . . . 74.129999999999995 112.381 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.04 -15.42 34.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 75.230000000000004 111.103 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.63 -57.71 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 74.109999999999999 110.916 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -29.33 67.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 65.109999999999999 110.876 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -74.7 -43.86 52.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 71.200000000000003 110.908 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.29 -24.41 28.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 54.219999999999999 111.17 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -66.63 -16.94 64.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 72.129999999999995 110.918 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.3 p -69.3 -21.8 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 75.239999999999995 111.068 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.8 t -77.77 -4.36 45.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 64.400000000000006 110.862 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -124.2 -58.14 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 74.109999999999999 110.858 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -146.35 142.21 28.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 74.439999999999998 110.878 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -116.46 118.33 32.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 63.439999999999998 110.907 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 6.3 p -48.39 107.16 0.7 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.585 0.707 . . . . 72.420000000000002 110.876 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HG2' ' CB ' ' A' ' 64' ' ' ALA . 53.6 Cg_endo -69.77 158.68 56.12 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.689 2.259 . . . . 71.409999999999997 112.328 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.93 -36.62 10.03 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.671 2.247 . . . . 61.399999999999999 112.278 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.455 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 39.8 p-90 -70.46 -4.62 23.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 74.310000000000002 110.912 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' CB ' ' HG2' ' A' ' 61' ' ' PRO . . . -109.97 172.78 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 65.200000000000003 111.073 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 70.41 28.55 3.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 70.329999999999998 111.103 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.71 68.06 11.65 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.611 0.72 . . . . 74.420000000000002 110.92 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.75 151.68 69.17 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.687 2.258 . . . . 61.25 112.336 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 m -136.85 11.4 3.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 73.510000000000005 110.842 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 p -127.99 153.25 37.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 75.439999999999998 111.159 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.31 111.66 23.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 64.310000000000002 111.086 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.0 p -150.91 174.96 12.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 74.329999999999998 110.878 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -148.4 167.1 26.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 74.120000000000005 110.867 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -121.11 136.09 55.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 75.439999999999998 110.866 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.86 136.37 51.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.5 110.889 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.79 144.71 51.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 74.530000000000001 110.864 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 p -107.36 148.37 29.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 73.200000000000003 111.143 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -149.74 113.96 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 75.519999999999996 110.863 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 53.67 39.02 29.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 73.219999999999999 110.909 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.37 19.69 77.75 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 73.200000000000003 112.484 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.2 mt -112.39 108.6 54.47 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.632 0.73 . . . . 73.219999999999999 110.975 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 94.52 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.261 . . . . 71.530000000000001 112.342 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.81 159.28 84.63 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 72.430000000000007 110.928 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 114.29 3.65 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 65.540000000000006 112.29 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.07 147.11 51.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 53.229999999999997 111.119 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 mt -148.64 141.95 25.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 110.925 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.1 102.0 0.32 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.693 -0.765 . . . . 74.040000000000006 112.409 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.7 mt -77.43 70.38 3.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.897 0.38 . . . . 72.540000000000006 110.917 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -112.2 6.32 18.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 74.019999999999996 110.805 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.02 -19.18 64.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 75.140000000000001 110.874 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -133.64 156.39 79.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.629 0.728 . . . . 75.230000000000004 110.857 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -34.47 14.36 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.705 2.27 . . . . 73.430000000000007 112.323 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -154.71 162.4 41.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 73.409999999999997 110.897 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -128.5 117.37 21.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 110.928 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.21 138.97 31.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 110.917 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -127.55 105.31 8.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 75.129999999999995 110.92 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.89 -146.28 4.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 72.439999999999998 112.45 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.48 -2.6 11.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.82 0.343 . . . . 62.229999999999997 110.891 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.0 t -70.32 156.28 39.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 75.430000000000007 110.878 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.05 -8.73 59.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 72.109999999999999 110.838 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.5 m -93.03 -21.37 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 73.439999999999998 111.128 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 p -58.24 165.34 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 75.049999999999997 110.838 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.38 -2.29 54.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 75.349999999999994 110.891 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.16 106.3 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 110.937 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 p -97.33 109.8 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 72.519999999999996 111.095 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.18 -168.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 64.310000000000002 110.893 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -133.41 106.75 7.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.868 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -167.35 142.46 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.675 0.75 . . . . 74.030000000000001 110.817 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -13.43 34.75 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.67 2.246 . . . . 65.340000000000003 112.367 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.9 p -97.4 -25.39 15.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 64.409999999999997 110.842 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.7 mt -75.55 116.54 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 74.530000000000001 111.087 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.2 m -96.2 169.88 9.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 65.340000000000003 110.828 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 m -45.58 -38.35 6.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 74.340000000000003 110.813 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -141.26 80.17 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 72.239999999999995 111.091 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -69.68 -49.01 57.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 74.420000000000002 110.903 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -168.2 159.18 10.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 111.112 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.98 137.04 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 72.409999999999997 111.186 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.71 144.33 38.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 110.925 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.9 t -132.11 128.69 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 71.430000000000007 111.128 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.84 95.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 55.299999999999997 110.92 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -65.43 108.17 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 74.319999999999993 110.907 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.28 -5.12 65.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 75.209999999999994 112.436 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.7 -42.77 5.97 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 70.109999999999999 112.466 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.16 8.36 16.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 74.230000000000004 110.888 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? 50.73 44.71 27.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 72.409999999999997 110.894 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 87.6 m -146.27 137.78 24.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.510000000000005 110.893 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -65.97 131.28 45.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 61.32 110.864 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.0 t -110.18 107.29 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 70.049999999999997 111.149 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 tt -101.68 134.84 44.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 74.129999999999995 110.865 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.1 mtm -131.41 133.9 45.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 74.439999999999998 110.89 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -83.64 132.56 34.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 72.120000000000005 110.873 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.35 -16.07 61.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 72.420000000000002 110.952 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.74 49.37 0.74 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 50.350000000000001 112.493 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 t -58.58 158.48 7.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 71.299999999999997 110.877 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.6 m -78.55 -25.73 45.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 70.530000000000001 111.109 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -80.39 -74.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 74.200000000000003 110.918 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 148.04 126.48 1.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.758 -0.734 . . . . 74.549999999999997 112.493 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.3 t -91.51 145.72 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.382 . . . . 73.219999999999999 111.14 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -100.23 154.71 18.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 110.966 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.11 126.19 19.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 74.299999999999997 110.95 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 56.34 23.82 7.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 75.409999999999997 110.912 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.66 19.76 55.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.69 -0.767 . . . . 62.109999999999999 112.493 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -145.3 130.19 18.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.781 0.324 . . . . 75.040000000000006 110.925 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.71 136.61 58.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 74.219999999999999 110.841 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.81 178.69 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 73.099999999999994 111.105 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -170.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 54.210000000000001 110.906 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.12 176.83 8.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 59.21 39.04 23.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 110.902 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.38 158.03 41.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 72.409999999999997 110.856 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 113.01 3.22 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.691 2.261 . . . . 75.150000000000006 112.317 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 69.9 mt -124.5 84.07 57.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.619 0.723 . . . . 74.219999999999999 110.931 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 134.15 27.37 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.681 2.254 . . . . 62.210000000000001 112.39 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -118.44 80.7 16.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.688 . . . . 75.140000000000001 111.124 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 179.28 3.79 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.755 2.303 . . . . 75.230000000000004 112.332 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.5 m -56.63 143.17 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 71.439999999999998 111.084 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.31 -12.7 61.9 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 73.340000000000003 112.528 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.83 168.48 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 64.439999999999998 110.89 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.7 m -124.4 165.44 17.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 74.310000000000002 110.806 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.1 mt -142.58 150.68 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 73.219999999999999 111.197 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.598 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -152.36 162.52 41.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 73.329999999999998 110.921 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.598 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 3.5 p90 -163.85 139.59 6.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 110.863 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 64.29 -154.03 48.04 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.718 -0.754 . . . . 72.120000000000005 112.46 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -104.89 8.97 34.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.896 0.379 . . . . 75.530000000000001 110.895 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.09 159.65 25.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 75.239999999999995 110.868 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 75.3 m -88.84 -20.66 24.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 63.049999999999997 110.8 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -53.13 137.81 32.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.209999999999994 110.813 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 19.5 t -139.26 122.83 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 75.140000000000001 111.104 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -92.85 105.07 17.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 64.450000000000003 110.934 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -105.94 110.14 22.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 75.430000000000007 110.891 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.72 153.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 71.450000000000003 111.118 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.12 148.48 15.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 75.349999999999994 110.926 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 11.0 tp -89.65 132.88 34.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 72.420000000000002 110.897 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -89.74 177.17 43.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 72.439999999999998 112.571 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 167.76 23.55 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.264 . . . . 75.030000000000001 112.358 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 112.51 3.1 Favored 'Trans proline' 0 C--O 1.23 0.112 0 C-N-CA 122.668 2.246 . . . . 65.209999999999994 112.348 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.8 p -85.78 124.39 32.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 74.340000000000003 110.906 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.3 m -154.38 150.15 27.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 74.400000000000006 110.845 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.919 -179.868 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 CA-C-O 121.374 0.43 . . . . 75.420000000000002 112.405 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 143.43 50.77 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.766 2.31 . . . . 71.450000000000003 112.327 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mtp -68.45 164.34 21.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 73.140000000000001 110.813 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -119.39 141.46 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 111.049 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.2 t -133.41 163.85 28.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 72.120000000000005 111.116 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.4 p -105.45 167.04 10.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 70.319999999999993 110.879 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -108.19 21.0 17.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 75.420000000000002 111.131 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.0 -19.5 37.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 73.409999999999997 112.526 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -136.45 165.77 25.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.824 0.345 . . . . 75.420000000000002 110.944 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.64 137.75 54.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 75.420000000000002 110.899 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 p -61.44 138.53 58.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.457 . . . . 75.310000000000002 110.872 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -87.72 146.66 25.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 71.120000000000005 110.793 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.91 149.91 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 75.510000000000005 111.143 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.06 150.17 51.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 111.081 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.11 113.49 27.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 75.0 111.114 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.99 106.6 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 75.340000000000003 111.155 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -140.25 113.89 8.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 70.340000000000003 110.901 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -124.3 162.98 22.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.461 . . . . 75.519999999999996 110.905 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.65 149.57 52.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 71.209999999999994 111.153 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.97 151.94 29.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 74.510000000000005 111.112 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -107.62 104.74 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 74.519999999999996 110.907 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 mp -81.87 137.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 75.230000000000004 111.131 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.08 112.22 12.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 111.143 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -140.81 86.72 11.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.618 0.723 . . . . 71.030000000000001 110.947 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 167.68 23.72 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.617 2.212 . . . . 63.219999999999999 112.362 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 167.76 23.49 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.652 2.235 . . . . 72.439999999999998 112.316 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 167.75 23.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.676 2.251 . . . . 53.119999999999997 112.348 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 117.45 5.09 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.692 2.262 . . . . 73.299999999999997 112.286 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.3 130.02 39.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 74.209999999999994 110.917 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.21 174.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 73.519999999999996 111.159 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -136.42 152.11 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 73.200000000000003 111.097 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.39 151.62 36.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 72.209999999999994 110.89 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.44 161.6 37.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 74.25 110.885 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.15 174.63 5.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 71.299999999999997 111.174 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.51 -38.17 68.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 73.530000000000001 110.887 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.78 -16.39 62.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 74.129999999999995 111.126 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.06 -36.25 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 72.219999999999999 111.065 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' C ' ' HD3' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -83.52 -1.21 53.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.414 . . . . 72.329999999999998 110.869 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -103.78 -13.58 16.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 71.129999999999995 110.943 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 pp -107.38 154.53 40.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.615 0.721 . . . . 73.120000000000005 110.849 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 146.54 60.04 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.711 2.274 . . . . 61.100000000000001 112.282 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -53.06 172.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 71.040000000000006 110.91 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -62.94 -55.61 24.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 110.788 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.26 -27.88 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 71.319999999999993 111.147 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.5 mt -77.91 -25.27 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 75.400000000000006 111.166 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.87 -18.09 56.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 74.010000000000005 112.432 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.34 -26.46 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.93 0.395 . . . . 65.219999999999999 111.176 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.7 p -96.63 153.57 17.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 111.175 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.32 159.79 63.9 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.513 0.673 . . . . 73.209999999999994 110.941 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 -35.39 12.82 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.71 2.274 . . . . 62.329999999999998 112.355 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -18.54 26.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 64.239999999999995 111.182 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.72 -61.24 1.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 65.409999999999997 110.934 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -29.73 40.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 71.239999999999995 110.864 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -74.66 -40.5 61.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.906 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.01 -27.94 48.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 72.530000000000001 111.122 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -92.55 -17.08 24.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 74.120000000000005 110.854 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -19.31 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 72.150000000000006 111.053 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.47 3.98 53.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 73.030000000000001 110.836 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -128.04 -57.95 1.23 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 75.129999999999995 110.877 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -147.94 141.42 25.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.439999999999998 110.891 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -90.19 152.38 21.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 74.200000000000003 110.993 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 23.1 p -89.0 120.8 69.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.589 0.709 . . . . 64.219999999999999 110.822 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.426 ' HG3' ' CZ2' ' A' ' 63' ' ' TRP . 54.3 Cg_endo -69.72 164.85 32.96 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.684 2.256 . . . . 74.200000000000003 112.363 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -41.94 3.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.731 2.287 . . . . 73.120000000000005 112.321 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.426 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 27.7 p-90 -68.51 -9.17 47.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 75.219999999999999 110.818 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.416 ' HB1' ' HG2' ' A' ' 61' ' ' PRO . . . -71.96 149.23 45.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 75.109999999999999 111.115 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 65.16 47.18 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 74.349999999999994 111.061 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.0 mt -146.29 66.3 11.13 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 74.530000000000001 110.902 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 151.17 69.02 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.691 2.261 . . . . 71.030000000000001 112.354 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.73 5.84 3.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 75.319999999999993 110.778 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.28 152.62 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 72.0 111.15 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.66 120.04 32.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 72.340000000000003 111.166 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 5.1 p -151.2 172.01 16.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 75.439999999999998 110.862 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -137.1 167.6 21.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 72.200000000000003 110.867 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.55 136.24 54.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 72.310000000000002 110.896 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.03 133.46 54.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 74.540000000000006 110.923 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.1 p -128.53 141.83 51.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 74.219999999999999 110.923 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 p -116.15 152.61 33.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 111.154 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -150.73 127.97 11.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 73.5 110.901 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 55.61 30.02 14.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 110.815 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.58 19.1 78.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 71.120000000000005 112.49 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.3 mt -109.94 108.56 59.21 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.6 0.714 . . . . 61.409999999999997 110.933 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 94.23 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.736 2.291 . . . . 75.200000000000003 112.279 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.1 mt -74.8 159.05 83.99 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.74 . . . . 74.019999999999996 110.891 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 127.63 14.91 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.741 2.294 . . . . 73.219999999999999 112.345 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.03 145.28 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 55.32 111.04 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.8 mt -142.17 140.84 32.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.299999999999997 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.82 100.36 0.2 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.683 -0.77 . . . . 62.25 112.504 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.35 71.18 2.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 74.430000000000007 110.925 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -111.68 6.29 19.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 75.319999999999993 110.91 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.36 -18.56 63.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.842 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -140.86 155.55 69.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.622 0.725 . . . . 74.150000000000006 110.916 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -30.21 22.78 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.769 2.313 . . . . 75.120000000000005 112.353 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -153.42 175.91 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 74.439999999999998 110.94 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -144.63 125.3 14.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 75.129999999999995 110.95 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.92 152.3 20.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.887 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -139.14 106.23 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 72.010000000000005 110.874 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -163.37 -144.23 3.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.738 . . . . 75.510000000000005 112.492 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.03 -7.15 9.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.799 0.333 . . . . 75.329999999999998 110.829 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.75 162.74 23.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.845 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -22.73 49.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 75.010000000000005 110.808 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.08 -22.17 27.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 74.340000000000003 111.109 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 94.8 m -74.09 163.47 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 63.420000000000002 110.876 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.06 -24.84 37.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.92 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.0 108.35 10.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.477 . . . . 63.229999999999997 110.943 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.2 t -96.42 103.97 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 111.139 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.59 -169.87 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 75.400000000000006 110.881 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -137.48 107.02 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 64.340000000000003 110.97 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.96 147.41 12.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 70.140000000000001 110.831 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -14.4 35.82 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.684 2.256 . . . . 74.319999999999993 112.317 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.7 p -100.12 -27.55 13.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 71.239999999999995 110.838 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 56.8 mt -76.02 111.01 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 111.048 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.7 m -89.02 169.57 11.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 72.150000000000006 110.878 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.3 m -46.14 -35.51 5.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 72.040000000000006 110.867 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.57 81.72 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 74.019999999999996 111.154 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -65.76 -60.42 2.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 110.85 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -160.46 165.18 31.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.192 -0.458 . . . . 73.239999999999995 111.067 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.71 134.77 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 74.230000000000004 111.141 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 pp -107.6 138.17 44.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 74.549999999999997 110.908 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.26 139.21 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 73.530000000000001 111.072 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.01 91.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.540000000000006 110.824 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -61.96 107.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 75.329999999999998 110.86 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.3 -6.87 62.34 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.806 -0.711 . . . . 73.450000000000003 112.45 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.88 -51.7 3.15 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.819 -0.705 . . . . 63.43 112.436 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -98.93 -1.57 39.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.864 0.364 . . . . 73.319999999999993 110.976 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.38 30.1 19.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 73.099999999999994 110.838 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 57.7 m -138.77 137.42 36.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 71.549999999999997 110.911 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -60.97 133.12 55.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 72.109999999999999 110.905 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.7 t -114.54 111.35 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 75.310000000000002 111.097 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.0 tt -101.57 121.44 41.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 72.239999999999995 110.873 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 74.1 mtm -115.75 133.36 56.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 75.549999999999997 110.874 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.04 126.84 35.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 72.420000000000002 110.876 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.36 -16.67 55.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 63.509999999999998 110.968 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.47 47.42 0.5 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 65.030000000000001 112.533 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.97 160.54 9.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.915 0.388 . . . . 51.439999999999998 110.883 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.2 t -83.79 -28.51 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.492 . . . . 73.310000000000002 111.159 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -71.85 -72.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 64.049999999999997 110.903 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 135.51 129.51 2.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.73 -0.748 . . . . 65.129999999999995 112.549 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.26 152.12 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.93 0.395 . . . . 74.129999999999995 111.093 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -108.24 140.47 41.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 74.209999999999994 110.862 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 tt -125.76 130.81 52.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 73.349999999999994 110.849 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 53.93 24.7 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 63.310000000000002 110.891 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 22.66 52.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.787 -0.72 . . . . 65.420000000000002 112.463 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -145.13 126.07 14.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 75.439999999999998 110.874 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -57.99 138.87 55.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 75.200000000000003 110.868 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.87 178.24 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.132 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.59 -169.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 110.912 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 -179.76 5.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 73.129999999999995 110.935 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 51.95 34.71 14.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 74.349999999999994 110.868 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.64 161.72 55.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 74.140000000000001 110.856 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 107.9 1.96 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.664 2.243 . . . . 72.209999999999994 112.371 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.2 mt -109.91 83.32 2.82 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.605 0.716 . . . . 73.219999999999999 110.902 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 134.7 28.74 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.664 2.243 . . . . 64.209999999999994 112.413 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.32 80.18 45.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.536 0.684 . . . . 72.239999999999995 111.08 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 165.29 31.46 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.679 2.253 . . . . 74.340000000000003 112.332 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.0 m -53.08 145.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 72.019999999999996 111.178 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.09 -9.98 67.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 73.510000000000005 112.508 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 12.1 p -96.76 -179.39 4.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 45.43 110.844 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.7 m -132.04 162.33 31.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.501 . . . . 73.040000000000006 110.909 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.4 mt -139.14 149.51 23.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 74.540000000000006 111.149 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.514 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -152.27 149.4 28.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 74.439999999999998 110.935 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.514 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 2.7 p90 -144.24 134.59 24.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.519999999999996 110.843 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.3 -154.06 41.9 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.747 -0.74 . . . . 74.400000000000006 112.423 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -101.69 17.79 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.908 0.385 . . . . 62.030000000000001 110.936 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.5 p -65.72 160.92 21.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 71.530000000000001 110.852 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.9 m -91.16 -31.98 15.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 71.409999999999997 110.874 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -53.29 149.85 6.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 74.150000000000006 110.923 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.38 130.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 62.399999999999999 111.078 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.62 103.6 15.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 74.230000000000004 110.874 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.74 110.26 22.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 74.409999999999997 110.919 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.4 153.56 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 70.319999999999993 111.123 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.67 146.09 14.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 74.25 110.924 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.0 tp -87.16 141.13 28.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 74.030000000000001 110.895 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.97 177.15 54.49 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.769 -0.729 . . . . 72.230000000000004 112.425 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 167.76 23.55 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.649 2.232 . . . . 72.519999999999996 112.341 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.46 69.06 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.663 2.242 . . . . 72.439999999999998 112.339 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 56.6 p -98.81 -50.37 4.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 55.219999999999999 110.784 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.4 t -108.18 153.32 23.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 64.040000000000006 110.769 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.494 . . . . 72.230000000000004 110.88 -179.831 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 CA-C-O 121.546 0.526 . . . . 61.310000000000002 112.42 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 171.24 14.87 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.749 2.299 . . . . 74.439999999999998 112.302 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 mtt -116.74 161.79 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 74.409999999999997 110.932 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.5 m -59.73 156.51 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 73.120000000000005 111.139 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.1 m -145.6 142.29 28.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 54.350000000000001 111.173 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 t -147.93 158.94 44.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.219999999999999 110.834 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 p -87.92 -19.04 27.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 74.200000000000003 111.18 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.11 20.29 65.28 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.741 . . . . 74.439999999999998 112.539 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.4 mt -52.5 132.09 34.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.36 . . . . 73.109999999999999 110.898 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tt -134.69 143.71 47.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 110.852 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.0 t -67.89 170.12 8.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.492 . . . . 73.129999999999995 110.827 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 44.4 ttm-85 -131.59 146.49 52.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 75.540000000000006 110.866 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.7 t -119.22 145.37 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 72.040000000000006 111.13 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.57 158.75 22.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 72.450000000000003 111.122 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.12 109.18 18.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 75.150000000000006 111.09 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.8 m -57.54 101.82 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 62.32 111.085 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -102.17 130.69 48.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 73.040000000000006 110.928 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.25 155.5 44.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.936 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.21 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 73.040000000000006 111.132 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -113.2 150.99 31.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 75.420000000000002 111.109 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -102.55 112.1 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 74.430000000000007 110.876 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mp -64.42 131.46 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 73.109999999999999 111.168 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.09 -179.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 111.059 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.59 157.62 40.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.53 0.681 . . . . 74.430000000000007 110.949 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 168.1 22.43 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.7 2.267 . . . . 74.25 112.368 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.83 168.05 22.78 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.781 2.32 . . . . 65.349999999999994 112.267 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 167.42 24.54 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.65 2.234 . . . . 73.420000000000002 112.394 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.67 -174.6 0.92 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.7 2.267 . . . . 70.430000000000007 112.43 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.17 146.78 29.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 75.099999999999994 110.875 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.5 m -143.64 174.74 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 72.019999999999996 111.132 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.1 p -52.3 130.74 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 73.120000000000005 111.185 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -132.98 167.82 19.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 75.219999999999999 110.857 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 37.3 mt -55.41 174.21 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.496 . . . . 74.409999999999997 110.906 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.23 165.01 7.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 73.310000000000002 111.083 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.83 -55.16 37.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 74.420000000000002 110.911 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.46 -20.45 58.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 62.109999999999999 111.084 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.39 -30.77 20.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 75.310000000000002 111.043 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.1 -32.7 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 71.329999999999998 110.911 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -73.0 -12.56 60.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 110.896 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.83 156.14 1.75 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 73.439999999999998 110.929 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 147.4 62.63 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.719 2.279 . . . . 72.340000000000003 112.331 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -54.52 173.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 110.943 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -61.26 -56.94 14.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 72.420000000000002 110.813 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.74 -27.84 23.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 74.230000000000004 111.138 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.6 mt -76.03 -25.44 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 63.119999999999997 111.174 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.16 -10.98 70.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.677 -0.773 . . . . 71.25 112.513 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.4 t -117.66 -22.61 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.848 0.356 . . . . 74.310000000000002 111.153 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.7 p -50.12 153.91 1.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 72.219999999999999 111.111 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.91 160.64 77.04 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.643 0.735 . . . . 65.120000000000005 110.794 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -37.53 8.92 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.622 2.215 . . . . 74.299999999999997 112.332 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.22 -20.9 23.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 71.329999999999998 111.155 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.33 -59.2 2.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 65.019999999999996 110.938 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.05 -29.23 63.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.129999999999995 110.92 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -78.79 -28.77 44.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.340000000000003 110.89 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.81 -18.27 51.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 52.409999999999997 111.06 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -92.46 -16.09 26.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 74.219999999999999 111.003 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.9 p -84.94 -14.63 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 74.310000000000002 111.124 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 t -82.72 0.7 42.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 64.129999999999995 110.909 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -120.59 -41.73 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 74.129999999999995 110.888 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -160.22 140.36 11.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 73.109999999999999 110.87 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -102.35 152.47 21.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 63.25 110.855 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.4 t -89.94 110.52 40.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.665 0.745 . . . . 74.420000000000002 110.825 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HG3' ' CZ2' ' A' ' 63' ' ' TRP . 53.6 Cg_endo -69.72 168.74 20.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.703 2.269 . . . . 73.430000000000007 112.328 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -39.4 6.53 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.654 2.236 . . . . 73.219999999999999 112.28 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.451 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 36.5 p-90 -73.26 -6.22 44.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 72.239999999999995 110.915 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.05 149.44 35.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 64.310000000000002 111.11 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 66.06 47.09 2.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 72.129999999999995 111.081 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.5 mt -146.33 66.68 11.34 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.551 0.691 . . . . 75.200000000000003 110.895 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 151.26 69.41 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.651 2.234 . . . . 70.439999999999998 112.357 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.07 5.2 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 74.099999999999994 110.863 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.5 t -138.07 151.84 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 73.510000000000005 111.12 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.68 122.33 34.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 51.0 111.136 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.0 p -151.08 173.31 14.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 75.219999999999999 110.884 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -143.33 166.77 23.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 73.219999999999999 110.835 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -120.66 135.71 55.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.91 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.21 136.33 52.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 73.439999999999998 110.897 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 15.7 p -127.37 131.8 50.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 63.140000000000001 110.926 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 p -93.6 156.4 16.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 74.299999999999997 111.122 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -158.37 112.38 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 74.400000000000006 110.876 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 53.74 39.59 30.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 54.240000000000002 110.863 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.86 18.31 77.45 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 73.200000000000003 112.501 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.0 mt -112.36 108.42 54.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.653 0.74 . . . . 74.140000000000001 110.883 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 91.45 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.65 2.234 . . . . 74.420000000000002 112.325 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.27 159.22 59.81 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.574 0.702 . . . . 75.230000000000004 111.008 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 114.85 3.84 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.271 . . . . 72.030000000000001 112.35 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.15 150.01 39.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 63.340000000000003 110.986 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.8 mt -147.05 133.34 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 63.219999999999999 110.883 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.53 98.93 0.19 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.732 -0.746 . . . . 43.240000000000002 112.453 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.6 mt -79.48 70.93 6.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 73.0 110.932 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -111.61 6.61 20.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 75.310000000000002 110.774 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -19.57 64.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 74.109999999999999 110.84 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.43 155.33 74.51 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.665 0.745 . . . . 74.319999999999993 110.79 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 -33.23 17.42 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.705 2.27 . . . . 75.310000000000002 112.347 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -151.68 175.71 12.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 110.916 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -143.1 111.38 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 74.109999999999999 110.923 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.9 tp -89.96 138.07 31.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 73.319999999999993 110.857 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -122.76 128.61 50.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 74.430000000000007 110.816 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.68 -158.62 21.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.758 -0.734 . . . . 52.310000000000002 112.534 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.43 -6.19 16.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 74.530000000000001 110.842 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.28 159.2 31.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 74.109999999999999 110.92 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 -19.39 49.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 75.409999999999997 110.899 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.3 m -80.46 -15.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 74.540000000000006 111.141 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 57.7 m -74.58 151.45 39.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 110.917 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.9 -23.34 65.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 72.439999999999998 110.845 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -134.13 108.2 8.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 75.340000000000003 110.942 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.9 p -105.03 108.62 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 63.25 111.114 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.46 -168.65 1.37 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 75.219999999999999 110.92 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -135.42 107.28 7.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 70.329999999999998 110.903 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.17 147.32 13.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.581 0.705 . . . . 65.230000000000004 110.916 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 -16.83 38.11 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 71.200000000000003 112.337 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 p -98.19 -25.7 14.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.426 . . . . 70.230000000000004 110.87 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt -77.96 116.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 74.010000000000005 111.131 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.4 m -93.75 170.34 9.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 72.25 110.802 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 p -43.57 -47.4 7.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 64.409999999999997 110.888 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.2 t -136.99 85.43 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 74.25 111.145 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -64.16 -51.71 62.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 74.230000000000004 110.835 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -171.83 175.19 3.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 111.13 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.3 p -147.86 138.22 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 71.129999999999995 111.176 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 pp -111.74 138.03 48.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 71.230000000000004 110.949 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.4 t -128.18 136.11 61.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 72.129999999999995 111.154 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.28 101.97 1.0 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 74.319999999999993 110.879 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -70.32 106.99 3.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 75.299999999999997 110.91 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.14 -4.13 62.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 74.200000000000003 112.493 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -89.45 -43.54 5.2 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.709 -0.758 . . . . 75.349999999999994 112.522 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.86 8.21 17.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.768 0.318 . . . . 75.219999999999999 110.866 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 50.3 57.45 6.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.310000000000002 110.868 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 35.5 t -160.28 137.65 9.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 74.510000000000005 110.857 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -67.14 131.9 46.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.310000000000002 110.814 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.4 t -110.03 108.56 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 63.240000000000002 111.2 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.5 tt -101.22 132.62 46.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 73.340000000000003 110.955 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 69.6 mtm -132.7 132.25 42.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 72.140000000000001 110.9 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -90.46 132.81 35.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 75.310000000000002 110.834 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.498 HD13 ' N ' ' A' ' 132' ' ' GLY . 0.0 OUTLIER -70.12 -7.15 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 75.430000000000007 110.963 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.498 ' N ' HD13 ' A' ' 131' ' ' LEU . . . 113.78 51.29 0.49 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.73 . . . . 72.420000000000002 112.446 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -67.12 117.4 9.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.923 0.392 . . . . 73.439999999999998 110.873 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 97.9 m -55.59 -24.67 34.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 64.150000000000006 111.107 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -67.33 -68.2 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 73.310000000000002 110.874 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 132.68 118.06 1.9 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 73.340000000000003 112.482 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.2 t -88.79 152.43 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.945 0.403 . . . . 74.299999999999997 111.116 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -117.45 130.03 56.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 75.450000000000003 110.87 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.85 143.3 50.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 73.310000000000002 110.897 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 56.13 22.69 6.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.129999999999995 110.871 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.69 20.53 70.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 61.450000000000003 112.487 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -146.54 142.3 27.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.895 0.379 . . . . 70.230000000000004 110.876 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -49.74 154.19 1.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 72.329999999999998 110.899 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.2 -174.16 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 71.400000000000006 111.078 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -98.76 171.29 8.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 70.430000000000007 110.866 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 -179.81 3.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 73.450000000000003 110.918 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 51.22 35.61 13.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 73.530000000000001 110.887 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -148.33 161.33 34.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.661 0.744 . . . . 74.209999999999994 110.829 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 116.84 4.75 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.617 2.211 . . . . 65.099999999999994 112.356 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.31 82.72 67.68 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.637 0.732 . . . . 74.450000000000003 110.954 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 144.85 55.29 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.663 2.242 . . . . 74.420000000000002 112.36 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.71 79.85 67.42 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.64 0.733 . . . . 74.120000000000005 111.123 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -177.98 2.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.269 . . . . 73.409999999999997 112.354 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.3 m -68.42 146.18 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 74.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.84 -11.44 64.5 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.758 . . . . 72.010000000000005 112.507 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 m -96.88 179.15 5.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.989 0.423 . . . . 64.340000000000003 110.753 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 14.5 m -130.57 163.43 27.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 53.240000000000002 110.855 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.0 mt -139.62 145.64 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 75.230000000000004 111.14 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.534 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -151.24 149.56 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 73.409999999999997 110.858 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.534 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 2.6 p90 -145.85 134.98 22.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 110.837 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 61.73 -136.92 46.65 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 65.140000000000001 112.493 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.56 19.21 15.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 74.299999999999997 110.885 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.02 156.5 2.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 70.230000000000004 110.817 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.0 t -91.49 -36.01 13.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 54.299999999999997 110.866 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.41 155.14 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 74.140000000000001 110.908 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.52 138.66 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 75.099999999999994 111.128 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -94.12 101.77 13.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 110.933 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.05 110.4 22.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 75.140000000000001 110.914 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.89 153.03 4.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 74.420000000000002 111.124 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -160.63 148.81 16.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.420000000000002 110.956 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.8 tp -90.47 139.83 30.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 65.510000000000005 110.873 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -68.78 168.19 44.07 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.703 -0.761 . . . . 61.340000000000003 112.486 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 167.64 23.85 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.619 2.213 . . . . 70.140000000000001 112.387 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 175.94 7.47 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.672 2.248 . . . . 73.540000000000006 112.304 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.2 m -88.61 57.03 4.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 72.040000000000006 110.863 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.2 t -119.38 127.92 53.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 72.120000000000005 110.936 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 72.120000000000005 110.856 -179.748 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 121.42 0.456 . . . . 65.239999999999995 112.508 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 127.43 14.62 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.639 2.226 . . . . 72.109999999999999 112.341 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmm -118.77 144.49 46.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 74.109999999999999 110.907 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.7 143.23 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 74.129999999999995 111.162 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 m -151.79 139.98 20.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 75.209999999999994 111.133 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.2 t -76.9 167.01 22.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 44.509999999999998 110.856 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.8 p -101.25 -19.05 15.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 74.439999999999998 111.12 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.53 18.98 79.62 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.757 -0.735 . . . . 65.040000000000006 112.484 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.05 99.18 3.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.779 0.323 . . . . 74.329999999999998 110.918 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 tp -70.43 115.87 10.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 74.019999999999996 110.885 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.3 m -95.65 133.95 39.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 73.209999999999994 110.846 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.3 mmt85 -93.61 146.03 24.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 75.010000000000005 110.883 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.5 p -87.97 150.19 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 74.540000000000006 111.137 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.18 160.5 15.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 73.400000000000006 111.044 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.53 168.3 12.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 73.439999999999998 111.139 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.0 t -116.49 111.8 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 73.239999999999995 111.113 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -124.0 106.23 10.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 75.430000000000007 110.926 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -103.23 162.96 12.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 110.888 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.16 130.62 51.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 73.150000000000006 111.113 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.02 143.34 7.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 65.430000000000007 111.112 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.5 101.96 3.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 110.91 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.5 mt -102.29 136.44 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 111.06 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.04 124.95 22.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 74.439999999999998 111.089 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -54.04 160.62 2.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.556 0.693 . . . . 74.109999999999999 110.959 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 167.79 23.41 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.653 2.236 . . . . 75.540000000000006 112.371 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 167.89 23.16 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.679 2.253 . . . . 74.420000000000002 112.324 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 167.7 23.83 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.726 2.284 . . . . 73.329999999999998 112.329 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 177.55 5.44 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.73 2.287 . . . . 73.549999999999997 112.349 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.05 145.18 48.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 64.510000000000005 110.907 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.1 m -51.47 144.43 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 73.239999999999995 111.059 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.4 t -143.04 147.32 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 71.510000000000005 111.11 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -51.78 168.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 75.319999999999993 110.927 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 pp -51.9 130.13 28.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.894 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 168.25 18.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 64.299999999999997 111.125 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -59.09 -38.9 80.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 73.019999999999996 110.923 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.94 -25.68 59.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 73.340000000000003 111.066 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.11 -27.64 67.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 74.019999999999996 111.083 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.78 -35.73 24.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 74.099999999999994 110.941 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.07 -45.63 56.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 75.040000000000006 110.877 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -109.4 85.85 3.89 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.545 0.688 . . . . 74.400000000000006 110.944 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -178.44 2.35 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.622 2.215 . . . . 75.400000000000006 112.325 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.74 170.66 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 71.510000000000005 110.951 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -68.36 -47.64 66.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 72.319999999999993 110.857 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 pp -81.08 -29.53 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 75.340000000000003 111.158 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.6 mt -79.07 -24.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 75.219999999999999 111.142 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.14 -11.76 64.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.697 -0.763 . . . . 54.5 112.573 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.31 -24.78 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.902 0.382 . . . . 74.340000000000003 111.108 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.9 p -74.64 153.46 38.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 74.310000000000002 111.146 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.28 160.95 50.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.604 0.716 . . . . 64.409999999999997 110.843 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -37.71 8.79 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 71.25 112.3 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.88 -14.5 31.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 73.420000000000002 111.076 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -82.22 -59.1 2.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 74.549999999999997 110.928 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.497 ' C ' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -62.07 -16.55 52.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 74.140000000000001 110.94 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 4.1 t30 -81.78 -39.42 24.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 110.882 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.29 -19.58 63.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 75.430000000000007 111.094 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -86.24 -14.61 43.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 73.530000000000001 110.92 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 t -66.44 -42.1 89.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 71.409999999999997 111.192 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.4 m -59.55 -19.87 51.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.097 -0.502 . . . . 74.25 110.817 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -97.26 -44.49 6.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 73.430000000000007 110.897 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -178.39 138.76 0.18 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.904 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.84 136.05 49.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 75.209999999999994 110.9 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 9.5 p -58.34 113.13 5.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.607 0.718 . . . . 75.310000000000002 110.855 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HG3' ' CZ2' ' A' ' 63' ' ' TRP . 53.7 Cg_endo -69.7 168.69 20.75 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.671 2.247 . . . . 74.340000000000003 112.357 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -37.93 8.48 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.712 2.275 . . . . 75.140000000000001 112.341 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.448 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 37.6 p-90 -74.86 -5.4 43.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.169 -0.469 . . . . 75.420000000000002 110.926 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.93 151.43 31.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 73.219999999999999 111.029 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 63.96 47.18 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 62.299999999999997 111.087 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.1 mt -146.07 67.92 12.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.616 0.722 . . . . 74.140000000000001 110.817 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 152.32 68.9 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.681 2.254 . . . . 74.010000000000005 112.282 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.23 9.5 2.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 64.129999999999995 110.879 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 p -142.84 152.34 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 64.230000000000004 111.129 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.61 116.03 27.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 72.540000000000006 111.096 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.6 p -151.2 177.56 10.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 74.25 110.924 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -148.72 167.79 24.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 75.230000000000004 110.862 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.23 136.11 54.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 75.430000000000007 110.899 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.07 135.63 52.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 74.230000000000004 110.913 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 26.5 p -126.85 137.11 53.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 60.530000000000001 110.85 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -105.69 145.7 30.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 75.420000000000002 111.158 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -146.32 116.96 7.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 55.310000000000002 110.889 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 54.21 37.18 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 61.399999999999999 110.875 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.43 19.53 78.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.682 -0.77 . . . . 75.430000000000007 112.539 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.5 mt -109.75 108.58 59.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.642 0.734 . . . . 72.239999999999995 110.883 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 94.89 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.752 2.302 . . . . 72.340000000000003 112.374 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.3 mt -73.34 159.23 85.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.632 0.73 . . . . 62.43 110.87 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 116.18 4.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.665 2.243 . . . . 72.019999999999996 112.336 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 146.08 55.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 65.049999999999997 111.098 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.3 mt -148.94 143.38 26.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 75.140000000000001 110.901 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.9 104.91 0.65 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.702 -0.761 . . . . 74.430000000000007 112.523 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.57 70.63 2.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.871 0.367 . . . . 71.049999999999997 110.95 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -112.04 6.28 19.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 110.848 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.29 -19.47 63.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 75.439999999999998 110.911 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -137.84 154.78 74.87 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.669 0.747 . . . . 71.319999999999993 110.906 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 -25.34 28.79 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.28 . . . . 74.299999999999997 112.324 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -156.46 178.84 9.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.297 -0.41 . . . . 73.209999999999994 110.848 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -144.44 111.52 5.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.108 -0.496 . . . . 72.140000000000001 110.916 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.406 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . 1.0 OUTLIER -92.3 125.96 37.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 72.540000000000006 110.854 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -116.21 111.81 20.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 73.519999999999996 110.854 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -165.4 -150.66 6.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 74.310000000000002 112.49 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.77 -2.95 10.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.825 0.345 . . . . 72.200000000000003 110.923 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.01 162.49 28.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 74.420000000000002 110.802 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.16 -8.89 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 74.400000000000006 110.892 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -91.51 -17.75 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 72.340000000000003 111.151 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 94' ' ' LEU . 12.1 p -63.81 171.09 2.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 53.25 110.909 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.48 -3.49 33.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 72.430000000000007 110.932 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -150.52 106.81 3.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 75.129999999999995 110.892 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.8 t -90.76 108.74 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 72.430000000000007 111.133 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.67 -169.02 1.38 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 110.924 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -137.97 107.05 6.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.200000000000003 110.894 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.43 143.51 5.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.563 0.697 . . . . 71.109999999999999 110.869 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -12.85 33.81 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.694 2.263 . . . . 72.400000000000006 112.337 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 p -100.49 -27.55 13.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 65.299999999999997 110.833 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.6 mt -75.48 109.36 8.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 74.510000000000005 111.131 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.8 m -89.7 170.58 10.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 72.329999999999998 110.89 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.46 -40.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 70.340000000000003 110.893 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.8 t -140.95 79.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 64.209999999999994 111.131 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -64.15 -49.34 72.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 74.5 110.907 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -166.17 174.76 8.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 71.319999999999993 111.124 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 p -155.69 136.1 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 111.114 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 pp -111.58 140.52 46.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 71.329999999999998 110.967 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.19 134.75 62.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 70.230000000000004 111.089 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.28 94.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.886 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -64.86 107.88 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 110.886 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.94 -4.62 67.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.743 -0.741 . . . . 71.109999999999999 112.572 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -88.01 -42.45 5.97 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.701 -0.761 . . . . 74.430000000000007 112.487 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.89 5.74 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.738 0.304 . . . . 73.209999999999994 110.883 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.31 42.46 32.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 75.209999999999994 110.886 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 73.9 m -146.05 137.22 24.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 52.25 110.906 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -66.13 132.52 48.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 75.409999999999997 110.845 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.3 t -111.7 108.44 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 75.450000000000003 111.121 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.8 tt -102.32 125.62 49.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 75.040000000000006 110.843 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 33.9 mtm -127.1 139.45 52.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 54.009999999999998 110.919 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.74 132.4 34.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 63.020000000000003 110.888 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -60.24 -20.92 60.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 74.510000000000005 110.945 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.82 45.88 0.75 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 75.040000000000006 112.471 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.0 t -76.89 157.66 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 72.549999999999997 110.875 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 99.7 m -64.21 -24.14 67.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.409999999999997 111.111 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -80.67 -67.39 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.25 110.856 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.57 143.43 13.71 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.735 -0.745 . . . . 40.240000000000002 112.552 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.1 m -91.88 173.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 74.230000000000004 111.103 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 137.8 51.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 73.129999999999995 110.936 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.48 123.99 51.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.427 . . . . 73.129999999999995 110.918 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 61.53 22.47 12.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 73.329999999999998 110.876 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.1 25.44 40.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 53.119999999999997 112.54 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -145.15 134.01 22.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.859 0.361 . . . . 73.010000000000005 110.9 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -60.32 133.65 56.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 73.430000000000007 110.823 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.62 175.61 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 74.030000000000001 111.121 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.67 -175.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 110.942 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 167.07 16.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 73.439999999999998 110.88 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 59.02 43.04 18.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 75.329999999999998 110.833 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -142.2 155.09 65.03 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.596 0.712 . . . . 74.340000000000003 110.906 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 102.84 1.07 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.724 2.282 . . . . 75.129999999999995 112.296 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.0 mt -110.69 83.37 3.42 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.627 0.727 . . . . 74.409999999999997 110.917 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.84 129.22 17.15 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.637 2.225 . . . . 74.409999999999997 112.305 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -116.08 79.45 8.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 50.32 111.125 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 170.85 15.63 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.701 2.267 . . . . 73.319999999999993 112.365 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.1 m -50.76 142.4 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 74.439999999999998 111.156 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.08 -12.86 62.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.75 -0.738 . . . . 71.299999999999997 112.476 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 177.26 5.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 62.229999999999997 110.892 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 40.7 m -130.51 165.2 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 110.83 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.3 mt -142.58 150.73 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 74.519999999999996 111.2 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.48 162.8 40.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 73.540000000000006 110.911 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -159.44 134.25 7.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 64.140000000000001 110.947 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.09 -152.06 51.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.741 -0.742 . . . . 62.310000000000002 112.454 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -102.62 13.89 33.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 74.120000000000005 110.801 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.81 158.62 18.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 64.430000000000007 110.852 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.52 -35.83 14.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 75.140000000000001 110.869 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -53.36 153.15 4.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 73.219999999999999 110.908 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 26.3 t -145.65 138.54 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 74.549999999999997 111.181 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -97.7 101.44 12.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 74.540000000000006 110.994 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -99.13 110.39 22.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 75.430000000000007 110.858 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.64 153.05 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 74.219999999999999 111.135 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -161.1 151.88 18.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 72.510000000000005 110.872 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.7 tp -96.67 135.07 39.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 73.200000000000003 110.912 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -64.65 177.65 9.48 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 61.210000000000001 112.471 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 167.77 23.6 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.656 2.238 . . . . 63.420000000000002 112.26 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 107.69 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.611 2.208 . . . . 71.209999999999994 112.41 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.7 m -95.73 169.63 9.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 51.310000000000002 110.807 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.4 m 53.58 29.63 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.030000000000001 110.902 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.498 . . . . 73.200000000000003 110.81 -179.83 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 CA-C-O 121.399 0.444 . . . . 45.43 112.507 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -35.48 12.53 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.647 2.231 . . . . 73.209999999999994 112.397 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mmt 57.41 50.79 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 71.420000000000002 110.857 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.1 m -63.93 158.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 75.040000000000006 111.137 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.6 p -126.64 151.71 47.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 72.439999999999998 111.112 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 m -136.59 169.71 17.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 72.430000000000007 110.853 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 t -108.88 -19.15 13.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 64.010000000000005 111.123 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.3 20.93 11.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.787 -0.72 . . . . 74.409999999999997 112.493 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.17 117.85 35.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 71.430000000000007 110.96 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -142.54 159.09 42.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 73.129999999999995 110.898 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.4 p -134.07 161.22 35.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 71.409999999999997 110.881 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -138.9 131.07 28.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 74.140000000000001 110.859 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.08 149.87 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 75.340000000000003 111.146 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.95 160.89 42.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.119 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.28 168.18 13.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 74.340000000000003 111.122 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 p -119.48 115.2 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.443 . . . . 71.239999999999995 111.145 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -143.65 136.35 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 73.099999999999994 110.876 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -141.9 157.4 45.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 74.549999999999997 110.916 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.6 114.52 10.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 74.209999999999994 111.145 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.09 152.16 12.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 71.030000000000001 111.132 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -107.04 101.96 11.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 72.049999999999997 110.863 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.75 130.52 54.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 111.082 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.6 -178.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 74.409999999999997 111.181 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -54.03 154.49 7.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.577 0.704 . . . . 75.129999999999995 110.851 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 167.65 23.79 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.675 2.25 . . . . 73.049999999999997 112.356 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 168.38 21.74 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.601 2.2 . . . . 70.319999999999993 112.39 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 112.23 3.02 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.719 2.279 . . . . 73.219999999999999 112.292 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.85 -170.77 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.7 2.267 . . . . 70.349999999999994 112.277 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 153.89 31.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 74.109999999999999 110.832 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 m -48.99 140.68 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 75.319999999999993 111.158 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.48 154.57 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 75.310000000000002 111.085 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -50.79 168.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 75.219999999999999 110.948 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mp -49.93 166.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 110.937 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 168.47 5.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 71.400000000000006 111.105 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.61 -38.35 90.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 75.319999999999993 110.888 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.18 -18.72 48.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 63.43 111.124 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.8 -23.68 63.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 72.420000000000002 111.099 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -90.57 -17.68 26.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 74.219999999999999 110.923 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -72.91 -48.12 39.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 73.140000000000001 110.928 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 pp -51.32 155.34 2.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.613 0.72 . . . . 70.439999999999998 110.944 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 159.6 52.85 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.673 2.249 . . . . 75.209999999999994 112.383 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -92.97 171.63 8.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 75.329999999999998 110.983 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -51.83 -36.6 48.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.817 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 pp -74.7 -33.17 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 74.329999999999998 111.119 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.1 mt -79.71 -25.29 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.420000000000002 111.145 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -10.41 58.21 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.703 -0.76 . . . . 64.209999999999994 112.476 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.1 t -113.07 -26.11 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 74.5 111.079 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.7 p -52.01 153.64 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 71.040000000000006 111.175 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.49 160.75 40.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.604 0.716 . . . . 75.109999999999999 110.848 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -35.65 12.22 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.685 2.257 . . . . 72.420000000000002 112.387 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.34 -25.22 22.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 71.540000000000006 111.21 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -76.63 -60.82 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 74.420000000000002 110.916 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.6 -29.06 35.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 74.010000000000005 110.975 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -76.54 -32.82 58.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 73.340000000000003 110.912 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.37 -18.93 47.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 62.210000000000001 111.113 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -93.22 -18.97 21.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 72.150000000000006 110.899 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 p -85.28 -16.52 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 73.510000000000005 111.218 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.2 t -77.11 -6.39 52.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 74.209999999999994 110.877 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -118.65 -50.56 2.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 72.230000000000004 110.884 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -149.25 155.75 41.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 64.329999999999998 110.875 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -118.91 152.33 36.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.516 . . . . 54.340000000000003 110.972 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 12.2 t -92.6 109.39 38.3 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.632 0.729 . . . . 72.140000000000001 110.93 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HG3' ' CZ2' ' A' ' 63' ' ' TRP . 53.6 Cg_endo -69.73 168.79 20.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 54.100000000000001 112.322 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.64 -39.01 7.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.683 2.256 . . . . 74.430000000000007 112.339 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.438 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 37.7 p-90 -73.76 -5.75 42.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 73.450000000000003 110.938 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.12 149.62 33.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 70.450000000000003 111.104 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 64.19 38.44 8.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 64.299999999999997 111.097 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.6 mt -135.95 66.94 62.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.56 0.695 . . . . 72.299999999999997 110.842 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 151.19 69.09 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.645 2.23 . . . . 73.150000000000006 112.362 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.6 m -132.66 5.29 3.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 63.219999999999999 110.822 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.3 152.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 64.319999999999993 111.103 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.96 123.67 33.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 73.150000000000006 111.095 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.4 p -151.16 178.06 9.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 73.120000000000005 110.865 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -152.2 165.48 34.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 74.310000000000002 110.939 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.5 136.39 50.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 70.319999999999993 110.873 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.71 135.39 44.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 110.908 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 22.9 m -122.28 137.1 54.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.902 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.7 p -110.12 150.59 28.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 73.030000000000001 111.129 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -155.62 123.3 5.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 74.530000000000001 110.936 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 55.66 32.58 19.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 74.299999999999997 110.838 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.97 17.25 79.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.773 -0.727 . . . . 65.430000000000007 112.491 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.8 mt -107.42 108.74 62.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.716 . . . . 74.239999999999995 110.959 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 90.17 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.691 2.261 . . . . 73.120000000000005 112.34 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.1 mt -70.55 159.49 84.81 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.622 0.725 . . . . 74.450000000000003 110.888 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 124.31 10.95 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.72 2.28 . . . . 74.299999999999997 112.334 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.67 148.4 51.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 64.549999999999997 111.111 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 mt -148.25 138.27 22.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 70.019999999999996 110.966 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.16 106.05 1.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 53.439999999999998 112.446 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.8 mt -76.43 70.87 3.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.339 . . . . 65.439999999999998 110.953 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -111.81 6.34 19.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 75.040000000000006 110.898 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -69.52 -19.32 63.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 74.219999999999999 110.891 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -140.28 155.4 70.28 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 75.200000000000003 110.905 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -26.72 27.49 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.747 2.298 . . . . 72.120000000000005 112.336 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -155.44 172.03 18.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 73.099999999999994 110.957 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -138.98 117.1 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 75.219999999999999 110.989 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.81 126.0 35.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 72.510000000000005 110.946 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -114.97 122.06 45.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 74.010000000000005 110.868 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.43 -149.6 9.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 65.439999999999998 112.491 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.78 -0.49 10.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.868 0.366 . . . . 74.030000000000001 110.859 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.8 t -68.31 161.57 27.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 110.845 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.75 -8.95 59.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 75.019999999999996 110.83 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.4 m -101.89 -6.66 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.401 . . . . 73.140000000000001 111.143 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 13.0 p -67.68 163.27 21.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 74.439999999999998 110.903 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -93.18 -0.78 56.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 75.230000000000004 110.883 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -152.93 106.18 3.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 110.988 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.4 t -94.3 109.31 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 74.329999999999998 111.102 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.79 -168.97 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 71.209999999999994 110.909 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.41 106.67 5.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 73.120000000000005 110.921 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -166.19 143.59 4.43 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.533 0.683 . . . . 74.040000000000006 110.913 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -12.37 32.67 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.673 2.249 . . . . 72.230000000000004 112.341 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.2 p -99.03 -28.07 13.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.219999999999999 110.883 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt -74.55 117.97 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 74.129999999999995 111.093 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.8 m -96.01 170.68 9.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 74.310000000000002 110.83 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.76 -32.6 3.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 73.129999999999995 110.832 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -147.1 79.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 73.310000000000002 111.117 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -65.4 -58.65 5.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 74.150000000000006 110.81 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -157.04 176.98 12.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 74.049999999999997 111.105 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.7 p -155.35 135.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 64.450000000000003 111.135 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 pp -112.04 141.2 46.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 75.120000000000005 110.901 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.0 t -128.47 135.27 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 75.200000000000003 111.099 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 90.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 71.120000000000005 110.938 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -61.77 107.64 0.87 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 73.129999999999995 110.863 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.3 -6.24 64.8 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 52.32 112.451 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -88.73 -51.05 3.16 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.736 -0.745 . . . . 50.520000000000003 112.469 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -99.05 -2.24 37.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.848 0.356 . . . . 74.420000000000002 110.927 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.48 30.75 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 74.319999999999993 110.901 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 58.7 m -137.61 138.24 39.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.856 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -64.67 130.07 42.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 75.510000000000005 110.927 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.5 t -108.79 109.67 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 111.119 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.6 tt -102.03 131.56 48.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 73.299999999999997 110.963 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 33.1 mtm -131.99 137.74 48.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 64.5 110.96 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.42 132.63 34.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.322 -0.399 . . . . 61.409999999999997 110.887 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -64.71 -14.64 59.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 74.540000000000006 110.901 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 107.03 49.55 0.88 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 63.240000000000002 112.489 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.2 p -78.93 153.78 30.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 70.340000000000003 110.858 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.2 t -75.79 -5.51 46.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 73.319999999999993 111.097 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.8 -64.87 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 74.030000000000001 110.902 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.52 142.99 6.5 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.76 -0.733 . . . . 62.130000000000003 112.52 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.7 t -119.71 146.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.368 . . . . 63.140000000000001 111.128 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -98.98 151.23 21.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 70.129999999999995 110.874 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -135.48 123.61 22.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.869 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 58.55 22.11 9.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 72.409999999999997 110.884 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.69 18.77 54.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 72.400000000000006 112.433 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.39 125.19 15.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 73.329999999999998 110.897 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 ptt85 -59.74 133.33 55.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 74.510000000000005 110.839 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.4 177.97 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 70.5 111.121 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -58.39 -176.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 74.540000000000006 110.935 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.508 ' HZ1' ' NE ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -124.68 -170.37 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 70.409999999999997 110.882 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.508 ' NE ' ' HZ1' ' A' ' 146' ' ' LYS . 11.4 ptp180 39.71 39.33 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 75.120000000000005 110.909 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -139.76 160.75 59.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.675 0.75 . . . . 72.310000000000002 110.853 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.64 2.86 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.714 2.276 . . . . 65.319999999999993 112.319 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 mt -118.05 83.75 20.1 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.541 0.686 . . . . 72.420000000000002 110.868 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 130.01 18.64 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.671 2.247 . . . . 71.140000000000001 112.404 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -114.38 77.09 4.04 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.577 0.703 . . . . 71.310000000000002 111.152 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 165.35 31.23 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.631 2.221 . . . . 75.400000000000006 112.424 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.4 m -52.06 144.27 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 71.430000000000007 111.126 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.16 -9.54 69.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.724 -0.75 . . . . 74.409999999999997 112.486 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.1 p -96.25 -174.48 3.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 75.120000000000005 110.921 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.7 m -138.85 165.5 26.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 75.25 110.87 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.6 mt -141.45 150.49 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 75.349999999999994 111.136 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.489 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -152.08 162.84 40.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 73.439999999999998 110.943 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.489 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 3.7 p90 -161.79 139.48 8.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 74.25 110.893 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 60.98 -148.83 45.5 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.714 -0.755 . . . . 62.200000000000003 112.506 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -107.23 10.51 29.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 75.329999999999998 110.886 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.6 p -62.7 159.97 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.439999999999998 110.812 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 58.1 m -91.54 -25.7 19.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 71.329999999999998 110.848 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -53.28 147.57 10.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 70.430000000000007 110.896 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.61 130.13 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 72.400000000000006 111.149 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -98.48 103.95 15.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 111.003 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.49 110.32 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 75.310000000000002 110.84 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.21 153.54 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 75.439999999999998 111.187 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.5 148.26 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 74.150000000000006 110.918 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 17.1 tp -94.09 132.7 38.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 75.510000000000005 110.928 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.38 178.15 1.05 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.787 -0.72 . . . . 61.140000000000001 112.484 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 167.65 23.83 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.75 2.3 . . . . 74.010000000000005 112.331 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 159.99 51.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.665 2.243 . . . . 73.319999999999993 112.359 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.6 t -122.38 170.43 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 73.109999999999999 110.831 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.9 m -110.39 -38.44 5.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 73.219999999999999 110.848 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 74.329999999999998 110.861 -179.785 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 121.407 0.449 . . . . 72.310000000000002 112.537 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 123.7 10.39 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.696 2.264 . . . . 71.219999999999999 112.397 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mmt -121.62 119.7 32.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 75.120000000000005 110.905 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.5 m -77.22 157.5 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 72.239999999999995 111.064 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 t -130.29 158.59 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 62.329999999999998 111.165 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -77.46 169.06 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.439999999999998 110.908 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 t -114.79 -19.32 11.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 63.310000000000002 111.199 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.6 21.12 62.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 75.150000000000006 112.469 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 pp -52.46 127.41 22.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 72.510000000000005 110.921 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.03 165.75 6.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 73.540000000000006 110.909 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -119.21 154.58 33.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.329999999999998 110.864 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -135.71 141.88 44.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 74.349999999999994 110.868 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.92 149.72 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 75.239999999999995 111.152 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.19 157.09 43.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 111.076 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.01 166.55 16.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 72.439999999999998 111.101 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 t -119.04 113.51 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 75.430000000000007 111.113 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.88 150.17 48.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 74.450000000000003 110.897 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 162.58 34.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 74.239999999999995 110.883 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.01 174.0 12.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 62.130000000000003 111.099 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.01 151.93 41.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 72.329999999999998 111.153 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -123.87 120.96 34.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.396 . . . . 61.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.3 mm -103.77 139.49 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 111.139 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.75 -179.06 5.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 74.230000000000004 111.167 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -101.07 160.65 26.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.544 0.687 . . . . 73.319999999999993 110.942 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 167.74 23.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.677 2.252 . . . . 75.120000000000005 112.365 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 167.95 22.88 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.691 2.261 . . . . 72.340000000000003 112.32 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 167.56 24.12 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.751 2.301 . . . . 74.209999999999994 112.323 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 175.5 7.95 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.677 2.251 . . . . 75.040000000000006 112.374 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.43 146.47 47.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 74.439999999999998 110.915 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.0 m -50.99 169.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.239999999999995 111.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.12 107.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 61.43 111.193 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -154.65 167.2 30.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.25 110.948 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.19 101.37 10.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 74.239999999999995 110.916 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.19 -174.13 2.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 73.019999999999996 111.145 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -55.43 -31.9 62.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 75.109999999999999 110.914 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 37' ' ' GLN . . . -61.99 -14.81 38.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 64.230000000000004 111.086 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.37 -39.84 14.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 71.439999999999998 111.121 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -13.01 58.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 74.5 110.864 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' A' ' 34' ' ' ALA . 1.6 pt20 -113.18 30.83 6.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 70.430000000000007 110.907 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -45.86 154.07 0.6 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.652 0.739 . . . . 74.430000000000007 110.983 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -179.41 2.89 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.627 2.218 . . . . 71.450000000000003 112.278 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -75.33 172.85 11.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 63.420000000000002 110.908 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -62.3 -43.29 99.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 75.340000000000003 110.929 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 pp -73.6 -32.62 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 111.193 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.5 mt -79.49 -24.5 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 73.230000000000004 111.104 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.06 -5.24 70.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.698 -0.763 . . . . 74.150000000000006 112.496 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.4 p -115.18 -21.99 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 75.140000000000001 111.105 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.5 p -50.43 153.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.109999999999999 111.131 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.51 159.35 85.6 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.617 0.722 . . . . 70.450000000000003 110.843 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -37.52 9.02 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.668 2.246 . . . . 72.519999999999996 112.333 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.03 -16.87 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 74.409999999999997 111.127 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -83.52 -52.46 6.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.510000000000005 110.906 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.65 -29.85 70.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 75.430000000000007 110.933 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -78.45 -35.05 47.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 73.5 110.918 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.2 -19.87 65.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 72.120000000000005 111.079 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -90.92 -12.91 34.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 65.200000000000003 110.893 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.84 -37.27 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 75.040000000000006 111.135 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 t -60.12 -19.1 51.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 73.5 110.825 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -100.9 -48.34 4.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 74.099999999999994 110.944 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -158.31 144.47 17.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 75.120000000000005 110.878 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.03 123.07 48.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 73.310000000000002 110.953 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.5 p -56.84 111.09 2.9 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.612 0.72 . . . . 71.450000000000003 110.905 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.437 ' HG3' ' CZ2' ' A' ' 63' ' ' TRP . 53.4 Cg_endo -69.86 169.19 19.6 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.644 2.23 . . . . 75.549999999999997 112.304 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -40.68 5.11 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.744 2.296 . . . . 70.230000000000004 112.318 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.437 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 35.7 p-90 -72.14 -6.78 45.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 70.5 110.921 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.22 150.96 35.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 74.549999999999997 111.097 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 64.9 47.44 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 74.129999999999995 111.071 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.1 mt -146.33 66.67 11.35 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.592 0.71 . . . . 73.409999999999997 110.917 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 150.97 68.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.713 2.276 . . . . 74.120000000000005 112.319 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 16.64 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 74.099999999999994 110.797 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.1 p -141.96 152.41 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 74.049999999999997 111.136 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.29 113.71 25.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 111.13 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.1 p -150.83 174.94 12.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 110.897 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -144.95 167.0 23.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 72.150000000000006 110.789 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -122.38 135.8 54.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 72.129999999999995 110.941 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.69 135.76 48.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 72.219999999999999 110.932 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 57.8 m -128.69 140.33 51.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 65.340000000000003 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -112.39 157.03 21.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 74.209999999999994 111.08 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -162.58 125.8 2.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 74.430000000000007 110.904 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t0 55.74 28.63 12.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 74.420000000000002 110.93 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.43 18.0 79.5 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.654 -0.784 . . . . 72.140000000000001 112.464 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.5 mt -110.69 108.5 58.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.577 0.704 . . . . 75.239999999999995 110.925 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 89.7 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.722 2.282 . . . . 74.209999999999994 112.371 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.1 mt -66.53 159.46 73.4 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.552 0.691 . . . . 72.329999999999998 110.918 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 119.98 6.83 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.648 2.232 . . . . 73.420000000000002 112.345 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.58 147.99 43.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 64.010000000000005 111.108 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -148.17 137.66 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 75.340000000000003 110.9 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.83 109.45 2.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 61.530000000000001 112.47 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.0 mt -78.13 71.27 4.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.868 0.366 . . . . 73.530000000000001 110.912 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -111.74 6.75 19.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 75.409999999999997 110.954 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -19.07 63.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 65.150000000000006 110.861 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -139.67 154.56 71.26 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.633 0.73 . . . . 75.120000000000005 110.894 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -29.22 24.15 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.788 2.325 . . . . 72.310000000000002 112.32 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -148.8 179.29 7.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 74.299999999999997 110.887 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -150.44 110.51 4.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 110.953 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.2 143.34 26.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.162 -0.472 . . . . 72.5 110.94 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.21 111.79 14.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 74.219999999999999 110.888 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -170.41 -160.12 18.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 74.129999999999995 112.469 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.23 0.81 21.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 64.040000000000006 110.9 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.51 156.48 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 73.030000000000001 110.874 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -21.34 57.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 110.847 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.4 m -70.15 -28.71 36.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.406 . . . . 74.239999999999995 111.116 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 91.6 m -65.78 159.86 24.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 71.319999999999993 110.889 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.71 -18.8 59.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 65.129999999999995 110.813 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -138.13 107.83 6.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 62.340000000000003 111.014 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 p -100.48 108.05 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 74.5 111.118 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.63 -169.18 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 74.129999999999995 110.957 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.14 107.47 7.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.876 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.13 148.65 19.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.549 0.69 . . . . 71.310000000000002 110.884 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -18.32 37.27 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.714 2.276 . . . . 72.099999999999994 112.342 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 p -102.46 -23.85 13.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 71.540000000000006 110.857 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.5 mt -77.09 108.14 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 70.519999999999996 111.158 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m -87.53 169.71 11.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 73.340000000000003 110.837 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -47.37 -36.56 9.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 61.25 110.849 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -141.47 80.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 74.420000000000002 111.159 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -65.73 -56.64 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 74.340000000000003 110.825 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -166.88 161.41 15.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 75.549999999999997 111.099 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.33 131.15 40.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 70.209999999999994 111.135 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.4 142.49 37.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 73.340000000000003 110.95 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.8 t -132.9 136.32 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 74.540000000000006 111.203 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.88 92.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 70.120000000000005 110.821 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -61.06 108.53 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 74.299999999999997 110.848 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.63 -7.4 61.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 33.409999999999997 112.508 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -89.66 -51.98 2.75 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.719 -0.753 . . . . 72.140000000000001 112.448 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -95.38 -3.11 47.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 74.400000000000006 110.94 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 61.66 33.1 18.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.857 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 49.5 m -139.22 158.71 43.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 64.049999999999997 110.935 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -82.35 127.42 33.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 75.439999999999998 110.89 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.49 110.34 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 74.299999999999997 111.137 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.8 tt -100.84 126.15 47.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 75.010000000000005 110.869 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 26.5 mtm -117.19 125.91 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 110.9 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -79.73 130.8 35.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 71.140000000000001 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -92.55 17.85 9.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 71.450000000000003 110.884 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 102.51 58.67 0.77 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 72.420000000000002 112.469 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 64.1 p -53.17 136.82 35.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 75.230000000000004 110.84 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.2 m -68.51 -29.46 68.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 73.299999999999997 111.17 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.15 -56.66 2.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 75.510000000000005 110.922 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 141.97 121.46 1.7 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 63.210000000000001 112.545 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.8 t -87.37 142.79 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 72.239999999999995 111.161 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.13 134.43 44.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 75.010000000000005 110.869 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.97 122.7 43.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 110.861 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 56.83 23.83 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 71.439999999999998 110.9 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.5 11.22 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.685 -0.769 . . . . 71.430000000000007 112.51 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.64 136.47 24.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.809 0.338 . . . . 64.340000000000003 110.887 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -65.23 145.2 56.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 74.430000000000007 110.839 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.23 175.51 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 64.299999999999997 111.131 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.24 168.4 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.934 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -105.16 178.32 4.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 75.200000000000003 110.907 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 38.4 50.94 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 73.540000000000006 110.824 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -143.92 156.15 58.89 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.603 0.716 . . . . 74.420000000000002 110.873 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 110.81 2.64 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.688 2.259 . . . . 72.109999999999999 112.352 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.9 mt -110.25 84.48 3.76 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.597 0.713 . . . . 74.319999999999993 110.887 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 120.69 7.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.659 2.239 . . . . 65.230000000000004 112.366 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -112.28 75.47 1.68 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.551 0.691 . . . . 72.329999999999998 111.11 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 171.3 14.69 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 74.209999999999994 112.396 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.5 m -50.97 136.69 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 111.117 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 93.91 -10.83 71.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.749 -0.739 . . . . 74.129999999999995 112.496 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.57 176.71 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.895 0.378 . . . . 75.430000000000007 110.836 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.1 m -133.34 161.71 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 72.200000000000003 110.902 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.8 mt -141.71 145.34 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 74.310000000000002 111.075 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.497 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -151.74 149.65 29.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 74.409999999999997 110.934 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.497 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 4.1 p90 -149.0 135.17 19.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 73.430000000000007 110.917 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 64.52 -143.81 47.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 65.409999999999997 112.457 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -110.29 11.37 23.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 73.430000000000007 110.931 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 94.6 p -52.42 148.88 6.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 74.099999999999994 110.817 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.0 m -91.74 5.1 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.517 . . . . 74.200000000000003 110.857 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.4 137.56 42.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 74.25 110.892 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.3 t -125.65 137.21 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 70.400000000000006 111.096 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -96.65 101.71 13.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 110.94 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.08 111.14 23.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 74.439999999999998 110.836 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.1 t -75.52 153.68 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.519999999999996 111.138 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -160.1 153.08 21.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 61.439999999999998 110.868 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 34.9 tp -94.54 135.07 36.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.87 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -75.14 178.25 47.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.703 -0.76 . . . . 72.140000000000001 112.475 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 167.59 23.93 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.721 2.281 . . . . 73.430000000000007 112.34 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.68 130.5 19.55 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.676 2.251 . . . . 74.310000000000002 112.406 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.3 p -104.97 25.74 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 74.530000000000001 110.817 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.1 t -84.17 115.05 22.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 64.420000000000002 110.863 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 94.8 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 73.120000000000005 110.877 -179.824 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 CA-C-O 121.384 0.435 . . . . 74.439999999999998 112.432 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 152.08 69.07 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.735 2.29 . . . . 73.099999999999994 112.315 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -154.56 161.0 41.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 74.450000000000003 110.857 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.9 m -97.1 155.16 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 74.25 111.106 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.24 138.3 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 111.141 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -56.44 150.87 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 55.049999999999997 110.825 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.7 p -76.55 -19.11 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 73.319999999999993 111.129 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.8 20.31 13.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 62.299999999999997 112.497 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.2 mt -60.67 122.43 14.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 72.129999999999995 110.934 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 tp -127.58 152.49 47.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 74.409999999999997 110.969 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.2 p -75.04 179.72 4.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 63.039999999999999 110.816 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.92 149.08 9.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 75.049999999999997 110.91 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.87 164.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 75.120000000000005 111.124 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.55 144.1 54.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.219999999999999 111.109 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.22 145.72 26.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 72.239999999999995 111.077 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 p -60.34 96.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 72.400000000000006 111.103 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -108.16 120.64 42.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 73.329999999999998 110.863 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -127.53 152.82 47.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 75.129999999999995 110.844 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.47 171.84 12.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 71.200000000000003 111.1 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.78 148.45 47.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 74.230000000000004 111.023 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -115.54 115.54 26.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 73.450000000000003 110.881 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 mp -80.54 121.54 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 71.239999999999995 111.157 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.68 175.88 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 111.08 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -131.9 157.55 77.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 74.549999999999997 110.935 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 167.66 23.67 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.699 2.266 . . . . 71.140000000000001 112.394 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 167.89 23.25 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.613 2.208 . . . . 75.340000000000003 112.354 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 167.74 23.51 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.756 2.304 . . . . 73.420000000000002 112.377 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.86 -173.84 0.81 Allowed 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.709 2.273 . . . . 75.420000000000002 112.298 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 102.57 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 74.329999999999998 110.872 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.9 m -53.03 167.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 74.430000000000007 111.148 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.2 t -77.82 143.62 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 75.519999999999996 111.127 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.96 166.63 13.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 72.340000000000003 110.879 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 162.04 17.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 74.219999999999999 110.926 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.95 176.88 4.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 63.329999999999998 111.134 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.14 -27.95 54.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 62.25 110.872 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.93 -16.4 55.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 111.063 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.63 -38.67 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 75.329999999999998 111.158 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -5.72 47.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 74.140000000000001 110.901 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -112.95 -40.43 3.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 72.319999999999993 110.933 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.3 153.15 40.58 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.657 0.741 . . . . 75.530000000000001 110.908 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 151.19 68.83 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.21 . . . . 72.530000000000001 112.338 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -69.62 172.02 8.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.209999999999994 110.877 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -64.05 -43.94 93.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 75.340000000000003 110.871 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 pp -72.5 -32.49 41.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 75.430000000000007 111.121 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.0 mt -79.34 -26.71 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 71.129999999999995 111.1 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.2 -18.16 40.94 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.766 -0.731 . . . . 71.030000000000001 112.446 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.7 t -107.58 -26.48 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 75.349999999999994 111.122 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 78.5 p -59.8 153.75 19.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 71.329999999999998 111.146 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.2 160.06 71.55 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.669 0.747 . . . . 74.420000000000002 110.874 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -38.75 7.37 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.673 2.249 . . . . 63.43 112.378 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.16 -14.74 35.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 73.120000000000005 111.148 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -83.5 -56.75 3.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 74.349999999999994 110.942 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -28.85 69.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 75.109999999999999 110.959 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -73.77 -43.95 57.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 75.340000000000003 110.881 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.24 -25.16 61.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 72.019999999999996 111.124 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -92.6 -18.69 22.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.281 -0.418 . . . . 74.209999999999994 110.93 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -28.68 45.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 74.519999999999996 111.145 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.53 3.73 17.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 64.319999999999993 110.884 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -126.55 -56.11 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 63.020000000000003 110.917 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -146.79 147.59 31.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 72.540000000000006 110.819 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -99.36 152.85 19.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 74.109999999999999 110.858 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.6 m -95.57 107.07 30.92 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.655 0.74 . . . . 73.019999999999996 110.844 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.429 ' HG3' ' CZ2' ' A' ' 63' ' ' TRP . 54.1 Cg_endo -69.73 162.32 42.51 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.697 2.265 . . . . 63.299999999999997 112.353 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.88 -37.76 8.45 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.672 2.248 . . . . 74.439999999999998 112.288 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.429 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 33.6 p-90 -71.67 -7.33 47.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 74.239999999999995 110.971 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 61' ' ' PRO . . . -75.46 148.33 39.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 72.040000000000006 111.107 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 64.15 38.34 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 73.200000000000003 111.121 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.7 mt -135.9 67.29 63.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.586 0.707 . . . . 74.510000000000005 110.901 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 151.46 69.24 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.68 2.253 . . . . 74.340000000000003 112.414 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.4 12.67 2.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 72.120000000000005 110.813 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.29 150.69 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 111.123 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.39 117.37 26.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 72.430000000000007 111.073 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.4 p -151.06 167.23 28.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 64.329999999999998 110.899 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -137.62 168.0 20.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 72.420000000000002 110.84 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -123.12 136.31 54.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 72.209999999999994 110.882 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.92 133.27 53.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 74.349999999999994 110.905 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.6 m -123.43 137.63 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 72.400000000000006 110.804 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.8 p -105.5 149.69 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 74.439999999999998 111.154 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -149.09 117.57 6.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.219999999999999 110.898 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 54.01 36.13 23.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 71.450000000000003 110.872 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.19 19.61 79.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 75.049999999999997 112.463 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.3 mt -110.58 108.49 58.2 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.58 0.705 . . . . 73.010000000000005 110.88 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 92.23 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.728 2.285 . . . . 75.120000000000005 112.364 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.2 mt -71.02 159.2 86.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.609 0.719 . . . . 53.509999999999998 110.914 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 118.5 5.72 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.628 2.218 . . . . 73.120000000000005 112.379 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.54 146.33 52.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 70.430000000000007 111.061 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mt -143.13 137.84 29.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 73.340000000000003 110.956 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.18 99.53 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 63.32 112.514 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.5 mt -75.48 71.24 2.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.823 0.344 . . . . 72.219999999999999 110.881 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -111.46 6.12 20.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 74.439999999999998 110.822 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -20.09 63.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 75.329999999999998 110.832 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -137.03 155.71 76.06 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.646 0.736 . . . . 74.409999999999997 110.893 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -30.77 21.79 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.645 2.23 . . . . 74.230000000000004 112.386 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -159.29 179.4 9.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 74.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -149.48 122.72 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 74.010000000000005 110.904 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.8 tp -96.07 129.13 43.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 72.450000000000003 110.911 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.53 113.63 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 110.881 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.48 -157.45 10.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.693 -0.765 . . . . 73.140000000000001 112.455 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.0 -1.86 12.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.743 0.306 . . . . 73.540000000000006 110.864 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.46 166.91 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 53.350000000000001 110.864 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.44 -10.85 57.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 73.120000000000005 110.92 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.8 m -92.75 -6.81 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 72.200000000000003 111.145 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 11.4 p -76.48 160.55 29.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 70.140000000000001 110.897 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.24 -0.13 57.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 110.807 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -155.89 106.13 2.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 74.129999999999995 110.944 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 p -97.48 109.62 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 75.420000000000002 111.194 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.59 -169.24 1.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 75.219999999999999 110.953 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -132.17 106.96 8.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 72.519999999999996 110.917 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.83 143.57 5.55 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 110.87 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -13.04 34.17 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 2.257 . . . . 70.349999999999994 112.287 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.9 p -99.48 -27.97 13.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.29 -0.414 . . . . 70.230000000000004 110.871 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.7 mt -75.07 112.94 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 75.420000000000002 111.132 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.3 m -93.87 170.52 9.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 74.530000000000001 110.91 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.85 -36.26 3.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 42.039999999999999 110.845 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.6 78.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 74.340000000000003 111.124 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -65.52 -55.7 16.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 73.310000000000002 110.868 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -168.78 153.58 5.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.264 -0.425 . . . . 71.030000000000001 111.108 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 p -131.96 135.57 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.148 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 pp -108.56 140.05 42.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 74.329999999999998 110.874 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.3 t -129.47 137.31 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 72.209999999999994 111.118 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.78 90.43 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 65.439999999999998 110.928 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -60.13 108.13 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 74.120000000000005 110.893 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.58 -8.24 59.63 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 63.229999999999997 112.461 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -90.02 -49.92 3.19 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.811 -0.709 . . . . 73.109999999999999 112.475 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -94.18 -5.43 47.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.76 0.314 . . . . 71.530000000000001 110.866 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.23 18.54 11.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 71.409999999999997 110.857 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 8.7 p -127.33 164.81 20.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 73.530000000000001 110.911 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -87.24 127.12 35.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 110.891 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.47 110.02 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 74.299999999999997 111.191 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 tt -101.72 121.46 42.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 64.439999999999998 110.936 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.1 mtt -115.72 133.01 56.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 75.400000000000006 110.805 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.64 132.58 34.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 73.540000000000006 110.893 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.67 -8.73 57.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 74.420000000000002 110.937 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 122.21 47.24 0.28 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.739 -0.743 . . . . 74.200000000000003 112.435 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.7 t -61.26 130.97 48.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 73.420000000000002 110.89 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.1 t -55.73 -24.68 36.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 60.5 111.173 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -100.43 -50.0 4.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 62.109999999999999 110.886 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 105.12 144.52 12.81 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.755 -0.736 . . . . 54.130000000000003 112.581 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 m -88.62 172.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 73.420000000000002 111.134 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -112.19 133.18 54.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 74.310000000000002 110.887 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.65 124.46 52.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.323 -0.399 . . . . 75.400000000000006 110.886 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.19 21.2 12.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 74.219999999999999 110.914 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.9 25.39 41.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 53.049999999999997 112.5 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -145.03 121.23 10.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.806 0.336 . . . . 74.340000000000003 110.948 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.9 135.97 35.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 75.310000000000002 110.836 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.9 pt -140.26 -173.21 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 75.530000000000001 111.105 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.24 -170.26 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 74.010000000000005 110.951 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.37 173.84 10.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 110.892 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.29 42.47 21.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 74.120000000000005 110.901 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.5 ptm85 -147.99 159.44 40.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.6 0.714 . . . . 73.209999999999994 110.886 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 112.73 3.17 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.719 2.28 . . . . 71.430000000000007 112.322 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.4 mt -114.61 83.77 9.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 75.140000000000001 110.901 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 124.81 11.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.608 2.205 . . . . 71.329999999999998 112.316 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -118.54 80.14 16.51 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.598 0.713 . . . . 71.099999999999994 111.035 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -175.87 1.31 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.755 2.303 . . . . 73.099999999999994 112.269 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.2 m -65.84 144.5 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 71.099999999999994 111.126 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.36 -11.83 64.54 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.754 -0.736 . . . . 51.299999999999997 112.471 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.68 174.68 6.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 61.219999999999999 110.827 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 53.5 m -126.18 164.88 19.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 74.430000000000007 110.884 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.4 mt -142.87 148.37 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 73.340000000000003 111.12 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.465 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -151.76 154.52 36.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 60.0 110.863 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.465 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 2.5 p90 -148.53 136.82 21.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 71.109999999999999 110.824 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.21 -151.45 45.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 75.450000000000003 112.479 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -103.38 10.62 37.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 53.43 110.82 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.54 160.39 5.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 73.040000000000006 110.916 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.7 t -91.48 -31.35 16.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 71.040000000000006 110.865 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -53.41 152.47 4.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 74.430000000000007 110.891 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.26 130.96 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 75.120000000000005 111.067 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -97.85 102.9 14.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 75.109999999999999 110.916 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.4 tppm? -103.47 110.17 22.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 73.400000000000006 110.963 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.71 153.04 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 75.239999999999995 111.188 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -160.71 147.65 15.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.219999999999999 110.96 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 31.6 tp -80.45 136.97 36.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 75.510000000000005 110.911 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.41 177.19 2.63 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.775 -0.726 . . . . 75.030000000000001 112.51 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.81 23.41 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.656 2.238 . . . . 75.209999999999994 112.335 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -24.25 29.73 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.597 2.198 . . . . 75.510000000000005 112.399 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.9 t -88.51 55.16 3.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 64.340000000000003 110.923 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.48 137.6 57.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.51 . . . . 74.040000000000006 110.852 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 63.219999999999999 110.927 -179.824 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 CA-C-O 121.475 0.486 . . . . 75.209999999999994 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 143.26 50.45 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.664 2.243 . . . . 64.540000000000006 112.378 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -175.27 154.86 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 73.129999999999995 110.881 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.6 148.27 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 73.140000000000001 111.079 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.3 p -134.54 101.73 5.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 111.122 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.8 p -159.91 133.79 7.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 71.439999999999998 110.9 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 t -116.89 -19.02 10.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 75.140000000000001 111.161 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.19 20.99 74.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 74.120000000000005 112.486 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.2 tp -51.87 154.36 2.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.887 0.375 . . . . 74.030000000000001 110.855 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.8 tp -125.2 167.87 14.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 72.329999999999998 110.923 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.65 176.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 72.230000000000004 110.838 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.8 ptt85 -110.3 148.5 31.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 74.129999999999995 110.871 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.85 150.77 10.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 65.25 111.121 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.51 160.93 0.54 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 73.319999999999993 111.053 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.87 168.99 11.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 64.329999999999998 111.16 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.5 p -115.5 113.33 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 73.5 111.152 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -154.46 166.87 31.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 61.140000000000001 110.894 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.97 163.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 74.209999999999994 110.881 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.87 174.26 10.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 63.329999999999998 111.109 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.94 152.07 3.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 111.136 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.17 101.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 74.349999999999994 110.924 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 mp -60.3 134.4 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 73.519999999999996 111.13 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.84 -178.86 0.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 75.230000000000004 111.147 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -53.63 110.04 1.83 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 73.239999999999995 110.913 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 168.18 22.43 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.715 2.277 . . . . 64.420000000000002 112.294 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 168.39 21.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 73.439999999999998 112.323 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 112.2 3.01 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.671 2.247 . . . . 73.430000000000007 112.349 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -169.5 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.731 2.287 . . . . 75.439999999999998 112.315 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.24 150.61 27.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 72.030000000000001 110.905 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -47.95 140.86 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 71.5 111.215 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.53 151.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 73.219999999999999 111.106 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.88 169.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.499 . . . . 73.439999999999998 110.872 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.9 mt -54.24 176.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 75.420000000000002 110.975 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 168.52 3.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 62.049999999999997 111.151 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -57.19 -60.79 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 72.420000000000002 110.866 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HA ' ' HG2' ' A' ' 37' ' ' GLN . . . -64.37 -14.63 57.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 111.156 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.03 -30.61 21.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 75.549999999999997 111.105 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -92.95 -23.7 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 74.239999999999995 110.918 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HG2' ' HA ' ' A' ' 34' ' ' ALA . 1.1 pt20 -105.78 35.17 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.838 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.459 ' CD1' ' H ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -42.69 158.63 0.22 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.597 0.713 . . . . 62.409999999999997 110.907 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 38' ' ' LEU . 53.9 Cg_endo -69.78 96.14 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.7 2.267 . . . . 73.099999999999994 112.356 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.56 172.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.323 -0.399 . . . . 74.329999999999998 110.976 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -46.21 -50.63 15.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 74.340000000000003 110.841 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -51.25 -39.49 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 73.310000000000002 111.119 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.2 mt -80.95 -28.84 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 64.099999999999994 111.096 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.53 -10.01 52.52 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.711 -0.757 . . . . 72.5 112.484 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.32 -26.24 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.889 0.376 . . . . 72.430000000000007 111.149 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.2 p -54.45 153.68 5.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 73.450000000000003 111.095 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.4 160.16 73.49 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.563 0.697 . . . . 74.340000000000003 110.905 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -36.84 10.11 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.716 2.278 . . . . 73.540000000000006 112.37 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.16 -18.16 27.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.089 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -83.29 -59.8 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 74.150000000000006 110.911 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.9 -29.61 42.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.3 -0.409 . . . . 73.340000000000003 110.855 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -73.53 -44.2 58.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 75.420000000000002 110.896 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.74 -26.98 25.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 72.129999999999995 111.099 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -93.66 -21.81 19.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 71.549999999999997 110.935 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.74 -13.16 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 73.230000000000004 111.077 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 t -82.99 0.82 42.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 70.129999999999995 110.915 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -129.38 -53.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 74.239999999999995 110.888 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -134.61 148.59 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 64.540000000000006 110.926 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -100.99 152.62 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 110.914 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 21.6 t -101.5 102.67 22.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.546 0.688 . . . . 71.319999999999993 110.893 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.459 ' HG3' ' CZ2' ' A' ' 63' ' ' TRP . 53.7 Cg_endo -69.71 165.43 30.92 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.71 2.273 . . . . 71.430000000000007 112.38 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -38.86 7.13 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.733 2.289 . . . . 63.0 112.323 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.459 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 40.3 p-90 -71.79 -6.51 42.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 110.939 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.07 149.55 32.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 72.540000000000006 111.13 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 63.98 30.89 14.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 70.120000000000005 111.115 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 71.2 mt -127.68 67.56 72.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.626 0.727 . . . . 75.519999999999996 110.945 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 151.27 69.16 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.623 2.216 . . . . 70.409999999999997 112.4 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.9 m -135.69 8.19 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 74.109999999999999 110.838 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.06 151.3 20.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 75.439999999999998 111.113 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.61 119.04 27.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 44.130000000000003 111.075 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.6 p -151.17 178.18 9.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.129999999999995 110.955 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -148.63 167.34 25.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 70.409999999999997 110.869 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -121.58 135.94 54.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 72.349999999999994 110.879 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.24 135.71 51.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 71.420000000000002 110.904 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -127.13 140.56 52.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 64.439999999999998 110.906 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.7 p -111.34 153.98 25.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 111.183 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -155.17 121.41 5.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.305 -0.407 . . . . 75.230000000000004 110.852 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.1 t0 54.38 35.12 22.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 74.030000000000001 110.806 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.08 19.89 79.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 64.430000000000007 112.531 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.1 mt -110.33 108.64 58.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.645 0.736 . . . . 74.299999999999997 110.853 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 92.46 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.642 2.228 . . . . 73.239999999999995 112.424 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.4 mt -71.44 159.24 86.12 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.668 0.747 . . . . 64.219999999999999 110.952 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 123.52 10.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 75.0 112.313 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.65 149.43 49.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 111.174 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 mt -147.05 136.9 23.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 110.794 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.91 100.28 0.2 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.649 -0.786 . . . . 70.230000000000004 112.491 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.5 mt -78.69 70.8 5.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 74.200000000000003 110.912 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -111.92 6.08 19.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 75.209999999999994 110.8 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 -69.21 -19.55 63.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 72.219999999999999 110.929 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.06 157.01 79.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.678 0.751 . . . . 72.329999999999998 110.845 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -28.49 25.27 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.702 2.268 . . . . 73.140000000000001 112.395 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -159.7 176.58 11.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 110.942 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -142.61 122.68 13.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 75.219999999999999 110.956 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.98 152.59 21.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 74.200000000000003 110.932 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -139.8 106.0 5.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 74.140000000000001 110.901 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -164.22 -145.13 4.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 71.420000000000002 112.452 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.14 -1.25 11.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.748 0.309 . . . . 75.230000000000004 110.854 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.9 159.11 21.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 73.099999999999994 110.904 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -21.39 52.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 110.917 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.8 m -71.41 -22.95 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 72.340000000000003 111.147 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.6 m -68.91 164.57 21.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 72.519999999999996 110.932 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -85.27 -19.98 30.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.206 -0.452 . . . . 73.519999999999996 110.83 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -132.9 108.49 8.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 73.319999999999993 110.914 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.08 107.57 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 75.299999999999997 111.118 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.93 -170.51 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 74.030000000000001 110.934 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.4 107.24 5.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 75.430000000000007 110.922 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.85 147.56 13.01 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.657 0.742 . . . . 74.450000000000003 110.857 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -15.48 37.13 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.662 2.241 . . . . 74.319999999999993 112.312 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 p -99.18 -27.33 13.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 72.120000000000005 110.825 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.5 mt -76.35 115.75 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 73.450000000000003 111.101 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.5 m -95.9 169.84 9.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 72.329999999999998 110.842 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.0 m -45.87 -35.63 4.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 74.239999999999995 110.844 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -143.01 78.0 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 73.299999999999997 111.099 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -65.53 -61.2 2.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 74.209999999999994 110.876 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.47 167.42 29.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 74.219999999999999 111.051 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.73 140.87 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 65.109999999999999 111.093 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.1 pp -114.73 141.9 47.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 74.140000000000001 110.912 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.1 t -128.56 136.77 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 75.530000000000001 111.126 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.76 88.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.25 110.914 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -58.42 108.06 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 73.310000000000002 110.816 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.88 -5.31 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.756 -0.735 . . . . 74.519999999999996 112.503 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -88.48 -49.32 3.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 71.109999999999999 112.533 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -101.82 -4.31 26.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 64.219999999999999 110.886 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 64.26 28.38 13.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 110.809 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 33.4 m -134.33 138.2 44.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 61.119999999999997 110.9 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -64.41 127.32 30.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.439999999999998 110.87 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.6 t -105.72 109.29 27.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 75.340000000000003 111.086 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 tt -102.09 131.62 48.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 75.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 16.4 mtp -130.96 137.96 49.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 73.450000000000003 110.881 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.94 129.0 40.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.28 -0.418 . . . . 73.129999999999995 110.892 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.86 -14.69 60.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 72.439999999999998 110.985 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.58 49.15 0.56 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 74.219999999999999 112.493 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.6 t -55.57 175.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.931 0.396 . . . . 74.430000000000007 110.854 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.13 -23.83 19.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 70.5 111.103 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -85.31 -73.27 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 73.219999999999999 110.878 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 141.65 127.89 2.3 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 41.009999999999998 112.479 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.02 145.96 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 54.509999999999998 111.072 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -99.59 148.72 24.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 75.230000000000004 110.901 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -130.95 122.64 27.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 74.120000000000005 110.978 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 61.0 21.9 12.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 54.310000000000002 110.889 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.54 21.85 42.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.794 -0.717 . . . . 73.030000000000001 112.489 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -144.89 125.87 14.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 72.510000000000005 110.898 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -60.17 135.03 57.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 74.150000000000006 110.833 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.69 176.08 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 73.439999999999998 111.137 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -57.97 -176.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 75.140000000000001 110.872 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.33 174.55 7.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 74.209999999999994 110.855 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 52.79 45.92 27.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 74.540000000000006 110.835 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -144.99 159.02 51.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.571 0.7 . . . . 72.400000000000006 110.918 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 102.47 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 73.010000000000005 112.383 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.4 mt -109.88 83.76 3.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.581 0.705 . . . . 62.539999999999999 110.897 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 130.61 19.56 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.625 2.217 . . . . 75.430000000000007 112.339 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.05 79.88 18.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.54 0.686 . . . . 71.329999999999998 111.069 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -179.2 2.75 Favored 'Trans proline' 0 N--CA 1.466 -0.128 0 C-N-CA 122.748 2.299 . . . . 63.310000000000002 112.295 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.0 m -64.44 144.9 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.18 -0.464 . . . . 74.319999999999993 111.139 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.62 -10.24 68.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.769 -0.729 . . . . 75.400000000000006 112.426 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.69 -178.67 4.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.892 0.377 . . . . 61.219999999999999 110.832 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 52.8 m -132.99 165.73 24.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 61.420000000000002 110.895 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.8 mt -143.35 151.06 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 74.239999999999995 111.081 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.402 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -151.97 157.69 42.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.019999999999996 110.943 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.402 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 2.8 p90 -153.73 134.65 13.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 110.938 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.22 -153.59 42.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 73.219999999999999 112.471 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -101.33 18.09 20.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.351 . . . . 73.510000000000005 110.803 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.0 p -64.83 158.82 24.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 74.409999999999997 110.953 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.8 p -91.31 -33.29 15.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 110.861 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -53.12 154.7 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 74.450000000000003 110.87 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.7 t -145.38 131.13 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.464 . . . . 74.5 111.111 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -98.46 103.12 15.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 74.409999999999997 110.939 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -104.93 110.49 22.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 74.430000000000007 110.873 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.92 153.88 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 75.340000000000003 111.151 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.66 145.92 14.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 73.030000000000001 110.894 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.6 tt -89.5 136.03 33.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 71.420000000000002 110.889 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.22 172.26 19.49 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.738 -0.744 . . . . 64.049999999999997 112.456 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.67 167.63 23.76 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.629 2.219 . . . . 71.230000000000004 112.378 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -24.79 29.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.635 2.223 . . . . 73.340000000000003 112.384 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 m -90.11 81.18 6.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 75.040000000000006 110.805 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.3 m -52.07 -30.61 26.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 65.239999999999995 110.861 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 63.350000000000001 110.816 -179.757 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.403 0 CA-C-O 121.422 0.456 . . . . 74.420000000000002 112.483 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 120.83 7.55 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.667 2.245 . . . . 71.319999999999993 112.346 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -138.4 149.33 45.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 75.510000000000005 110.976 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.3 t -98.42 138.39 23.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 75.329999999999998 111.103 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 t -125.74 140.05 53.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 53.530000000000001 111.167 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 p -107.51 164.49 12.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 71.549999999999997 110.797 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -93.84 -19.12 21.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 74.540000000000006 111.183 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.85 20.96 79.07 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.746 -0.74 . . . . 74.450000000000003 112.573 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.7 mt -55.92 117.5 3.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 62.340000000000003 110.9 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 tp -142.56 157.2 44.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 74.439999999999998 110.945 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.3 t -155.87 136.13 13.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 74.530000000000001 110.946 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.96 133.16 31.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 72.430000000000007 110.888 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.9 t -124.04 125.6 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 74.409999999999997 111.156 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.92 153.5 28.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.340000000000003 111.139 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.97 109.75 13.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 74.239999999999995 111.126 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.5 t -118.96 105.57 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 72.099999999999994 111.153 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -129.16 110.55 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 74.420000000000002 110.907 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -126.4 155.7 41.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 75.049999999999997 110.933 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.85 148.47 30.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 111.138 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.91 145.22 8.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 111.11 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -119.26 101.99 8.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 74.109999999999999 110.885 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 mp -80.53 99.2 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 73.510000000000005 111.103 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.05 156.62 48.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 63.25 111.153 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -130.32 86.67 53.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.59 0.709 . . . . 75.319999999999993 110.893 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 167.65 23.79 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.712 2.274 . . . . 73.340000000000003 112.374 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 167.78 23.41 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.718 2.278 . . . . 72.140000000000001 112.293 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 167.64 23.85 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.757 2.305 . . . . 74.200000000000003 112.294 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -170.98 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.716 2.277 . . . . 55.409999999999997 112.313 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.56 142.55 49.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 73.340000000000003 110.908 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 m -90.2 171.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 111.107 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.8 t -145.02 146.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 73.230000000000004 111.118 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -95.78 161.01 14.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 73.150000000000006 110.89 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.8 mt -118.12 174.77 6.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.530000000000001 110.891 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.76 175.47 7.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 111.055 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -72.2 -41.51 66.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 75.549999999999997 110.822 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.97 -20.65 34.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 64.349999999999994 111.05 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.92 -27.36 42.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 71.430000000000007 111.176 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -20.87 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.814 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -73.04 -52.0 16.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 72.530000000000001 110.868 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.84 85.76 4.27 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.549 0.69 . . . . 75.140000000000001 110.945 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 155.26 66.25 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.241 . . . . 72.239999999999995 112.336 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -67.52 172.52 4.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 75.400000000000006 110.907 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.28 -47.28 77.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 74.430000000000007 110.868 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 pp -70.05 -32.5 51.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 73.329999999999998 111.132 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.6 mt -79.41 -27.36 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 74.540000000000006 111.109 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.83 -14.34 60.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.786 -0.721 . . . . 63.200000000000003 112.517 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.93 -25.83 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.945 0.403 . . . . 73.510000000000005 111.139 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 48.4 p -58.86 153.56 16.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 75.409999999999997 111.154 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.06 159.72 61.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.535 0.684 . . . . 74.439999999999998 110.876 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -38.73 7.39 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.672 2.248 . . . . 71.25 112.315 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.27 -14.65 32.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 111.187 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.64 -59.18 2.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 73.349999999999994 110.88 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.505 ' C ' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -63.11 -16.29 59.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.927 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.43 ' N ' ' CD1' ' A' ' 51' ' ' LEU . 4.0 t30 -81.35 -48.18 12.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 73.409999999999997 110.946 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.78 -24.47 50.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 65.030000000000001 111.146 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.83 -17.18 25.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.223 -0.444 . . . . 74.140000000000001 110.906 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.57 -15.45 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 75.230000000000004 111.177 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.9 t -90.12 -2.74 58.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 63.229999999999997 110.885 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -126.86 -57.42 1.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 75.150000000000006 110.959 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -139.58 142.55 37.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 74.239999999999995 110.839 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -114.41 118.08 32.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 75.109999999999999 110.954 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.5 p -49.98 108.45 1.0 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 74.200000000000003 110.862 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.417 ' HG3' ' CZ2' ' A' ' 63' ' ' TRP . 53.3 Cg_endo -69.77 168.93 20.15 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.708 2.272 . . . . 60.240000000000002 112.344 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -38.02 8.49 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.621 2.214 . . . . 65.239999999999995 112.4 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.417 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 32.7 p-90 -75.36 -5.62 45.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 73.439999999999998 110.896 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.3 147.42 42.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 64.329999999999998 111.082 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 64.98 48.51 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 55.340000000000003 111.044 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.5 mt -146.25 66.67 11.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.628 0.727 . . . . 72.540000000000006 110.927 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 151.3 69.11 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.243 . . . . 75.109999999999999 112.352 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.59 -4.3 8.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 110.802 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.09 147.9 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 74.510000000000005 111.188 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.03 126.55 31.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 75.430000000000007 111.143 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.2 p -151.0 176.07 11.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 70.329999999999998 110.87 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -143.69 167.53 22.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 74.519999999999996 110.839 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -121.73 135.97 54.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 73.109999999999999 110.894 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.54 135.03 52.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 75.109999999999999 110.918 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 14.5 p -125.04 134.87 52.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 73.310000000000002 110.902 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.4 p -99.85 155.15 17.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 73.010000000000005 111.105 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -156.9 115.05 3.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 75.209999999999994 110.839 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.3 t70 53.87 37.92 27.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 70.030000000000001 110.892 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.14 78.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.696 -0.764 . . . . 70.420000000000002 112.496 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.7 mt -110.99 108.57 57.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.663 0.744 . . . . 73.439999999999998 110.916 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 91.2 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.671 2.247 . . . . 70.209999999999994 112.358 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.88 159.35 76.19 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 75.25 110.91 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 117.99 5.41 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.689 2.259 . . . . 74.040000000000006 112.39 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.63 147.51 52.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 73.519999999999996 111.084 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.9 mt -147.89 144.17 27.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 110.886 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.89 101.65 0.28 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 71.109999999999999 112.49 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 69.0 mt -75.49 70.55 2.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 74.129999999999995 110.939 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -111.96 6.13 19.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 110.854 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -19.03 63.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 75.319999999999993 110.856 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -137.51 156.29 74.99 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.672 0.749 . . . . 72.109999999999999 110.863 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 -25.92 28.55 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.671 2.247 . . . . 70.230000000000004 112.354 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -164.98 172.39 12.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 72.329999999999998 110.856 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -138.46 112.05 8.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.113 -0.494 . . . . 73.239999999999995 110.877 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tt -91.95 140.34 29.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 74.319999999999993 110.96 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -122.72 119.2 29.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 110.886 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.76 -157.71 12.54 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.731 . . . . 73.540000000000006 112.487 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.65 -11.93 13.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.826 0.346 . . . . 71.5 110.882 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.8 t -75.47 167.69 21.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 71.329999999999998 110.846 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -16.73 55.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 75.129999999999995 110.896 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.1 m -76.35 -24.01 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 71.040000000000006 111.141 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.5 p -62.62 156.47 23.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 110.867 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.56 -0.16 57.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.230000000000004 110.809 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.19 106.24 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 71.140000000000001 110.92 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.97 108.58 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 73.230000000000004 111.131 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.99 -176.55 3.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 75.5 110.93 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.76 106.56 8.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 110.869 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.95 145.29 6.01 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.618 0.723 . . . . 72.430000000000007 110.847 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -16.93 37.72 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.695 2.263 . . . . 74.329999999999998 112.322 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 p -96.25 -26.83 15.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 62.439999999999998 110.92 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.3 mt -74.14 110.1 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.509 . . . . 74.530000000000001 111.139 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -92.63 171.37 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.181 -0.463 . . . . 74.200000000000003 110.853 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -40.0 -44.77 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 75.150000000000006 110.863 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.0 t -138.24 81.54 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 73.299999999999997 111.128 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -64.85 -47.05 79.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 75.430000000000007 110.872 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -175.1 171.57 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 72.400000000000006 111.09 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 p -152.03 134.66 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 75.409999999999997 111.152 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.34 138.2 43.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 72.010000000000005 110.928 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.0 t -129.61 138.32 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 73.439999999999998 111.178 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.69 98.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.9 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -72.29 104.48 3.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 73.400000000000006 110.841 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.63 -5.34 68.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.803 -0.713 . . . . 74.099999999999994 112.456 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.89 -40.91 6.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.792 -0.718 . . . . 74.239999999999995 112.441 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.55 5.41 16.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.837 0.351 . . . . 74.030000000000001 110.92 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? 51.84 57.54 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 75.510000000000005 110.878 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 24.2 p -167.85 138.07 2.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 75.030000000000001 110.852 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -64.7 131.07 45.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 75.530000000000001 110.908 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.8 t -112.26 111.61 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 75.150000000000006 111.133 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.6 tt -100.62 125.75 47.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 75.239999999999995 110.923 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.0 mtt -116.93 132.43 56.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 70.450000000000003 110.845 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -84.52 132.41 34.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 74.319999999999993 110.862 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.35 -15.29 61.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 75.109999999999999 110.836 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.62 43.96 0.93 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.774 -0.727 . . . . 75.150000000000006 112.488 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.9 t -52.01 168.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 73.310000000000002 110.875 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.23 -21.08 33.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 111.116 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -92.76 -75.3 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 72.439999999999998 110.899 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 147.97 142.58 3.68 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.714 -0.755 . . . . 74.140000000000001 112.462 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.0 t -102.1 143.12 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.925 0.393 . . . . 71.049999999999997 111.12 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -101.83 147.93 25.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 74.140000000000001 110.924 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.8 tp -135.83 135.87 40.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.915 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.39 22.24 6.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 64.230000000000004 110.859 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.93 21.47 57.38 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 72.120000000000005 112.483 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -145.8 132.82 20.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.763 0.316 . . . . 74.329999999999998 110.892 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -64.13 135.47 56.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 73.409999999999997 110.874 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.39 177.77 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.140000000000001 111.121 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -171.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.040000000000006 110.884 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 172.71 12.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 74.450000000000003 110.923 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 58.49 41.22 23.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.540000000000006 110.882 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -147.59 158.67 42.9 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.573 0.701 . . . . 64.439999999999998 110.905 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 107.06 1.77 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.678 2.252 . . . . 73.400000000000006 112.343 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.7 mt -111.84 83.88 5.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.597 0.713 . . . . 70.329999999999998 110.902 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 135.99 31.9 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.718 2.278 . . . . 73.230000000000004 112.344 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.32 79.99 64.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.57 0.7 . . . . 74.120000000000005 111.096 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -178.36 2.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.67 2.247 . . . . 74.200000000000003 112.38 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.5 m -54.08 143.08 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 73.150000000000006 111.074 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.94 -11.22 65.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 74.5 112.519 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.5 m -96.5 174.34 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 74.120000000000005 110.789 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.2 m -130.05 163.86 25.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 75.310000000000002 110.877 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.9 mt -142.12 145.18 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.072 -0.513 . . . . 73.340000000000003 111.155 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.413 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -151.93 148.82 28.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 70.099999999999994 111.003 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.413 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 4.4 p90 -148.37 140.84 24.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 73.010000000000005 110.884 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 64.17 -145.5 49.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 64.019999999999996 112.473 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -113.61 14.43 18.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.901 0.382 . . . . 74.329999999999998 110.869 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.76 160.86 11.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 61.210000000000001 110.88 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 61.9 m -91.32 -32.92 15.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 65.219999999999999 110.881 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.72 152.45 9.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 65.129999999999995 110.848 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.9 t -144.84 132.41 16.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 71.019999999999996 111.17 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -95.41 103.25 15.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 74.409999999999997 110.871 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 7.3 tptp -105.29 110.38 22.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 74.109999999999999 110.913 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.66 153.2 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 111.116 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -160.76 150.87 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 63.520000000000003 110.893 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 16.1 tp -89.74 139.16 30.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 71.010000000000005 110.906 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -91.53 173.33 36.93 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 33.530000000000001 112.451 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 167.76 23.52 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.676 2.251 . . . . 74.099999999999994 112.382 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 117.82 5.31 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.729 2.286 . . . . 55.43 112.343 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.6 t -52.12 156.65 1.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 73.310000000000002 110.894 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.6 t -53.53 -45.39 69.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 63.210000000000001 110.86 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 75.129999999999995 110.834 -179.784 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 121.367 0.426 . . . . 52.240000000000002 112.537 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -23.2 31.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.651 2.234 . . . . 33.329999999999998 112.329 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 tpt 53.71 53.39 11.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.84 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 63.8 t -117.37 119.55 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.263 -0.426 . . . . 71.400000000000006 111.139 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.3 p -131.09 116.13 17.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 65.420000000000002 111.166 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.6 t -71.43 147.99 47.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 71.400000000000006 110.907 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.529 ' HB ' HD23 ' A' ' 7' ' ' LEU . 66.9 p -96.91 -19.16 19.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 64.310000000000002 111.148 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.72 20.81 73.21 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.705 -0.76 . . . . 21.309999999999999 112.479 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.529 HD23 ' HB ' ' A' ' 5' ' ' THR . 4.4 mm? -86.29 141.44 29.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 74.310000000000002 110.932 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 9' ' ' SER . 1.4 tt -76.87 153.36 34.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 64.150000000000006 110.95 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.627 ' N ' HD23 ' A' ' 8' ' ' LEU . 54.6 p -67.13 -179.11 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 62.049999999999997 110.827 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -109.77 148.97 30.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 74.340000000000003 110.889 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.57 145.81 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 72.420000000000002 111.146 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.04 161.02 3.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 62.43 111.072 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.13 159.61 15.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 71.120000000000005 111.071 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.02 113.87 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 75.299999999999997 111.109 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -52.58 107.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 73.230000000000004 110.853 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -126.25 162.36 25.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 70.019999999999996 110.912 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.37 173.38 11.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 71.450000000000003 111.141 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.57 51.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 111.132 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -103.27 118.22 36.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 63.539999999999999 110.874 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.7 mt -99.46 106.74 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 61.219999999999999 111.094 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.42 161.85 26.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 74.439999999999998 111.113 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -140.5 86.61 12.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.537 0.684 . . . . 63.219999999999999 110.869 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 167.72 23.67 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.678 2.252 . . . . 75.230000000000004 112.326 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 167.76 23.47 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.7 2.267 . . . . 75.239999999999995 112.378 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 167.57 24.07 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.704 2.269 . . . . 71.140000000000001 112.35 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 173.72 10.51 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.709 2.273 . . . . 72.200000000000003 112.358 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.48 145.32 48.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 72.420000000000002 110.906 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.6 m -51.57 162.29 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 71.519999999999996 111.125 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.3 t -85.91 117.64 31.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.510000000000005 111.138 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -150.76 163.5 38.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 35.450000000000003 110.896 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.4 101.83 1.3 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.472 . . . . 71.349999999999994 110.894 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.8 175.66 7.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 64.400000000000006 111.126 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -54.1 -40.79 67.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 72.340000000000003 110.915 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.42 -26.54 31.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 71.25 111.107 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.53 78.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 71.109999999999999 111.065 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.21 -31.89 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 71.230000000000004 110.923 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -109.73 39.48 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 75.109999999999999 110.904 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.07 153.54 1.19 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.719 . . . . 73.040000000000006 110.893 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 177.47 5.53 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.663 2.242 . . . . 73.140000000000001 112.34 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.742 ' HG3' HD12 ' A' ' 43' ' ' ILE . 40.5 mt-30 -61.74 171.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 63.130000000000003 110.907 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -61.76 -44.9 96.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 61.409999999999997 110.858 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.86 -36.51 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 63.32 111.087 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.742 HD12 ' HG3' ' A' ' 40' ' ' GLN . 54.8 mt -70.34 -30.87 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 55.310000000000002 111.13 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.95 -10.33 58.61 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 74.230000000000004 112.474 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.0 t -104.08 -24.56 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 40.420000000000002 111.118 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.444 HG23 ' HA ' ' A' ' 43' ' ' ILE . 66.1 p -50.37 153.75 1.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 71.129999999999995 111.185 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.523 ' O ' HD22 ' A' ' 51' ' ' LEU . 1.1 m-20 -66.57 160.71 65.41 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.606 0.717 . . . . 72.0 110.866 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HA ' HD22 ' A' ' 51' ' ' LEU . 54.0 Cg_endo -69.74 -36.08 11.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.642 2.228 . . . . 73.140000000000001 112.335 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.86 -24.25 23.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 55.310000000000002 111.153 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.49 -54.93 5.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.519999999999996 110.884 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.615 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -63.18 -28.87 70.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 53.229999999999997 110.903 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.615 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.3 t30 -78.65 -29.4 45.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 54.509999999999998 110.907 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.8 -19.0 60.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 51.539999999999999 111.098 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.556 ' NE2' HD12 ' A' ' 94' ' ' LEU . 7.7 mm-40 -92.99 -14.58 27.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 70.109999999999999 110.908 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -85.79 -17.37 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 73.439999999999998 111.128 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 t -77.18 -7.94 56.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 62.420000000000002 110.846 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.743 ' CD2' HG11 ' A' ' 113' ' ' VAL . 37.6 m-85 -114.04 -51.52 2.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 62.350000000000001 110.899 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CZ ' HG21 ' A' ' 116' ' ' VAL . 20.7 p90 -154.83 148.23 25.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 71.319999999999993 110.846 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.05 152.25 26.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 64.430000000000007 110.895 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.4 t -86.99 112.09 45.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.649 0.738 . . . . 73.019999999999996 110.856 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.814 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 54.0 Cg_endo -69.73 169.6 18.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.735 2.29 . . . . 72.310000000000002 112.352 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 -41.67 3.95 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.654 2.236 . . . . 64.349999999999994 112.341 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.561 ' HA ' HD12 ' A' ' 66' ' ' LEU . 29.3 p-90 -71.62 -7.85 50.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 72.209999999999994 110.893 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.814 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -70.33 143.3 52.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 73.319999999999993 111.102 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 64' ' ' ALA . . . 66.81 48.64 1.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 72.140000000000001 111.108 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 63' ' ' TRP . 80.3 mt -146.32 65.99 10.87 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.625 0.726 . . . . 72.310000000000002 110.919 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 154.07 68.1 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 71.109999999999999 112.355 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.0 t -131.44 4.59 4.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 43.149999999999999 110.857 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.05 151.67 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 73.439999999999998 111.14 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 171' ' ' LEU . . . -90.27 119.54 30.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 111.117 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 26.4 p -150.84 176.97 10.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 75.409999999999997 110.909 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -143.89 168.16 20.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 74.209999999999994 110.826 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 74' ' ' GLN . 2.8 tm? -120.49 136.24 54.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 75.319999999999993 110.893 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.671 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -112.56 135.37 53.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 110.915 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 11.7 m -124.21 136.79 54.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 60.009999999999998 110.869 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.5 p -104.24 149.79 24.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.129999999999995 111.176 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -151.57 115.75 5.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 71.219999999999999 110.867 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 54.01 37.91 27.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 71.439999999999998 110.878 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.17 18.47 77.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 55.030000000000001 112.518 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 25.5 mt -108.63 108.6 61.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.648 0.737 . . . . 75.140000000000001 110.9 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 52.9 Cg_endo -69.81 92.58 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.683 2.255 . . . . 64.329999999999998 112.299 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.4 mt -70.34 159.23 85.47 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.6 0.714 . . . . 52.329999999999998 110.96 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 117.88 5.35 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 54.130000000000003 112.3 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.99 146.86 54.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 62.530000000000001 111.08 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.1 mt -147.88 139.47 23.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 63.43 110.911 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.89 107.86 1.48 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 63.25 112.45 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.1 mt -80.07 71.14 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 71.209999999999994 110.941 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -111.49 6.3 20.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 110.885 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.23 -19.65 63.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 75.530000000000001 110.866 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -136.76 155.96 76.32 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.627 0.727 . . . . 74.340000000000003 110.907 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 -27.85 26.38 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 74.129999999999995 112.355 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.554 ' HB3' HG22 ' A' ' 118' ' ' VAL . 2.8 p90 -159.83 176.97 11.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 64.450000000000003 110.859 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -144.71 124.19 13.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 74.200000000000003 110.907 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.556 HD12 ' NE2' ' A' ' 54' ' ' GLN . 0.6 OUTLIER -94.81 148.7 22.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 61.009999999999998 110.906 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -130.34 105.3 7.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.420000000000002 110.887 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.49 -157.85 17.05 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.725 -0.75 . . . . 72.310000000000002 112.46 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -102.69 -16.52 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 74.200000000000003 110.857 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.412 ' OG ' HG22 ' A' ' 100' ' ' VAL . 4.3 t -59.23 138.19 57.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 63.140000000000001 110.797 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -16.93 63.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 63.210000000000001 110.923 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.412 HG22 ' OG ' ' A' ' 98' ' ' SER . 27.4 m -80.88 -25.8 10.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 74.219999999999999 111.134 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.538 ' SG ' HD13 ' A' ' 94' ' ' LEU . 90.2 m -58.9 157.76 9.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 51.210000000000001 110.88 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.27 -15.26 53.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 64.329999999999998 110.834 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -140.53 108.26 5.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 65.530000000000001 110.913 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 p -100.54 108.15 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 74.030000000000001 111.091 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.478 HD13 HD13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -110.61 -169.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 61.43 110.905 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -137.24 107.35 6.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 74.219999999999999 110.868 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.465 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -160.6 146.8 11.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.616 0.722 . . . . 65.409999999999997 110.848 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -13.71 35.16 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.713 2.275 . . . . 64.0 112.385 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 p -99.09 -29.8 12.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.845 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.478 HD13 HD13 ' A' ' 105' ' ' LEU . 52.0 mt -76.35 121.36 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 70.310000000000002 111.105 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.88 170.64 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 61.420000000000002 110.881 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -33.94 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 75.439999999999998 110.889 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.743 HG11 ' CD2' ' A' ' 57' ' ' TYR . 2.6 m -145.69 81.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 72.340000000000003 111.11 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.619 ' CD2' HG22 ' A' ' 137' ' ' VAL . 2.3 t60 -65.62 -61.32 2.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 70.310000000000002 110.814 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -163.34 164.59 24.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 71.230000000000004 111.066 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.581 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 6.2 p -143.16 139.52 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 72.439999999999998 111.112 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.689 HD12 ' O ' ' A' ' 117' ' ' LEU . 2.7 pp -111.76 147.39 35.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 53.25 110.871 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 92' ' ' PHE . 11.4 t -137.66 132.85 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 64.209999999999994 111.179 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.87 99.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 65.340000000000003 110.911 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -74.17 104.0 4.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 71.299999999999997 110.885 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.96 -2.22 70.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 51.520000000000003 112.522 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.95 -38.8 5.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 70.430000000000007 112.467 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.86 5.82 19.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 75.230000000000004 110.925 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 51.64 57.82 6.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 75.109999999999999 110.873 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 30.7 p -173.38 136.96 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 73.129999999999995 110.86 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CD1' HD13 ' A' ' 117' ' ' LEU . 39.7 m-85 -56.94 128.93 39.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 73.0 110.862 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 118' ' ' VAL . 2.7 p -106.92 108.02 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.491 . . . . 55.399999999999999 111.097 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.401 ' C ' HD23 ' A' ' 128' ' ' LEU . 10.4 tt -102.62 134.24 46.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 75.5 110.944 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.6 mtm -129.48 133.9 47.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 71.400000000000006 110.855 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.38 132.56 34.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 71.519999999999996 110.846 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 131' ' ' LEU . 3.0 mm? -75.07 -8.96 58.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 63.109999999999999 110.929 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.9 51.04 0.7 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 72.019999999999996 112.495 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 m -67.07 174.93 2.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 63.240000000000002 110.897 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 p -78.71 -70.69 0.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 71.140000000000001 111.141 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.512 ' ND2' ' H ' ' A' ' 135' ' ' ASN . 0.4 OUTLIER -49.18 -63.11 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 72.420000000000002 110.838 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 127.8 139.55 4.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.791 -0.719 . . . . 75.099999999999994 112.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.619 HG22 ' CD2' ' A' ' 114' ' ' HIS . 20.4 t -88.44 147.44 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 72.209999999999994 111.141 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.74 150.03 22.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 45.130000000000003 110.861 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.74 HD13 ' HB2' ' A' ' 140' ' ' ASN . 3.1 tm? -133.11 121.37 22.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 70.340000000000003 110.918 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.74 ' HB2' HD13 ' A' ' 139' ' ' LEU . 1.3 m-80 62.08 23.29 13.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 62.509999999999998 110.903 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.24 20.61 54.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 71.140000000000001 112.481 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 144' ' ' ILE . 27.6 m120 -144.7 128.89 17.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 73.5 110.914 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 28.4 ptt-85 -60.75 136.79 58.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 72.340000000000003 110.896 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -141.48 178.71 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 74.239999999999995 111.114 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -170.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 110.92 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -172.53 2.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.140000000000001 110.905 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.33 39.69 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 63.549999999999997 110.894 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -139.71 154.9 71.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.644 0.735 . . . . 71.200000000000003 110.818 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 111.74 2.88 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.714 2.276 . . . . 71.430000000000007 112.336 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 144' ' ' ILE . 17.6 mt -110.23 83.38 3.09 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.569 0.7 . . . . 74.010000000000005 110.916 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 119.91 6.78 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.721 2.281 . . . . 73.409999999999997 112.289 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -116.06 78.86 7.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.557 0.694 . . . . 75.049999999999997 111.153 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -173.93 0.82 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 74.319999999999993 112.332 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 m -64.01 144.46 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 53.119999999999997 111.137 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.41 -10.41 66.88 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 75.549999999999997 112.524 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.0 m -96.45 -175.38 3.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 60.219999999999999 110.86 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.8 m -138.89 166.12 25.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 63.329999999999998 110.828 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.2 mt -141.48 148.03 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 70.239999999999995 111.073 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.2 149.01 28.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 72.540000000000006 110.912 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -150.2 134.29 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 73.219999999999999 110.876 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 63.65 -158.03 40.76 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 61.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -97.22 15.16 23.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 72.5 110.891 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.9 p -64.53 156.78 28.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 63.409999999999997 110.856 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.5 t -91.25 -29.7 17.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.864 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.26 135.58 56.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 72.420000000000002 110.871 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.3 t -130.14 131.76 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.030000000000001 111.082 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -96.57 103.19 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 75.200000000000003 110.927 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.438 ' HE2' ' NE2' ' A' ' 74' ' ' GLN . 2.6 tmmm? -104.23 110.71 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 72.519999999999996 110.887 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.3 153.12 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.349999999999994 111.094 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -160.83 149.93 16.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 75.140000000000001 110.909 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 70' ' ' ALA . 13.6 tp -84.33 136.82 33.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 73.109999999999999 110.905 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -110.37 177.68 19.67 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 34.310000000000002 112.498 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 167.78 23.43 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.27 . . . . 62.299999999999997 112.36 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 110.16 2.48 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.683 2.255 . . . . 65.340000000000003 112.318 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 92.3 p -71.98 -37.03 69.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 71.129999999999995 110.863 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.7 p -92.27 128.91 38.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 52.329999999999998 110.839 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 55.549999999999997 110.866 -179.814 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 CA-C-O 121.445 0.469 . . . . 72.239999999999995 112.533 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 160.39 49.87 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.732 2.288 . . . . 70.030000000000001 112.324 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpp -110.03 136.58 49.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 62.439999999999998 110.889 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.9 t -118.46 148.79 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 111.123 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.3 t -92.03 155.06 18.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 52.299999999999997 111.105 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -73.46 157.38 36.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 60.530000000000001 110.913 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -19.1 35.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 64.129999999999995 111.116 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.32 20.31 75.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 54.509999999999998 112.519 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.0 112.03 14.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.933 0.397 . . . . 71.420000000000002 110.918 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -137.44 136.86 38.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 73.420000000000002 110.888 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -95.66 156.33 16.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 64.409999999999997 110.88 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -127.66 123.52 35.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 73.099999999999994 110.883 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -133.98 139.86 47.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 74.25 111.125 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.92 116.97 3.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 111.112 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.38 149.29 29.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 71.409999999999997 111.11 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.36 90.83 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 63.240000000000002 111.08 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -141.11 134.27 29.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 64.140000000000001 110.883 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 pptp? -124.53 162.35 24.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 72.209999999999994 110.937 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.9 167.73 24.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 54.43 111.066 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.2 128.62 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 72.230000000000004 111.109 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -117.56 116.59 27.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 65.120000000000005 110.871 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.7 mt -84.15 127.68 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 75.430000000000007 111.123 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.51 -179.39 4.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 73.430000000000007 111.135 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 86.61 46.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.532 0.682 . . . . 73.340000000000003 110.852 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 167.78 23.49 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.677 2.251 . . . . 74.430000000000007 112.327 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 167.81 23.28 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.658 2.239 . . . . 72.319999999999993 112.335 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 167.55 24.07 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.683 2.255 . . . . 74.530000000000001 112.374 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 177.4 5.62 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.665 2.243 . . . . 72.109999999999999 112.346 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.04 120.82 15.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 54.32 110.898 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.3 m -56.07 170.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.432 . . . . 54.340000000000003 111.107 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.0 p -101.62 151.78 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 62.450000000000003 111.085 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -107.52 168.19 9.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.409999999999997 110.93 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 31' ' ' LEU . 2.8 pp -51.74 135.17 29.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 110.977 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.611 ' H ' ' HB3' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -92.32 169.01 10.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 72.120000000000005 111.166 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -60.96 -41.8 97.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 73.409999999999997 110.848 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.48 -16.55 34.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.510000000000005 111.12 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.611 ' HB3' ' H ' ' A' ' 32' ' ' THR . . . -82.92 -39.1 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 75.299999999999997 111.116 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -67.39 -12.51 60.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 73.5 110.929 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -73.32 -24.92 60.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 71.420000000000002 110.943 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.569 HD21 ' HA ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -109.38 85.7 3.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.579 0.705 . . . . 52.149999999999999 110.895 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 158.26 57.62 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.249 . . . . 60.299999999999997 112.342 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.749 ' HG3' HD12 ' A' ' 43' ' ' ILE . 9.0 mt-30 -67.24 171.12 6.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 72.140000000000001 110.944 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -67.19 -38.29 85.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.839 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 46' ' ' THR . 1.7 pp -80.11 -32.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.421 . . . . 71.400000000000006 111.214 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.749 HD12 ' HG3' ' A' ' 40' ' ' GLN . 61.4 mt -78.79 -25.11 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 70.099999999999994 111.202 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.18 -17.13 65.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.706 -0.759 . . . . 74.019999999999996 112.491 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.51 -25.93 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.368 . . . . 74.0 111.146 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 42' ' ' ILE . 37.9 p -89.91 153.62 20.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 111.068 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.553 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -84.14 160.47 57.44 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.591 0.71 . . . . 70.140000000000001 110.852 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -37.28 9.47 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.71 2.273 . . . . 74.129999999999995 112.381 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.04 -15.42 34.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 74.510000000000005 111.103 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.63 -57.71 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 74.109999999999999 110.916 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.7 OUTLIER -59.66 -29.33 67.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 65.109999999999999 110.876 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.569 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.7 t30 -74.7 -43.86 52.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 71.200000000000003 110.908 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.29 -24.41 28.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 54.219999999999999 111.17 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.424 HE22 HD12 ' A' ' 94' ' ' LEU . 5.4 mm-40 -66.63 -16.94 64.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 72.129999999999995 110.918 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 52' ' ' ASN . 4.3 p -69.3 -21.8 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 75.239999999999995 111.068 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.8 t -77.77 -4.36 45.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 64.400000000000006 110.862 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.772 ' CE1' HG21 ' A' ' 100' ' ' VAL . 31.1 m-85 -124.2 -58.14 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 72.349999999999994 110.858 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.597 ' CZ ' HD11 ' A' ' 131' ' ' LEU . 19.5 m-85 -146.35 142.21 28.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 74.439999999999998 110.878 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.436 ' HG3' HG23 ' A' ' 55' ' ' VAL . 1.2 mp0 -116.46 118.33 32.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 60.240000000000002 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 6.3 p -48.39 107.16 0.7 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.585 0.707 . . . . 72.420000000000002 110.876 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.473 ' HG2' ' CB ' ' A' ' 64' ' ' ALA . 53.6 Cg_endo -69.77 158.68 56.12 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.689 2.259 . . . . 34.109999999999999 112.328 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.93 -36.62 10.03 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.671 2.247 . . . . 61.399999999999999 112.278 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 39.8 p-90 -70.46 -4.62 23.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 64.510000000000005 110.912 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' CB ' ' HG2' ' A' ' 61' ' ' PRO . . . -109.97 172.78 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 65.200000000000003 111.073 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 64' ' ' ALA . . . 70.41 28.55 3.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 70.329999999999998 111.103 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.532 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -146.71 68.06 11.65 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.611 0.72 . . . . 71.430000000000007 110.92 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.75 151.68 69.17 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.687 2.258 . . . . 60.539999999999999 112.336 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 m -136.85 11.4 3.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 73.510000000000005 110.842 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 p -127.99 153.25 37.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 63.43 111.159 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 171' ' ' LEU . . . -93.31 111.66 23.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 64.310000000000002 111.086 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.0 p -150.91 174.96 12.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 74.329999999999998 110.878 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -148.4 167.1 26.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 65.019999999999996 110.867 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 74' ' ' GLN . 2.1 tm? -121.11 136.09 55.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 75.439999999999998 110.866 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.703 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -111.86 136.37 51.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 72.040000000000006 110.889 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.79 144.71 51.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 74.530000000000001 110.864 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 p -107.36 148.37 29.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 70.129999999999995 111.143 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.413 ' CD ' HD11 ' A' ' 82' ' ' LEU . 5.2 ptm180 -149.74 113.96 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 73.140000000000001 110.863 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 53.67 39.02 29.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 73.219999999999999 110.909 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.37 19.69 77.75 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 73.200000000000003 112.484 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 8.2 mt -112.39 108.6 54.47 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.632 0.73 . . . . 71.530000000000001 110.975 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 54.2 Cg_endo -69.7 94.52 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.261 . . . . 71.530000000000001 112.342 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.413 HD11 ' CD ' ' A' ' 77' ' ' ARG . 20.4 mt -69.81 159.28 84.63 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 71.450000000000003 110.928 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 114.29 3.65 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 65.540000000000006 112.29 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.07 147.11 51.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 43.240000000000002 111.119 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 mt -148.64 141.95 25.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.199 -0.455 . . . . 60.299999999999997 110.925 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.1 102.0 0.32 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.693 -0.765 . . . . 21.440000000000001 112.409 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.7 mt -77.43 70.38 3.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.897 0.38 . . . . 61.539999999999999 110.917 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -112.2 6.32 18.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 74.019999999999996 110.805 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.02 -19.18 64.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 73.239999999999995 110.874 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -133.64 156.39 79.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.629 0.728 . . . . 75.230000000000004 110.857 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -34.47 14.36 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.705 2.27 . . . . 73.430000000000007 112.323 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.559 ' HB3' HG22 ' A' ' 118' ' ' VAL . 32.7 p90 -154.71 162.4 41.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 65.420000000000002 110.897 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -128.5 117.37 21.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 110.928 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.428 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . 0.3 OUTLIER -91.21 138.97 31.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 110.917 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.406 ' CE2' HD21 ' A' ' 117' ' ' LEU . 21.9 m-85 -127.55 105.31 8.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 72.019999999999996 110.92 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.89 -146.28 4.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 21.129999999999999 112.45 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.48 -2.6 11.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.82 0.343 . . . . 60.399999999999999 110.891 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.0 t -70.32 156.28 39.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 63.420000000000002 110.878 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.444 ' HD2' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -81.05 -8.73 59.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 72.109999999999999 110.838 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.772 HG21 ' CE1' ' A' ' 57' ' ' TYR . 18.5 m -93.03 -21.37 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 72.25 111.128 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 94' ' ' LEU . 12.8 p -58.24 165.34 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 51.219999999999999 110.838 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.38 -2.29 54.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 75.349999999999994 110.891 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.16 106.3 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 73.239999999999995 110.937 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 104' ' ' VAL . 3.0 p -97.33 109.8 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 72.519999999999996 111.095 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.596 HD13 HD13 ' A' ' 110' ' ' ILE . 0.4 OUTLIER -104.18 -168.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 64.310000000000002 110.893 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -133.41 106.75 7.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 71.219999999999999 110.868 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.428 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -167.35 142.46 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.675 0.75 . . . . 73.430000000000007 110.817 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -13.43 34.75 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.67 2.246 . . . . 55.43 112.367 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.434 ' HB3' ' ND2' ' A' ' 135' ' ' ASN . 3.9 p -97.4 -25.39 15.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 63.439999999999998 110.842 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.596 HD13 HD13 ' A' ' 105' ' ' LEU . 58.7 mt -75.55 116.54 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 72.439999999999998 111.087 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.476 ' H ' ' HD2' ' A' ' 114' ' ' HIS . 4.2 m -96.2 169.88 9.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 60.43 110.828 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 m -45.58 -38.35 6.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 74.340000000000003 110.813 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.548 HG11 ' HD2' ' A' ' 57' ' ' TYR . 2.8 m -141.26 80.17 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 72.099999999999994 111.091 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.476 ' HD2' ' H ' ' A' ' 111' ' ' SER . 4.4 t-80 -69.68 -49.01 57.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 74.420000000000002 110.903 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -168.2 159.18 10.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 64.319999999999993 111.112 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.98 137.04 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 64.409999999999997 111.186 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.737 HD12 ' CD1' ' A' ' 126' ' ' PHE . 0.4 OUTLIER -109.71 144.33 38.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 73.319999999999993 110.925 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 92' ' ' PHE . 23.9 t -132.11 128.69 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 62.329999999999998 111.128 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.84 95.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 53.100000000000001 110.92 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.542 ' HB2' HG23 ' A' ' 127' ' ' VAL . 12.6 t-80 -65.43 108.17 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 55.539999999999999 110.907 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.28 -5.12 65.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 75.209999999999994 112.436 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.7 -42.77 5.97 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 64.299999999999997 112.466 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.16 8.36 16.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 74.230000000000004 110.888 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? 50.73 44.71 27.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 72.019999999999996 110.894 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 87.6 m -146.27 137.78 24.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.510000000000005 110.893 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.737 ' CD1' HD12 ' A' ' 117' ' ' LEU . 31.7 m-85 -65.97 131.28 45.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 54.140000000000001 110.864 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.542 HG23 ' HB2' ' A' ' 120' ' ' HIS . 88.0 t -110.18 107.29 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 61.520000000000003 111.149 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 158' ' ' ILE . 2.0 tt -101.68 134.84 44.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 71.439999999999998 110.865 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.1 mtm -131.41 133.9 45.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 74.439999999999998 110.89 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -83.64 132.56 34.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 72.120000000000005 110.873 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.597 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 3.1 mm? -73.35 -16.07 61.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 71.549999999999997 110.952 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.74 49.37 0.74 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 50.350000000000001 112.493 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 t -58.58 158.48 7.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 64.420000000000002 110.877 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.6 m -78.55 -25.73 45.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 70.310000000000002 111.109 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 109' ' ' SER . 9.1 m120 -80.39 -74.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 74.200000000000003 110.918 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 148.04 126.48 1.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.758 -0.734 . . . . 74.549999999999997 112.493 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.453 HG22 ' ND1' ' A' ' 114' ' ' HIS . 20.3 t -91.51 145.72 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.382 . . . . 73.219999999999999 111.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -100.23 154.71 18.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.150000000000006 110.966 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.518 ' HB2' HD12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -140.11 126.19 19.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 74.299999999999997 110.95 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.6 m120 56.34 23.82 7.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 75.409999999999997 110.912 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.66 19.76 55.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.69 -0.767 . . . . 61.399999999999999 112.493 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' ' 144' ' ' ILE . 31.4 m120 -145.3 130.19 18.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.781 0.324 . . . . 75.040000000000006 110.925 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.71 136.61 58.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 74.219999999999999 110.841 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -142.81 178.69 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 73.099999999999994 111.105 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -170.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 51.340000000000003 110.906 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.12 176.83 8.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 59.21 39.04 23.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 110.902 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.626 ' NE ' HD21 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -148.38 158.03 41.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 72.150000000000006 110.856 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 113.01 3.22 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.691 2.261 . . . . 75.150000000000006 112.317 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.626 HD21 ' NE ' ' A' ' 148' ' ' ARG . 69.9 mt -124.5 84.07 57.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.619 0.723 . . . . 71.450000000000003 110.931 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 134.15 27.37 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.681 2.254 . . . . 43.43 112.39 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.538 ' O ' HG21 ' A' ' 169' ' ' VAL . . . -118.44 80.7 16.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.688 . . . . 64.019999999999996 111.124 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 179.28 3.79 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.755 2.303 . . . . 71.349999999999994 112.332 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.5 m -56.63 143.17 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 71.439999999999998 111.084 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.31 -12.7 61.9 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 73.340000000000003 112.528 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.83 168.48 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 64.439999999999998 110.89 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.7 m -124.4 165.44 17.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 63.109999999999999 110.806 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.629 HG21 HD13 ' A' ' 128' ' ' LEU . 7.1 mt -142.58 150.68 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 72.340000000000003 111.197 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.36 162.52 41.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 72.310000000000002 110.921 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -163.85 139.59 6.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 73.129999999999995 110.863 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 64.29 -154.03 48.04 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.718 -0.754 . . . . 72.010000000000005 112.46 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -104.89 8.97 34.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.896 0.379 . . . . 75.530000000000001 110.895 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.09 159.65 25.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 41.340000000000003 110.868 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.531 ' O ' HG23 ' A' ' 166' ' ' VAL . 75.3 m -88.84 -20.66 24.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 63.049999999999997 110.8 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -53.13 137.81 32.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 72.430000000000007 110.813 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 164' ' ' SER . 19.5 t -139.26 122.83 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 74.319999999999993 111.104 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.415 ' HB3' HD11 ' A' ' 73' ' ' LEU . 6.6 m-85 -92.85 105.07 17.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 63.409999999999997 110.934 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -105.94 110.14 22.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 75.430000000000007 110.891 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 152' ' ' ALA . 2.8 t -77.72 153.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 71.450000000000003 111.118 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.12 148.48 15.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 74.510000000000005 110.926 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 70' ' ' ALA . 11.0 tp -89.65 132.88 34.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 64.340000000000003 110.897 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -89.74 177.17 43.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 72.439999999999998 112.571 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 167.76 23.55 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.264 . . . . 75.030000000000001 112.358 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 112.51 3.1 Favored 'Trans proline' 0 C--O 1.23 0.112 0 C-N-CA 122.668 2.246 . . . . 65.209999999999994 112.348 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.8 p -85.78 124.39 32.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 74.340000000000003 110.906 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.3 m -154.38 150.15 27.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 74.400000000000006 110.845 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.919 -179.868 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 CA-C-O 121.374 0.43 . . . . 75.420000000000002 112.405 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 143.43 50.77 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.766 2.31 . . . . 71.450000000000003 112.327 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mtp -68.45 164.34 21.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 72.530000000000001 110.813 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -119.39 141.46 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 111.049 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.2 t -133.41 163.85 28.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 61.509999999999998 111.116 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.4 p -105.45 167.04 10.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 70.129999999999995 110.879 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -108.19 21.0 17.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 72.510000000000005 111.131 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.0 -19.5 37.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 73.409999999999997 112.526 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.661 ' N ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -136.45 165.77 25.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.824 0.345 . . . . 63.32 110.944 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.64 137.75 54.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 70.25 110.899 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 p -61.44 138.53 58.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.457 . . . . 53.240000000000002 110.872 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -87.72 146.66 25.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 55.240000000000002 110.793 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.91 149.91 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 74.409999999999997 111.143 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.06 150.17 51.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 111.081 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.11 113.49 27.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 75.0 111.114 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.99 106.6 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 72.299999999999997 111.155 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -140.25 113.89 8.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 70.340000000000003 110.901 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -124.3 162.98 22.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.461 . . . . 64.530000000000001 110.905 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.65 149.57 52.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 71.209999999999994 111.153 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.97 151.94 29.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 72.140000000000001 111.112 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -107.62 104.74 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 74.519999999999996 110.907 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.6 mp -81.87 137.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 71.200000000000003 111.131 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.08 112.22 12.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 111.143 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -140.81 86.72 11.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.618 0.723 . . . . 54.530000000000001 110.947 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 167.68 23.72 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.617 2.212 . . . . 63.219999999999999 112.362 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 167.76 23.49 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.652 2.235 . . . . 63.210000000000001 112.316 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 167.75 23.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.676 2.251 . . . . 40.439999999999998 112.348 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 117.45 5.09 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.692 2.262 . . . . 52.109999999999999 112.286 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.3 130.02 39.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 74.209999999999994 110.917 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.21 174.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 71.299999999999997 111.159 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.445 ' O ' HD23 ' A' ' 31' ' ' LEU . 10.6 p -136.42 152.11 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 64.140000000000001 111.097 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.39 151.62 36.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 64.310000000000002 110.89 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -139.44 161.6 37.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 64.209999999999994 110.885 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.15 174.63 5.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 53.439999999999998 111.174 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.51 -38.17 68.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 73.530000000000001 110.887 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.78 -16.39 62.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 74.129999999999995 111.126 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -89.06 -36.25 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 64.140000000000001 111.065 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -83.52 -1.21 53.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.414 . . . . 71.150000000000006 110.869 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -103.78 -13.58 16.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 71.129999999999995 110.943 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.56 ' O ' HD12 ' A' ' 38' ' ' LEU . 3.9 pp -107.38 154.53 40.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.615 0.721 . . . . 64.239999999999995 110.849 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 146.54 60.04 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.711 2.274 . . . . 55.409999999999997 112.282 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.805 ' HG3' HD12 ' A' ' 43' ' ' ILE . 24.0 mt-30 -53.06 172.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 71.040000000000006 110.91 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -62.94 -55.61 24.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 110.788 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.449 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -72.26 -27.88 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 71.319999999999993 111.147 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.805 HD12 ' HG3' ' A' ' 40' ' ' GLN . 31.5 mt -77.91 -25.27 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 72.25 111.166 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.87 -18.09 56.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 62.149999999999999 112.432 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.34 -26.46 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.93 0.395 . . . . 53.539999999999999 111.176 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 42' ' ' ILE . 37.7 p -96.63 153.57 17.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 111.175 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.553 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -82.32 159.79 63.9 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.513 0.673 . . . . 73.209999999999994 110.941 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 -35.39 12.82 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.71 2.274 . . . . 43.039999999999999 112.355 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -18.54 26.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 64.239999999999995 111.182 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.72 -61.24 1.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 65.409999999999997 110.934 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 52' ' ' ASN . 0.6 OUTLIER -53.68 -29.73 40.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 71.239999999999995 110.864 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.577 ' H ' HD23 ' A' ' 51' ' ' LEU . 3.3 t30 -74.66 -40.5 61.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.906 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 1.007 ' HB1' HG12 ' A' ' 100' ' ' VAL . . . -55.01 -27.94 48.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 54.520000000000003 111.122 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.486 HE21 HD12 ' A' ' 94' ' ' LEU . 6.3 mp0 -92.55 -17.08 24.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 74.120000000000005 110.854 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -60.66 -19.31 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 72.150000000000006 111.053 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.47 3.98 53.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 73.030000000000001 110.836 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.732 ' CD2' HG11 ' A' ' 113' ' ' VAL . 39.0 m-85 -128.04 -57.95 1.23 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 75.129999999999995 110.877 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.766 ' CZ ' HG21 ' A' ' 116' ' ' VAL . 24.4 p90 -147.94 141.42 25.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.439999999999998 110.891 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -90.19 152.38 21.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 71.310000000000002 110.993 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 23.1 p -89.0 120.8 69.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.589 0.709 . . . . 52.43 110.822 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.824 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 54.3 Cg_endo -69.72 164.85 32.96 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.684 2.256 . . . . 74.200000000000003 112.363 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -41.94 3.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.731 2.287 . . . . 73.120000000000005 112.321 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.438 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 27.7 p-90 -68.51 -9.17 47.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 75.219999999999999 110.818 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.824 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -71.96 149.23 45.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 75.109999999999999 111.115 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.746 ' HB2' ' HB3' ' A' ' 91' ' ' PRO . . . 65.16 47.18 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 70.319999999999993 111.061 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 63' ' ' TRP . 81.0 mt -146.29 66.3 11.13 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 71.340000000000003 110.902 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 151.17 69.02 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.691 2.261 . . . . 71.030000000000001 112.354 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.73 5.84 3.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 73.049999999999997 110.778 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.28 152.62 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 71.200000000000003 111.15 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.66 120.04 32.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 72.340000000000003 111.166 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 5.1 p -151.2 172.01 16.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 75.439999999999998 110.862 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -137.1 167.6 21.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 72.200000000000003 110.867 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.709 HD13 ' N ' ' A' ' 74' ' ' GLN . 1.9 tm? -123.55 136.24 54.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 63.549999999999997 110.896 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.709 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -112.03 133.46 54.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 64.450000000000003 110.923 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.1 p -128.53 141.83 51.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 54.229999999999997 110.923 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.642 HG22 ' HA ' ' A' ' 81' ' ' PRO . 2.2 p -116.15 152.61 33.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 111.154 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -150.73 127.97 11.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 70.5 110.901 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 55.61 30.02 14.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 110.815 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.58 19.1 78.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 71.120000000000005 112.49 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.3 mt -109.94 108.56 59.21 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.6 0.714 . . . . 54.140000000000001 110.933 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.642 ' HA ' HG22 ' A' ' 76' ' ' THR . 53.9 Cg_endo -69.77 94.23 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.736 2.291 . . . . 72.120000000000005 112.279 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.1 mt -74.8 159.05 83.99 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.74 . . . . 74.019999999999996 110.891 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 127.63 14.91 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.741 2.294 . . . . 73.219999999999999 112.345 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 74' ' ' GLN . . . -70.03 145.28 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 55.32 111.04 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.8 mt -142.17 140.84 32.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.82 100.36 0.2 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.683 -0.77 . . . . 53.340000000000003 112.504 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.35 71.18 2.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 74.010000000000005 110.925 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -111.68 6.29 19.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 75.319999999999993 110.91 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.36 -18.56 63.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 65.430000000000007 110.842 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -140.86 155.55 69.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.622 0.725 . . . . 72.409999999999997 110.916 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.746 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 53.5 Cg_endo -69.73 -30.21 22.78 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.769 2.313 . . . . 63.450000000000003 112.353 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.589 ' HB3' HG22 ' A' ' 118' ' ' VAL . 13.2 p90 -153.42 175.91 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 70.040000000000006 110.94 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -144.63 125.3 14.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 75.129999999999995 110.95 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.502 HD13 ' SG ' ' A' ' 101' ' ' CYS . 0.7 OUTLIER -90.92 152.3 20.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.162 -0.472 . . . . 74.230000000000004 110.887 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -139.14 106.23 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 72.010000000000005 110.874 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -163.37 -144.23 3.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.738 . . . . 73.019999999999996 112.492 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.03 -7.15 9.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.799 0.333 . . . . 74.319999999999993 110.829 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.529 ' HB3' HG22 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -80.75 162.74 23.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.845 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -22.73 49.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 75.010000000000005 110.808 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.007 HG12 ' HB1' ' A' ' 53' ' ' ALA . 15.4 m -68.08 -22.17 27.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 72.310000000000002 111.109 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.502 ' SG ' HD13 ' A' ' 94' ' ' LEU . 94.8 m -74.09 163.47 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 63.119999999999997 110.876 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.06 -24.84 37.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.92 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.0 108.35 10.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.477 . . . . 63.229999999999997 110.943 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 98' ' ' SER . 32.2 t -96.42 103.97 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 111.139 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.515 HD13 HD13 ' A' ' 110' ' ' ILE . 0.4 OUTLIER -106.59 -169.87 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 110.881 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -137.48 107.02 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 64.340000000000003 110.97 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.464 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -159.96 147.41 12.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 62.149999999999999 110.831 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -14.4 35.82 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.684 2.256 . . . . 74.319999999999993 112.317 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.7 p -100.12 -27.55 13.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 71.239999999999995 110.838 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.515 HD13 HD13 ' A' ' 105' ' ' LEU . 56.8 mt -76.02 111.01 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 63.43 111.048 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.479 ' H ' ' HD2' ' A' ' 114' ' ' HIS . 5.7 m -89.02 169.57 11.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 63.039999999999999 110.878 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.3 m -46.14 -35.51 5.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 64.150000000000006 110.867 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.798 HG23 HD13 ' A' ' 131' ' ' LEU . 1.2 m -145.57 81.72 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 60.020000000000003 111.154 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.479 ' HD2' ' H ' ' A' ' 111' ' ' SER . 2.3 t-80 -65.76 -60.42 2.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 110.85 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -160.46 165.18 31.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.192 -0.458 . . . . 60.420000000000002 111.067 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.766 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 6.2 p -142.71 134.77 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 74.230000000000004 111.141 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.432 HD13 ' CD2' ' A' ' 126' ' ' PHE . 2.9 pp -107.6 138.17 44.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 110.908 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 92' ' ' PHE . 12.0 t -129.26 139.21 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 73.530000000000001 111.072 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.01 91.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.540000000000006 110.824 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -61.96 107.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 75.329999999999998 110.86 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.3 -6.87 62.34 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.806 -0.711 . . . . 73.450000000000003 112.45 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.88 -51.7 3.15 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.819 -0.705 . . . . 63.43 112.436 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -98.93 -1.57 39.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.864 0.364 . . . . 73.319999999999993 110.976 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.38 30.1 19.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 73.099999999999994 110.838 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 57.7 m -138.77 137.42 36.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 52.100000000000001 110.911 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.432 ' CD2' HD13 ' A' ' 117' ' ' LEU . 63.6 m-85 -60.97 133.12 55.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 72.109999999999999 110.905 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.7 t -114.54 111.35 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 111.097 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.675 HD23 HD12 ' A' ' 150' ' ' LEU . 5.0 tt -101.57 121.44 41.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 63.229999999999997 110.873 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 74.1 mtm -115.75 133.36 56.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 75.549999999999997 110.874 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.635 ' OD2' HD11 ' A' ' 150' ' ' LEU . 1.3 m-20 -90.04 126.84 35.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 72.420000000000002 110.876 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.798 HD13 HG23 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -62.36 -16.67 55.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 63.509999999999998 110.968 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.535 ' N ' HD23 ' A' ' 131' ' ' LEU . . . 116.47 47.42 0.5 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 65.030000000000001 112.533 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.97 160.54 9.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.915 0.388 . . . . 44.329999999999998 110.883 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.2 t -83.79 -28.51 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.492 . . . . 73.310000000000002 111.159 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -71.85 -72.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 64.049999999999997 110.903 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 135.51 129.51 2.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.73 -0.748 . . . . 65.129999999999995 112.549 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.517 HG21 ' OD1' ' A' ' 130' ' ' ASP . 15.8 t -90.26 152.12 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.93 0.395 . . . . 61.140000000000001 111.093 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -108.24 140.47 41.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 74.150000000000006 110.862 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.623 HD12 ' HB3' ' A' ' 150' ' ' LEU . 1.5 tt -125.76 130.81 52.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 73.349999999999994 110.849 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.52 ' HB2' HD23 ' A' ' 139' ' ' LEU . 3.0 m120 53.93 24.7 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 63.310000000000002 110.891 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 22.66 52.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.787 -0.72 . . . . 65.420000000000002 112.463 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.454 ' O ' HG23 ' A' ' 144' ' ' ILE . 7.5 t30 -145.13 126.07 14.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 75.439999999999998 110.874 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -57.99 138.87 55.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.519999999999996 110.868 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 142' ' ' ASN . 0.0 OUTLIER -142.87 178.24 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 64.540000000000006 111.132 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.59 -169.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 110.912 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 -179.76 5.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 73.129999999999995 110.935 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 51.95 34.71 14.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.549999999999997 110.868 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.64 161.72 55.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 72.230000000000004 110.856 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 107.9 1.96 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.664 2.243 . . . . 63.310000000000002 112.371 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.675 HD12 HD23 ' A' ' 128' ' ' LEU . 4.2 mt -109.91 83.32 2.82 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.605 0.716 . . . . 70.219999999999999 110.902 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 134.7 28.74 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.664 2.243 . . . . 64.209999999999994 112.413 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.32 80.18 45.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.536 0.684 . . . . 72.140000000000001 111.08 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 165.29 31.46 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.679 2.253 . . . . 62.450000000000003 112.332 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.451 HG21 ' HB2' ' A' ' 171' ' ' LEU . 11.0 m -53.08 145.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 44.229999999999997 111.178 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.09 -9.98 67.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 73.510000000000005 112.508 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 12.1 p -96.76 -179.39 4.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 45.43 110.844 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.7 m -132.04 162.33 31.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.501 . . . . 71.510000000000005 110.909 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.4 mt -139.14 149.51 23.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 74.540000000000006 111.149 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.27 149.4 28.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 74.439999999999998 110.935 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -144.24 134.59 24.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.519999999999996 110.843 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.3 -154.06 41.9 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.747 -0.74 . . . . 74.400000000000006 112.423 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -101.69 17.79 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.908 0.385 . . . . 61.439999999999998 110.936 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.411 ' HB3' HD11 ' A' ' 110' ' ' ILE . 51.5 p -65.72 160.92 21.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 44.210000000000001 110.852 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.9 m -91.16 -31.98 15.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 71.409999999999997 110.874 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -53.29 149.85 6.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 74.140000000000001 110.923 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.38 130.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 62.399999999999999 111.078 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' A' ' 73' ' ' LEU . 7.1 m-85 -98.62 103.6 15.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 74.230000000000004 110.874 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.74 110.26 22.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 74.409999999999997 110.919 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.4 153.56 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 62.310000000000002 111.123 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.67 146.09 14.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 65.030000000000001 110.924 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.451 ' HB2' HG21 ' A' ' 154' ' ' VAL . 7.0 tp -87.16 141.13 28.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 74.030000000000001 110.895 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.97 177.15 54.49 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.769 -0.729 . . . . 72.230000000000004 112.425 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 167.76 23.55 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.649 2.232 . . . . 71.329999999999998 112.341 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.46 69.06 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.663 2.242 . . . . 72.439999999999998 112.339 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 56.6 p -98.81 -50.37 4.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 55.219999999999999 110.784 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.4 t -108.18 153.32 23.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 52.520000000000003 110.769 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.494 . . . . 52.409999999999997 110.88 -179.831 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 CA-C-O 121.546 0.526 . . . . 61.310000000000002 112.42 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 171.24 14.87 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.749 2.299 . . . . 71.439999999999998 112.302 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 mtt -116.74 161.79 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 62.219999999999999 110.932 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.5 m -59.73 156.51 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 63.200000000000003 111.139 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.1 m -145.6 142.29 28.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 54.350000000000001 111.173 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 t -147.93 158.94 44.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.219999999999999 110.834 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 p -87.92 -19.04 27.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 74.200000000000003 111.18 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.11 20.29 65.28 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.741 . . . . 74.439999999999998 112.539 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.4 mt -52.5 132.09 34.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.36 . . . . 73.109999999999999 110.898 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 9' ' ' SER . 1.4 tt -134.69 143.71 47.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 110.852 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.435 ' N ' HD23 ' A' ' 8' ' ' LEU . 38.0 t -67.89 170.12 8.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.492 . . . . 72.150000000000006 110.827 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 44.4 ttm-85 -131.59 146.49 52.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 71.140000000000001 110.866 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.7 t -119.22 145.37 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 61.420000000000002 111.13 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.57 158.75 22.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 64.129999999999995 111.122 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.12 109.18 18.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 22.039999999999999 111.09 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 14' ' ' VAL . 4.8 m -57.54 101.82 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 62.039999999999999 111.085 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -102.17 130.69 48.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 73.040000000000006 110.928 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.25 155.5 44.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.936 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.21 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 73.040000000000006 111.132 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -113.2 150.99 31.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 75.420000000000002 111.109 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -102.55 112.1 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 74.430000000000007 110.876 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mp -64.42 131.46 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 73.109999999999999 111.168 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.09 -179.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 111.059 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.59 157.62 40.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.53 0.681 . . . . 74.430000000000007 110.949 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 168.1 22.43 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.7 2.267 . . . . 61.530000000000001 112.368 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.83 168.05 22.78 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.781 2.32 . . . . 54.109999999999999 112.267 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 167.42 24.54 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.65 2.234 . . . . 71.519999999999996 112.394 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.67 -174.6 0.92 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.7 2.267 . . . . 70.430000000000007 112.43 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -106.17 146.78 29.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 65.329999999999998 110.875 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.5 m -143.64 174.74 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 72.019999999999996 111.132 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.1 p -52.3 130.74 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 73.120000000000005 111.185 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -132.98 167.82 19.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.150000000000006 110.857 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 37.3 mt -55.41 174.21 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.496 . . . . 62.420000000000002 110.906 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.661 ' OG1' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -63.23 165.01 7.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 62.420000000000002 111.083 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.83 -55.16 37.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 64.329999999999998 110.911 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.46 -20.45 58.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 45.200000000000003 111.084 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.708 ' O ' HD22 ' A' ' 38' ' ' LEU . . . -51.39 -30.77 20.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 75.310000000000002 111.043 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.1 -32.7 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 61.210000000000001 110.911 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -73.0 -12.56 60.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 110.896 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.708 HD22 ' O ' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -50.83 156.14 1.75 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 73.439999999999998 110.929 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 147.4 62.63 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.719 2.279 . . . . 60.100000000000001 112.331 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.821 ' HG3' HD12 ' A' ' 43' ' ' ILE . 28.0 mt-30 -54.52 173.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 110.943 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -61.26 -56.94 14.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 72.420000000000002 110.813 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.784 ' O ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -73.74 -27.84 23.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 70.239999999999995 111.138 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.821 HD12 ' HG3' ' A' ' 40' ' ' GLN . 34.6 mt -76.03 -25.44 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 63.119999999999997 111.174 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.16 -10.98 70.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.677 -0.773 . . . . 71.25 112.513 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.4 t -117.66 -22.61 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.848 0.356 . . . . 71.129999999999995 111.153 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 42' ' ' ILE . 12.7 p -50.12 153.91 1.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 62.350000000000001 111.111 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.562 ' O ' HD22 ' A' ' 51' ' ' LEU . 1.1 m-20 -68.91 160.64 77.04 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.643 0.735 . . . . 65.120000000000005 110.794 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -37.53 8.92 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.622 2.215 . . . . 73.140000000000001 112.332 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.22 -20.9 23.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 71.329999999999998 111.155 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.33 -59.2 2.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 65.019999999999996 110.938 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -57.05 -29.23 63.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 65.239999999999995 110.92 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.69 ' O ' HG12 ' A' ' 55' ' ' VAL . 3.4 t30 -78.79 -28.77 44.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 63.039999999999999 110.89 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.81 -18.27 51.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 52.409999999999997 111.06 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.434 HE22 HD23 ' A' ' 94' ' ' LEU . 12.5 mm100 -92.46 -16.09 26.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 62.350000000000001 111.003 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 52' ' ' ASN . 8.9 p -84.94 -14.63 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 74.310000000000002 111.124 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 t -82.72 0.7 42.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 63.340000000000003 110.909 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.7 ' CD2' HG21 ' A' ' 113' ' ' VAL . 26.3 m-85 -120.59 -41.73 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 74.129999999999995 110.888 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.602 ' HE1' HD22 ' A' ' 94' ' ' LEU . 19.3 p90 -160.22 140.36 11.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 73.109999999999999 110.87 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -102.35 152.47 21.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 63.25 110.855 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 4.4 t -89.94 110.52 40.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.665 0.745 . . . . 74.420000000000002 110.825 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.801 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 53.6 Cg_endo -69.72 168.74 20.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.703 2.269 . . . . 73.430000000000007 112.328 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -39.4 6.53 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.654 2.236 . . . . 73.219999999999999 112.28 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 36.5 p-90 -73.26 -6.22 44.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 63.539999999999999 110.915 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.801 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -77.05 149.44 35.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 62.219999999999999 111.11 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 91' ' ' PRO . . . 66.06 47.09 2.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 63.32 111.081 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.5 mt -146.33 66.68 11.34 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.551 0.691 . . . . 61.43 110.895 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 151.26 69.41 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.651 2.234 . . . . 65.230000000000004 112.357 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.07 5.2 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 61.210000000000001 110.863 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.5 t -138.07 151.84 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 73.510000000000005 111.12 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.68 122.33 34.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 51.0 111.136 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.0 p -151.08 173.31 14.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 70.319999999999993 110.884 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -143.33 166.77 23.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 73.219999999999999 110.835 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.685 HD13 ' N ' ' A' ' 74' ' ' GLN . 2.5 tm? -120.66 135.71 55.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.91 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.685 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -113.21 136.33 52.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 73.439999999999998 110.897 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 15.7 p -127.37 131.8 50.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 63.109999999999999 110.926 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 p -93.6 156.4 16.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 74.299999999999997 111.122 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.554 ' HE ' HD12 ' A' ' 80' ' ' LEU . 6.1 ptm180 -158.37 112.38 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 63.43 110.876 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 53.74 39.59 30.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 54.240000000000002 110.863 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.86 18.31 77.45 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 71.239999999999995 112.501 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD12 ' HE ' ' A' ' 77' ' ' ARG . 13.0 mt -112.36 108.42 54.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.653 0.74 . . . . 72.430000000000007 110.883 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 91.45 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.65 2.234 . . . . 35.039999999999999 112.325 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.27 159.22 59.81 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.574 0.702 . . . . 75.230000000000004 111.008 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 114.85 3.84 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.271 . . . . 72.030000000000001 112.35 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.15 150.01 39.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 63.340000000000003 110.986 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.8 mt -147.05 133.34 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 63.219999999999999 110.883 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.53 98.93 0.19 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.732 -0.746 . . . . 42.100000000000001 112.453 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.6 mt -79.48 70.93 6.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 53.409999999999997 110.932 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -111.61 6.61 20.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 73.230000000000004 110.774 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -19.57 64.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 71.109999999999999 110.84 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.43 155.33 74.51 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.665 0.745 . . . . 74.319999999999993 110.79 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.606 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 54.3 Cg_endo -69.65 -33.23 17.42 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.705 2.27 . . . . 73.310000000000002 112.347 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.651 ' HB3' HG22 ' A' ' 118' ' ' VAL . 3.3 p90 -151.68 175.71 12.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 110.916 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -143.1 111.38 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 74.109999999999999 110.923 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.622 HD12 ' H ' ' A' ' 95' ' ' PHE . 13.9 tp -89.96 138.07 31.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 71.319999999999993 110.857 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.622 ' H ' HD12 ' A' ' 94' ' ' LEU . 80.1 m-85 -122.76 128.61 50.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 72.340000000000003 110.816 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.68 -158.62 21.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.758 -0.734 . . . . 51.450000000000003 112.534 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.43 -6.19 16.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 74.530000000000001 110.842 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.28 159.2 31.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 70.040000000000006 110.92 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.411 ' HD2' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -79.56 -19.39 49.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 75.409999999999997 110.899 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.411 HG13 ' HD2' ' A' ' 99' ' ' LYS . 17.3 m -80.46 -15.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 74.540000000000006 111.141 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 57.7 m -74.58 151.45 39.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 51.439999999999998 110.917 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.9 -23.34 65.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 55.350000000000001 110.845 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -134.13 108.2 8.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 75.340000000000003 110.942 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.9 p -105.03 108.62 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 63.25 111.114 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.563 HD21 ' NH1' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -113.46 -168.65 1.37 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 54.240000000000002 110.92 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -135.42 107.28 7.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 70.329999999999998 110.903 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.504 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -159.17 147.32 13.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.581 0.705 . . . . 54.200000000000003 110.916 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 -16.83 38.11 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 71.200000000000003 112.337 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 p -98.19 -25.7 14.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.426 . . . . 55.210000000000001 110.87 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.504 HD12 ' HB2' ' A' ' 107' ' ' HIS . 59.3 mt -77.96 116.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 64.25 111.131 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.4 m -93.75 170.34 9.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 72.25 110.802 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 p -43.57 -47.4 7.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 64.409999999999997 110.888 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.7 HG21 ' CD2' ' A' ' 57' ' ' TYR . 93.2 t -136.99 85.43 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 74.25 111.145 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.577 ' CD2' HG22 ' A' ' 137' ' ' VAL . 1.6 t60 -64.16 -51.71 62.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 74.230000000000004 110.835 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.475 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -171.83 175.19 3.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 111.13 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.444 HG21 ' CE2' ' A' ' 58' ' ' PHE . 8.3 p -147.86 138.22 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 65.150000000000006 111.176 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.406 HD21 ' HE1' ' A' ' 95' ' ' PHE . 1.6 pp -111.74 138.03 48.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 53.229999999999997 110.949 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.651 HG22 ' HB3' ' A' ' 92' ' ' PHE . 23.4 t -128.18 136.11 61.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 64.239999999999995 111.154 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.28 101.97 1.0 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 74.319999999999993 110.879 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.471 ' HB2' HG23 ' A' ' 127' ' ' VAL . 12.9 t-80 -70.32 106.99 3.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 75.299999999999997 110.91 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.14 -4.13 62.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 63.210000000000001 112.493 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -89.45 -43.54 5.2 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.709 -0.758 . . . . 61.009999999999998 112.522 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.86 8.21 17.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.768 0.318 . . . . 74.310000000000002 110.866 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 50.3 57.45 6.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 64.319999999999993 110.868 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 35.5 t -160.28 137.65 9.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 74.510000000000005 110.857 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -67.14 131.9 46.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.310000000000002 110.814 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 120' ' ' HIS . 26.4 t -110.03 108.56 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 63.240000000000002 111.2 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 150' ' ' LEU . 2.5 tt -101.22 132.62 46.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 73.340000000000003 110.955 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 69.6 mtm -132.7 132.25 42.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 62.43 110.9 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.601 ' CG ' HG21 ' A' ' 137' ' ' VAL . 11.0 m-20 -90.46 132.81 35.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 75.310000000000002 110.834 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.736 ' C ' HD22 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -70.12 -7.15 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 75.430000000000007 110.963 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.505 ' N ' HD13 ' A' ' 131' ' ' LEU . . . 113.78 51.29 0.49 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.73 . . . . 72.420000000000002 112.446 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -67.12 117.4 9.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.923 0.392 . . . . 73.439999999999998 110.873 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 97.9 m -55.59 -24.67 34.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 51.43 111.107 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -67.33 -68.2 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 73.310000000000002 110.874 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 132.68 118.06 1.9 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 73.340000000000003 112.482 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.601 HG21 ' CG ' ' A' ' 130' ' ' ASP . 13.2 t -88.79 152.43 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.945 0.403 . . . . 74.299999999999997 111.116 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -117.45 130.03 56.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 72.200000000000003 110.87 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 150' ' ' LEU . 0.7 OUTLIER -123.85 143.3 50.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 73.310000000000002 110.897 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.535 ' HB2' HD23 ' A' ' 139' ' ' LEU . 2.3 m120 56.13 22.69 6.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.129999999999995 110.871 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.69 20.53 70.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 43.119999999999997 112.487 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -146.54 142.3 27.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.895 0.379 . . . . 70.230000000000004 110.876 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -49.74 154.19 1.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 72.329999999999998 110.899 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.717 HD13 HD22 ' A' ' 150' ' ' LEU . 1.0 OUTLIER -152.2 -174.16 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 71.400000000000006 111.078 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.629 ' O ' HD12 ' A' ' 144' ' ' ILE . 3.9 tp10 -98.76 171.29 8.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 70.430000000000007 110.866 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 -179.81 3.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 73.329999999999998 110.918 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 51.22 35.61 13.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 73.530000000000001 110.887 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -148.33 161.33 34.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.661 0.744 . . . . 71.409999999999997 110.829 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 116.84 4.75 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.617 2.211 . . . . 65.099999999999994 112.356 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.717 HD22 HD13 ' A' ' 144' ' ' ILE . 1.0 OUTLIER -127.31 82.72 67.68 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.637 0.732 . . . . 74.400000000000006 110.954 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 144.85 55.29 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.663 2.242 . . . . 63.039999999999999 112.36 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.71 79.85 67.42 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.64 0.733 . . . . 71.030000000000001 111.123 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -177.98 2.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.269 . . . . 65.519999999999996 112.354 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 171' ' ' LEU . 13.3 m -68.42 146.18 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 70.25 111.134 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.84 -11.44 64.5 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.758 . . . . 72.010000000000005 112.507 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 m -96.88 179.15 5.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.989 0.423 . . . . 64.340000000000003 110.753 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 14.5 m -130.57 163.43 27.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 50.509999999999998 110.855 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 166' ' ' VAL . 8.0 mt -139.62 145.64 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 75.230000000000004 111.14 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.24 149.56 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 73.409999999999997 110.858 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -145.85 134.98 22.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 110.837 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 61.73 -136.92 46.65 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 65.140000000000001 112.493 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.56 19.21 15.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 74.299999999999997 110.885 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.02 156.5 2.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 70.230000000000004 110.817 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.0 t -91.49 -36.01 13.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 54.299999999999997 110.866 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.563 ' NH1' HD21 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -74.41 155.14 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 74.140000000000001 110.908 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 158' ' ' ILE . 21.4 t -136.52 138.66 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 111.128 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -94.12 101.77 13.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 110.933 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.05 110.4 22.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 74.0 110.914 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.89 153.03 4.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 65.129999999999995 111.124 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -160.63 148.81 16.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 73.109999999999999 110.956 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.486 ' HB2' HG21 ' A' ' 154' ' ' VAL . 5.8 tp -90.47 139.83 30.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 65.510000000000005 110.873 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -68.78 168.19 44.07 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.703 -0.761 . . . . 61.340000000000003 112.486 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 167.64 23.85 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.619 2.213 . . . . 70.140000000000001 112.387 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 175.94 7.47 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.672 2.248 . . . . 65.109999999999999 112.304 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.2 m -88.61 57.03 4.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 72.040000000000006 110.863 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.2 t -119.38 127.92 53.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 72.120000000000005 110.936 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 51.140000000000001 110.856 -179.748 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 121.42 0.456 . . . . 63.229999999999997 112.508 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 127.43 14.62 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.639 2.226 . . . . 70.25 112.341 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmm -118.77 144.49 46.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 61.140000000000001 110.907 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.7 143.23 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 74.129999999999995 111.162 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 m -151.79 139.98 20.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 65.329999999999998 111.133 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.2 t -76.9 167.01 22.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 42.039999999999999 110.856 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.442 ' HB ' HD23 ' A' ' 7' ' ' LEU . 57.8 p -101.25 -19.05 15.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 74.439999999999998 111.12 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.53 18.98 79.62 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.757 -0.735 . . . . 65.040000000000006 112.484 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.442 HD23 ' HB ' ' A' ' 5' ' ' THR . 3.5 mm? -74.05 99.18 3.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.779 0.323 . . . . 61.240000000000002 110.918 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 tp -70.43 115.87 10.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 74.019999999999996 110.885 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.3 m -95.65 133.95 39.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 73.209999999999994 110.846 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.3 mmt85 -93.61 146.03 24.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 73.129999999999995 110.883 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.5 p -87.97 150.19 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 74.540000000000006 111.137 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.18 160.5 15.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 73.239999999999995 111.044 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.53 168.3 12.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 73.439999999999998 111.139 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.0 t -116.49 111.8 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 55.439999999999998 111.113 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -124.0 106.23 10.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 64.150000000000006 110.926 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -103.23 162.96 12.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 110.888 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.16 130.62 51.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 73.150000000000006 111.113 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.02 143.34 7.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 65.430000000000007 111.112 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.5 101.96 3.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 110.91 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.5 mt -102.29 136.44 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 111.06 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.04 124.95 22.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 53.43 111.089 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -54.04 160.62 2.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.556 0.693 . . . . 74.109999999999999 110.959 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 167.79 23.41 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.653 2.236 . . . . 72.420000000000002 112.371 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 167.89 23.16 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.679 2.253 . . . . 53.009999999999998 112.324 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 167.7 23.83 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.726 2.284 . . . . 71.019999999999996 112.329 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 177.55 5.44 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.73 2.287 . . . . 64.549999999999997 112.349 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -121.05 145.18 48.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 45.310000000000002 110.907 179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.1 m -51.47 144.43 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 73.239999999999995 111.059 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 27' ' ' LYS . 45.4 t -143.04 147.32 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 70.239999999999995 111.11 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -51.78 168.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 75.319999999999993 110.927 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.574 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.5 pp -51.9 130.13 28.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 64.099999999999994 110.894 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 168.25 18.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 64.299999999999997 111.125 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -59.09 -38.9 80.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 73.019999999999996 110.923 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.94 -25.68 59.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 73.340000000000003 111.066 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.11 -27.64 67.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 74.019999999999996 111.083 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.78 -35.73 24.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 74.099999999999994 110.941 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.07 -45.63 56.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 74.310000000000002 110.877 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 38' ' ' LEU . 4.1 mm? -109.4 85.85 3.89 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.545 0.688 . . . . 70.420000000000002 110.944 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -178.44 2.35 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.622 2.215 . . . . 73.400000000000006 112.325 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.463 ' HB2' HD12 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -58.74 170.66 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 71.510000000000005 110.951 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -68.36 -47.64 66.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 72.319999999999993 110.857 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.691 ' O ' HG23 ' A' ' 46' ' ' THR . 1.1 pp -81.08 -29.53 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 72.140000000000001 111.158 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 40' ' ' GLN . 63.6 mt -79.07 -24.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 75.219999999999999 111.142 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.14 -11.76 64.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.697 -0.763 . . . . 54.140000000000001 112.573 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 42' ' ' ILE . 7.5 p -110.31 -24.78 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.902 0.382 . . . . 62.420000000000002 111.108 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 42' ' ' ILE . 62.9 p -74.64 153.46 38.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 53.399999999999999 111.146 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.737 ' O ' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.28 160.95 50.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.604 0.716 . . . . 53.130000000000003 110.843 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -37.71 8.79 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 71.25 112.3 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.88 -14.5 31.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.340000000000003 111.076 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -82.22 -59.1 2.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 61.32 110.928 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.928 HD13 ' N ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -62.07 -16.55 52.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 62.030000000000001 110.94 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.928 ' N ' HD13 ' A' ' 51' ' ' LEU . 4.1 t30 -81.78 -39.42 24.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 110.882 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.29 -19.58 63.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 75.430000000000007 111.094 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.576 ' OE1' HD12 ' A' ' 94' ' ' LEU . 4.4 mm-40 -86.24 -14.61 43.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 73.430000000000007 110.92 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 t -66.44 -42.1 89.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 71.409999999999997 111.192 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.4 m -59.55 -19.87 51.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.097 -0.502 . . . . 74.25 110.817 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.742 ' CD2' HG21 ' A' ' 113' ' ' VAL . 31.3 m-85 -97.26 -44.49 6.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 72.109999999999999 110.897 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' ' 116' ' ' VAL . 30.5 p90 -178.39 138.76 0.18 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.904 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -108.84 136.05 49.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 62.509999999999998 110.9 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 9.5 p -58.34 113.13 5.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.607 0.718 . . . . 75.310000000000002 110.855 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.807 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 53.7 Cg_endo -69.7 168.69 20.75 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.671 2.247 . . . . 63.539999999999999 112.357 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -37.93 8.48 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.712 2.275 . . . . 75.019999999999996 112.341 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.465 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 37.6 p-90 -74.86 -5.4 43.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.169 -0.469 . . . . 73.230000000000004 110.926 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.807 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -78.93 151.43 31.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 73.219999999999999 111.029 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 63.96 47.18 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 62.299999999999997 111.087 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.1 mt -146.07 67.92 12.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.616 0.722 . . . . 74.140000000000001 110.817 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 152.32 68.9 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.681 2.254 . . . . 74.010000000000005 112.282 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.23 9.5 2.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 64.129999999999995 110.879 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.488 HG12 ' HB3' ' A' ' 124' ' ' ARG . 10.5 p -142.84 152.34 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 43.140000000000001 111.129 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.61 116.03 27.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 63.119999999999997 111.096 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.6 p -151.2 177.56 10.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 71.209999999999994 110.924 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -148.72 167.79 24.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 63.200000000000003 110.862 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.711 HD13 ' N ' ' A' ' 74' ' ' GLN . 1.9 tm? -122.23 136.11 54.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 64.310000000000002 110.899 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.711 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -112.07 135.63 52.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 73.140000000000001 110.913 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 26.5 p -126.85 137.11 53.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 60.530000000000001 110.85 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -105.69 145.7 30.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 74.129999999999995 111.158 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -146.32 116.96 7.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 55.310000000000002 110.889 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 54.21 37.18 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 61.399999999999999 110.875 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.43 19.53 78.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.682 -0.77 . . . . 75.430000000000007 112.539 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.5 mt -109.75 108.58 59.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.642 0.734 . . . . 72.239999999999995 110.883 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 94.89 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.752 2.302 . . . . 72.340000000000003 112.374 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.3 mt -73.34 159.23 85.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.632 0.73 . . . . 62.43 110.87 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 116.18 4.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.665 2.243 . . . . 72.019999999999996 112.336 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 146.08 55.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 63.109999999999999 111.098 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.3 mt -148.94 143.38 26.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 70.109999999999999 110.901 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.9 104.91 0.65 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.702 -0.761 . . . . 74.430000000000007 112.523 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.57 70.63 2.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.871 0.367 . . . . 71.049999999999997 110.95 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -112.04 6.28 19.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 110.848 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.29 -19.47 63.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 75.439999999999998 110.911 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -137.84 154.78 74.87 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.669 0.747 . . . . 71.319999999999993 110.906 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' O ' HG13 ' A' ' 118' ' ' VAL . 54.6 Cg_endo -69.74 -25.34 28.79 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.28 . . . . 50.210000000000001 112.324 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.7 ' HB3' HG22 ' A' ' 118' ' ' VAL . 14.9 p90 -156.46 178.84 9.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.297 -0.41 . . . . 73.209999999999994 110.848 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -144.44 111.52 5.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.108 -0.496 . . . . 62.439999999999998 110.916 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.66 HD21 HG13 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -92.3 125.96 37.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 72.540000000000006 110.854 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.524 ' N ' HD23 ' A' ' 94' ' ' LEU . 94.4 m-85 -116.21 111.81 20.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 61.329999999999998 110.854 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -165.4 -150.66 6.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 74.310000000000002 112.49 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.77 -2.95 10.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.825 0.345 . . . . 70.299999999999997 110.923 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.01 162.49 28.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 74.420000000000002 110.802 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.16 -8.89 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 110.892 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -91.51 -17.75 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 72.340000000000003 111.151 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.607 ' HA ' HD13 ' A' ' 94' ' ' LEU . 12.1 p -63.81 171.09 2.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 53.25 110.909 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.48 -3.49 33.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 54.140000000000001 110.932 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -150.52 106.81 3.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 75.129999999999995 110.892 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.8 t -90.76 108.74 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 72.430000000000007 111.133 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.658 HD13 HD13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -110.67 -169.02 1.38 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 63.140000000000001 110.924 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -137.97 107.05 6.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.200000000000003 110.894 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.47 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -165.43 143.51 5.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.563 0.697 . . . . 65.420000000000002 110.869 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -12.85 33.81 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.694 2.263 . . . . 72.400000000000006 112.337 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 p -100.49 -27.55 13.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 65.299999999999997 110.833 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.658 HD13 HD13 ' A' ' 105' ' ' LEU . 57.6 mt -75.48 109.36 8.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 74.510000000000005 111.131 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.8 m -89.7 170.58 10.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 72.329999999999998 110.89 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.46 -40.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 70.340000000000003 110.893 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.742 HG21 ' CD2' ' A' ' 57' ' ' TYR . 84.8 t -140.95 79.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 52.210000000000001 111.131 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.613 ' HD2' HG12 ' A' ' 137' ' ' VAL . 3.7 t60 -64.15 -49.34 72.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.907 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -166.17 174.76 8.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 71.319999999999993 111.124 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 58' ' ' PHE . 6.2 p -155.69 136.1 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 62.210000000000001 111.114 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.411 HD13 ' CD2' ' A' ' 126' ' ' PHE . 2.0 pp -111.58 140.52 46.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 71.329999999999998 110.967 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.7 HG22 ' HB3' ' A' ' 92' ' ' PHE . 14.9 t -130.19 134.75 62.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 70.230000000000004 111.089 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.28 94.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.886 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.502 ' HB2' HG23 ' A' ' 127' ' ' VAL . 12.2 t-80 -64.86 107.88 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 110.886 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.94 -4.62 67.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.743 -0.741 . . . . 71.109999999999999 112.572 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -88.01 -42.45 5.97 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.701 -0.761 . . . . 61.310000000000002 112.487 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.89 5.74 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.738 0.304 . . . . 73.209999999999994 110.883 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.488 ' HB3' HG12 ' A' ' 69' ' ' VAL . 0.2 OUTLIER 53.31 42.46 32.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 75.209999999999994 110.886 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 73.9 m -146.05 137.22 24.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 52.25 110.906 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CD2' HD13 ' A' ' 117' ' ' LEU . 58.9 m-85 -66.13 132.52 48.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.845 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.502 HG23 ' HB2' ' A' ' 120' ' ' HIS . 42.3 t -111.7 108.44 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 75.450000000000003 111.121 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 137' ' ' VAL . 4.8 tt -102.32 125.62 49.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 54.310000000000002 110.843 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 33.9 mtm -127.1 139.45 52.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 54.009999999999998 110.919 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.668 ' OD2' HG13 ' A' ' 137' ' ' VAL . 28.6 t0 -87.74 132.4 34.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 63.020000000000003 110.888 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 113' ' ' VAL . 1.5 pt? -60.24 -20.92 60.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 74.510000000000005 110.945 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.82 45.88 0.75 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 75.040000000000006 112.471 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.0 t -76.89 157.66 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 72.549999999999997 110.875 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 99.7 m -64.21 -24.14 67.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 72.129999999999995 111.111 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -80.67 -67.39 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 64.109999999999999 110.856 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.57 143.43 13.71 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.735 -0.745 . . . . 40.240000000000002 112.552 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.668 HG13 ' OD2' ' A' ' 130' ' ' ASP . 2.1 m -91.88 173.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 74.230000000000004 111.103 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -114.4 137.8 51.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 71.239999999999995 110.936 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 140' ' ' ASN . 3.1 tm? -113.48 123.99 51.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.427 . . . . 72.109999999999999 110.918 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.68 ' HB2' HD13 ' A' ' 139' ' ' LEU . 2.0 m120 61.53 22.47 12.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 73.329999999999998 110.876 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.1 25.44 40.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 33.240000000000002 112.54 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 144' ' ' ILE . 4.4 t30 -145.15 134.01 22.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.859 0.361 . . . . 42.240000000000002 110.9 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -60.32 133.65 56.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 63.539999999999999 110.823 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 142' ' ' ASN . 0.0 OUTLIER -141.62 175.61 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 71.319999999999993 111.121 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.67 -175.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 61.549999999999997 110.942 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 167.07 16.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 72.519999999999996 110.88 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 59.02 43.04 18.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 73.219999999999999 110.833 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -142.2 155.09 65.03 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.596 0.712 . . . . 70.230000000000004 110.906 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 102.84 1.07 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.724 2.282 . . . . 64.239999999999995 112.296 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.0 mt -110.69 83.37 3.42 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.627 0.727 . . . . 60.43 110.917 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.84 129.22 17.15 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.637 2.225 . . . . 74.409999999999997 112.305 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.562 ' O ' HG21 ' A' ' 169' ' ' VAL . . . -116.08 79.45 8.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 44.32 111.125 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 170.85 15.63 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.701 2.267 . . . . 70.109999999999999 112.365 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.432 HG21 ' HB2' ' A' ' 171' ' ' LEU . 13.1 m -50.76 142.4 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 64.439999999999998 111.156 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.08 -12.86 62.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.75 -0.738 . . . . 61.5 112.476 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 177.26 5.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 60.109999999999999 110.892 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 40.7 m -130.51 165.2 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 72.430000000000007 110.83 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 166' ' ' VAL . 3.3 mt -142.58 150.73 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 74.519999999999996 111.2 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -152.48 162.8 40.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 70.109999999999999 110.911 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -159.44 134.25 7.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 64.140000000000001 110.947 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.09 -152.06 51.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.741 -0.742 . . . . 54.219999999999999 112.454 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -102.62 13.89 33.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 70.120000000000005 110.801 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.81 158.62 18.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 63.439999999999998 110.852 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.52 -35.83 14.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.869 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -53.36 153.15 4.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 71.129999999999995 110.908 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 158' ' ' ILE . 26.3 t -145.65 138.54 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 51.420000000000002 111.181 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.564 ' HB3' HD11 ' A' ' 73' ' ' LEU . 9.6 m-85 -97.7 101.44 12.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 74.540000000000006 110.994 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -99.13 110.39 22.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 75.430000000000007 110.858 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 152' ' ' ALA . 2.9 t -78.64 153.05 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 61.25 111.135 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -161.1 151.88 18.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 72.510000000000005 110.872 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.432 ' HB2' HG21 ' A' ' 154' ' ' VAL . 5.7 tp -96.67 135.07 39.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 73.200000000000003 110.912 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -64.65 177.65 9.48 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 52.509999999999998 112.471 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 167.77 23.6 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.656 2.238 . . . . 63.420000000000002 112.26 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 107.69 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.611 2.208 . . . . 51.530000000000001 112.41 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.7 m -95.73 169.63 9.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 51.310000000000002 110.807 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.4 m 53.58 29.63 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.030000000000001 110.902 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.498 . . . . 73.200000000000003 110.81 -179.83 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 CA-C-O 121.399 0.444 . . . . 45.43 112.507 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -35.48 12.53 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.647 2.231 . . . . 70.140000000000001 112.397 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mmt 57.41 50.79 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 65.400000000000006 110.857 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.1 m -63.93 158.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 75.040000000000006 111.137 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.6 p -126.64 151.71 47.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 70.109999999999999 111.112 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 m -136.59 169.71 17.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 55.409999999999997 110.853 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 t -108.88 -19.15 13.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 64.010000000000005 111.123 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.3 20.93 11.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.787 -0.72 . . . . 74.409999999999997 112.493 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.17 117.85 35.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 71.409999999999997 110.96 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -142.54 159.09 42.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 62.32 110.898 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.4 p -134.07 161.22 35.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 71.409999999999997 110.881 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -138.9 131.07 28.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 74.140000000000001 110.859 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.08 149.87 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 111.146 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.95 160.89 42.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.119 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.28 168.18 13.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 23.539999999999999 111.122 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 14' ' ' VAL . 3.9 p -119.48 115.2 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.443 . . . . 54.530000000000001 111.145 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -143.65 136.35 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 73.099999999999994 110.876 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -141.9 157.4 45.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 70.310000000000002 110.916 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.6 114.52 10.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 74.209999999999994 111.145 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.09 152.16 12.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 51.210000000000001 111.132 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -107.04 101.96 11.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 72.049999999999997 110.863 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.75 130.52 54.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 61.009999999999998 111.082 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.6 -178.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 74.409999999999997 111.181 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -54.03 154.49 7.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.577 0.704 . . . . 72.230000000000004 110.851 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 167.65 23.79 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.675 2.25 . . . . 73.049999999999997 112.356 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 168.38 21.74 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.601 2.2 . . . . 61.229999999999997 112.39 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.459 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.2 Cg_endo -69.73 112.23 3.02 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.719 2.279 . . . . 72.549999999999997 112.292 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 52.6 Cg_endo -69.85 -170.77 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.7 2.267 . . . . 70.349999999999994 112.277 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 153.89 31.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 71.540000000000006 110.832 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 m -48.99 140.68 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 111.158 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.48 154.57 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 55.350000000000001 111.085 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -50.79 168.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 75.219999999999999 110.948 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.414 ' H ' HD12 ' A' ' 31' ' ' LEU . 1.9 mp -49.93 166.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.209999999999994 110.937 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 168.47 5.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 71.400000000000006 111.105 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.61 -38.35 90.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 43.109999999999999 110.888 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.18 -18.72 48.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 55.149999999999999 111.124 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.8 -23.68 63.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 64.299999999999997 111.099 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -90.57 -17.68 26.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 72.040000000000006 110.923 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -72.91 -48.12 39.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 73.140000000000001 110.928 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 pp -51.32 155.34 2.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.613 0.72 . . . . 70.439999999999998 110.944 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 159.6 52.85 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.673 2.249 . . . . 70.120000000000005 112.383 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.425 ' HG2' HD12 ' A' ' 43' ' ' ILE . 7.6 mm-40 -92.97 171.63 8.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 75.049999999999997 110.983 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.49 ' ND1' HG23 ' A' ' 42' ' ' ILE . 10.3 p80 -51.83 -36.6 48.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.817 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 46' ' ' THR . 1.6 pp -74.7 -33.17 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 72.25 111.119 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.437 ' CG2' HD12 ' A' ' 51' ' ' LEU . 57.1 mt -79.71 -25.29 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.420000000000002 111.145 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -10.41 58.21 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.703 -0.76 . . . . 44.119999999999997 112.476 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.1 t -113.07 -26.11 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 74.5 111.079 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 42' ' ' ILE . 39.7 p -52.01 153.64 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 52.229999999999997 111.175 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.546 ' O ' HD22 ' A' ' 51' ' ' LEU . 1.1 m-20 -63.49 160.75 40.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.604 0.716 . . . . 75.109999999999999 110.848 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -35.65 12.22 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.685 2.257 . . . . 63.240000000000002 112.387 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.34 -25.22 22.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 71.540000000000006 111.21 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -76.63 -60.82 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 74.420000000000002 110.916 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.4 OUTLIER -53.6 -29.06 35.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 74.010000000000005 110.975 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.603 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.5 t30 -76.54 -32.82 58.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 73.340000000000003 110.912 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.37 -18.93 47.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 62.210000000000001 111.113 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -93.22 -18.97 21.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 72.150000000000006 110.899 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.526 HG23 ' HG3' ' A' ' 59' ' ' GLN . 5.4 p -85.28 -16.52 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 73.510000000000005 111.218 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.2 t -77.11 -6.39 52.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 72.329999999999998 110.877 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.733 ' CD2' HG11 ' A' ' 113' ' ' VAL . 29.7 m-85 -118.65 -50.56 2.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 64.329999999999998 110.884 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.482 ' CE1' HD21 ' A' ' 94' ' ' LEU . 39.1 m-85 -149.25 155.75 41.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 63.520000000000003 110.875 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.526 ' HG3' HG23 ' A' ' 55' ' ' VAL . 1.4 mp0 -118.91 152.33 36.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.516 . . . . 51.329999999999998 110.972 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 12.2 t -92.6 109.39 38.3 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.632 0.729 . . . . 63.119999999999997 110.93 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.789 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 53.6 Cg_endo -69.73 168.79 20.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 54.100000000000001 112.322 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.64 -39.01 7.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.683 2.256 . . . . 74.430000000000007 112.339 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.456 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 37.7 p-90 -73.76 -5.75 42.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 70.049999999999997 110.938 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.789 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -78.12 149.62 33.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 42.210000000000001 111.104 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 91' ' ' PRO . . . 64.19 38.44 8.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 64.299999999999997 111.097 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 65' ' ' ALA . 77.6 mt -135.95 66.94 62.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.56 0.695 . . . . 72.299999999999997 110.842 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 151.19 69.09 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.645 2.23 . . . . 73.150000000000006 112.362 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.6 m -132.66 5.29 3.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 63.210000000000001 110.822 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.425 HG12 ' HB3' ' A' ' 124' ' ' ARG . 9.8 p -145.3 152.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 64.319999999999993 111.103 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 171' ' ' LEU . . . -88.96 123.67 33.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 73.150000000000006 111.095 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.4 p -151.16 178.06 9.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 73.120000000000005 110.865 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -152.2 165.48 34.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 74.040000000000006 110.939 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.782 HD22 HD11 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -128.5 136.39 50.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 70.319999999999993 110.873 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.71 135.39 44.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 110.908 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.409 ' SG ' HD23 ' A' ' 73' ' ' LEU . 22.9 m -122.28 137.1 54.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.902 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.7 p -110.12 150.59 28.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 61.329999999999998 111.129 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -155.62 123.3 5.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 74.530000000000001 110.936 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 55.66 32.58 19.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 74.299999999999997 110.838 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.97 17.25 79.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.773 -0.727 . . . . 65.430000000000007 112.491 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.8 mt -107.42 108.74 62.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.716 . . . . 74.239999999999995 110.959 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 90.17 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.691 2.261 . . . . 72.200000000000003 112.34 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.1 mt -70.55 159.49 84.81 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.622 0.725 . . . . 74.450000000000003 110.888 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 124.31 10.95 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.72 2.28 . . . . 71.030000000000001 112.334 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.67 148.4 51.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 64.549999999999997 111.111 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 mt -148.25 138.27 22.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 65.120000000000005 110.966 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.16 106.05 1.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 45.219999999999999 112.446 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.782 HD11 HD22 ' A' ' 73' ' ' LEU . 13.8 mt -76.43 70.87 3.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.339 . . . . 65.439999999999998 110.953 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -111.81 6.34 19.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 74.340000000000003 110.898 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -69.52 -19.32 63.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 71.510000000000005 110.891 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -140.28 155.4 70.28 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 75.200000000000003 110.905 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.525 ' O ' HG13 ' A' ' 118' ' ' VAL . 54.4 Cg_endo -69.72 -26.72 27.49 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.747 2.298 . . . . 72.120000000000005 112.336 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.718 ' HB3' HG22 ' A' ' 118' ' ' VAL . 35.1 p90 -155.44 172.03 18.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 73.099999999999994 110.957 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -138.98 117.1 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 75.219999999999999 110.989 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.745 HD22 ' HB ' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -89.81 126.0 35.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 71.430000000000007 110.946 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.465 ' N ' HD13 ' A' ' 94' ' ' LEU . 78.4 m-85 -114.97 122.06 45.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 72.209999999999994 110.868 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.43 -149.6 9.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 63.020000000000003 112.491 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.78 -0.49 10.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.868 0.366 . . . . 74.030000000000001 110.859 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.8 t -68.31 161.57 27.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 54.039999999999999 110.845 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.75 -8.95 59.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 75.019999999999996 110.83 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.4 m -101.89 -6.66 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.401 . . . . 73.140000000000001 111.143 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 94' ' ' LEU . 13.0 p -67.68 163.27 21.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 74.439999999999998 110.903 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -93.18 -0.78 56.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 75.230000000000004 110.883 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -152.93 106.18 3.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 45.310000000000002 110.988 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.4 t -94.3 109.31 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 64.030000000000001 111.102 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.634 HD13 HD13 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -111.79 -168.97 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 64.430000000000007 110.909 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.41 106.67 5.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 73.120000000000005 110.921 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.444 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -166.19 143.59 4.43 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.533 0.683 . . . . 71.200000000000003 110.913 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -12.37 32.67 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.673 2.249 . . . . 50.5 112.341 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.2 p -99.03 -28.07 13.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.219999999999999 110.883 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 105' ' ' LEU . 59.3 mt -74.55 117.97 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 65.549999999999997 111.093 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.8 m -96.01 170.68 9.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 70.120000000000005 110.83 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.76 -32.6 3.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 73.129999999999995 110.832 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.755 HG23 HD13 ' A' ' 131' ' ' LEU . 2.3 m -147.1 79.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 73.0 111.117 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.492 ' CD2' HG22 ' A' ' 137' ' ' VAL . 2.1 t60 -65.4 -58.65 5.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.81 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -157.04 176.98 12.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 64.25 111.105 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.745 ' HB ' HD22 ' A' ' 94' ' ' LEU . 14.7 p -155.35 135.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 64.450000000000003 111.135 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.555 HD13 ' CD2' ' A' ' 126' ' ' PHE . 3.1 pp -112.04 141.2 46.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 75.120000000000005 110.901 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 92' ' ' PHE . 17.0 t -128.47 135.27 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 111.099 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 90.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 70.420000000000002 110.938 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -61.77 107.64 0.87 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 64.420000000000002 110.863 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.3 -6.24 64.8 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 52.32 112.451 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -88.73 -51.05 3.16 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.736 -0.745 . . . . 43.100000000000001 112.469 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -99.05 -2.24 37.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.848 0.356 . . . . 74.239999999999995 110.927 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.425 ' HB3' HG12 ' A' ' 69' ' ' VAL . 0.2 OUTLIER 60.48 30.75 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 74.319999999999993 110.901 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 58.7 m -137.61 138.24 39.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 60.310000000000002 110.856 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.555 ' CD2' HD13 ' A' ' 117' ' ' LEU . 59.2 m-85 -64.67 130.07 42.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 71.340000000000003 110.927 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.5 t -108.79 109.67 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 73.219999999999999 111.119 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.56 HD23 HD12 ' A' ' 150' ' ' LEU . 4.6 tt -102.03 131.56 48.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 73.299999999999997 110.963 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 33.1 mtm -131.99 137.74 48.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 64.439999999999998 110.96 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.42 132.63 34.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.322 -0.399 . . . . 54.140000000000001 110.887 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.755 HD13 HG23 ' A' ' 113' ' ' VAL . 1.3 pt? -64.71 -14.64 59.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 34.43 110.901 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.405 ' N ' HD23 ' A' ' 131' ' ' LEU . . . 107.03 49.55 0.88 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 63.240000000000002 112.489 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.2 p -78.93 153.78 30.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 61.32 110.858 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.2 t -75.79 -5.51 46.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 63.350000000000001 111.097 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.8 -64.87 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 74.030000000000001 110.902 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.52 142.99 6.5 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.76 -0.733 . . . . 62.130000000000003 112.52 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.492 HG22 ' CD2' ' A' ' 114' ' ' HIS . 21.7 t -119.71 146.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.368 . . . . 63.140000000000001 111.128 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -98.98 151.23 21.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 62.329999999999998 110.874 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.706 HD13 ' HB2' ' A' ' 140' ' ' ASN . 3.2 tm? -135.48 123.61 22.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.869 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.706 ' HB2' HD13 ' A' ' 139' ' ' LEU . 1.2 m-80 58.55 22.11 9.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 44.340000000000003 110.884 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.69 18.77 54.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 51.100000000000001 112.433 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -143.39 125.19 15.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 64.239999999999995 110.897 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 ptt85 -59.74 133.33 55.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 74.510000000000005 110.839 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 142' ' ' ASN . 0.0 OUTLIER -141.4 177.97 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 70.5 111.121 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -58.39 -176.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 73.319999999999993 110.935 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.68 -170.37 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 63.229999999999997 110.882 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 39.71 39.33 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 73.409999999999997 110.909 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -139.76 160.75 59.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.675 0.75 . . . . 72.310000000000002 110.853 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.64 2.86 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.714 2.276 . . . . 51.130000000000003 112.319 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.56 HD12 HD23 ' A' ' 128' ' ' LEU . 3.1 mt -118.05 83.75 20.1 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.541 0.686 . . . . 64.099999999999994 110.868 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 130.01 18.64 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.671 2.247 . . . . 65.340000000000003 112.404 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.438 ' O ' HG21 ' A' ' 169' ' ' VAL . . . -114.38 77.09 4.04 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.577 0.703 . . . . 71.310000000000002 111.152 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 165.35 31.23 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.631 2.221 . . . . 72.120000000000005 112.424 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.4 m -52.06 144.27 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 71.430000000000007 111.126 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.16 -9.54 69.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.724 -0.75 . . . . 74.409999999999997 112.486 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.1 p -96.25 -174.48 3.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 73.230000000000004 110.921 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.7 m -138.85 165.5 26.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 51.5 110.87 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.6 mt -141.45 150.49 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 71.230000000000004 111.136 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.08 162.84 40.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 73.099999999999994 110.943 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -161.79 139.48 8.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 74.25 110.893 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 60.98 -148.83 45.5 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.714 -0.755 . . . . 62.200000000000003 112.506 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -107.23 10.51 29.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 75.329999999999998 110.886 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.6 p -62.7 159.97 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.439999999999998 110.812 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 166' ' ' VAL . 58.1 m -91.54 -25.7 19.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 71.329999999999998 110.848 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -53.28 147.57 10.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 62.200000000000003 110.896 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 164' ' ' SER . 21.2 t -144.61 130.13 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 72.400000000000006 111.149 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.622 ' HB3' HD21 ' A' ' 73' ' ' LEU . 7.0 m-85 -98.48 103.95 15.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 71.25 111.003 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.49 110.32 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 71.129999999999995 110.84 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.668 HG22 HD12 ' A' ' 73' ' ' LEU . 3.2 t -76.21 153.54 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 75.439999999999998 111.187 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.5 148.26 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 73.030000000000001 110.918 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 70' ' ' ALA . 17.1 tp -94.09 132.7 38.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 74.349999999999994 110.928 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.38 178.15 1.05 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.787 -0.72 . . . . 61.140000000000001 112.484 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 167.65 23.83 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.75 2.3 . . . . 74.010000000000005 112.331 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 159.99 51.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.665 2.243 . . . . 73.319999999999993 112.359 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.6 t -122.38 170.43 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 73.109999999999999 110.831 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.9 m -110.39 -38.44 5.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 73.219999999999999 110.848 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 74.329999999999998 110.861 -179.785 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 121.407 0.449 . . . . 51.439999999999998 112.537 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 123.7 10.39 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.696 2.264 . . . . 65.450000000000003 112.397 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mmt -121.62 119.7 32.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 75.120000000000005 110.905 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.5 m -77.22 157.5 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 72.239999999999995 111.064 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 t -130.29 158.59 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 62.329999999999998 111.165 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -77.46 169.06 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 61.229999999999997 110.908 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.563 HG23 ' H ' ' A' ' 7' ' ' LEU . 11.7 t -114.79 -19.32 11.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 111.199 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.6 21.12 62.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 75.150000000000006 112.469 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.563 ' H ' HG23 ' A' ' 5' ' ' THR . 3.5 pp -52.46 127.41 22.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 72.510000000000005 110.921 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.03 165.75 6.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 73.540000000000006 110.909 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -119.21 154.58 33.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.329999999999998 110.864 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -135.71 141.88 44.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 74.349999999999994 110.868 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.92 149.72 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 75.239999999999995 111.152 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.19 157.09 43.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 111.076 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.01 166.55 16.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 72.439999999999998 111.101 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 t -119.04 113.51 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 75.430000000000007 111.113 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.88 150.17 48.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 74.450000000000003 110.897 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 162.58 34.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 51.140000000000001 110.883 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.01 174.0 12.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 24.539999999999999 111.099 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.01 151.93 41.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 72.329999999999998 111.153 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -123.87 120.96 34.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.396 . . . . 61.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.3 mm -103.77 139.49 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 111.139 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.75 -179.06 5.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 74.230000000000004 111.167 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -101.07 160.65 26.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.544 0.687 . . . . 73.319999999999993 110.942 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 167.74 23.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.677 2.252 . . . . 64.340000000000003 112.365 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 167.95 22.88 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.691 2.261 . . . . 70.519999999999996 112.32 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 167.56 24.12 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.751 2.301 . . . . 74.209999999999994 112.323 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 175.5 7.95 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.677 2.251 . . . . 74.120000000000005 112.374 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.43 146.47 47.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 62.420000000000002 110.915 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.0 m -50.99 169.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 62.130000000000003 111.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.12 107.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 51.0 111.193 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -154.65 167.2 30.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.25 110.948 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.19 101.37 10.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 74.239999999999995 110.916 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.19 -174.13 2.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 54.329999999999998 111.145 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 36' ' ' LYS . 4.8 mm-40 -55.43 -31.9 62.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 75.109999999999999 110.914 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HA ' ' HG2' ' A' ' 37' ' ' GLN . . . -61.99 -14.81 38.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 64.230000000000004 111.086 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.659 ' O ' HD13 ' A' ' 38' ' ' LEU . . . -88.37 -39.84 14.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 70.239999999999995 111.121 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -81.48 -13.01 58.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 74.5 110.864 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 34' ' ' ALA . 9.8 pt20 -113.18 30.83 6.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 64.030000000000001 110.907 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -45.86 154.07 0.6 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.652 0.739 . . . . 74.430000000000007 110.983 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.409 ' HD2' ' HG ' ' A' ' 38' ' ' LEU . 53.8 Cg_endo -69.75 -179.41 2.89 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.627 2.218 . . . . 71.450000000000003 112.278 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.643 ' HG3' HD12 ' A' ' 43' ' ' ILE . 25.3 mt-30 -75.33 172.85 11.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 55.149999999999999 110.908 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.594 ' ND1' HG23 ' A' ' 42' ' ' ILE . 14.2 p80 -62.3 -43.29 99.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.929 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.594 HG23 ' ND1' ' A' ' 41' ' ' HIS . 1.1 pp -73.6 -32.62 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 111.193 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.643 HD12 ' HG3' ' A' ' 40' ' ' GLN . 58.5 mt -79.49 -24.5 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 111.104 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.06 -5.24 70.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.698 -0.763 . . . . 74.150000000000006 112.496 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 42' ' ' ILE . 9.4 p -115.18 -21.99 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 62.119999999999997 111.105 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 42' ' ' ILE . 34.5 p -50.43 153.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.109999999999999 111.131 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.529 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -72.51 159.35 85.6 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.617 0.722 . . . . 70.450000000000003 110.843 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -37.52 9.02 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.668 2.246 . . . . 64.519999999999996 112.333 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.03 -16.87 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 74.409999999999997 111.127 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -83.52 -52.46 6.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.510000000000005 110.906 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -65.65 -29.85 70.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 62.109999999999999 110.933 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.593 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.7 t30 -78.45 -35.05 47.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 73.5 110.918 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.2 -19.87 65.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 45.130000000000003 111.079 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.502 ' NE2' HD12 ' A' ' 94' ' ' LEU . 1.6 mt-30 -90.92 -12.91 34.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 65.200000000000003 110.893 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.84 -37.27 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 75.040000000000006 111.135 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 t -60.12 -19.1 51.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 73.5 110.825 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.794 ' CD2' HG11 ' A' ' 113' ' ' VAL . 28.9 m-85 -100.9 -48.34 4.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 74.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -158.31 144.47 17.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 75.120000000000005 110.878 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -115.03 123.07 48.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 64.409999999999997 110.953 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 8.5 p -56.84 111.09 2.9 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.612 0.72 . . . . 42.32 110.905 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.808 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 53.4 Cg_endo -69.86 169.19 19.6 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.644 2.23 . . . . 63.420000000000002 112.304 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -40.68 5.11 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.744 2.296 . . . . 70.230000000000004 112.318 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.449 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 35.7 p-90 -72.14 -6.78 45.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 70.5 110.921 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.808 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -77.22 150.96 35.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 74.549999999999997 111.097 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' A' ' 91' ' ' PRO . . . 64.9 47.44 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 74.129999999999995 111.071 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.1 mt -146.33 66.67 11.35 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.592 0.71 . . . . 71.219999999999999 110.917 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 150.97 68.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.713 2.276 . . . . 71.209999999999994 112.319 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 16.64 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 32.520000000000003 110.797 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.1 p -141.96 152.41 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.25 111.136 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.555 ' O ' HD12 ' A' ' 171' ' ' LEU . . . -94.29 113.71 25.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 111.13 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.1 p -150.83 174.94 12.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 110.897 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -144.95 167.0 23.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 72.150000000000006 110.789 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.694 HD13 ' N ' ' A' ' 74' ' ' GLN . 2.0 tm? -122.38 135.8 54.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 44.520000000000003 110.941 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.694 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -107.69 135.76 48.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 72.219999999999999 110.932 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 57.8 m -128.69 140.33 51.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 61.420000000000002 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -112.39 157.03 21.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 54.509999999999998 111.08 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.63 ' HD3' HD11 ' A' ' 82' ' ' LEU . 5.8 ptm180 -162.58 125.8 2.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 74.430000000000007 110.904 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t0 55.74 28.63 12.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 72.329999999999998 110.93 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.43 18.0 79.5 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.654 -0.784 . . . . 72.140000000000001 112.464 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.576 HD12 ' NH1' ' A' ' 77' ' ' ARG . 31.5 mt -110.69 108.5 58.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.577 0.704 . . . . 75.239999999999995 110.925 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 54.1 Cg_endo -69.69 89.7 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.722 2.282 . . . . 71.230000000000004 112.371 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.63 HD11 ' HD3' ' A' ' 77' ' ' ARG . 20.1 mt -66.53 159.46 73.4 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.552 0.691 . . . . 62.039999999999999 110.918 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 119.98 6.83 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.648 2.232 . . . . 63.340000000000003 112.345 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.58 147.99 43.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 21.0 111.108 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -148.17 137.66 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 75.340000000000003 110.9 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.83 109.45 2.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 61.530000000000001 112.47 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.0 mt -78.13 71.27 4.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.868 0.366 . . . . 72.209999999999994 110.912 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -111.74 6.75 19.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 63.210000000000001 110.954 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -19.07 63.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 65.040000000000006 110.861 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -139.67 154.56 71.26 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.633 0.73 . . . . 72.5 110.894 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.603 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 53.9 Cg_endo -69.77 -29.22 24.15 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.788 2.325 . . . . 41.020000000000003 112.32 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.609 ' HB3' HG22 ' A' ' 118' ' ' VAL . 11.6 p90 -148.8 179.29 7.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 74.299999999999997 110.887 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -150.44 110.51 4.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 110.953 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.528 HD13 ' SG ' ' A' ' 101' ' ' CYS . 0.4 OUTLIER -89.2 143.34 26.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.162 -0.472 . . . . 72.5 110.94 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.21 111.79 14.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 72.219999999999999 110.888 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -170.41 -160.12 18.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 74.129999999999995 112.469 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.23 0.81 21.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 52.109999999999999 110.9 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.458 ' HB3' HG22 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -85.51 156.48 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 34.140000000000001 110.874 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -21.34 57.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.129999999999995 110.847 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 98' ' ' SER . 15.4 m -70.15 -28.71 36.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.406 . . . . 74.239999999999995 111.116 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.528 ' SG ' HD13 ' A' ' 94' ' ' LEU . 91.6 m -65.78 159.86 24.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 64.230000000000004 110.889 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.71 -18.8 59.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 65.129999999999995 110.813 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -138.13 107.83 6.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 62.340000000000003 111.014 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 p -100.48 108.05 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 63.43 111.118 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.63 -169.18 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 71.099999999999994 110.957 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.14 107.47 7.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.876 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.563 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -154.13 148.65 19.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.549 0.69 . . . . 65.400000000000006 110.884 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -18.32 37.27 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.714 2.276 . . . . 71.040000000000006 112.342 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 p -102.46 -23.85 13.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 62.509999999999998 110.857 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 107' ' ' HIS . 44.5 mt -77.09 108.14 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 64.219999999999999 111.158 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m -87.53 169.71 11.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 73.340000000000003 110.837 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -47.37 -36.56 9.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 61.210000000000001 110.849 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.794 HG11 ' CD2' ' A' ' 57' ' ' TYR . 1.7 m -141.47 80.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 72.450000000000003 111.159 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.68 ' CD2' HG22 ' A' ' 137' ' ' VAL . 2.0 t60 -65.73 -56.64 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 72.439999999999998 110.825 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.406 ' CB ' HD21 ' A' ' 128' ' ' LEU . . . -166.88 161.41 15.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 75.549999999999997 111.099 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.33 131.15 40.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 70.209999999999994 111.135 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.4 142.49 37.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 53.009999999999998 110.95 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.609 HG22 ' HB3' ' A' ' 92' ' ' PHE . 13.8 t -132.9 136.32 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 74.540000000000006 111.203 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.88 92.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 44.450000000000003 110.821 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -61.06 108.53 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 74.299999999999997 110.848 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.63 -7.4 61.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 33.409999999999997 112.508 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -89.66 -51.98 2.75 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.719 -0.753 . . . . 22.109999999999999 112.448 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -95.38 -3.11 47.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 74.400000000000006 110.94 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 61.66 33.1 18.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.857 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 49.5 m -139.22 158.71 43.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 64.049999999999997 110.935 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -82.35 127.42 33.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 75.439999999999998 110.89 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.49 110.34 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 74.299999999999997 111.137 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.406 HD21 ' CB ' ' A' ' 115' ' ' ALA . 8.8 tt -100.84 126.15 47.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 53.030000000000001 110.869 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 26.5 mtm -117.19 125.91 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 110.9 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -79.73 130.8 35.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 71.140000000000001 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.463 ' N ' HD22 ' A' ' 131' ' ' LEU . 1.2 mm? -92.55 17.85 9.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 71.239999999999995 110.884 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 102.51 58.67 0.77 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 65.019999999999996 112.469 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 64.1 p -53.17 136.82 35.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 75.230000000000004 110.84 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.2 m -68.51 -29.46 68.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 64.439999999999998 111.17 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.15 -56.66 2.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 75.510000000000005 110.922 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 141.97 121.46 1.7 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 63.210000000000001 112.545 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.68 HG22 ' CD2' ' A' ' 114' ' ' HIS . 1.8 t -87.37 142.79 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 71.439999999999998 111.161 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 0.8 OUTLIER -101.13 134.43 44.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 75.010000000000005 110.869 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.706 HD13 ' HB2' ' A' ' 140' ' ' ASN . 3.2 tm? -117.97 122.7 43.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 110.861 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.706 ' HB2' HD13 ' A' ' 139' ' ' LEU . 1.3 m-80 56.83 23.83 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 71.439999999999998 110.9 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.5 11.22 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.685 -0.769 . . . . 71.430000000000007 112.51 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.64 136.47 24.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.809 0.338 . . . . 54.32 110.887 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -65.23 145.2 56.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 74.430000000000007 110.839 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.575 HG13 HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -145.23 175.51 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 64.299999999999997 111.131 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.408 ' HB2' ' HD2' ' A' ' 148' ' ' ARG . 0.7 OUTLIER -53.24 168.4 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.934 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -105.16 178.32 4.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 75.200000000000003 110.907 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 38.4 50.94 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 63.340000000000003 110.824 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.565 ' HG3' HD21 ' A' ' 150' ' ' LEU . 10.9 ptm180 -143.92 156.15 58.89 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.603 0.716 . . . . 52.450000000000003 110.873 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 148' ' ' ARG . 53.9 Cg_endo -69.76 110.81 2.64 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.688 2.259 . . . . 52.420000000000002 112.352 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.575 HD22 HG13 ' A' ' 144' ' ' ILE . 13.9 mt -110.25 84.48 3.76 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.597 0.713 . . . . 74.319999999999993 110.887 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 120.69 7.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.659 2.239 . . . . 61.450000000000003 112.366 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.692 ' O ' HG21 ' A' ' 169' ' ' VAL . . . -112.28 75.47 1.68 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.551 0.691 . . . . 63.119999999999997 111.11 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 171.3 14.69 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 43.140000000000001 112.396 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.5 m -50.97 136.69 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 70.540000000000006 111.117 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 93.91 -10.83 71.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.749 -0.739 . . . . 74.129999999999995 112.496 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.57 176.71 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.895 0.378 . . . . 64.329999999999998 110.836 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.1 m -133.34 161.71 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 61.399999999999999 110.902 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 166' ' ' VAL . 3.8 mt -141.71 145.34 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 74.310000000000002 111.075 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -151.74 149.65 29.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 53.420000000000002 110.934 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -149.0 135.17 19.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 73.430000000000007 110.917 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 64.52 -143.81 47.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 23.199999999999999 112.457 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -110.29 11.37 23.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 64.409999999999997 110.931 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 94.6 p -52.42 148.88 6.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 110.817 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.0 m -91.74 5.1 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.517 . . . . 73.430000000000007 110.857 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.4 137.56 42.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 62.420000000000002 110.892 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 158' ' ' ILE . 24.3 t -125.65 137.21 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 63.530000000000001 111.096 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.598 ' HB3' HD11 ' A' ' 73' ' ' LEU . 5.4 m-85 -96.65 101.71 13.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 110.94 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.08 111.14 23.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 71.420000000000002 110.836 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.692 HG21 ' O ' ' A' ' 152' ' ' ALA . 3.1 t -75.52 153.68 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.519999999999996 111.138 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -160.1 153.08 21.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 61.439999999999998 110.868 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 70' ' ' ALA . 34.9 tp -94.54 135.07 36.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 51.25 110.87 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -75.14 178.25 47.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.703 -0.76 . . . . 72.140000000000001 112.475 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 167.59 23.93 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.721 2.281 . . . . 61.109999999999999 112.34 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.68 130.5 19.55 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.676 2.251 . . . . 74.310000000000002 112.406 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.3 p -104.97 25.74 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 65.25 110.817 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.1 t -84.17 115.05 22.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 63.240000000000002 110.863 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 94.8 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 73.120000000000005 110.877 -179.824 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 CA-C-O 121.384 0.435 . . . . 74.439999999999998 112.432 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 152.08 69.07 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.735 2.29 . . . . 73.099999999999994 112.315 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -154.56 161.0 41.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 73.030000000000001 110.857 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.9 m -97.1 155.16 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 111.106 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.24 138.3 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 61.140000000000001 111.141 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -56.44 150.87 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 55.049999999999997 110.825 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.7 p -76.55 -19.11 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 73.319999999999993 111.129 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.8 20.31 13.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 62.299999999999997 112.497 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.2 mt -60.67 122.43 14.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 71.540000000000006 110.934 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 tp -127.58 152.49 47.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 53.5 110.969 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.2 p -75.04 179.72 4.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 54.43 110.816 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.92 149.08 9.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 75.049999999999997 110.91 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.87 164.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 63.43 111.124 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.55 144.1 54.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.219999999999999 111.109 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.22 145.72 26.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 64.230000000000004 111.077 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 14' ' ' VAL . 2.6 p -60.34 96.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 63.0 111.103 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -108.16 120.64 42.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 73.329999999999998 110.863 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -127.53 152.82 47.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 64.129999999999995 110.844 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.47 171.84 12.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 64.010000000000005 111.1 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.78 148.45 47.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 73.25 111.023 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -115.54 115.54 26.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 73.450000000000003 110.881 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.5 mp -80.54 121.54 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 71.239999999999995 111.157 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.68 175.88 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 51.25 111.08 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -131.9 157.55 77.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 62.32 110.935 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 167.66 23.67 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.699 2.266 . . . . 71.140000000000001 112.394 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 167.89 23.25 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.613 2.208 . . . . 75.340000000000003 112.354 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 167.74 23.51 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.756 2.304 . . . . 73.420000000000002 112.377 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.86 -173.84 0.81 Allowed 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.709 2.273 . . . . 75.420000000000002 112.298 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 102.57 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 74.329999999999998 110.872 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.9 m -53.03 167.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 74.430000000000007 111.148 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.2 t -77.82 143.62 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 75.519999999999996 111.127 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.96 166.63 13.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 72.340000000000003 110.879 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -64.86 162.04 17.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 61.229999999999997 110.926 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.95 176.88 4.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 63.329999999999998 111.134 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.14 -27.95 54.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 52.049999999999997 110.872 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.93 -16.4 55.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 111.063 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.63 -38.67 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 75.329999999999998 111.158 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -5.72 47.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 70.219999999999999 110.901 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -112.95 -40.43 3.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 72.129999999999995 110.933 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.3 153.15 40.58 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.657 0.741 . . . . 75.530000000000001 110.908 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 151.19 68.83 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.21 . . . . 72.530000000000001 112.338 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.69 ' HG3' HD12 ' A' ' 43' ' ' ILE . 29.9 mt-30 -69.62 172.02 8.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.209999999999994 110.877 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.613 ' ND1' HG23 ' A' ' 42' ' ' ILE . 14.3 p80 -64.05 -43.94 93.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 75.340000000000003 110.871 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.7 ' O ' HG23 ' A' ' 46' ' ' THR . 1.1 pp -72.5 -32.49 41.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 72.219999999999999 111.121 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.69 HD12 ' HG3' ' A' ' 40' ' ' GLN . 63.0 mt -79.34 -26.71 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 63.109999999999999 111.1 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.2 -18.16 40.94 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.766 -0.731 . . . . 71.030000000000001 112.446 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.7 t -107.58 -26.48 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 75.349999999999994 111.122 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 42' ' ' ILE . 78.5 p -59.8 153.75 19.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 71.109999999999999 111.146 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.57 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -79.2 160.06 71.55 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.669 0.747 . . . . 73.430000000000007 110.874 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -38.75 7.37 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.673 2.249 . . . . 61.25 112.378 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.16 -14.74 35.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 71.049999999999997 111.148 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -83.5 -56.75 3.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 53.140000000000001 110.942 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.6 OUTLIER -61.29 -28.85 69.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 75.109999999999999 110.959 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.593 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.3 t30 -73.77 -43.95 57.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 75.340000000000003 110.881 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.681 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -58.24 -25.16 61.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 72.019999999999996 111.124 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -92.6 -18.69 22.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.281 -0.418 . . . . 54.409999999999997 110.93 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -28.68 45.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 74.519999999999996 111.145 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.53 3.73 17.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 64.319999999999993 110.884 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.767 ' CD2' HG11 ' A' ' 113' ' ' VAL . 42.7 m-85 -126.55 -56.11 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 62.439999999999998 110.917 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HE2' HD22 ' A' ' 94' ' ' LEU . 28.2 p90 -146.79 147.59 31.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 72.349999999999994 110.819 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -99.36 152.85 19.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 63.219999999999999 110.858 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.6 m -95.57 107.07 30.92 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.655 0.74 . . . . 31.239999999999998 110.844 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.82 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 54.1 Cg_endo -69.73 162.32 42.51 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.697 2.265 . . . . 53.329999999999998 112.353 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.88 -37.76 8.45 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.672 2.248 . . . . 74.439999999999998 112.288 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.495 ' HA ' HD12 ' A' ' 66' ' ' LEU . 33.6 p-90 -71.67 -7.33 47.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 74.239999999999995 110.971 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.82 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -75.46 148.33 39.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 65.299999999999997 111.107 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.748 ' HB2' ' HB3' ' A' ' 91' ' ' PRO . . . 64.15 38.34 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 73.200000000000003 111.121 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 63' ' ' TRP . 94.7 mt -135.9 67.29 63.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.586 0.707 . . . . 71.409999999999997 110.901 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 151.46 69.24 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.68 2.253 . . . . 70.140000000000001 112.414 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.4 12.67 2.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 72.120000000000005 110.813 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.29 150.69 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 70.109999999999999 111.123 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.623 ' O ' HD12 ' A' ' 171' ' ' LEU . . . -87.39 117.37 26.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 22.329999999999998 111.073 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.4 p -151.06 167.23 28.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 64.329999999999998 110.899 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -137.62 168.0 20.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 72.420000000000002 110.84 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 74' ' ' GLN . 2.7 tm? -123.12 136.31 54.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 72.209999999999994 110.882 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.68 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -110.92 133.27 53.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 74.349999999999994 110.905 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.6 m -123.43 137.63 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 72.400000000000006 110.804 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.8 p -105.5 149.69 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 74.439999999999998 111.154 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.446 ' HD3' HD11 ' A' ' 82' ' ' LEU . 6.8 ptm180 -149.09 117.57 6.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.219999999999999 110.898 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 54.01 36.13 23.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 71.450000000000003 110.872 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.19 19.61 79.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 64.040000000000006 112.463 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 62.3 mt -110.58 108.49 58.2 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.58 0.705 . . . . 72.299999999999997 110.88 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 53.7 Cg_endo -69.65 92.23 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.728 2.285 . . . . 75.120000000000005 112.364 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.446 HD11 ' HD3' ' A' ' 77' ' ' ARG . 20.2 mt -71.02 159.2 86.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.609 0.719 . . . . 53.509999999999998 110.914 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 118.5 5.72 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.628 2.218 . . . . 73.120000000000005 112.379 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.54 146.33 52.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 32.240000000000002 111.061 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mt -143.13 137.84 29.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 73.340000000000003 110.956 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.18 99.53 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 61.039999999999999 112.514 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.5 mt -75.48 71.24 2.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.823 0.344 . . . . 72.019999999999996 110.881 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -111.46 6.12 20.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 65.040000000000006 110.822 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -20.09 63.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 63.030000000000001 110.832 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -137.03 155.71 76.06 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.646 0.736 . . . . 74.329999999999998 110.893 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.748 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 53.1 Cg_endo -69.75 -30.77 21.79 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.645 2.23 . . . . 74.230000000000004 112.386 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.582 ' HB3' HG22 ' A' ' 118' ' ' VAL . 3.7 p90 -159.29 179.4 9.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 61.549999999999997 110.893 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -149.48 122.72 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 73.340000000000003 110.904 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.619 HD21 HG12 ' A' ' 113' ' ' VAL . 25.8 tp -96.07 129.13 43.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 72.450000000000003 110.911 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.53 113.63 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 110.881 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.48 -157.45 10.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.693 -0.765 . . . . 40.240000000000002 112.455 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.0 -1.86 12.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.743 0.306 . . . . 73.540000000000006 110.864 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.46 166.91 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 51.240000000000002 110.864 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.44 -10.85 57.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 73.120000000000005 110.92 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.681 HG11 ' HB1' ' A' ' 53' ' ' ALA . 16.8 m -92.75 -6.81 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 70.450000000000003 111.145 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.588 ' HA ' HD23 ' A' ' 94' ' ' LEU . 11.4 p -76.48 160.55 29.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 64.420000000000002 110.897 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.24 -0.13 57.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 110.807 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -155.89 106.13 2.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 74.129999999999995 110.944 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 104' ' ' VAL . 3.0 p -97.48 109.62 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 75.420000000000002 111.194 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.656 HD13 HD13 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -110.59 -169.24 1.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 62.340000000000003 110.953 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -132.17 106.96 8.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 72.519999999999996 110.917 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.476 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -164.83 143.57 5.55 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 110.87 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -13.04 34.17 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 2.257 . . . . 70.349999999999994 112.287 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.9 p -99.48 -27.97 13.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.29 -0.414 . . . . 64.120000000000005 110.871 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.656 HD13 HD13 ' A' ' 105' ' ' LEU . 58.7 mt -75.07 112.94 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 75.420000000000002 111.132 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.464 ' H ' ' HD2' ' A' ' 114' ' ' HIS . 28.3 m -93.87 170.52 9.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.91 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.85 -36.26 3.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 42.039999999999999 110.845 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.767 HG11 ' CD2' ' A' ' 57' ' ' TYR . 2.7 m -142.6 78.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 72.140000000000001 111.124 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.464 ' HD2' ' H ' ' A' ' 111' ' ' SER . 2.9 t-80 -65.52 -55.7 16.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.868 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -168.78 153.58 5.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.264 -0.425 . . . . 71.030000000000001 111.108 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.475 ' HB ' HD13 ' A' ' 94' ' ' LEU . 6.7 p -131.96 135.57 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.148 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 126' ' ' PHE . 3.0 pp -108.56 140.05 42.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 74.25 110.874 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 92' ' ' PHE . 15.3 t -129.47 137.31 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 63.43 111.118 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.78 90.43 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 65.439999999999998 110.928 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -60.13 108.13 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 74.120000000000005 110.893 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.58 -8.24 59.63 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 63.229999999999997 112.461 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -90.02 -49.92 3.19 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.811 -0.709 . . . . 73.109999999999999 112.475 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -94.18 -5.43 47.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.76 0.314 . . . . 71.530000000000001 110.866 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.23 18.54 11.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 71.409999999999997 110.857 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 8.7 p -127.33 164.81 20.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 70.329999999999998 110.911 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.493 ' CD2' HD13 ' A' ' 117' ' ' LEU . 60.4 m-85 -87.24 127.12 35.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 61.109999999999999 110.891 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.47 110.02 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 74.299999999999997 111.191 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 128' ' ' LEU . 6.7 tt -101.72 121.46 42.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 60.399999999999999 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.1 mtt -115.72 133.01 56.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 63.119999999999997 110.805 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.64 132.58 34.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 73.540000000000006 110.893 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.454 ' N ' HD22 ' A' ' 131' ' ' LEU . 2.9 mm? -75.67 -8.73 57.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 74.420000000000002 110.937 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 122.21 47.24 0.28 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.739 -0.743 . . . . 54.329999999999998 112.435 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.7 t -61.26 130.97 48.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 52.420000000000002 110.89 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.1 t -55.73 -24.68 36.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 42.039999999999999 111.173 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -100.43 -50.0 4.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 62.109999999999999 110.886 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 105.12 144.52 12.81 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.755 -0.736 . . . . 53.420000000000002 112.581 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 m -88.62 172.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 64.109999999999999 111.134 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 3.6 mtmt -112.19 133.18 54.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 74.310000000000002 110.887 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.711 HD13 ' HB2' ' A' ' 140' ' ' ASN . 3.1 tm? -113.65 124.46 52.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.323 -0.399 . . . . 75.400000000000006 110.886 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.711 ' HB2' HD13 ' A' ' 139' ' ' LEU . 1.7 m120 62.19 21.2 12.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 74.219999999999999 110.914 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.9 25.39 41.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 43.509999999999998 112.5 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.563 ' O ' HG23 ' A' ' 144' ' ' ILE . 30.3 m120 -145.03 121.23 10.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.806 0.336 . . . . 74.340000000000003 110.948 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.9 135.97 35.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 75.310000000000002 110.836 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.697 HD11 HD13 ' A' ' 150' ' ' LEU . 32.9 pt -140.26 -173.21 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 64.540000000000006 111.105 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.24 -170.26 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 74.010000000000005 110.951 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.37 173.84 10.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 110.892 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.29 42.47 21.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 110.901 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.726 ' HG3' HD21 ' A' ' 150' ' ' LEU . 2.5 ptm85 -147.99 159.44 40.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.6 0.714 . . . . 71.140000000000001 110.886 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 112.73 3.17 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.719 2.28 . . . . 71.299999999999997 112.322 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.726 HD21 ' HG3' ' A' ' 148' ' ' ARG . 5.4 mt -114.61 83.77 9.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 73.219999999999999 110.901 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 124.81 11.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.608 2.205 . . . . 54.340000000000003 112.316 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -118.54 80.14 16.51 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.598 0.713 . . . . 71.099999999999994 111.035 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -175.87 1.31 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.755 2.303 . . . . 73.099999999999994 112.269 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.2 m -65.84 144.5 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 63.5 111.126 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.36 -11.83 64.54 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.754 -0.736 . . . . 51.299999999999997 112.471 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.68 174.68 6.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 61.219999999999999 110.827 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 53.5 m -126.18 164.88 19.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 74.430000000000007 110.884 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.4 mt -142.87 148.37 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 111.12 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.434 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -151.76 154.52 36.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 40.049999999999997 110.863 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -148.53 136.82 21.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 61.240000000000002 110.824 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.21 -151.45 45.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 54.130000000000003 112.479 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -103.38 10.62 37.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 53.43 110.82 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.54 160.39 5.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 70.319999999999993 110.916 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.7 t -91.48 -31.35 16.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 71.040000000000006 110.865 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -53.41 152.47 4.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 74.430000000000007 110.891 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.26 130.96 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 75.120000000000005 111.067 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -97.85 102.9 14.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 75.109999999999999 110.916 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.4 tppm? -103.47 110.17 22.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 73.400000000000006 110.963 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.71 153.04 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 75.239999999999995 111.188 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -160.71 147.65 15.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.219999999999999 110.96 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.623 HD12 ' O ' ' A' ' 70' ' ' ALA . 31.6 tp -80.45 136.97 36.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 55.039999999999999 110.911 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.41 177.19 2.63 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.775 -0.726 . . . . 52.310000000000002 112.51 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.81 23.41 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.656 2.238 . . . . 75.209999999999994 112.335 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -24.25 29.73 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.597 2.198 . . . . 73.439999999999998 112.399 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.9 t -88.51 55.16 3.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 63.109999999999999 110.923 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.48 137.6 57.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.51 . . . . 74.040000000000006 110.852 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 62.439999999999998 110.927 -179.824 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 CA-C-O 121.475 0.486 . . . . 42.409999999999997 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 143.26 50.45 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.664 2.243 . . . . 51.130000000000003 112.378 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -175.27 154.86 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 73.129999999999995 110.881 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.6 148.27 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 71.230000000000004 111.079 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.3 p -134.54 101.73 5.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 111.122 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.8 p -159.91 133.79 7.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 71.439999999999998 110.9 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.651 HG23 ' H ' ' A' ' 7' ' ' LEU . 10.9 t -116.89 -19.02 10.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 73.120000000000005 111.161 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.19 20.99 74.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 74.120000000000005 112.486 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.651 ' H ' HG23 ' A' ' 5' ' ' THR . 68.2 tp -51.87 154.36 2.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.887 0.375 . . . . 70.540000000000006 110.855 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.8 tp -125.2 167.87 14.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 72.329999999999998 110.923 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.65 176.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 72.230000000000004 110.838 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.8 ptt85 -110.3 148.5 31.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 54.409999999999997 110.871 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.85 150.77 10.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 63.420000000000002 111.121 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.51 160.93 0.54 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 73.319999999999993 111.053 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.87 168.99 11.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 64.329999999999998 111.16 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 14' ' ' VAL . 3.5 p -115.5 113.33 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 55.039999999999999 111.152 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -154.46 166.87 31.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 60.109999999999999 110.894 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.97 163.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 64.400000000000006 110.881 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.87 174.26 10.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 63.329999999999998 111.109 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.94 152.07 3.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 70.329999999999998 111.136 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.17 101.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 74.349999999999994 110.924 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.4 mp -60.3 134.4 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 73.519999999999996 111.13 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.84 -178.86 0.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 111.147 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -53.63 110.04 1.83 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 71.25 110.913 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 168.18 22.43 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.715 2.277 . . . . 64.420000000000002 112.294 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 168.39 21.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 73.439999999999998 112.323 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.4 Cg_endo -69.74 112.2 3.01 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.671 2.247 . . . . 72.420000000000002 112.349 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.0 Cg_endo -69.73 -169.5 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.731 2.287 . . . . 75.439999999999998 112.315 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.24 150.61 27.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 62.219999999999999 110.905 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -47.95 140.86 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 70.409999999999997 111.215 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.53 151.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 63.520000000000003 111.106 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.88 169.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.499 . . . . 70.25 110.872 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.9 mt -54.24 176.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 73.439999999999998 110.975 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 168.52 3.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 53.240000000000002 111.151 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -57.19 -60.79 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 72.420000000000002 110.866 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HA ' ' HG2' ' A' ' 37' ' ' GLN . . . -64.37 -14.63 57.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 64.319999999999993 111.156 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.03 -30.61 21.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 52.240000000000002 111.105 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -92.95 -23.7 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 73.150000000000006 110.918 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HG2' ' HA ' ' A' ' 34' ' ' ALA . 7.4 pt20 -105.78 35.17 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.838 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.844 ' H ' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -42.69 158.63 0.22 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.597 0.713 . . . . 62.409999999999997 110.907 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 38' ' ' LEU . 53.9 Cg_endo -69.78 96.14 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.7 2.267 . . . . 61.140000000000001 112.356 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.56 172.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.323 -0.399 . . . . 73.400000000000006 110.976 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.473 ' CE1' HG23 ' A' ' 42' ' ' ILE . 8.5 p80 -46.21 -50.63 15.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 74.340000000000003 110.841 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.74 ' O ' HG23 ' A' ' 46' ' ' THR . 0.9 OUTLIER -51.25 -39.49 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 73.310000000000002 111.119 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.488 HG23 HD12 ' A' ' 51' ' ' LEU . 8.2 mt -80.95 -28.84 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 64.099999999999994 111.096 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.53 -10.01 52.52 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.711 -0.757 . . . . 72.5 112.484 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.32 -26.24 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.889 0.376 . . . . 63.340000000000003 111.149 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 42' ' ' ILE . 23.2 p -54.45 153.68 5.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 73.450000000000003 111.095 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.542 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.4 160.16 73.49 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.563 0.697 . . . . 74.340000000000003 110.905 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -36.84 10.11 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.716 2.278 . . . . 71.150000000000006 112.37 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.16 -18.16 27.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.089 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -83.29 -59.8 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 62.329999999999998 110.911 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -53.9 -29.61 42.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.3 -0.409 . . . . 73.340000000000003 110.855 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.585 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.5 t30 -73.53 -44.2 58.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 63.140000000000001 110.896 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.643 ' HB1' ' CG1' ' A' ' 100' ' ' VAL . . . -53.74 -26.98 25.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 72.129999999999995 111.099 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.402 HE22 HD12 ' A' ' 94' ' ' LEU . 11.0 mm-40 -93.66 -21.81 19.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 71.549999999999997 110.935 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.412 HG22 ' OE1' ' A' ' 59' ' ' GLN . 0.3 OUTLIER -83.74 -13.16 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 70.450000000000003 111.077 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 t -82.99 0.82 42.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 70.129999999999995 110.915 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.705 ' CD2' HG11 ' A' ' 113' ' ' VAL . 27.0 m-85 -129.38 -53.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 73.430000000000007 110.888 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -134.61 148.59 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 64.450000000000003 110.926 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.412 ' OE1' HG22 ' A' ' 55' ' ' VAL . 5.9 mm100 -100.99 152.62 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 64.019999999999996 110.914 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 21.6 t -101.5 102.67 22.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.546 0.688 . . . . 71.319999999999993 110.893 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.792 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 53.7 Cg_endo -69.71 165.43 30.92 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.71 2.273 . . . . 54.039999999999999 112.38 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -38.86 7.13 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.733 2.289 . . . . 63.0 112.323 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.473 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 40.3 p-90 -71.79 -6.51 42.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 62.140000000000001 110.939 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.792 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -79.07 149.55 32.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 62.450000000000003 111.13 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 91' ' ' PRO . . . 63.98 30.89 14.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 70.120000000000005 111.115 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 63' ' ' TRP . 71.2 mt -127.68 67.56 72.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.626 0.727 . . . . 61.329999999999998 110.945 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 151.27 69.16 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.623 2.216 . . . . 70.409999999999997 112.4 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.9 m -135.69 8.19 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 74.109999999999999 110.838 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.06 151.3 20.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 73.439999999999998 111.113 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.61 119.04 27.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 44.130000000000003 111.075 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.6 p -151.17 178.18 9.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.019999999999996 110.955 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -148.63 167.34 25.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 64.019999999999996 110.869 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.712 HD13 ' N ' ' A' ' 74' ' ' GLN . 1.6 tm? -121.58 135.94 54.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 72.349999999999994 110.879 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.712 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -111.24 135.71 51.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 71.420000000000002 110.904 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -127.13 140.56 52.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 64.439999999999998 110.906 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.7 p -111.34 153.98 25.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 111.183 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -155.17 121.41 5.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.305 -0.407 . . . . 64.019999999999996 110.852 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.1 t0 54.38 35.12 22.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 64.120000000000005 110.806 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.08 19.89 79.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 64.430000000000007 112.531 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 24.1 mt -110.33 108.64 58.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.645 0.736 . . . . 74.299999999999997 110.853 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 54.5 Cg_endo -69.7 92.46 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.642 2.228 . . . . 73.140000000000001 112.424 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.4 mt -71.44 159.24 86.12 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.668 0.747 . . . . 64.219999999999999 110.952 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 123.52 10.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 75.0 112.313 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.65 149.43 49.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 72.129999999999995 111.174 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 mt -147.05 136.9 23.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 55.399999999999999 110.794 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.91 100.28 0.2 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.649 -0.786 . . . . 70.230000000000004 112.491 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.5 mt -78.69 70.8 5.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 73.310000000000002 110.912 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -111.92 6.08 19.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 53.329999999999998 110.8 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 -69.21 -19.55 63.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 63.140000000000001 110.929 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.06 157.01 79.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.678 0.751 . . . . 72.329999999999998 110.845 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.545 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 53.3 Cg_endo -69.74 -28.49 25.27 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.702 2.268 . . . . 62.229999999999997 112.395 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.64 ' HB3' HG22 ' A' ' 118' ' ' VAL . 18.7 p90 -159.7 176.58 11.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 62.039999999999999 110.942 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -142.61 122.68 13.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.956 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.551 HD13 ' SG ' ' A' ' 101' ' ' CYS . 0.7 OUTLIER -89.98 152.59 21.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 71.209999999999994 110.932 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -139.8 106.0 5.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 71.549999999999997 110.901 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -164.22 -145.13 4.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 44.549999999999997 112.452 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.14 -1.25 11.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.748 0.309 . . . . 74.439999999999998 110.854 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -83.9 159.11 21.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 73.099999999999994 110.904 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -21.39 52.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 110.917 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.643 ' CG1' ' HB1' ' A' ' 53' ' ' ALA . 15.8 m -71.41 -22.95 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 71.209999999999994 111.147 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.551 ' SG ' HD13 ' A' ' 94' ' ' LEU . 99.6 m -68.91 164.57 21.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 72.519999999999996 110.932 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -85.27 -19.98 30.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.206 -0.452 . . . . 73.519999999999996 110.83 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -132.9 108.49 8.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 73.319999999999993 110.914 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.08 107.57 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 75.299999999999997 111.118 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.533 HD13 HD13 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -112.93 -170.51 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 71.230000000000004 110.934 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.4 107.24 5.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 71.230000000000004 110.922 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.49 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -159.85 147.56 13.01 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.657 0.742 . . . . 72.450000000000003 110.857 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -15.48 37.13 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.662 2.241 . . . . 65.340000000000003 112.312 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.447 ' HB3' ' ND2' ' A' ' 135' ' ' ASN . 6.7 p -99.18 -27.33 13.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 63.219999999999999 110.825 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.533 HD13 HD13 ' A' ' 105' ' ' LEU . 59.5 mt -76.35 115.75 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 72.420000000000002 111.101 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.458 ' H ' ' HD2' ' A' ' 114' ' ' HIS . 4.5 m -95.9 169.84 9.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 72.329999999999998 110.842 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.0 m -45.87 -35.63 4.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 74.239999999999995 110.844 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.705 HG11 ' CD2' ' A' ' 57' ' ' TYR . 1.7 m -143.01 78.0 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 73.299999999999997 111.099 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.458 ' HD2' ' H ' ' A' ' 111' ' ' SER . 3.4 t-80 -65.53 -61.2 2.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 73.420000000000002 110.876 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.47 167.42 29.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 62.109999999999999 111.051 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.73 140.87 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 65.109999999999999 111.093 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 126' ' ' PHE . 3.1 pp -114.73 141.9 47.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 74.140000000000001 110.912 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.64 HG22 ' HB3' ' A' ' 92' ' ' PHE . 16.1 t -128.56 136.77 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 75.530000000000001 111.126 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.76 88.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 70.030000000000001 110.914 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -58.42 108.06 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 71.239999999999995 110.816 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.88 -5.31 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.756 -0.735 . . . . 74.519999999999996 112.503 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -88.48 -49.32 3.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 62.100000000000001 112.533 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -101.82 -4.31 26.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 62.329999999999998 110.886 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 64.26 28.38 13.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 110.809 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 33.4 m -134.33 138.2 44.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 44.210000000000001 110.9 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 117' ' ' LEU . 55.6 m-85 -64.41 127.32 30.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.439999999999998 110.87 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.6 t -105.72 109.29 27.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 75.340000000000003 111.086 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.444 HD13 HG21 ' A' ' 158' ' ' ILE . 6.3 tt -102.09 131.62 48.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 75.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 16.4 mtp -130.96 137.96 49.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.881 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.94 129.0 40.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.28 -0.418 . . . . 73.129999999999995 110.892 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.696 HD13 HG23 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -64.86 -14.69 60.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 64.219999999999999 110.985 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.5 ' N ' HD23 ' A' ' 131' ' ' LEU . . . 113.58 49.15 0.56 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 54.0 112.493 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.6 t -55.57 175.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.931 0.396 . . . . 74.430000000000007 110.854 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.13 -23.83 19.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 70.5 111.103 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 109' ' ' SER . 6.4 m120 -85.31 -73.27 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 73.219999999999999 110.878 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 141.65 127.89 2.3 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 41.009999999999998 112.479 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.02 145.96 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 52.409999999999997 111.072 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 1.5 mtmm -99.59 148.72 24.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 74.150000000000006 110.901 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.7 HD13 ' HB2' ' A' ' 140' ' ' ASN . 3.1 tm? -130.95 122.64 27.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 74.120000000000005 110.978 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.7 ' HB2' HD13 ' A' ' 139' ' ' LEU . 1.1 m-80 61.0 21.9 12.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 54.310000000000002 110.889 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.54 21.85 42.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.794 -0.717 . . . . 63.439999999999998 112.489 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 144' ' ' ILE . 29.1 m-20 -144.89 125.87 14.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 52.439999999999998 110.898 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -60.17 135.03 57.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 74.010000000000005 110.833 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.488 HG23 ' O ' ' A' ' 142' ' ' ASN . 0.0 OUTLIER -141.69 176.08 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 72.349999999999994 111.137 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -57.97 -176.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 75.140000000000001 110.872 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.33 174.55 7.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 74.209999999999994 110.855 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 52.79 45.92 27.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 72.120000000000005 110.835 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.746 ' HG3' HD21 ' A' ' 150' ' ' LEU . 3.4 ptp180 -144.99 159.02 51.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.571 0.7 . . . . 70.409999999999997 110.918 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 102.47 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 73.010000000000005 112.383 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.746 HD21 ' HG3' ' A' ' 148' ' ' ARG . 3.4 mt -109.88 83.76 3.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.581 0.705 . . . . 60.310000000000002 110.897 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 130.61 19.56 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.625 2.217 . . . . 73.230000000000004 112.339 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.05 79.88 18.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.54 0.686 . . . . 71.329999999999998 111.069 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -179.2 2.75 Favored 'Trans proline' 0 N--CA 1.466 -0.128 0 C-N-CA 122.748 2.299 . . . . 54.030000000000001 112.295 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.413 HG21 ' HB2' ' A' ' 171' ' ' LEU . 11.0 m -64.44 144.9 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.18 -0.464 . . . . 74.319999999999993 111.139 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.62 -10.24 68.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.769 -0.729 . . . . 75.400000000000006 112.426 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.69 -178.67 4.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.892 0.377 . . . . 61.219999999999999 110.832 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 52.8 m -132.99 165.73 24.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 61.420000000000002 110.895 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.444 HG21 HD13 ' A' ' 128' ' ' LEU . 6.8 mt -143.35 151.06 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 74.239999999999995 111.081 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -151.97 157.69 42.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.019999999999996 110.943 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -153.73 134.65 13.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 110.938 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.22 -153.59 42.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 73.219999999999999 112.471 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -101.33 18.09 20.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.351 . . . . 73.109999999999999 110.803 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.0 p -64.83 158.82 24.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 74.409999999999997 110.953 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.8 p -91.31 -33.29 15.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 54.350000000000001 110.861 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -53.12 154.7 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.209999999999994 110.87 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.7 t -145.38 131.13 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.464 . . . . 74.5 111.111 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.466 ' HB3' HD11 ' A' ' 73' ' ' LEU . 5.3 m-85 -98.46 103.12 15.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 74.409999999999997 110.939 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -104.93 110.49 22.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 51.43 110.873 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.92 153.88 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 75.340000000000003 111.151 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.66 145.92 14.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 72.200000000000003 110.894 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.413 ' HB2' HG21 ' A' ' 154' ' ' VAL . 7.6 tt -89.5 136.03 33.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 71.010000000000005 110.889 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.22 172.26 19.49 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.738 -0.744 . . . . 62.140000000000001 112.456 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.67 167.63 23.76 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.629 2.219 . . . . 64.239999999999995 112.378 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -24.79 29.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.635 2.223 . . . . 71.329999999999998 112.384 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 m -90.11 81.18 6.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 75.040000000000006 110.805 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.3 m -52.07 -30.61 26.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 52.549999999999997 110.861 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 63.350000000000001 110.816 -179.757 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.403 0 CA-C-O 121.422 0.456 . . . . 74.420000000000002 112.483 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 120.83 7.55 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.667 2.245 . . . . 71.140000000000001 112.346 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -138.4 149.33 45.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 74.409999999999997 110.976 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.3 t -98.42 138.39 23.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 53.530000000000001 111.103 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 t -125.74 140.05 53.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 53.530000000000001 111.167 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 p -107.51 164.49 12.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 71.549999999999997 110.797 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -93.84 -19.12 21.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 51.240000000000002 111.183 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.85 20.96 79.07 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.746 -0.74 . . . . 74.450000000000003 112.573 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.7 mt -55.92 117.5 3.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 62.340000000000003 110.9 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 tp -142.56 157.2 44.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 110.945 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.3 t -155.87 136.13 13.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 74.530000000000001 110.946 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.96 133.16 31.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 72.230000000000004 110.888 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.9 t -124.04 125.6 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.540000000000006 111.156 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.92 153.5 28.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.340000000000003 111.139 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.97 109.75 13.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 74.239999999999995 111.126 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.5 t -118.96 105.57 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 54.109999999999999 111.153 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -129.16 110.55 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 74.420000000000002 110.907 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -126.4 155.7 41.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 75.049999999999997 110.933 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.85 148.47 30.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 63.420000000000002 111.138 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.91 145.22 8.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 111.11 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -119.26 101.99 8.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 74.109999999999999 110.885 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.5 mp -80.53 99.2 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 73.510000000000005 111.103 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.05 156.62 48.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 63.25 111.153 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -130.32 86.67 53.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.59 0.709 . . . . 64.530000000000001 110.893 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 167.65 23.79 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.712 2.274 . . . . 62.299999999999997 112.374 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 167.78 23.41 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.718 2.278 . . . . 65.340000000000003 112.293 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 167.64 23.85 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.757 2.305 . . . . 71.519999999999996 112.294 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -170.98 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.716 2.277 . . . . 55.409999999999997 112.313 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.56 142.55 49.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 70.239999999999995 110.908 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 m -90.2 171.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 51.299999999999997 111.107 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.8 t -145.02 146.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 73.230000000000004 111.118 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -95.78 161.01 14.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 61.25 110.89 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.8 mt -118.12 174.77 6.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.239999999999995 110.891 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.603 ' OG1' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -88.76 175.47 7.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 62.119999999999997 111.055 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -72.2 -41.51 66.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 51.409999999999997 110.822 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.97 -20.65 34.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 61.020000000000003 111.05 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.603 ' HB2' ' OG1' ' A' ' 32' ' ' THR . . . -54.92 -27.36 42.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 44.140000000000001 111.176 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -20.87 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 72.420000000000002 110.814 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -73.04 -52.0 16.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 62.43 110.868 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.84 85.76 4.27 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.549 0.69 . . . . 61.020000000000003 110.945 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 155.26 66.25 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.241 . . . . 72.109999999999999 112.336 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.69 ' HG3' HD12 ' A' ' 43' ' ' ILE . 8.5 mt-30 -67.52 172.52 4.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 75.400000000000006 110.907 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.28 -47.28 77.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 73.129999999999995 110.868 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.695 ' O ' HG23 ' A' ' 46' ' ' THR . 1.6 pp -70.05 -32.5 51.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 64.409999999999997 111.132 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.69 HD12 ' HG3' ' A' ' 40' ' ' GLN . 61.6 mt -79.41 -27.36 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 71.530000000000001 111.109 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.83 -14.34 60.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.786 -0.721 . . . . 63.200000000000003 112.517 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.93 -25.83 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.945 0.403 . . . . 73.510000000000005 111.139 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 42' ' ' ILE . 48.4 p -58.86 153.56 16.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 71.420000000000002 111.154 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.746 ' O ' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -83.06 159.72 61.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.535 0.684 . . . . 74.439999999999998 110.876 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -38.73 7.39 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.672 2.248 . . . . 71.200000000000003 112.315 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.27 -14.65 32.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 111.187 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.64 -59.18 2.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 110.88 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.932 HD13 ' N ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -63.11 -16.29 59.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.927 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.932 ' N ' HD13 ' A' ' 51' ' ' LEU . 4.0 t30 -81.35 -48.18 12.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 61.240000000000002 110.946 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.815 ' HB1' HG12 ' A' ' 100' ' ' VAL . . . -56.78 -24.47 50.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 65.030000000000001 111.146 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.83 -17.18 25.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.223 -0.444 . . . . 73.530000000000001 110.906 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -64.57 -15.45 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 73.040000000000006 111.177 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.9 t -90.12 -2.74 58.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 63.229999999999997 110.885 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.772 ' CD2' HG21 ' A' ' 113' ' ' VAL . 23.8 m-85 -126.86 -57.42 1.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 75.150000000000006 110.959 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CE1' HD11 ' A' ' 131' ' ' LEU . 58.1 m-85 -139.58 142.55 37.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 73.140000000000001 110.839 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -114.41 118.08 32.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 75.109999999999999 110.954 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.5 p -49.98 108.45 1.0 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 74.200000000000003 110.862 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.779 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 53.3 Cg_endo -69.77 168.93 20.15 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.708 2.272 . . . . 53.210000000000001 112.344 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -38.02 8.49 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.621 2.214 . . . . 63.520000000000003 112.4 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.455 ' HA ' HD12 ' A' ' 66' ' ' LEU . 32.7 p-90 -75.36 -5.62 45.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 73.439999999999998 110.896 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.779 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -74.3 147.42 42.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 45.109999999999999 111.082 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.487 ' CB ' HG21 ' A' ' 42' ' ' ILE . . . 64.98 48.51 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 51.119999999999997 111.044 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 63' ' ' TRP . 85.5 mt -146.25 66.67 11.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.628 0.727 . . . . 63.210000000000001 110.927 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 151.3 69.11 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.243 . . . . 72.439999999999998 112.352 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.59 -4.3 8.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 110.802 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.09 147.9 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 74.510000000000005 111.188 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.557 ' O ' HD12 ' A' ' 171' ' ' LEU . . . -81.03 126.55 31.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 72.219999999999999 111.143 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.2 p -151.0 176.07 11.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 63.140000000000001 110.87 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -143.69 167.53 22.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 74.519999999999996 110.839 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 74' ' ' GLN . 2.2 tm? -121.73 135.97 54.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 52.240000000000002 110.894 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.698 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -111.54 135.03 52.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 75.109999999999999 110.918 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 14.5 p -125.04 134.87 52.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 73.310000000000002 110.902 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.4 p -99.85 155.15 17.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 53.32 111.105 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.419 ' CD ' HD11 ' A' ' 82' ' ' LEU . 6.6 ptm180 -156.9 115.05 3.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 75.209999999999994 110.839 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.3 t70 53.87 37.92 27.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 63.340000000000003 110.892 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.14 78.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.696 -0.764 . . . . 70.420000000000002 112.496 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 16.7 mt -110.99 108.57 57.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.663 0.744 . . . . 62.240000000000002 110.916 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 53.1 Cg_endo -69.83 91.2 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.671 2.247 . . . . 41.439999999999998 112.358 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.419 HD11 ' CD ' ' A' ' 77' ' ' ARG . 20.3 mt -66.88 159.35 76.19 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 75.25 110.91 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 117.99 5.41 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.689 2.259 . . . . 53.439999999999998 112.39 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.63 147.51 52.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 73.510000000000005 111.084 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.9 mt -147.89 144.17 27.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 71.25 110.886 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.89 101.65 0.28 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 71.109999999999999 112.49 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 69.0 mt -75.49 70.55 2.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 74.129999999999995 110.939 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -111.96 6.13 19.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 110.854 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -19.03 63.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 110.856 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -137.51 156.29 74.99 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.672 0.749 . . . . 70.310000000000002 110.863 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.401 ' HB3' HD13 ' A' ' 42' ' ' ILE . 53.8 Cg_endo -69.66 -25.92 28.55 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.671 2.247 . . . . 70.230000000000004 112.354 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.648 ' HB3' HG22 ' A' ' 118' ' ' VAL . 35.2 p90 -164.98 172.39 12.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 72.329999999999998 110.856 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -138.46 112.05 8.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.113 -0.494 . . . . 73.239999999999995 110.877 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.665 HD22 ' HA ' ' A' ' 101' ' ' CYS . 5.5 tt -91.95 140.34 29.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 73.540000000000006 110.96 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.401 ' N ' HD23 ' A' ' 94' ' ' LEU . 18.4 m-85 -122.72 119.2 29.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.886 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.76 -157.71 12.54 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.731 . . . . 73.540000000000006 112.487 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.65 -11.93 13.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.826 0.346 . . . . 63.299999999999997 110.882 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 100' ' ' VAL . 32.8 t -75.47 167.69 21.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 54.149999999999999 110.846 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -16.73 55.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 75.129999999999995 110.896 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.815 HG12 ' HB1' ' A' ' 53' ' ' ALA . 17.1 m -76.35 -24.01 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 64.230000000000004 111.141 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.665 ' HA ' HD22 ' A' ' 94' ' ' LEU . 7.5 p -62.62 156.47 23.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 110.867 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.56 -0.16 57.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.430000000000007 110.809 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.19 106.24 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 71.140000000000001 110.92 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.97 108.58 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 73.230000000000004 111.131 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.717 HD13 HD13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -109.99 -176.55 3.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 75.5 110.93 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.76 106.56 8.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 110.869 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.486 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -164.95 145.29 6.01 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.618 0.723 . . . . 72.430000000000007 110.847 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -16.93 37.72 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.695 2.263 . . . . 74.329999999999998 112.322 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.439 ' HB3' ' ND2' ' A' ' 135' ' ' ASN . 1.5 p -96.25 -26.83 15.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 62.439999999999998 110.92 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.717 HD13 HD13 ' A' ' 105' ' ' LEU . 55.3 mt -74.14 110.1 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.509 . . . . 74.530000000000001 111.139 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.408 ' H ' ' HD2' ' A' ' 114' ' ' HIS . 1.3 m -92.63 171.37 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.181 -0.463 . . . . 74.200000000000003 110.853 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -40.0 -44.77 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 42.43 110.863 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.772 HG21 ' CD2' ' A' ' 57' ' ' TYR . 26.0 t -138.24 81.54 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 73.209999999999994 111.128 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.448 ' CD2' ' HA ' ' A' ' 110' ' ' ILE . 5.4 t-80 -64.85 -47.05 79.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 75.430000000000007 110.872 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -175.1 171.57 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 72.400000000000006 111.09 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 p -152.03 134.66 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 75.409999999999997 111.152 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.467 HD12 ' CD2' ' A' ' 126' ' ' PHE . 0.7 OUTLIER -107.34 138.2 43.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 71.109999999999999 110.928 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' A' ' 92' ' ' PHE . 17.0 t -129.61 138.32 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 65.310000000000002 111.178 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.69 98.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.9 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -72.29 104.48 3.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 72.239999999999995 110.841 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.63 -5.34 68.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.803 -0.713 . . . . 74.099999999999994 112.456 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.89 -40.91 6.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.792 -0.718 . . . . 74.239999999999995 112.441 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.55 5.41 16.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.837 0.351 . . . . 71.129999999999995 110.92 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? 51.84 57.54 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 52.43 110.878 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 24.2 p -167.85 138.07 2.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 75.030000000000001 110.852 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.467 ' CD2' HD12 ' A' ' 117' ' ' LEU . 67.7 m-85 -64.7 131.07 45.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 75.530000000000001 110.908 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.8 t -112.26 111.61 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 75.150000000000006 111.133 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.6 tt -100.62 125.75 47.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 75.239999999999995 110.923 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.0 mtt -116.93 132.43 56.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 61.229999999999997 110.845 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -84.52 132.41 34.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 74.319999999999993 110.862 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.654 ' CD2' HG12 ' A' ' 113' ' ' VAL . 3.8 mm? -73.35 -15.29 61.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 75.109999999999999 110.836 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.62 43.96 0.93 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.774 -0.727 . . . . 72.209999999999994 112.488 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.9 t -52.01 168.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 40.119999999999997 110.875 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.23 -21.08 33.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 111.116 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.439 ' ND2' ' HB3' ' A' ' 109' ' ' SER . 8.0 m120 -92.76 -75.3 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 110.899 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 147.97 142.58 3.68 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.714 -0.755 . . . . 74.140000000000001 112.462 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.415 HG22 ' ND1' ' A' ' 114' ' ' HIS . 16.0 t -102.1 143.12 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.925 0.393 . . . . 71.049999999999997 111.12 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 4.6 mtmm -101.83 147.93 25.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 62.43 110.924 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.562 HD13 ' HB3' ' A' ' 150' ' ' LEU . 6.8 tp -135.83 135.87 40.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.915 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.7 m120 56.39 22.24 6.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 64.230000000000004 110.859 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.93 21.47 57.38 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 62.530000000000001 112.483 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -145.8 132.82 20.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.763 0.316 . . . . 74.129999999999995 110.892 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -64.13 135.47 56.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 64.530000000000001 110.874 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.454 HD13 ' H ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -140.39 177.77 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.140000000000001 111.121 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -171.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.040000000000006 110.884 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 172.71 12.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 74.450000000000003 110.923 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 58.49 41.22 23.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.540000000000006 110.882 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.76 ' HG3' HD21 ' A' ' 150' ' ' LEU . 7.7 ptm180 -147.59 158.67 42.9 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.573 0.701 . . . . 64.099999999999994 110.905 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 107.06 1.77 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.678 2.252 . . . . 72.409999999999997 112.343 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.76 HD21 ' HG3' ' A' ' 148' ' ' ARG . 4.7 mt -111.84 83.88 5.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.597 0.713 . . . . 51.409999999999997 110.902 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 135.99 31.9 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.718 2.278 . . . . 73.230000000000004 112.344 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.422 ' O ' HG21 ' A' ' 169' ' ' VAL . . . -132.32 79.99 64.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.57 0.7 . . . . 74.120000000000005 111.096 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -178.36 2.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.67 2.247 . . . . 65.140000000000001 112.38 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.5 m -54.08 143.08 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 73.150000000000006 111.074 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.94 -11.22 65.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 74.5 112.519 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.5 m -96.5 174.34 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 74.120000000000005 110.789 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.2 m -130.05 163.86 25.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 74.329999999999998 110.877 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.9 mt -142.12 145.18 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.072 -0.513 . . . . 73.340000000000003 111.155 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -151.93 148.82 28.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 63.100000000000001 111.003 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -148.37 140.84 24.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 73.010000000000005 110.884 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 64.17 -145.5 49.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 61.130000000000003 112.473 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -113.61 14.43 18.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.901 0.382 . . . . 74.329999999999998 110.869 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.76 160.86 11.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 61.210000000000001 110.88 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 61.9 m -91.32 -32.92 15.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 64.209999999999994 110.881 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.72 152.45 9.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 64.409999999999997 110.848 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.9 t -144.84 132.41 16.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 71.019999999999996 111.17 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -95.41 103.25 15.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 74.299999999999997 110.871 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 7.3 tptp -105.29 110.38 22.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 71.239999999999995 110.913 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 152' ' ' ALA . 2.9 t -78.66 153.2 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 111.116 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -160.76 150.87 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 63.039999999999999 110.893 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 70' ' ' ALA . 16.1 tp -89.74 139.16 30.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 64.5 110.906 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -91.53 173.33 36.93 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 33.530000000000001 112.451 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 167.76 23.52 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.676 2.251 . . . . 74.099999999999994 112.382 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 117.82 5.31 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.729 2.286 . . . . 51.299999999999997 112.343 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.6 t -52.12 156.65 1.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 64.450000000000003 110.894 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.6 t -53.53 -45.39 69.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 53.530000000000001 110.86 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 75.129999999999995 110.834 -179.784 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 121.367 0.426 . . . . 52.240000000000002 112.537 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -23.2 31.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.651 2.234 . . . . 33.329999999999998 112.329 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 tpt 53.71 53.39 11.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.84 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 63.8 t -117.37 119.55 62.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.263 -0.426 . . . . 71.400000000000006 111.139 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.3 p -131.09 116.13 17.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 65.420000000000002 111.166 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.6 t -71.43 147.99 47.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 71.400000000000006 110.907 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.529 ' HB ' HD23 ' A' ' 7' ' ' LEU . 66.9 p -96.91 -19.16 19.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 64.310000000000002 111.148 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.72 20.81 73.21 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.705 -0.76 . . . . 21.309999999999999 112.479 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.529 HD23 ' HB ' ' A' ' 5' ' ' THR . 4.4 mm? -86.29 141.44 29.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 74.310000000000002 110.932 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 9' ' ' SER . 1.4 tt -76.87 153.36 34.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 64.150000000000006 110.95 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.627 ' N ' HD23 ' A' ' 8' ' ' LEU . 54.6 p -67.13 -179.11 0.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 62.049999999999997 110.827 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -109.77 148.97 30.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 74.340000000000003 110.889 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.57 145.81 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 72.420000000000002 111.146 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.04 161.02 3.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 62.43 111.072 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.13 159.61 15.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 71.120000000000005 111.071 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.02 113.87 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 75.299999999999997 111.109 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -52.58 107.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 73.230000000000004 110.853 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.7 pttt -126.25 162.36 25.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 70.019999999999996 110.912 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.37 173.38 11.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 71.450000000000003 111.141 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.43 150.57 51.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 111.132 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -103.27 118.22 36.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 63.539999999999999 110.874 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.7 mt -99.46 106.74 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 61.219999999999999 111.094 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.42 161.85 26.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 74.439999999999998 111.113 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -140.5 86.61 12.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.537 0.684 . . . . 63.219999999999999 110.869 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 167.72 23.67 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.678 2.252 . . . . 75.230000000000004 112.326 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 167.76 23.47 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.7 2.267 . . . . 75.239999999999995 112.378 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 167.57 24.07 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.704 2.269 . . . . 71.140000000000001 112.35 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 173.72 10.51 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.709 2.273 . . . . 72.200000000000003 112.358 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.48 145.32 48.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 72.420000000000002 110.906 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.6 m -51.57 162.29 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 71.519999999999996 111.125 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.3 t -85.91 117.64 31.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 71.510000000000005 111.138 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -150.76 163.5 38.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 35.450000000000003 110.896 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 mt -68.4 101.83 1.3 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.472 . . . . 71.349999999999994 110.894 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.8 175.66 7.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 64.400000000000006 111.126 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -54.1 -40.79 67.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 72.340000000000003 110.915 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -54.42 -26.54 31.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 71.25 111.107 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.91 -34.53 78.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 71.109999999999999 111.065 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.21 -31.89 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 71.230000000000004 110.923 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -109.73 39.48 2.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 75.109999999999999 110.904 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.07 153.54 1.19 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.719 . . . . 73.040000000000006 110.893 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 177.47 5.53 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.663 2.242 . . . . 73.140000000000001 112.34 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.742 ' HG3' HD12 ' A' ' 43' ' ' ILE . 11.9 mt-30 -61.74 171.8 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 63.130000000000003 110.907 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -61.76 -44.9 96.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 61.409999999999997 110.858 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.86 -36.51 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 63.32 111.087 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.742 HD12 ' HG3' ' A' ' 40' ' ' GLN . 54.8 mt -70.34 -30.87 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 55.310000000000002 111.13 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.95 -10.33 58.61 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 74.230000000000004 112.474 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.0 t -104.08 -24.56 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 40.420000000000002 111.118 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.444 HG23 ' HA ' ' A' ' 43' ' ' ILE . 66.1 p -50.37 153.75 1.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 71.129999999999995 111.185 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.523 ' O ' HD22 ' A' ' 51' ' ' LEU . 1.1 m-20 -66.57 160.71 65.41 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.606 0.717 . . . . 72.0 110.866 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HA ' HD22 ' A' ' 51' ' ' LEU . 54.0 Cg_endo -69.74 -36.08 11.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.642 2.228 . . . . 73.140000000000001 112.335 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.86 -24.25 23.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 55.310000000000002 111.153 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.49 -54.93 5.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.519999999999996 110.884 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.615 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -63.18 -28.87 70.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 53.229999999999997 110.903 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.615 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.3 t30 -78.65 -29.4 45.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 54.509999999999998 110.907 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.8 -19.0 60.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 51.539999999999999 111.098 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.556 ' NE2' HD12 ' A' ' 94' ' ' LEU . 7.7 mm-40 -92.99 -14.58 27.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 70.109999999999999 110.908 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -85.79 -17.37 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 73.439999999999998 111.128 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 t -77.18 -7.94 56.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.47 . . . . 62.420000000000002 110.846 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.743 ' CD2' HG11 ' A' ' 113' ' ' VAL . 37.6 m-85 -114.04 -51.52 2.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 62.350000000000001 110.899 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CZ ' HG21 ' A' ' 116' ' ' VAL . 20.7 p90 -154.83 148.23 25.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 71.319999999999993 110.846 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -110.05 152.25 26.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 64.430000000000007 110.895 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.4 t -86.99 112.09 45.04 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.649 0.738 . . . . 73.019999999999996 110.856 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.814 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 54.0 Cg_endo -69.73 169.6 18.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.735 2.29 . . . . 72.310000000000002 112.352 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 -41.67 3.95 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.654 2.236 . . . . 64.349999999999994 112.341 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.561 ' HA ' HD12 ' A' ' 66' ' ' LEU . 29.3 p-90 -71.62 -7.85 50.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.265 -0.425 . . . . 72.209999999999994 110.893 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.814 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -70.33 143.3 52.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 73.319999999999993 111.102 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 64' ' ' ALA . . . 66.81 48.64 1.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 72.140000000000001 111.108 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 63' ' ' TRP . 80.3 mt -146.32 65.99 10.87 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.625 0.726 . . . . 72.310000000000002 110.919 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 154.07 68.1 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.668 2.245 . . . . 71.109999999999999 112.355 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.0 t -131.44 4.59 4.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 43.149999999999999 110.857 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.05 151.67 25.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 73.439999999999998 111.14 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 171' ' ' LEU . . . -90.27 119.54 30.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 73.409999999999997 111.117 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 26.4 p -150.84 176.97 10.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 75.409999999999997 110.909 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -143.89 168.16 20.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 74.209999999999994 110.826 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 74' ' ' GLN . 2.8 tm? -120.49 136.24 54.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 75.319999999999993 110.893 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.671 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -112.56 135.37 53.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 110.915 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 11.7 m -124.21 136.79 54.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 60.009999999999998 110.869 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.498 HG23 ' NE2' ' A' ' 74' ' ' GLN . 6.5 p -104.24 149.79 24.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.129999999999995 111.176 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -151.57 115.75 5.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 71.219999999999999 110.867 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 54.01 37.91 27.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 71.439999999999998 110.878 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.17 18.47 77.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.786 -0.721 . . . . 55.030000000000001 112.518 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 25.5 mt -108.63 108.6 61.01 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.648 0.737 . . . . 75.140000000000001 110.9 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 52.9 Cg_endo -69.81 92.58 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.683 2.255 . . . . 64.329999999999998 112.299 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.4 mt -70.34 159.23 85.47 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.6 0.714 . . . . 52.329999999999998 110.96 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 117.88 5.35 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 54.130000000000003 112.3 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.99 146.86 54.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 62.530000000000001 111.08 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.1 mt -147.88 139.47 23.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 63.43 110.911 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.89 107.86 1.48 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 63.25 112.45 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.1 mt -80.07 71.14 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 71.209999999999994 110.941 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -111.49 6.3 20.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 110.885 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.23 -19.65 63.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 75.530000000000001 110.866 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -136.76 155.96 76.32 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.627 0.727 . . . . 74.340000000000003 110.907 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 -27.85 26.38 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 74.129999999999995 112.355 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.554 ' HB3' HG22 ' A' ' 118' ' ' VAL . 2.8 p90 -159.83 176.97 11.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 64.450000000000003 110.859 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -144.71 124.19 13.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 74.200000000000003 110.907 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.556 HD12 ' NE2' ' A' ' 54' ' ' GLN . 0.6 OUTLIER -94.81 148.7 22.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 61.009999999999998 110.906 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -130.34 105.3 7.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.420000000000002 110.887 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.49 -157.85 17.05 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.725 -0.75 . . . . 72.310000000000002 112.46 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -102.69 -16.52 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.826 0.346 . . . . 74.200000000000003 110.857 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.412 ' OG ' HG22 ' A' ' 100' ' ' VAL . 4.3 t -59.23 138.19 57.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 63.140000000000001 110.797 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -16.93 63.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 63.210000000000001 110.923 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.412 HG22 ' OG ' ' A' ' 98' ' ' SER . 27.4 m -80.88 -25.8 10.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 74.219999999999999 111.134 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.538 ' SG ' HD13 ' A' ' 94' ' ' LEU . 90.2 m -58.9 157.76 9.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 51.210000000000001 110.88 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -82.27 -15.26 53.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 64.329999999999998 110.834 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -140.53 108.26 5.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 65.530000000000001 110.913 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 p -100.54 108.15 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 74.030000000000001 111.091 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.478 HD13 HD13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -110.61 -169.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 61.43 110.905 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -137.24 107.35 6.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 74.219999999999999 110.868 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.465 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -160.6 146.8 11.58 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.616 0.722 . . . . 65.409999999999997 110.848 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -13.71 35.16 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.713 2.275 . . . . 64.0 112.385 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 p -99.09 -29.8 12.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.845 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.478 HD13 HD13 ' A' ' 105' ' ' LEU . 52.0 mt -76.35 121.36 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 70.310000000000002 111.105 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.88 170.64 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 61.420000000000002 110.881 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -33.94 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 75.439999999999998 110.889 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.743 HG11 ' CD2' ' A' ' 57' ' ' TYR . 2.6 m -145.69 81.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 72.340000000000003 111.11 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.619 ' CD2' HG22 ' A' ' 137' ' ' VAL . 2.3 t60 -65.62 -61.32 2.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 70.310000000000002 110.814 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -163.34 164.59 24.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 71.230000000000004 111.066 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.581 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 6.2 p -143.16 139.52 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 72.439999999999998 111.112 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.689 HD12 ' O ' ' A' ' 117' ' ' LEU . 2.7 pp -111.76 147.39 35.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 53.25 110.871 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 92' ' ' PHE . 11.4 t -137.66 132.85 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 64.209999999999994 111.179 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.87 99.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 65.340000000000003 110.911 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -74.17 104.0 4.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 71.299999999999997 110.885 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.96 -2.22 70.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 51.520000000000003 112.522 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.95 -38.8 5.36 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 70.430000000000007 112.467 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.86 5.82 19.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 75.230000000000004 110.925 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? 51.64 57.82 6.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 75.109999999999999 110.873 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 30.7 p -173.38 136.96 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 73.129999999999995 110.86 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CD1' HD13 ' A' ' 117' ' ' LEU . 39.7 m-85 -56.94 128.93 39.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 73.0 110.862 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 118' ' ' VAL . 2.7 p -106.92 108.02 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.491 . . . . 55.399999999999999 111.097 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.401 ' C ' HD23 ' A' ' 128' ' ' LEU . 10.4 tt -102.62 134.24 46.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 75.5 110.944 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 55.6 mtm -129.48 133.9 47.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 71.400000000000006 110.855 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.38 132.56 34.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 71.519999999999996 110.846 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 131' ' ' LEU . 3.0 mm? -75.07 -8.96 58.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 63.109999999999999 110.929 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.9 51.04 0.7 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.72 -0.752 . . . . 72.019999999999996 112.495 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 m -67.07 174.93 2.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 63.240000000000002 110.897 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 p -78.71 -70.69 0.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 71.140000000000001 111.141 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.512 ' ND2' ' H ' ' A' ' 135' ' ' ASN . 0.4 OUTLIER -49.18 -63.11 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 72.420000000000002 110.838 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 127.8 139.55 4.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.791 -0.719 . . . . 75.099999999999994 112.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.619 HG22 ' CD2' ' A' ' 114' ' ' HIS . 20.4 t -88.44 147.44 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 72.209999999999994 111.141 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.74 150.03 22.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 45.130000000000003 110.861 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.74 HD13 ' HB2' ' A' ' 140' ' ' ASN . 3.1 tm? -133.11 121.37 22.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 70.340000000000003 110.918 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.74 ' HB2' HD13 ' A' ' 139' ' ' LEU . 1.3 m-80 62.08 23.29 13.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 62.509999999999998 110.903 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.24 20.61 54.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 71.140000000000001 112.481 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 144' ' ' ILE . 27.6 m120 -144.7 128.89 17.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 73.5 110.914 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 28.4 ptt-85 -60.75 136.79 58.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 72.340000000000003 110.896 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -141.48 178.71 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 74.239999999999995 111.114 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -170.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 110.92 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -172.53 2.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.140000000000001 110.905 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.33 39.69 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 63.549999999999997 110.894 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -139.71 154.9 71.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.644 0.735 . . . . 71.200000000000003 110.818 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 111.74 2.88 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.714 2.276 . . . . 71.430000000000007 112.336 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 144' ' ' ILE . 17.6 mt -110.23 83.38 3.09 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.569 0.7 . . . . 74.010000000000005 110.916 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 119.91 6.78 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.721 2.281 . . . . 73.409999999999997 112.289 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -116.06 78.86 7.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.557 0.694 . . . . 75.049999999999997 111.153 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -173.93 0.82 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.69 2.26 . . . . 74.319999999999993 112.332 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 m -64.01 144.46 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 53.119999999999997 111.137 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.41 -10.41 66.88 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 75.549999999999997 112.524 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 34.0 m -96.45 -175.38 3.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 60.219999999999999 110.86 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 45.8 m -138.89 166.12 25.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 63.329999999999998 110.828 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.2 mt -141.48 148.03 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 70.239999999999995 111.073 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.2 149.01 28.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 72.540000000000006 110.912 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -150.2 134.29 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 73.219999999999999 110.876 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 63.65 -158.03 40.76 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.719 -0.753 . . . . 61.0 112.49 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -97.22 15.16 23.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 72.5 110.891 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.9 p -64.53 156.78 28.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 63.409999999999997 110.856 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.5 t -91.25 -29.7 17.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.864 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.26 135.58 56.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 72.420000000000002 110.871 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.3 t -130.14 131.76 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.030000000000001 111.082 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -96.57 103.19 15.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 75.200000000000003 110.927 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -104.23 110.71 23.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.074 -0.512 . . . . 72.519999999999996 110.887 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.3 153.12 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.349999999999994 111.094 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -160.83 149.93 16.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 75.140000000000001 110.909 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 70' ' ' ALA . 13.6 tp -84.33 136.82 33.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 73.109999999999999 110.905 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -110.37 177.68 19.67 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 34.310000000000002 112.498 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 167.78 23.43 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.704 2.27 . . . . 62.299999999999997 112.36 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 110.16 2.48 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.683 2.255 . . . . 65.340000000000003 112.318 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 92.3 p -71.98 -37.03 69.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 71.129999999999995 110.863 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.7 p -92.27 128.91 38.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 52.329999999999998 110.839 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 55.549999999999997 110.866 -179.814 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 CA-C-O 121.445 0.469 . . . . 72.239999999999995 112.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 160.39 49.87 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.732 2.288 . . . . 70.030000000000001 112.324 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpp -110.03 136.58 49.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 62.439999999999998 110.889 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.9 t -118.46 148.79 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 111.123 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.3 t -92.03 155.06 18.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 52.299999999999997 111.105 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -73.46 157.38 36.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 60.530000000000001 110.913 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.02 -19.1 35.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 64.129999999999995 111.116 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.32 20.31 75.24 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 54.509999999999998 112.519 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.0 112.03 14.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.933 0.397 . . . . 71.420000000000002 110.918 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -137.44 136.86 38.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 73.420000000000002 110.888 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -95.66 156.33 16.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 64.409999999999997 110.88 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -127.66 123.52 35.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 73.099999999999994 110.883 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 p -133.98 139.86 47.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 74.25 111.125 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.92 116.97 3.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 111.112 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.38 149.29 29.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 71.409999999999997 111.11 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.36 90.83 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 63.240000000000002 111.08 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -141.11 134.27 29.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 64.140000000000001 110.883 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 pptp? -124.53 162.35 24.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 72.209999999999994 110.937 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.9 167.73 24.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 54.43 111.066 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.2 128.62 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 72.230000000000004 111.109 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -117.56 116.59 27.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 65.120000000000005 110.871 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.7 mt -84.15 127.68 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 75.430000000000007 111.123 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.51 -179.39 4.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 73.430000000000007 111.135 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 86.61 46.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.532 0.682 . . . . 73.340000000000003 110.852 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 167.78 23.49 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.677 2.251 . . . . 74.430000000000007 112.327 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 167.81 23.28 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.658 2.239 . . . . 72.319999999999993 112.335 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 167.55 24.07 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.683 2.255 . . . . 74.530000000000001 112.374 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 177.4 5.62 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.665 2.243 . . . . 72.109999999999999 112.346 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.04 120.82 15.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 54.32 110.898 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.3 m -56.07 170.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.432 . . . . 54.340000000000003 111.107 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.0 p -101.62 151.78 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 62.450000000000003 111.085 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -107.52 168.19 9.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.409999999999997 110.93 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 31' ' ' LEU . 2.8 pp -51.74 135.17 29.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 110.977 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.611 ' H ' ' HB3' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -92.32 169.01 10.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 72.120000000000005 111.166 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -60.96 -41.8 97.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 73.409999999999997 110.848 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.48 -16.55 34.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.510000000000005 111.12 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.611 ' HB3' ' H ' ' A' ' 32' ' ' THR . . . -82.92 -39.1 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 75.299999999999997 111.116 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -67.39 -12.51 60.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 73.5 110.929 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -73.32 -24.92 60.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 71.420000000000002 110.943 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.569 HD21 ' HA ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -109.38 85.7 3.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.579 0.705 . . . . 52.149999999999999 110.895 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 158.26 57.62 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.249 . . . . 60.299999999999997 112.342 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.749 ' HG3' HD12 ' A' ' 43' ' ' ILE . 9.0 mt-30 -67.24 171.12 6.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 72.140000000000001 110.944 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -67.19 -38.29 85.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.839 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 46' ' ' THR . 1.7 pp -80.11 -32.72 13.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.421 . . . . 71.400000000000006 111.214 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.749 HD12 ' HG3' ' A' ' 40' ' ' GLN . 61.4 mt -78.79 -25.11 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 70.099999999999994 111.202 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.18 -17.13 65.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.706 -0.759 . . . . 74.019999999999996 112.491 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.51 -25.93 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.368 . . . . 74.0 111.146 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 42' ' ' ILE . 37.9 p -89.91 153.62 20.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 111.068 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.553 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -84.14 160.47 57.44 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.591 0.71 . . . . 70.140000000000001 110.852 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -37.28 9.47 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.71 2.273 . . . . 74.129999999999995 112.381 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.04 -15.42 34.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 74.510000000000005 111.103 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.63 -57.71 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 74.109999999999999 110.916 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.569 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.7 OUTLIER -59.66 -29.33 67.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 65.109999999999999 110.876 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.569 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.7 t30 -74.7 -43.86 52.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 71.200000000000003 110.908 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.29 -24.41 28.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 54.219999999999999 111.17 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.424 HE22 HD12 ' A' ' 94' ' ' LEU . 5.4 mm-40 -66.63 -16.94 64.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 72.129999999999995 110.918 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 52' ' ' ASN . 4.3 p -69.3 -21.8 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 75.239999999999995 111.068 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.8 t -77.77 -4.36 45.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 64.400000000000006 110.862 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.772 ' CE1' HG21 ' A' ' 100' ' ' VAL . 31.1 m-85 -124.2 -58.14 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 72.349999999999994 110.858 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.597 ' CZ ' HD11 ' A' ' 131' ' ' LEU . 19.5 m-85 -146.35 142.21 28.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 74.439999999999998 110.878 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.436 ' HG3' HG23 ' A' ' 55' ' ' VAL . 3.7 mp0 -116.46 118.33 32.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 60.240000000000002 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 6.3 p -48.39 107.16 0.7 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.585 0.707 . . . . 72.420000000000002 110.876 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.473 ' HG2' ' CB ' ' A' ' 64' ' ' ALA . 53.6 Cg_endo -69.77 158.68 56.12 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.689 2.259 . . . . 34.109999999999999 112.328 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.93 -36.62 10.03 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.671 2.247 . . . . 61.399999999999999 112.278 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 39.8 p-90 -70.46 -4.62 23.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 64.510000000000005 110.912 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' CB ' ' HG2' ' A' ' 61' ' ' PRO . . . -109.97 172.78 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 65.200000000000003 111.073 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 64' ' ' ALA . . . 70.41 28.55 3.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 70.329999999999998 111.103 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.532 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -146.71 68.06 11.65 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.611 0.72 . . . . 71.430000000000007 110.92 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.75 151.68 69.17 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.687 2.258 . . . . 60.539999999999999 112.336 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 m -136.85 11.4 3.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 73.510000000000005 110.842 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.5 p -127.99 153.25 37.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 63.43 111.159 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 171' ' ' LEU . . . -93.31 111.66 23.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 64.310000000000002 111.086 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.0 p -150.91 174.96 12.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 74.329999999999998 110.878 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -148.4 167.1 26.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 65.019999999999996 110.867 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 74' ' ' GLN . 2.1 tm? -121.11 136.09 55.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 75.439999999999998 110.866 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.703 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -111.86 136.37 51.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 72.040000000000006 110.889 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -127.79 144.71 51.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 74.530000000000001 110.864 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 p -107.36 148.37 29.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 70.129999999999995 111.143 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.413 ' CD ' HD11 ' A' ' 82' ' ' LEU . 5.2 ptm180 -149.74 113.96 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 73.140000000000001 110.863 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 53.67 39.02 29.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 73.219999999999999 110.909 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.37 19.69 77.75 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.673 -0.775 . . . . 73.200000000000003 112.484 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 8.2 mt -112.39 108.6 54.47 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.632 0.73 . . . . 71.530000000000001 110.975 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 54.2 Cg_endo -69.7 94.52 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.691 2.261 . . . . 71.530000000000001 112.342 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.413 HD11 ' CD ' ' A' ' 77' ' ' ARG . 20.4 mt -69.81 159.28 84.63 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 71.450000000000003 110.928 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 114.29 3.65 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 65.540000000000006 112.29 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.07 147.11 51.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 43.240000000000002 111.119 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 mt -148.64 141.95 25.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.199 -0.455 . . . . 60.299999999999997 110.925 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.1 102.0 0.32 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.693 -0.765 . . . . 21.440000000000001 112.409 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.7 mt -77.43 70.38 3.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.897 0.38 . . . . 61.539999999999999 110.917 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -112.2 6.32 18.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.462 . . . . 74.019999999999996 110.805 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.02 -19.18 64.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 73.239999999999995 110.874 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -133.64 156.39 79.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.629 0.728 . . . . 75.230000000000004 110.857 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -34.47 14.36 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.705 2.27 . . . . 73.430000000000007 112.323 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.559 ' HB3' HG22 ' A' ' 118' ' ' VAL . 32.7 p90 -154.71 162.4 41.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 65.420000000000002 110.897 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -128.5 117.37 21.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 110.928 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.428 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . 0.3 OUTLIER -91.21 138.97 31.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 110.917 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.406 ' CE2' HD21 ' A' ' 117' ' ' LEU . 21.9 m-85 -127.55 105.31 8.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 72.019999999999996 110.92 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.89 -146.28 4.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 21.129999999999999 112.45 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.48 -2.6 11.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.82 0.343 . . . . 60.399999999999999 110.891 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.0 t -70.32 156.28 39.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 63.420000000000002 110.878 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.444 ' HD2' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -81.05 -8.73 59.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 72.109999999999999 110.838 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.772 HG21 ' CE1' ' A' ' 57' ' ' TYR . 18.5 m -93.03 -21.37 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 72.25 111.128 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 94' ' ' LEU . 12.8 p -58.24 165.34 2.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 51.219999999999999 110.838 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.38 -2.29 54.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 75.349999999999994 110.891 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.16 106.3 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 73.239999999999995 110.937 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 104' ' ' VAL . 3.0 p -97.33 109.8 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 72.519999999999996 111.095 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.596 HD13 HD13 ' A' ' 110' ' ' ILE . 0.4 OUTLIER -104.18 -168.65 1.52 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 64.310000000000002 110.893 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -133.41 106.75 7.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 71.219999999999999 110.868 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.428 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -167.35 142.46 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.675 0.75 . . . . 73.430000000000007 110.817 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -13.43 34.75 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.67 2.246 . . . . 55.43 112.367 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.9 p -97.4 -25.39 15.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 63.439999999999998 110.842 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.596 HD13 HD13 ' A' ' 105' ' ' LEU . 58.7 mt -75.55 116.54 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 72.439999999999998 111.087 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.2 m -96.2 169.88 9.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 60.43 110.828 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 m -45.58 -38.35 6.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 74.340000000000003 110.813 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.548 HG11 ' HD2' ' A' ' 57' ' ' TYR . 2.8 m -141.26 80.17 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 72.099999999999994 111.091 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.661 ' CD2' HG22 ' A' ' 137' ' ' VAL . 2.1 t60 -69.68 -49.01 57.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 74.420000000000002 110.903 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -168.2 159.18 10.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 64.319999999999993 111.112 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.98 137.04 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 64.409999999999997 111.186 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.737 HD12 ' CD1' ' A' ' 126' ' ' PHE . 0.4 OUTLIER -109.71 144.33 38.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 73.319999999999993 110.925 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.559 HG22 ' HB3' ' A' ' 92' ' ' PHE . 23.9 t -132.11 128.69 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 62.329999999999998 111.128 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.84 95.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 53.100000000000001 110.92 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.542 ' HB2' HG23 ' A' ' 127' ' ' VAL . 12.6 t-80 -65.43 108.17 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 55.539999999999999 110.907 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.28 -5.12 65.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 75.209999999999994 112.436 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.7 -42.77 5.97 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 64.299999999999997 112.466 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.16 8.36 16.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 74.230000000000004 110.888 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? 50.73 44.71 27.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 72.019999999999996 110.894 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 87.6 m -146.27 137.78 24.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.510000000000005 110.893 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.737 ' CD1' HD12 ' A' ' 117' ' ' LEU . 31.7 m-85 -65.97 131.28 45.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 54.140000000000001 110.864 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.542 HG23 ' HB2' ' A' ' 120' ' ' HIS . 88.0 t -110.18 107.29 22.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 61.520000000000003 111.149 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 158' ' ' ILE . 2.0 tt -101.68 134.84 44.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 71.439999999999998 110.865 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 8.1 mtm -131.41 133.9 45.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 74.439999999999998 110.89 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -83.64 132.56 34.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 72.120000000000005 110.873 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.597 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 3.1 mm? -73.35 -16.07 61.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 71.549999999999997 110.952 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.74 49.37 0.74 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 50.350000000000001 112.493 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 t -58.58 158.48 7.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 64.420000000000002 110.877 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.6 m -78.55 -25.73 45.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 70.310000000000002 111.109 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -80.39 -74.48 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 74.200000000000003 110.918 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 148.04 126.48 1.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.758 -0.734 . . . . 74.549999999999997 112.493 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.661 HG22 ' CD2' ' A' ' 114' ' ' HIS . 20.3 t -91.51 145.72 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.382 . . . . 73.219999999999999 111.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -100.23 154.71 18.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.150000000000006 110.966 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.518 ' HB2' HD12 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -140.11 126.19 19.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 74.299999999999997 110.95 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 56.34 23.82 7.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 75.409999999999997 110.912 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 86.66 19.76 55.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.69 -0.767 . . . . 61.399999999999999 112.493 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' ' 144' ' ' ILE . 31.4 m120 -145.3 130.19 18.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.781 0.324 . . . . 75.040000000000006 110.925 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.71 136.61 58.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.453 . . . . 74.219999999999999 110.841 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 139' ' ' LEU . 0.0 OUTLIER -142.81 178.69 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 73.099999999999994 111.105 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -170.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 51.340000000000003 110.906 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.12 176.83 8.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 59.21 39.04 23.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 110.902 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.626 ' NE ' HD21 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -148.38 158.03 41.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 72.150000000000006 110.856 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 113.01 3.22 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.691 2.261 . . . . 75.150000000000006 112.317 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.626 HD21 ' NE ' ' A' ' 148' ' ' ARG . 69.9 mt -124.5 84.07 57.3 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.619 0.723 . . . . 71.450000000000003 110.931 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 134.15 27.37 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.681 2.254 . . . . 43.43 112.39 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.538 ' O ' HG21 ' A' ' 169' ' ' VAL . . . -118.44 80.7 16.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.688 . . . . 64.019999999999996 111.124 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 179.28 3.79 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.755 2.303 . . . . 71.349999999999994 112.332 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.5 m -56.63 143.17 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 71.439999999999998 111.084 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.31 -12.7 61.9 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.722 -0.751 . . . . 73.340000000000003 112.528 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.83 168.48 10.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 64.439999999999998 110.89 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.7 m -124.4 165.44 17.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 63.109999999999999 110.806 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.629 HG21 HD13 ' A' ' 128' ' ' LEU . 7.1 mt -142.58 150.68 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 72.340000000000003 111.197 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.61 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -152.36 162.52 41.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 72.310000000000002 110.921 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.61 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 3.5 p90 -163.85 139.59 6.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 73.129999999999995 110.863 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 64.29 -154.03 48.04 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.718 -0.754 . . . . 72.010000000000005 112.46 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -104.89 8.97 34.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.896 0.379 . . . . 75.530000000000001 110.895 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.09 159.65 25.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 41.340000000000003 110.868 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.531 ' O ' HG23 ' A' ' 166' ' ' VAL . 75.3 m -88.84 -20.66 24.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 63.049999999999997 110.8 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -53.13 137.81 32.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 72.430000000000007 110.813 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 164' ' ' SER . 19.5 t -139.26 122.83 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 74.319999999999993 111.104 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.415 ' HB3' HD11 ' A' ' 73' ' ' LEU . 6.6 m-85 -92.85 105.07 17.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 63.409999999999997 110.934 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -105.94 110.14 22.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 75.430000000000007 110.891 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 152' ' ' ALA . 2.8 t -77.72 153.44 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 71.450000000000003 111.118 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.12 148.48 15.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 74.510000000000005 110.926 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 70' ' ' ALA . 11.0 tp -89.65 132.88 34.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 64.340000000000003 110.897 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -89.74 177.17 43.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 72.439999999999998 112.571 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 167.76 23.55 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.264 . . . . 75.030000000000001 112.358 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 112.51 3.1 Favored 'Trans proline' 0 C--O 1.23 0.112 0 C-N-CA 122.668 2.246 . . . . 65.209999999999994 112.348 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.8 p -85.78 124.39 32.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 74.340000000000003 110.906 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.3 m -154.38 150.15 27.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 74.400000000000006 110.845 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.4 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.919 -179.868 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 CA-C-O 121.374 0.43 . . . . 75.420000000000002 112.405 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 143.43 50.77 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.766 2.31 . . . . 71.450000000000003 112.327 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mtp -68.45 164.34 21.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 72.530000000000001 110.813 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -119.39 141.46 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 111.049 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.2 t -133.41 163.85 28.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 61.509999999999998 111.116 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.4 p -105.45 167.04 10.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 70.129999999999995 110.879 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -108.19 21.0 17.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 72.510000000000005 111.131 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.0 -19.5 37.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 73.409999999999997 112.526 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.661 ' N ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -136.45 165.77 25.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.824 0.345 . . . . 63.32 110.944 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 tt -124.64 137.75 54.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 70.25 110.899 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 p -61.44 138.53 58.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.457 . . . . 53.240000000000002 110.872 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -87.72 146.66 25.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 55.240000000000002 110.793 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.91 149.91 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.502 . . . . 74.409999999999997 111.143 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.06 150.17 51.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 111.081 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.11 113.49 27.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 75.0 111.114 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.99 106.6 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 72.299999999999997 111.155 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -140.25 113.89 8.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.241 -0.436 . . . . 70.340000000000003 110.901 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -124.3 162.98 22.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.461 . . . . 64.530000000000001 110.905 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.65 149.57 52.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 71.209999999999994 111.153 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.97 151.94 29.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 72.140000000000001 111.112 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -107.62 104.74 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 74.519999999999996 110.907 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.6 mp -81.87 137.59 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 71.200000000000003 111.131 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.08 112.22 12.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 111.143 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -140.81 86.72 11.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.618 0.723 . . . . 54.530000000000001 110.947 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 167.68 23.72 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.617 2.212 . . . . 63.219999999999999 112.362 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 167.76 23.49 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.652 2.235 . . . . 63.210000000000001 112.316 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 167.75 23.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.676 2.251 . . . . 40.439999999999998 112.348 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 117.45 5.09 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.692 2.262 . . . . 52.109999999999999 112.286 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.3 130.02 39.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 74.209999999999994 110.917 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.21 174.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 71.299999999999997 111.159 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.445 ' O ' HD23 ' A' ' 31' ' ' LEU . 10.6 p -136.42 152.11 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 64.140000000000001 111.097 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.39 151.62 36.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 64.310000000000002 110.89 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -139.44 161.6 37.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.106 -0.497 . . . . 64.209999999999994 110.885 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.15 174.63 5.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 53.439999999999998 111.174 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.51 -38.17 68.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 73.530000000000001 110.887 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.78 -16.39 62.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 74.129999999999995 111.126 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 31' ' ' LEU . . . -89.06 -36.25 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 64.140000000000001 111.065 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -83.52 -1.21 53.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.288 -0.414 . . . . 71.150000000000006 110.869 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -103.78 -13.58 16.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 71.129999999999995 110.943 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.56 ' O ' HD12 ' A' ' 38' ' ' LEU . 3.9 pp -107.38 154.53 40.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.615 0.721 . . . . 64.239999999999995 110.849 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 146.54 60.04 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.711 2.274 . . . . 55.409999999999997 112.282 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.805 ' HG3' HD12 ' A' ' 43' ' ' ILE . 9.5 mt-30 -53.06 172.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 71.040000000000006 110.91 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -62.94 -55.61 24.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 110.788 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.449 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -72.26 -27.88 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 71.319999999999993 111.147 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.805 HD12 ' HG3' ' A' ' 40' ' ' GLN . 31.5 mt -77.91 -25.27 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 72.25 111.166 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.87 -18.09 56.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 62.149999999999999 112.432 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 t -119.34 -26.46 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.93 0.395 . . . . 53.539999999999999 111.176 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 42' ' ' ILE . 37.7 p -96.63 153.57 17.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 111.175 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.553 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -82.32 159.79 63.9 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.513 0.673 . . . . 73.209999999999994 110.941 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 -35.39 12.82 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.71 2.274 . . . . 43.039999999999999 112.355 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -18.54 26.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 64.239999999999995 111.182 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.72 -61.24 1.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 65.409999999999997 110.934 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 52' ' ' ASN . 0.6 OUTLIER -53.68 -29.73 40.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 71.239999999999995 110.864 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.577 ' H ' HD23 ' A' ' 51' ' ' LEU . 3.3 t30 -74.66 -40.5 61.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.906 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 1.007 ' HB1' HG12 ' A' ' 100' ' ' VAL . . . -55.01 -27.94 48.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 54.520000000000003 111.122 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.486 HE21 HD12 ' A' ' 94' ' ' LEU . 6.3 mp0 -92.55 -17.08 24.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 74.120000000000005 110.854 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -60.66 -19.31 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 72.150000000000006 111.053 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.47 3.98 53.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 73.030000000000001 110.836 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.732 ' CD2' HG11 ' A' ' 113' ' ' VAL . 39.0 m-85 -128.04 -57.95 1.23 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 75.129999999999995 110.877 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.766 ' CZ ' HG21 ' A' ' 116' ' ' VAL . 24.4 p90 -147.94 141.42 25.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.439999999999998 110.891 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.519 HE22 HG22 ' A' ' 55' ' ' VAL . 26.3 mm-40 -90.19 152.38 21.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 71.310000000000002 110.993 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 23.1 p -89.0 120.8 69.98 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.589 0.709 . . . . 52.43 110.822 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.824 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 54.3 Cg_endo -69.72 164.85 32.96 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.684 2.256 . . . . 74.200000000000003 112.363 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -41.94 3.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.731 2.287 . . . . 73.120000000000005 112.321 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.438 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 27.7 p-90 -68.51 -9.17 47.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 75.219999999999999 110.818 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.824 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -71.96 149.23 45.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 75.109999999999999 111.115 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.746 ' HB2' ' HB3' ' A' ' 91' ' ' PRO . . . 65.16 47.18 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 70.319999999999993 111.061 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 63' ' ' TRP . 81.0 mt -146.29 66.3 11.13 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 71.340000000000003 110.902 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 151.17 69.02 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.691 2.261 . . . . 71.030000000000001 112.354 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.73 5.84 3.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 73.049999999999997 110.778 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.28 152.62 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 71.200000000000003 111.15 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.66 120.04 32.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 72.340000000000003 111.166 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 5.1 p -151.2 172.01 16.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 75.439999999999998 110.862 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -137.1 167.6 21.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 72.200000000000003 110.867 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.709 HD13 ' N ' ' A' ' 74' ' ' GLN . 1.9 tm? -123.55 136.24 54.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 63.549999999999997 110.896 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.709 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -112.03 133.46 54.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 64.450000000000003 110.923 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.1 p -128.53 141.83 51.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 54.229999999999997 110.923 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.642 HG22 ' HA ' ' A' ' 81' ' ' PRO . 2.2 p -116.15 152.61 33.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 111.154 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -150.73 127.97 11.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 70.5 110.901 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 55.61 30.02 14.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 110.815 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.58 19.1 78.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 71.120000000000005 112.49 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.3 mt -109.94 108.56 59.21 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.6 0.714 . . . . 54.140000000000001 110.933 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.642 ' HA ' HG22 ' A' ' 76' ' ' THR . 53.9 Cg_endo -69.77 94.23 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.736 2.291 . . . . 72.120000000000005 112.279 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.1 mt -74.8 159.05 83.99 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.74 . . . . 74.019999999999996 110.891 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 127.63 14.91 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.741 2.294 . . . . 73.219999999999999 112.345 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 74' ' ' GLN . . . -70.03 145.28 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 55.32 111.04 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.8 mt -142.17 140.84 32.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.82 100.36 0.2 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.683 -0.77 . . . . 53.340000000000003 112.504 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 75.8 mt -75.35 71.18 2.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 74.010000000000005 110.925 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -111.68 6.29 19.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 75.319999999999993 110.91 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.36 -18.56 63.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 65.430000000000007 110.842 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -140.86 155.55 69.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.622 0.725 . . . . 72.409999999999997 110.916 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.746 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 53.5 Cg_endo -69.73 -30.21 22.78 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.769 2.313 . . . . 63.450000000000003 112.353 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.589 ' HB3' HG22 ' A' ' 118' ' ' VAL . 13.2 p90 -153.42 175.91 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 70.040000000000006 110.94 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -144.63 125.3 14.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 75.129999999999995 110.95 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.502 HD13 ' SG ' ' A' ' 101' ' ' CYS . 0.7 OUTLIER -90.92 152.3 20.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.162 -0.472 . . . . 74.230000000000004 110.887 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -139.14 106.23 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 72.010000000000005 110.874 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -163.37 -144.23 3.96 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.738 . . . . 73.019999999999996 112.492 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.03 -7.15 9.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.799 0.333 . . . . 74.319999999999993 110.829 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.529 ' HB3' HG22 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -80.75 162.74 23.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.845 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -22.73 49.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 75.010000000000005 110.808 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.007 HG12 ' HB1' ' A' ' 53' ' ' ALA . 15.4 m -68.08 -22.17 27.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 72.310000000000002 111.109 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.502 ' SG ' HD13 ' A' ' 94' ' ' LEU . 94.8 m -74.09 163.47 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 63.119999999999997 110.876 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.06 -24.84 37.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.92 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.0 108.35 10.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.477 . . . . 63.229999999999997 110.943 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 98' ' ' SER . 32.2 t -96.42 103.97 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 111.139 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.515 HD13 HD13 ' A' ' 110' ' ' ILE . 0.4 OUTLIER -106.59 -169.87 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 110.881 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -137.48 107.02 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 64.340000000000003 110.97 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.464 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -159.96 147.41 12.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 62.149999999999999 110.831 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -14.4 35.82 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.684 2.256 . . . . 74.319999999999993 112.317 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.7 p -100.12 -27.55 13.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 71.239999999999995 110.838 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.515 HD13 HD13 ' A' ' 105' ' ' LEU . 56.8 mt -76.02 111.01 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 63.43 111.048 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.7 m -89.02 169.57 11.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 63.039999999999999 110.878 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.3 m -46.14 -35.51 5.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 64.150000000000006 110.867 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.798 HG23 HD13 ' A' ' 131' ' ' LEU . 1.2 m -145.57 81.72 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 60.020000000000003 111.154 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.445 ' CD2' HG22 ' A' ' 137' ' ' VAL . 1.9 t60 -65.76 -60.42 2.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 110.85 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -160.46 165.18 31.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.192 -0.458 . . . . 60.420000000000002 111.067 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.766 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 6.2 p -142.71 134.77 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 74.230000000000004 111.141 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.432 HD13 ' CD2' ' A' ' 126' ' ' PHE . 2.9 pp -107.6 138.17 44.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 110.908 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 92' ' ' PHE . 12.0 t -129.26 139.21 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 73.530000000000001 111.072 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.01 91.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.540000000000006 110.824 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -61.96 107.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.095 -0.502 . . . . 75.329999999999998 110.86 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.3 -6.87 62.34 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.806 -0.711 . . . . 73.450000000000003 112.45 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.88 -51.7 3.15 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.819 -0.705 . . . . 63.43 112.436 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -98.93 -1.57 39.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.864 0.364 . . . . 73.319999999999993 110.976 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.38 30.1 19.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 73.099999999999994 110.838 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 57.7 m -138.77 137.42 36.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.182 -0.463 . . . . 52.100000000000001 110.911 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.432 ' CD2' HD13 ' A' ' 117' ' ' LEU . 63.6 m-85 -60.97 133.12 55.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 72.109999999999999 110.905 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.7 t -114.54 111.35 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 111.097 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.675 HD23 HD12 ' A' ' 150' ' ' LEU . 5.0 tt -101.57 121.44 41.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 63.229999999999997 110.873 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 74.1 mtm -115.75 133.36 56.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 75.549999999999997 110.874 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.635 ' OD2' HD11 ' A' ' 150' ' ' LEU . 1.3 m-20 -90.04 126.84 35.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 72.420000000000002 110.876 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.798 HD13 HG23 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -62.36 -16.67 55.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 63.509999999999998 110.968 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.535 ' N ' HD23 ' A' ' 131' ' ' LEU . . . 116.47 47.42 0.5 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.7 -0.762 . . . . 65.030000000000001 112.533 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.97 160.54 9.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.915 0.388 . . . . 44.329999999999998 110.883 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.2 t -83.79 -28.51 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.492 . . . . 73.310000000000002 111.159 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -71.85 -72.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 64.049999999999997 110.903 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 135.51 129.51 2.87 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.73 -0.748 . . . . 65.129999999999995 112.549 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.517 HG21 ' OD1' ' A' ' 130' ' ' ASP . 15.8 t -90.26 152.12 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.93 0.395 . . . . 61.140000000000001 111.093 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -108.24 140.47 41.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.499 . . . . 74.150000000000006 110.862 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.623 HD12 ' HB3' ' A' ' 150' ' ' LEU . 1.5 tt -125.76 130.81 52.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 73.349999999999994 110.849 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.52 ' HB2' HD23 ' A' ' 139' ' ' LEU . 1.5 m-80 53.93 24.7 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 63.310000000000002 110.891 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 22.66 52.22 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.787 -0.72 . . . . 65.420000000000002 112.463 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.454 ' O ' HG23 ' A' ' 144' ' ' ILE . 2.2 t-20 -145.13 126.07 14.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.895 0.379 . . . . 75.439999999999998 110.874 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -57.99 138.87 55.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.519999999999996 110.868 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 142' ' ' ASN . 0.0 OUTLIER -142.87 178.24 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 64.540000000000006 111.132 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.59 -169.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 110.912 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.7 -179.76 5.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 73.129999999999995 110.935 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 51.95 34.71 14.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.549999999999997 110.868 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.64 161.72 55.07 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 72.230000000000004 110.856 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 107.9 1.96 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.664 2.243 . . . . 63.310000000000002 112.371 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.675 HD12 HD23 ' A' ' 128' ' ' LEU . 4.2 mt -109.91 83.32 2.82 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.605 0.716 . . . . 70.219999999999999 110.902 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 134.7 28.74 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.664 2.243 . . . . 64.209999999999994 112.413 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -122.32 80.18 45.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.536 0.684 . . . . 72.140000000000001 111.08 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 165.29 31.46 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.679 2.253 . . . . 62.450000000000003 112.332 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.451 HG21 ' HB2' ' A' ' 171' ' ' LEU . 11.0 m -53.08 145.35 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 44.229999999999997 111.178 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.09 -9.98 67.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.8 -0.714 . . . . 73.510000000000005 112.508 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 12.1 p -96.76 -179.39 4.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 45.43 110.844 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 26.7 m -132.04 162.33 31.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.097 -0.501 . . . . 71.510000000000005 110.909 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.4 mt -139.14 149.51 23.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 74.540000000000006 111.149 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.511 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -152.27 149.4 28.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 74.439999999999998 110.935 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.511 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 2.7 p90 -144.24 134.59 24.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.519999999999996 110.843 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.3 -154.06 41.9 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.747 -0.74 . . . . 74.400000000000006 112.423 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -101.69 17.79 22.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.908 0.385 . . . . 61.439999999999998 110.936 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.411 ' HB3' HD11 ' A' ' 110' ' ' ILE . 51.5 p -65.72 160.92 21.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 44.210000000000001 110.852 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.9 m -91.16 -31.98 15.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.133 -0.485 . . . . 71.409999999999997 110.874 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -53.29 149.85 6.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 74.140000000000001 110.923 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.38 130.92 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 62.399999999999999 111.078 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' A' ' 73' ' ' LEU . 7.1 m-85 -98.62 103.6 15.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 74.230000000000004 110.874 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.74 110.26 22.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 74.409999999999997 110.919 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.4 153.56 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 62.310000000000002 111.123 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.67 146.09 14.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 65.030000000000001 110.924 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.451 ' HB2' HG21 ' A' ' 154' ' ' VAL . 7.0 tp -87.16 141.13 28.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 74.030000000000001 110.895 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -80.97 177.15 54.49 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.769 -0.729 . . . . 72.230000000000004 112.425 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 167.76 23.55 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.649 2.232 . . . . 71.329999999999998 112.341 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.46 69.06 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.663 2.242 . . . . 72.439999999999998 112.339 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 56.6 p -98.81 -50.37 4.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 55.219999999999999 110.784 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.4 t -108.18 153.32 23.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 52.520000000000003 110.769 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.494 . . . . 52.409999999999997 110.88 -179.831 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 CA-C-O 121.546 0.526 . . . . 61.310000000000002 112.42 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 171.24 14.87 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.749 2.299 . . . . 71.439999999999998 112.302 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 mtt -116.74 161.79 18.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 62.219999999999999 110.932 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.5 m -59.73 156.51 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 63.200000000000003 111.139 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.1 m -145.6 142.29 28.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 54.350000000000001 111.173 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 t -147.93 158.94 44.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 73.219999999999999 110.834 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.4 p -87.92 -19.04 27.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 74.200000000000003 111.18 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.11 20.29 65.28 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.741 . . . . 74.439999999999998 112.539 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.4 mt -52.5 132.09 34.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.857 0.36 . . . . 73.109999999999999 110.898 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 9' ' ' SER . 1.4 tt -134.69 143.71 47.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 110.852 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.435 ' N ' HD23 ' A' ' 8' ' ' LEU . 38.0 t -67.89 170.12 8.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.492 . . . . 72.150000000000006 110.827 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 44.4 ttm-85 -131.59 146.49 52.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 71.140000000000001 110.866 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.7 t -119.22 145.37 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 61.420000000000002 111.13 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.57 158.75 22.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 64.129999999999995 111.122 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -113.12 109.18 18.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 22.039999999999999 111.09 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 14' ' ' VAL . 4.8 m -57.54 101.82 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 62.039999999999999 111.085 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -102.17 130.69 48.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 73.040000000000006 110.928 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.25 155.5 44.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.936 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.21 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 73.040000000000006 111.132 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -113.2 150.99 31.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 75.420000000000002 111.109 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -102.55 112.1 24.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 74.430000000000007 110.876 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 mp -64.42 131.46 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 73.109999999999999 111.168 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.09 -179.03 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 111.059 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.59 157.62 40.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.53 0.681 . . . . 74.430000000000007 110.949 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 168.1 22.43 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.7 2.267 . . . . 61.530000000000001 112.368 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.83 168.05 22.78 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.781 2.32 . . . . 54.109999999999999 112.267 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 167.42 24.54 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.65 2.234 . . . . 71.519999999999996 112.394 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.67 -174.6 0.92 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.7 2.267 . . . . 70.430000000000007 112.43 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' H ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -106.17 146.78 29.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 65.329999999999998 110.875 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.5 m -143.64 174.74 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 72.019999999999996 111.132 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.1 p -52.3 130.74 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 73.120000000000005 111.185 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -132.98 167.82 19.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.150000000000006 110.857 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 37.3 mt -55.41 174.21 0.1 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.496 . . . . 62.420000000000002 110.906 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.661 ' OG1' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -63.23 165.01 7.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 62.420000000000002 111.083 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.83 -55.16 37.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 64.329999999999998 110.911 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.46 -20.45 58.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 45.200000000000003 111.084 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.708 ' O ' HD22 ' A' ' 38' ' ' LEU . . . -51.39 -30.77 20.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 75.310000000000002 111.043 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.1 -32.7 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 61.210000000000001 110.911 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -73.0 -12.56 60.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 110.896 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.708 HD22 ' O ' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -50.83 156.14 1.75 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 73.439999999999998 110.929 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 147.4 62.63 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.719 2.279 . . . . 60.100000000000001 112.331 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.821 ' HG3' HD12 ' A' ' 43' ' ' ILE . 9.9 mt-30 -54.52 173.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 110.943 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -61.26 -56.94 14.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 72.420000000000002 110.813 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.784 ' O ' HG23 ' A' ' 46' ' ' THR . 0.2 OUTLIER -73.74 -27.84 23.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 70.239999999999995 111.138 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.821 HD12 ' HG3' ' A' ' 40' ' ' GLN . 34.6 mt -76.03 -25.44 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 63.119999999999997 111.174 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.16 -10.98 70.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.677 -0.773 . . . . 71.25 112.513 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.4 t -117.66 -22.61 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.848 0.356 . . . . 71.129999999999995 111.153 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 42' ' ' ILE . 12.7 p -50.12 153.91 1.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 62.350000000000001 111.111 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.562 ' O ' HD22 ' A' ' 51' ' ' LEU . 1.1 m-20 -68.91 160.64 77.04 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.643 0.735 . . . . 65.120000000000005 110.794 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -37.53 8.92 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.622 2.215 . . . . 73.140000000000001 112.332 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.22 -20.9 23.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 71.329999999999998 111.155 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -78.33 -59.2 2.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 65.019999999999996 110.938 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.595 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -57.05 -29.23 63.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 65.239999999999995 110.92 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.69 ' O ' HG12 ' A' ' 55' ' ' VAL . 3.4 t30 -78.79 -28.77 44.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 63.039999999999999 110.89 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.81 -18.27 51.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 52.409999999999997 111.06 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.434 HE22 HD23 ' A' ' 94' ' ' LEU . 12.5 mm100 -92.46 -16.09 26.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 62.350000000000001 111.003 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.69 HG12 ' O ' ' A' ' 52' ' ' ASN . 8.9 p -84.94 -14.63 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 74.310000000000002 111.124 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.0 t -82.72 0.7 42.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 63.340000000000003 110.909 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.7 ' CD2' HG21 ' A' ' 113' ' ' VAL . 26.3 m-85 -120.59 -41.73 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 74.129999999999995 110.888 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.602 ' HE1' HD22 ' A' ' 94' ' ' LEU . 19.3 p90 -160.22 140.36 11.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 73.109999999999999 110.87 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -102.35 152.47 21.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 63.25 110.855 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 4.4 t -89.94 110.52 40.51 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.665 0.745 . . . . 74.420000000000002 110.825 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.801 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 53.6 Cg_endo -69.72 168.74 20.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.703 2.269 . . . . 73.430000000000007 112.328 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -39.4 6.53 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.654 2.236 . . . . 73.219999999999999 112.28 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 36.5 p-90 -73.26 -6.22 44.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 63.539999999999999 110.915 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.801 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -77.05 149.44 35.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.326 -0.397 . . . . 62.219999999999999 111.11 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 91' ' ' PRO . . . 66.06 47.09 2.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 63.32 111.081 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.5 mt -146.33 66.68 11.34 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.551 0.691 . . . . 61.43 110.895 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 151.26 69.41 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.651 2.234 . . . . 65.230000000000004 112.357 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.07 5.2 3.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 61.210000000000001 110.863 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.5 t -138.07 151.84 25.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 73.510000000000005 111.12 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.68 122.33 34.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 51.0 111.136 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.0 p -151.08 173.31 14.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 70.319999999999993 110.884 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -143.33 166.77 23.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 73.219999999999999 110.835 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.685 HD13 ' N ' ' A' ' 74' ' ' GLN . 2.5 tm? -120.66 135.71 55.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.91 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.685 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -113.21 136.33 52.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 73.439999999999998 110.897 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 15.7 p -127.37 131.8 50.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 63.109999999999999 110.926 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.448 HG23 ' NE2' ' A' ' 74' ' ' GLN . 70.3 p -93.6 156.4 16.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 74.299999999999997 111.122 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.554 ' HE ' HD12 ' A' ' 80' ' ' LEU . 6.1 ptm180 -158.37 112.38 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 63.43 110.876 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 53.74 39.59 30.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 54.240000000000002 110.863 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.86 18.31 77.45 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 71.239999999999995 112.501 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD12 ' HE ' ' A' ' 77' ' ' ARG . 13.0 mt -112.36 108.42 54.66 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.653 0.74 . . . . 72.430000000000007 110.883 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 91.45 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.65 2.234 . . . . 35.039999999999999 112.325 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.27 159.22 59.81 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.574 0.702 . . . . 75.230000000000004 111.008 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 114.85 3.84 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.271 . . . . 72.030000000000001 112.35 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.15 150.01 39.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 63.340000000000003 110.986 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.8 mt -147.05 133.34 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 63.219999999999999 110.883 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -61.53 98.93 0.19 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.732 -0.746 . . . . 42.100000000000001 112.453 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.6 mt -79.48 70.93 6.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.792 0.33 . . . . 53.409999999999997 110.932 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -111.61 6.61 20.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 73.230000000000004 110.774 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -19.57 64.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 71.109999999999999 110.84 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.43 155.33 74.51 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.665 0.745 . . . . 74.319999999999993 110.79 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.606 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 54.3 Cg_endo -69.65 -33.23 17.42 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.705 2.27 . . . . 73.310000000000002 112.347 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.651 ' HB3' HG22 ' A' ' 118' ' ' VAL . 3.3 p90 -151.68 175.71 12.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 110.916 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -143.1 111.38 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 74.109999999999999 110.923 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.622 HD12 ' H ' ' A' ' 95' ' ' PHE . 13.9 tp -89.96 138.07 31.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 71.319999999999993 110.857 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.622 ' H ' HD12 ' A' ' 94' ' ' LEU . 80.1 m-85 -122.76 128.61 50.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 72.340000000000003 110.816 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.68 -158.62 21.59 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.758 -0.734 . . . . 51.450000000000003 112.534 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.43 -6.19 16.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 74.530000000000001 110.842 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.28 159.2 31.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 70.040000000000006 110.92 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.411 ' HD2' HG13 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -79.56 -19.39 49.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 75.409999999999997 110.899 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.411 HG13 ' HD2' ' A' ' 99' ' ' LYS . 17.3 m -80.46 -15.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 74.540000000000006 111.141 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 57.7 m -74.58 151.45 39.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 51.439999999999998 110.917 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.9 -23.34 65.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 55.350000000000001 110.845 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -134.13 108.2 8.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 75.340000000000003 110.942 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.9 p -105.03 108.62 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 63.25 111.114 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.563 HD21 ' NH1' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -113.46 -168.65 1.37 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 54.240000000000002 110.92 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -135.42 107.28 7.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 70.329999999999998 110.903 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.504 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -159.17 147.32 13.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.581 0.705 . . . . 54.200000000000003 110.916 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 -16.83 38.11 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.706 2.271 . . . . 71.200000000000003 112.337 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 p -98.19 -25.7 14.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.264 -0.426 . . . . 55.210000000000001 110.87 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.504 HD12 ' HB2' ' A' ' 107' ' ' HIS . 59.3 mt -77.96 116.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 64.25 111.131 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.4 m -93.75 170.34 9.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 72.25 110.802 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 p -43.57 -47.4 7.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 64.409999999999997 110.888 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.7 HG21 ' CD2' ' A' ' 57' ' ' TYR . 93.2 t -136.99 85.43 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 74.25 111.145 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.577 ' CD2' HG22 ' A' ' 137' ' ' VAL . 1.6 t60 -64.16 -51.71 62.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 74.230000000000004 110.835 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.475 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -171.83 175.19 3.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 111.13 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.444 HG21 ' CE2' ' A' ' 58' ' ' PHE . 8.3 p -147.86 138.22 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.417 . . . . 65.150000000000006 111.176 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.406 HD21 ' HE1' ' A' ' 95' ' ' PHE . 1.6 pp -111.74 138.03 48.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 53.229999999999997 110.949 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.651 HG22 ' HB3' ' A' ' 92' ' ' PHE . 23.4 t -128.18 136.11 61.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 64.239999999999995 111.154 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.28 101.97 1.0 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 74.319999999999993 110.879 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.471 ' HB2' HG23 ' A' ' 127' ' ' VAL . 12.9 t-80 -70.32 106.99 3.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 75.299999999999997 110.91 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.14 -4.13 62.59 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 63.210000000000001 112.493 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -89.45 -43.54 5.2 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.709 -0.758 . . . . 61.009999999999998 112.522 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.86 8.21 17.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.768 0.318 . . . . 74.310000000000002 110.866 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 50.3 57.45 6.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 64.319999999999993 110.868 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 35.5 t -160.28 137.65 9.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 74.510000000000005 110.857 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -67.14 131.9 46.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.310000000000002 110.814 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 120' ' ' HIS . 26.4 t -110.03 108.56 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 63.240000000000002 111.2 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 150' ' ' LEU . 2.5 tt -101.22 132.62 46.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 73.340000000000003 110.955 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 69.6 mtm -132.7 132.25 42.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 62.43 110.9 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.601 ' CG ' HG21 ' A' ' 137' ' ' VAL . 11.0 m-20 -90.46 132.81 35.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 75.310000000000002 110.834 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.736 ' C ' HD22 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -70.12 -7.15 39.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 75.430000000000007 110.963 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.505 ' N ' HD13 ' A' ' 131' ' ' LEU . . . 113.78 51.29 0.49 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.766 -0.73 . . . . 72.420000000000002 112.446 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.1 m -67.12 117.4 9.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.923 0.392 . . . . 73.439999999999998 110.873 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 97.9 m -55.59 -24.67 34.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 51.43 111.107 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -67.33 -68.2 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 73.310000000000002 110.874 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 132.68 118.06 1.9 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 73.340000000000003 112.482 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.601 HG21 ' CG ' ' A' ' 130' ' ' ASP . 13.2 t -88.79 152.43 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.945 0.403 . . . . 74.299999999999997 111.116 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -117.45 130.03 56.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 72.200000000000003 110.87 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 150' ' ' LEU . 0.7 OUTLIER -123.85 143.3 50.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 73.310000000000002 110.897 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.535 ' HB2' HD23 ' A' ' 139' ' ' LEU . 1.3 m-80 56.13 22.69 6.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.129999999999995 110.871 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 78.69 20.53 70.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 43.119999999999997 112.487 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -146.54 142.3 27.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.895 0.379 . . . . 70.230000000000004 110.876 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -49.74 154.19 1.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 72.329999999999998 110.899 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.717 HD13 HD22 ' A' ' 150' ' ' LEU . 1.0 OUTLIER -152.2 -174.16 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 71.400000000000006 111.078 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.629 ' O ' HD12 ' A' ' 144' ' ' ILE . 3.9 tp10 -98.76 171.29 8.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 70.430000000000007 110.866 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 -179.81 3.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 73.329999999999998 110.918 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 51.22 35.61 13.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 73.530000000000001 110.887 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -148.33 161.33 34.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.661 0.744 . . . . 71.409999999999997 110.829 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 116.84 4.75 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.617 2.211 . . . . 65.099999999999994 112.356 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.717 HD22 HD13 ' A' ' 144' ' ' ILE . 1.0 OUTLIER -127.31 82.72 67.68 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.637 0.732 . . . . 74.400000000000006 110.954 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 144.85 55.29 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.663 2.242 . . . . 63.039999999999999 112.36 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.71 79.85 67.42 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.64 0.733 . . . . 71.030000000000001 111.123 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -177.98 2.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.703 2.269 . . . . 65.519999999999996 112.354 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 171' ' ' LEU . 13.3 m -68.42 146.18 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 70.25 111.134 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.84 -11.44 64.5 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.758 . . . . 72.010000000000005 112.507 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 m -96.88 179.15 5.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.989 0.423 . . . . 64.340000000000003 110.753 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 14.5 m -130.57 163.43 27.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 50.509999999999998 110.855 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.413 ' O ' HG13 ' A' ' 166' ' ' VAL . 8.0 mt -139.62 145.64 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 75.230000000000004 111.14 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.532 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -151.24 149.56 29.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 73.409999999999997 110.858 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.532 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 2.6 p90 -145.85 134.98 22.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 110.837 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 61.73 -136.92 46.65 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 65.140000000000001 112.493 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.56 19.21 15.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.854 0.359 . . . . 74.299999999999997 110.885 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.02 156.5 2.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 70.230000000000004 110.817 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.0 t -91.49 -36.01 13.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 54.299999999999997 110.866 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.563 ' NH1' HD21 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -74.41 155.14 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 74.140000000000001 110.908 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 158' ' ' ILE . 21.4 t -136.52 138.66 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 111.128 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -94.12 101.77 13.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 110.933 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.05 110.4 22.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 74.0 110.914 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.89 153.03 4.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.166 -0.47 . . . . 65.129999999999995 111.124 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -160.63 148.81 16.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 73.109999999999999 110.956 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.486 ' HB2' HG21 ' A' ' 154' ' ' VAL . 5.8 tp -90.47 139.83 30.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 65.510000000000005 110.873 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -68.78 168.19 44.07 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.703 -0.761 . . . . 61.340000000000003 112.486 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 167.64 23.85 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.619 2.213 . . . . 70.140000000000001 112.387 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 175.94 7.47 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.672 2.248 . . . . 65.109999999999999 112.304 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.2 m -88.61 57.03 4.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 72.040000000000006 110.863 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.2 t -119.38 127.92 53.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 72.120000000000005 110.936 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 51.140000000000001 110.856 -179.748 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 121.42 0.456 . . . . 63.229999999999997 112.508 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 127.43 14.62 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.639 2.226 . . . . 70.25 112.341 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmm -118.77 144.49 46.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 61.140000000000001 110.907 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.7 143.23 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 74.129999999999995 111.162 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 m -151.79 139.98 20.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 65.329999999999998 111.133 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.2 t -76.9 167.01 22.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 42.039999999999999 110.856 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.442 ' HB ' HD23 ' A' ' 7' ' ' LEU . 57.8 p -101.25 -19.05 15.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.487 . . . . 74.439999999999998 111.12 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.53 18.98 79.62 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.757 -0.735 . . . . 65.040000000000006 112.484 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.442 HD23 ' HB ' ' A' ' 5' ' ' THR . 3.5 mm? -74.05 99.18 3.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.779 0.323 . . . . 61.240000000000002 110.918 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 tp -70.43 115.87 10.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 74.019999999999996 110.885 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.3 m -95.65 133.95 39.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 73.209999999999994 110.846 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.3 mmt85 -93.61 146.03 24.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 73.129999999999995 110.883 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.5 p -87.97 150.19 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 74.540000000000006 111.137 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.18 160.5 15.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 73.239999999999995 111.044 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -122.53 168.3 12.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 73.439999999999998 111.139 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.0 t -116.49 111.8 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 55.439999999999998 111.113 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -124.0 106.23 10.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 64.150000000000006 110.926 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -103.23 162.96 12.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 110.888 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.16 130.62 51.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 73.150000000000006 111.113 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.02 143.34 7.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 65.430000000000007 111.112 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.5 101.96 3.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 110.91 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.5 mt -102.29 136.44 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 111.06 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.04 124.95 22.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 53.43 111.089 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -54.04 160.62 2.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.556 0.693 . . . . 74.109999999999999 110.959 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 167.79 23.41 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.653 2.236 . . . . 72.420000000000002 112.371 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 167.89 23.16 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.679 2.253 . . . . 53.009999999999998 112.324 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 167.7 23.83 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.726 2.284 . . . . 71.019999999999996 112.329 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 177.55 5.44 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.73 2.287 . . . . 64.549999999999997 112.349 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -121.05 145.18 48.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 45.310000000000002 110.907 179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.1 m -51.47 144.43 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 73.239999999999995 111.059 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 27' ' ' LYS . 45.4 t -143.04 147.32 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 70.239999999999995 111.11 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -51.78 168.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 75.319999999999993 110.927 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.574 ' O ' HD12 ' A' ' 31' ' ' LEU . 3.5 pp -51.9 130.13 28.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 64.099999999999994 110.894 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.27 168.25 18.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 64.299999999999997 111.125 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -59.09 -38.9 80.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 73.019999999999996 110.923 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.94 -25.68 59.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 73.340000000000003 111.066 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.11 -27.64 67.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 74.019999999999996 111.083 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.78 -35.73 24.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 74.099999999999994 110.941 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -73.07 -45.63 56.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 74.310000000000002 110.877 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 38' ' ' LEU . 4.1 mm? -109.4 85.85 3.89 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.545 0.688 . . . . 70.420000000000002 110.944 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -178.44 2.35 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.622 2.215 . . . . 73.400000000000006 112.325 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.463 ' HB2' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -58.74 170.66 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 71.510000000000005 110.951 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -68.36 -47.64 66.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 72.319999999999993 110.857 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.691 ' O ' HG23 ' A' ' 46' ' ' THR . 1.1 pp -81.08 -29.53 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 72.140000000000001 111.158 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 40' ' ' GLN . 63.6 mt -79.07 -24.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 75.219999999999999 111.142 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.14 -11.76 64.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.697 -0.763 . . . . 54.140000000000001 112.573 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 42' ' ' ILE . 7.5 p -110.31 -24.78 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.902 0.382 . . . . 62.420000000000002 111.108 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 42' ' ' ILE . 62.9 p -74.64 153.46 38.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 53.399999999999999 111.146 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.737 ' O ' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.28 160.95 50.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.604 0.716 . . . . 53.130000000000003 110.843 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -37.71 8.79 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.708 2.272 . . . . 71.25 112.3 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.88 -14.5 31.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 72.340000000000003 111.076 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -82.22 -59.1 2.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 61.32 110.928 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.928 HD13 ' N ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -62.07 -16.55 52.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 62.030000000000001 110.94 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.928 ' N ' HD13 ' A' ' 51' ' ' LEU . 4.1 t30 -81.78 -39.42 24.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 110.882 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.29 -19.58 63.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 75.430000000000007 111.094 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.576 ' OE1' HD12 ' A' ' 94' ' ' LEU . 4.4 mm-40 -86.24 -14.61 43.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 73.430000000000007 110.92 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 t -66.44 -42.1 89.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 71.409999999999997 111.192 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.4 m -59.55 -19.87 51.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.097 -0.502 . . . . 74.25 110.817 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.742 ' CD2' HG21 ' A' ' 113' ' ' VAL . 31.3 m-85 -97.26 -44.49 6.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 72.109999999999999 110.897 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.485 ' CE2' HG21 ' A' ' 116' ' ' VAL . 30.5 p90 -178.39 138.76 0.18 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.904 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.84 136.05 49.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 62.509999999999998 110.9 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 9.5 p -58.34 113.13 5.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.607 0.718 . . . . 75.310000000000002 110.855 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.807 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 53.7 Cg_endo -69.7 168.69 20.75 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.671 2.247 . . . . 63.539999999999999 112.357 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -37.93 8.48 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.712 2.275 . . . . 75.019999999999996 112.341 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.465 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 37.6 p-90 -74.86 -5.4 43.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.169 -0.469 . . . . 73.230000000000004 110.926 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.807 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -78.93 151.43 31.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 73.219999999999999 111.029 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 63.96 47.18 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 62.299999999999997 111.087 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.1 mt -146.07 67.92 12.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.616 0.722 . . . . 74.140000000000001 110.817 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 152.32 68.9 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.681 2.254 . . . . 74.010000000000005 112.282 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.23 9.5 2.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 64.129999999999995 110.879 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.488 HG12 ' HB3' ' A' ' 124' ' ' ARG . 10.5 p -142.84 152.34 17.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 43.140000000000001 111.129 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.61 116.03 27.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 63.119999999999997 111.096 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.6 p -151.2 177.56 10.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 71.209999999999994 110.924 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -148.72 167.79 24.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 63.200000000000003 110.862 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.711 HD13 ' N ' ' A' ' 74' ' ' GLN . 1.9 tm? -122.23 136.11 54.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 64.310000000000002 110.899 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.711 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -112.07 135.63 52.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 73.140000000000001 110.913 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 26.5 p -126.85 137.11 53.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 60.530000000000001 110.85 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -105.69 145.7 30.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 74.129999999999995 111.158 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -146.32 116.96 7.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 55.310000000000002 110.889 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 54.21 37.18 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 61.399999999999999 110.875 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.43 19.53 78.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.682 -0.77 . . . . 75.430000000000007 112.539 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.5 mt -109.75 108.58 59.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.642 0.734 . . . . 72.239999999999995 110.883 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 94.89 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.752 2.302 . . . . 72.340000000000003 112.374 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.3 mt -73.34 159.23 85.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.632 0.73 . . . . 62.43 110.87 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 116.18 4.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.665 2.243 . . . . 72.019999999999996 112.336 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.0 146.08 55.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 63.109999999999999 111.098 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.3 mt -148.94 143.38 26.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 70.109999999999999 110.901 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.9 104.91 0.65 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.702 -0.761 . . . . 74.430000000000007 112.523 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.57 70.63 2.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.871 0.367 . . . . 71.049999999999997 110.95 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -112.04 6.28 19.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 110.848 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.29 -19.47 63.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 75.439999999999998 110.911 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -137.84 154.78 74.87 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.669 0.747 . . . . 71.319999999999993 110.906 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' O ' HG13 ' A' ' 118' ' ' VAL . 54.6 Cg_endo -69.74 -25.34 28.79 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.719 2.28 . . . . 50.210000000000001 112.324 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.7 ' HB3' HG22 ' A' ' 118' ' ' VAL . 14.9 p90 -156.46 178.84 9.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.297 -0.41 . . . . 73.209999999999994 110.848 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -144.44 111.52 5.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.108 -0.496 . . . . 62.439999999999998 110.916 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.66 HD21 HG13 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -92.3 125.96 37.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 72.540000000000006 110.854 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.524 ' N ' HD23 ' A' ' 94' ' ' LEU . 94.4 m-85 -116.21 111.81 20.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 61.329999999999998 110.854 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -165.4 -150.66 6.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 74.310000000000002 112.49 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.77 -2.95 10.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.825 0.345 . . . . 70.299999999999997 110.923 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.01 162.49 28.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 74.420000000000002 110.802 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.16 -8.89 59.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 110.892 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -91.51 -17.75 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 72.340000000000003 111.151 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.607 ' HA ' HD13 ' A' ' 94' ' ' LEU . 12.1 p -63.81 171.09 2.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 53.25 110.909 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.48 -3.49 33.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 54.140000000000001 110.932 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -150.52 106.81 3.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.477 . . . . 75.129999999999995 110.892 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.8 t -90.76 108.74 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 72.430000000000007 111.133 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.658 HD13 HD13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -110.67 -169.02 1.38 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 63.140000000000001 110.924 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -137.97 107.05 6.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 75.200000000000003 110.894 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.47 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -165.43 143.51 5.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.563 0.697 . . . . 65.420000000000002 110.869 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -12.85 33.81 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.694 2.263 . . . . 72.400000000000006 112.337 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 p -100.49 -27.55 13.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 65.299999999999997 110.833 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.658 HD13 HD13 ' A' ' 105' ' ' LEU . 57.6 mt -75.48 109.36 8.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 74.510000000000005 111.131 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.8 m -89.7 170.58 10.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 72.329999999999998 110.89 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.46 -40.66 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 70.340000000000003 110.893 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.742 HG21 ' CD2' ' A' ' 57' ' ' TYR . 84.8 t -140.95 79.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 52.210000000000001 111.131 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.613 ' HD2' HG12 ' A' ' 137' ' ' VAL . 3.7 t60 -64.15 -49.34 72.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.907 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -166.17 174.76 8.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 71.319999999999993 111.124 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 58' ' ' PHE . 6.2 p -155.69 136.1 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 62.210000000000001 111.114 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.411 HD13 ' CD2' ' A' ' 126' ' ' PHE . 2.0 pp -111.58 140.52 46.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 71.329999999999998 110.967 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.7 HG22 ' HB3' ' A' ' 92' ' ' PHE . 14.9 t -130.19 134.75 62.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 70.230000000000004 111.089 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.28 94.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 110.886 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.502 ' HB2' HG23 ' A' ' 127' ' ' VAL . 12.2 t-80 -64.86 107.88 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 110.886 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.94 -4.62 67.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.743 -0.741 . . . . 71.109999999999999 112.572 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -88.01 -42.45 5.97 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.701 -0.761 . . . . 61.310000000000002 112.487 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.89 5.74 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.738 0.304 . . . . 73.209999999999994 110.883 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.488 ' HB3' HG12 ' A' ' 69' ' ' VAL . 0.2 OUTLIER 53.31 42.46 32.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 75.209999999999994 110.886 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 73.9 m -146.05 137.22 24.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.455 . . . . 52.25 110.906 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CD2' HD13 ' A' ' 117' ' ' LEU . 58.9 m-85 -66.13 132.52 48.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.845 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.502 HG23 ' HB2' ' A' ' 120' ' ' HIS . 42.3 t -111.7 108.44 25.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 75.450000000000003 111.121 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 137' ' ' VAL . 4.8 tt -102.32 125.62 49.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 54.310000000000002 110.843 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 33.9 mtm -127.1 139.45 52.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 54.009999999999998 110.919 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.668 ' OD2' HG13 ' A' ' 137' ' ' VAL . 28.6 t0 -87.74 132.4 34.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 63.020000000000003 110.888 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 113' ' ' VAL . 1.5 pt? -60.24 -20.92 60.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 74.510000000000005 110.945 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.82 45.88 0.75 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.769 -0.729 . . . . 75.040000000000006 112.471 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.0 t -76.89 157.66 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 72.549999999999997 110.875 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 99.7 m -64.21 -24.14 67.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 72.129999999999995 111.111 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -80.67 -67.39 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 64.109999999999999 110.856 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.57 143.43 13.71 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.735 -0.745 . . . . 40.240000000000002 112.552 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.668 HG13 ' OD2' ' A' ' 130' ' ' ASP . 2.1 m -91.88 173.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.919 0.39 . . . . 74.230000000000004 111.103 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -114.4 137.8 51.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 71.239999999999995 110.936 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 140' ' ' ASN . 3.1 tm? -113.48 123.99 51.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.427 . . . . 72.109999999999999 110.918 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.68 ' HB2' HD13 ' A' ' 139' ' ' LEU . 1.1 m-80 61.53 22.47 12.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 73.329999999999998 110.876 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.1 25.44 40.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 33.240000000000002 112.54 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.519 ' O ' HG23 ' A' ' 144' ' ' ILE . 4.4 t30 -145.15 134.01 22.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.859 0.361 . . . . 42.240000000000002 110.9 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -60.32 133.65 56.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 63.539999999999999 110.823 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 142' ' ' ASN . 0.0 OUTLIER -141.62 175.61 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 71.319999999999993 111.121 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.67 -175.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 61.549999999999997 110.942 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 167.07 16.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 72.519999999999996 110.88 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 59.02 43.04 18.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.41 . . . . 73.219999999999999 110.833 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -142.2 155.09 65.03 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.596 0.712 . . . . 70.230000000000004 110.906 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 102.84 1.07 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.724 2.282 . . . . 64.239999999999995 112.296 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.0 mt -110.69 83.37 3.42 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.627 0.727 . . . . 60.43 110.917 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.84 129.22 17.15 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.637 2.225 . . . . 74.409999999999997 112.305 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.562 ' O ' HG21 ' A' ' 169' ' ' VAL . . . -116.08 79.45 8.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 44.32 111.125 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 170.85 15.63 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.701 2.267 . . . . 70.109999999999999 112.365 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.432 HG21 ' HB2' ' A' ' 171' ' ' LEU . 13.1 m -50.76 142.4 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 64.439999999999998 111.156 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.08 -12.86 62.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.75 -0.738 . . . . 61.5 112.476 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.51 177.26 5.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.9 0.381 . . . . 60.109999999999999 110.892 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 40.7 m -130.51 165.2 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 72.430000000000007 110.83 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 166' ' ' VAL . 3.3 mt -142.58 150.73 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 74.519999999999996 111.2 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -152.48 162.8 40.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 70.109999999999999 110.911 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -159.44 134.25 7.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 64.140000000000001 110.947 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.09 -152.06 51.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.741 -0.742 . . . . 54.219999999999999 112.454 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -102.62 13.89 33.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.82 0.343 . . . . 70.120000000000005 110.801 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.81 158.62 18.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 63.439999999999998 110.852 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.52 -35.83 14.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 74.420000000000002 110.869 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -53.36 153.15 4.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 71.129999999999995 110.908 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 158' ' ' ILE . 26.3 t -145.65 138.54 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 51.420000000000002 111.181 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.564 ' HB3' HD11 ' A' ' 73' ' ' LEU . 9.6 m-85 -97.7 101.44 12.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 74.540000000000006 110.994 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -99.13 110.39 22.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 75.430000000000007 110.858 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 152' ' ' ALA . 2.9 t -78.64 153.05 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 61.25 111.135 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -161.1 151.88 18.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 72.510000000000005 110.872 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.432 ' HB2' HG21 ' A' ' 154' ' ' VAL . 5.7 tp -96.67 135.07 39.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 73.200000000000003 110.912 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -64.65 177.65 9.48 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 52.509999999999998 112.471 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 167.77 23.6 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.656 2.238 . . . . 63.420000000000002 112.26 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 107.69 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.611 2.208 . . . . 51.530000000000001 112.41 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.7 m -95.73 169.63 9.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 51.310000000000002 110.807 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.4 m 53.58 29.63 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.030000000000001 110.902 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.498 . . . . 73.200000000000003 110.81 -179.83 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 CA-C-O 121.399 0.444 . . . . 45.43 112.507 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -35.48 12.53 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.647 2.231 . . . . 70.140000000000001 112.397 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mmt 57.41 50.79 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 65.400000000000006 110.857 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.1 m -63.93 158.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 75.040000000000006 111.137 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 80.6 p -126.64 151.71 47.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 70.109999999999999 111.112 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 m -136.59 169.71 17.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 55.409999999999997 110.853 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 t -108.88 -19.15 13.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 64.010000000000005 111.123 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.3 20.93 11.31 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.787 -0.72 . . . . 74.409999999999997 112.493 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.17 117.85 35.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 71.409999999999997 110.96 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -142.54 159.09 42.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 62.32 110.898 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.4 p -134.07 161.22 35.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 71.409999999999997 110.881 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -138.9 131.07 28.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 74.140000000000001 110.859 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.08 149.87 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 111.146 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.95 160.89 42.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.119 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.28 168.18 13.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 23.539999999999999 111.122 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 14' ' ' VAL . 3.9 p -119.48 115.2 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.443 . . . . 54.530000000000001 111.145 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -143.65 136.35 27.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 73.099999999999994 110.876 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -141.9 157.4 45.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.098 -0.501 . . . . 70.310000000000002 110.916 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.6 114.52 10.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 74.209999999999994 111.145 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.09 152.16 12.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 51.210000000000001 111.132 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -107.04 101.96 11.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 72.049999999999997 110.863 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.75 130.52 54.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 61.009999999999998 111.082 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.6 -178.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 74.409999999999997 111.181 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -54.03 154.49 7.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.577 0.704 . . . . 72.230000000000004 110.851 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 167.65 23.79 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.675 2.25 . . . . 73.049999999999997 112.356 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 168.38 21.74 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.601 2.2 . . . . 61.229999999999997 112.39 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.459 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.2 Cg_endo -69.73 112.23 3.02 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.719 2.279 . . . . 72.549999999999997 112.292 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 52.6 Cg_endo -69.85 -170.77 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.7 2.267 . . . . 70.349999999999994 112.277 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 153.89 31.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 71.540000000000006 110.832 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 m -48.99 140.68 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 111.158 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.48 154.57 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 55.350000000000001 111.085 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -50.79 168.55 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 75.219999999999999 110.948 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.414 ' H ' HD12 ' A' ' 31' ' ' LEU . 1.9 mp -49.93 166.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.209999999999994 110.937 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 168.47 5.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 71.400000000000006 111.105 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.61 -38.35 90.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 43.109999999999999 110.888 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.18 -18.72 48.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 55.149999999999999 111.124 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.8 -23.68 63.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 64.299999999999997 111.099 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -90.57 -17.68 26.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 72.040000000000006 110.923 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -72.91 -48.12 39.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 73.140000000000001 110.928 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 pp -51.32 155.34 2.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.613 0.72 . . . . 70.439999999999998 110.944 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 159.6 52.85 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.673 2.249 . . . . 70.120000000000005 112.383 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.425 ' HG2' HD12 ' A' ' 43' ' ' ILE . 7.6 mm-40 -92.97 171.63 8.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 75.049999999999997 110.983 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.69 ' CD2' HG23 ' A' ' 42' ' ' ILE . 12.0 p-80 -51.83 -36.6 48.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.817 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.69 HG23 ' CD2' ' A' ' 41' ' ' HIS . 1.6 pp -74.7 -33.17 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 72.25 111.119 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.437 ' CG2' HD12 ' A' ' 51' ' ' LEU . 57.1 mt -79.71 -25.29 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.420000000000002 111.145 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -10.41 58.21 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.703 -0.76 . . . . 44.119999999999997 112.476 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.1 t -113.07 -26.11 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 74.5 111.079 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 42' ' ' ILE . 39.7 p -52.01 153.64 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 52.229999999999997 111.175 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.546 ' O ' HD22 ' A' ' 51' ' ' LEU . 1.1 m-20 -63.49 160.75 40.19 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.604 0.716 . . . . 75.109999999999999 110.848 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -35.65 12.22 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.685 2.257 . . . . 63.240000000000002 112.387 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.34 -25.22 22.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 71.540000000000006 111.21 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -76.63 -60.82 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 74.420000000000002 110.916 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.4 OUTLIER -53.6 -29.06 35.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 74.010000000000005 110.975 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.603 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.5 t30 -76.54 -32.82 58.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 73.340000000000003 110.912 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.37 -18.93 47.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 62.210000000000001 111.113 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -93.22 -18.97 21.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 72.150000000000006 110.899 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.526 HG23 ' HG3' ' A' ' 59' ' ' GLN . 5.4 p -85.28 -16.52 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 73.510000000000005 111.218 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.2 t -77.11 -6.39 52.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 72.329999999999998 110.877 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.733 ' CD2' HG11 ' A' ' 113' ' ' VAL . 29.7 m-85 -118.65 -50.56 2.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 64.329999999999998 110.884 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.482 ' CE1' HD21 ' A' ' 94' ' ' LEU . 39.1 m-85 -149.25 155.75 41.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 63.520000000000003 110.875 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.526 ' HG3' HG23 ' A' ' 55' ' ' VAL . 4.4 mp0 -118.91 152.33 36.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.516 . . . . 51.329999999999998 110.972 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 12.2 t -92.6 109.39 38.3 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.632 0.729 . . . . 63.119999999999997 110.93 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.789 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 53.6 Cg_endo -69.73 168.79 20.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 54.100000000000001 112.322 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.64 -39.01 7.26 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.683 2.256 . . . . 74.430000000000007 112.339 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.456 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 37.7 p-90 -73.76 -5.75 42.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 70.049999999999997 110.938 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.789 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -78.12 149.62 33.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 42.210000000000001 111.104 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 91' ' ' PRO . . . 64.19 38.44 8.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 64.299999999999997 111.097 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 65' ' ' ALA . 77.6 mt -135.95 66.94 62.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.56 0.695 . . . . 72.299999999999997 110.842 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 151.19 69.09 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.645 2.23 . . . . 73.150000000000006 112.362 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.6 m -132.66 5.29 3.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.2 -0.455 . . . . 63.210000000000001 110.822 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.425 HG12 ' HB3' ' A' ' 124' ' ' ARG . 9.8 p -145.3 152.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 64.319999999999993 111.103 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 171' ' ' LEU . . . -88.96 123.67 33.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 73.150000000000006 111.095 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.4 p -151.16 178.06 9.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 73.120000000000005 110.865 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -152.2 165.48 34.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 74.040000000000006 110.939 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.782 HD22 HD11 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -128.5 136.39 50.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.204 -0.453 . . . . 70.319999999999993 110.873 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.485 ' NE2' HG23 ' A' ' 76' ' ' THR . 0.4 OUTLIER -102.71 135.39 44.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 110.908 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.409 ' SG ' HD23 ' A' ' 73' ' ' LEU . 22.9 m -122.28 137.1 54.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.902 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.485 HG23 ' NE2' ' A' ' 74' ' ' GLN . 3.7 p -110.12 150.59 28.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 61.329999999999998 111.129 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -155.62 123.3 5.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 74.530000000000001 110.936 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 55.66 32.58 19.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 74.299999999999997 110.838 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.97 17.25 79.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.773 -0.727 . . . . 65.430000000000007 112.491 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.8 mt -107.42 108.74 62.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.716 . . . . 74.239999999999995 110.959 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 90.17 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.691 2.261 . . . . 72.200000000000003 112.34 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.1 mt -70.55 159.49 84.81 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.622 0.725 . . . . 74.450000000000003 110.888 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 124.31 10.95 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.72 2.28 . . . . 71.030000000000001 112.334 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.67 148.4 51.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 64.549999999999997 111.111 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 mt -148.25 138.27 22.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 65.120000000000005 110.966 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -63.16 106.05 1.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 45.219999999999999 112.446 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.782 HD11 HD22 ' A' ' 73' ' ' LEU . 13.8 mt -76.43 70.87 3.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.339 . . . . 65.439999999999998 110.953 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -111.81 6.34 19.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 74.340000000000003 110.898 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.4 mmt85 -69.52 -19.32 63.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 71.510000000000005 110.891 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -140.28 155.4 70.28 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 75.200000000000003 110.905 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.525 ' O ' HG13 ' A' ' 118' ' ' VAL . 54.4 Cg_endo -69.72 -26.72 27.49 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.747 2.298 . . . . 72.120000000000005 112.336 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.718 ' HB3' HG22 ' A' ' 118' ' ' VAL . 35.1 p90 -155.44 172.03 18.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 73.099999999999994 110.957 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -138.98 117.1 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 75.219999999999999 110.989 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.745 HD22 ' HB ' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -89.81 126.0 35.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 71.430000000000007 110.946 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.465 ' N ' HD13 ' A' ' 94' ' ' LEU . 78.4 m-85 -114.97 122.06 45.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 72.209999999999994 110.868 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.43 -149.6 9.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 63.020000000000003 112.491 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.78 -0.49 10.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.868 0.366 . . . . 74.030000000000001 110.859 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.8 t -68.31 161.57 27.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 54.039999999999999 110.845 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.75 -8.95 59.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 75.019999999999996 110.83 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 15.4 m -101.89 -6.66 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.401 . . . . 73.140000000000001 111.143 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 94' ' ' LEU . 13.0 p -67.68 163.27 21.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 74.439999999999998 110.903 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -93.18 -0.78 56.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 75.230000000000004 110.883 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -152.93 106.18 3.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 45.310000000000002 110.988 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 76.4 t -94.3 109.31 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 64.030000000000001 111.102 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.634 HD13 HD13 ' A' ' 110' ' ' ILE . 0.7 OUTLIER -111.79 -168.97 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 64.430000000000007 110.909 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -138.41 106.67 5.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 73.120000000000005 110.921 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.444 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -166.19 143.59 4.43 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.533 0.683 . . . . 71.200000000000003 110.913 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -12.37 32.67 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.673 2.249 . . . . 50.5 112.341 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.2 p -99.03 -28.07 13.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.219999999999999 110.883 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.634 HD13 HD13 ' A' ' 105' ' ' LEU . 59.3 mt -74.55 117.97 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 65.549999999999997 111.093 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.8 m -96.01 170.68 9.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 70.120000000000005 110.83 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.76 -32.6 3.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 73.129999999999995 110.832 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.755 HG23 HD13 ' A' ' 131' ' ' LEU . 2.3 m -147.1 79.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 73.0 111.117 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.492 ' CD2' HG22 ' A' ' 137' ' ' VAL . 2.1 t60 -65.4 -58.65 5.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.81 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -157.04 176.98 12.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 64.25 111.105 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.745 ' HB ' HD22 ' A' ' 94' ' ' LEU . 14.7 p -155.35 135.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 64.450000000000003 111.135 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.555 HD13 ' CD2' ' A' ' 126' ' ' PHE . 3.1 pp -112.04 141.2 46.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 75.120000000000005 110.901 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.718 HG22 ' HB3' ' A' ' 92' ' ' PHE . 17.0 t -128.47 135.27 62.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 111.099 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 90.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 70.420000000000002 110.938 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -61.77 107.64 0.87 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 64.420000000000002 110.863 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.3 -6.24 64.8 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.73 -0.748 . . . . 52.32 112.451 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -88.73 -51.05 3.16 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.736 -0.745 . . . . 43.100000000000001 112.469 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -99.05 -2.24 37.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.848 0.356 . . . . 74.239999999999995 110.927 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.425 ' HB3' HG12 ' A' ' 69' ' ' VAL . 0.2 OUTLIER 60.48 30.75 20.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 74.319999999999993 110.901 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 58.7 m -137.61 138.24 39.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 60.310000000000002 110.856 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.555 ' CD2' HD13 ' A' ' 117' ' ' LEU . 59.2 m-85 -64.67 130.07 42.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 71.340000000000003 110.927 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.5 t -108.79 109.67 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 73.219999999999999 111.119 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.56 HD23 HD12 ' A' ' 150' ' ' LEU . 4.6 tt -102.03 131.56 48.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 73.299999999999997 110.963 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 33.1 mtm -131.99 137.74 48.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 64.439999999999998 110.96 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -89.42 132.63 34.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.322 -0.399 . . . . 54.140000000000001 110.887 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.755 HD13 HG23 ' A' ' 113' ' ' VAL . 1.3 pt? -64.71 -14.64 59.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 34.43 110.901 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.405 ' N ' HD23 ' A' ' 131' ' ' LEU . . . 107.03 49.55 0.88 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.728 -0.748 . . . . 63.240000000000002 112.489 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.2 p -78.93 153.78 30.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.938 0.399 . . . . 61.32 110.858 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.2 t -75.79 -5.51 46.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 63.350000000000001 111.097 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.8 -64.87 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 74.030000000000001 110.902 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.52 142.99 6.5 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.76 -0.733 . . . . 62.130000000000003 112.52 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.492 HG22 ' CD2' ' A' ' 114' ' ' HIS . 21.7 t -119.71 146.87 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.874 0.368 . . . . 63.140000000000001 111.128 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -98.98 151.23 21.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 62.329999999999998 110.874 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.706 HD13 ' HB2' ' A' ' 140' ' ' ASN . 3.2 tm? -135.48 123.61 22.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.869 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.706 ' HB2' HD13 ' A' ' 139' ' ' LEU . 1.2 m-80 58.55 22.11 9.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 44.340000000000003 110.884 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.69 18.77 54.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 51.100000000000001 112.433 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -143.39 125.19 15.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 64.239999999999995 110.897 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.2 ptt85 -59.74 133.33 55.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 74.510000000000005 110.839 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 142' ' ' ASN . 0.0 OUTLIER -141.4 177.97 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 70.5 111.121 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -58.39 -176.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 73.319999999999993 110.935 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.68 -170.37 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 63.229999999999997 110.882 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 39.71 39.33 0.53 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 73.409999999999997 110.909 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -139.76 160.75 59.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.675 0.75 . . . . 72.310000000000002 110.853 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.64 2.86 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.714 2.276 . . . . 51.130000000000003 112.319 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.56 HD12 HD23 ' A' ' 128' ' ' LEU . 3.1 mt -118.05 83.75 20.1 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.541 0.686 . . . . 64.099999999999994 110.868 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 130.01 18.64 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.671 2.247 . . . . 65.340000000000003 112.404 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.438 ' O ' HG21 ' A' ' 169' ' ' VAL . . . -114.38 77.09 4.04 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.577 0.703 . . . . 71.310000000000002 111.152 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 165.35 31.23 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.631 2.221 . . . . 72.120000000000005 112.424 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.4 m -52.06 144.27 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 71.430000000000007 111.126 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.16 -9.54 69.4 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.724 -0.75 . . . . 74.409999999999997 112.486 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.1 p -96.25 -174.48 3.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 73.230000000000004 110.921 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.7 m -138.85 165.5 26.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 51.5 110.87 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.6 mt -141.45 150.49 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 71.230000000000004 111.136 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.49 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -152.08 162.84 40.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 73.099999999999994 110.943 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.49 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 3.7 p90 -161.79 139.48 8.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 74.25 110.893 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 60.98 -148.83 45.5 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.714 -0.755 . . . . 62.200000000000003 112.506 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -107.23 10.51 29.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 75.329999999999998 110.886 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.6 p -62.7 159.97 15.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 73.439999999999998 110.812 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 166' ' ' VAL . 58.1 m -91.54 -25.7 19.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 71.329999999999998 110.848 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 26.4 mtt85 -53.28 147.57 10.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 62.200000000000003 110.896 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 164' ' ' SER . 21.2 t -144.61 130.13 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 72.400000000000006 111.149 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.622 ' HB3' HD21 ' A' ' 73' ' ' LEU . 7.0 m-85 -98.48 103.95 15.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 71.25 111.003 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.49 110.32 22.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 71.129999999999995 110.84 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.668 HG22 HD12 ' A' ' 73' ' ' LEU . 3.2 t -76.21 153.54 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 75.439999999999998 111.187 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.5 148.26 16.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 73.030000000000001 110.918 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 70' ' ' ALA . 17.1 tp -94.09 132.7 38.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 74.349999999999994 110.928 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -57.38 178.15 1.05 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.787 -0.72 . . . . 61.140000000000001 112.484 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 167.65 23.83 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.75 2.3 . . . . 74.010000000000005 112.331 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 159.99 51.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.665 2.243 . . . . 73.319999999999993 112.359 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.6 t -122.38 170.43 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 73.109999999999999 110.831 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.9 m -110.39 -38.44 5.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 73.219999999999999 110.848 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 74.329999999999998 110.861 -179.785 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 121.407 0.449 . . . . 51.439999999999998 112.537 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 123.7 10.39 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.696 2.264 . . . . 65.450000000000003 112.397 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mmt -121.62 119.7 32.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 75.120000000000005 110.905 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.5 m -77.22 157.5 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 72.239999999999995 111.064 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 t -130.29 158.59 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 62.329999999999998 111.165 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -77.46 169.06 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 61.229999999999997 110.908 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.563 HG23 ' H ' ' A' ' 7' ' ' LEU . 11.7 t -114.79 -19.32 11.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 111.199 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.6 21.12 62.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 75.150000000000006 112.469 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.563 ' H ' HG23 ' A' ' 5' ' ' THR . 3.5 pp -52.46 127.41 22.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 72.510000000000005 110.921 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.03 165.75 6.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 73.540000000000006 110.909 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -119.21 154.58 33.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 74.329999999999998 110.864 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -135.71 141.88 44.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.127 -0.488 . . . . 74.349999999999994 110.868 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.92 149.72 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 75.239999999999995 111.152 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.19 157.09 43.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 111.076 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.01 166.55 16.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 72.439999999999998 111.101 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.6 t -119.04 113.51 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 75.430000000000007 111.113 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.88 150.17 48.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 74.450000000000003 110.897 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 162.58 34.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 51.140000000000001 110.883 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.01 174.0 12.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 24.539999999999999 111.099 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.01 151.93 41.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 72.329999999999998 111.153 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -123.87 120.96 34.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.396 . . . . 61.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.3 mm -103.77 139.49 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 111.139 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.75 -179.06 5.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 74.230000000000004 111.167 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -101.07 160.65 26.06 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.544 0.687 . . . . 73.319999999999993 110.942 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 167.74 23.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.677 2.252 . . . . 64.340000000000003 112.365 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 167.95 22.88 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.691 2.261 . . . . 70.519999999999996 112.32 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 167.56 24.12 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.751 2.301 . . . . 74.209999999999994 112.323 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 175.5 7.95 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.677 2.251 . . . . 74.120000000000005 112.374 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.43 146.47 47.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 62.420000000000002 110.915 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.0 m -50.99 169.47 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 62.130000000000003 111.174 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.12 107.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 51.0 111.193 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -154.65 167.2 30.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.25 110.948 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.19 101.37 10.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 74.239999999999995 110.916 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.19 -174.13 2.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.242 -0.435 . . . . 54.329999999999998 111.145 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HA ' ' HG3' ' A' ' 36' ' ' LYS . 4.8 mm-40 -55.43 -31.9 62.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 75.109999999999999 110.914 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HA ' ' HG2' ' A' ' 37' ' ' GLN . . . -61.99 -14.81 38.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 64.230000000000004 111.086 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.659 ' O ' HD13 ' A' ' 38' ' ' LEU . . . -88.37 -39.84 14.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 70.239999999999995 111.121 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.414 ' HG3' ' HA ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -81.48 -13.01 58.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 74.5 110.864 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 34' ' ' ALA . 1.6 pt20 -113.18 30.83 6.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 64.030000000000001 110.907 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -45.86 154.07 0.6 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.652 0.739 . . . . 74.430000000000007 110.983 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.409 ' HD2' ' HG ' ' A' ' 38' ' ' LEU . 53.8 Cg_endo -69.75 -179.41 2.89 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.627 2.218 . . . . 71.450000000000003 112.278 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.643 ' HG3' HD12 ' A' ' 43' ' ' ILE . 6.5 mt-30 -75.33 172.85 11.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 55.149999999999999 110.908 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.808 ' CD2' HG23 ' A' ' 42' ' ' ILE . 19.6 p-80 -62.3 -43.29 99.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.929 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.808 HG23 ' CD2' ' A' ' 41' ' ' HIS . 1.1 pp -73.6 -32.62 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 111.193 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.643 HD12 ' HG3' ' A' ' 40' ' ' GLN . 58.5 mt -79.49 -24.5 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 111.104 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.06 -5.24 70.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.698 -0.763 . . . . 74.150000000000006 112.496 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 42' ' ' ILE . 9.4 p -115.18 -21.99 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 62.119999999999997 111.105 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 42' ' ' ILE . 34.5 p -50.43 153.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.109999999999999 111.131 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.529 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -72.51 159.35 85.6 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.617 0.722 . . . . 70.450000000000003 110.843 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -37.52 9.02 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.668 2.246 . . . . 64.519999999999996 112.333 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.03 -16.87 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 74.409999999999997 111.127 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt -83.52 -52.46 6.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.510000000000005 110.906 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -65.65 -29.85 70.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 62.109999999999999 110.933 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.593 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.7 t30 -78.45 -35.05 47.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 73.5 110.918 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.2 -19.87 65.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 45.130000000000003 111.079 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.502 ' NE2' HD12 ' A' ' 94' ' ' LEU . 1.6 mt-30 -90.92 -12.91 34.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 65.200000000000003 110.893 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.84 -37.27 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 75.040000000000006 111.135 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.9 t -60.12 -19.1 51.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 73.5 110.825 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.794 ' CD2' HG11 ' A' ' 113' ' ' VAL . 28.9 m-85 -100.9 -48.34 4.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 74.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -158.31 144.47 17.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 75.120000000000005 110.878 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.03 123.07 48.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 64.409999999999997 110.953 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 8.5 p -56.84 111.09 2.9 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.612 0.72 . . . . 42.32 110.905 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.808 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 53.4 Cg_endo -69.86 169.19 19.6 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.644 2.23 . . . . 63.420000000000002 112.304 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -40.68 5.11 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.744 2.296 . . . . 70.230000000000004 112.318 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.449 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 35.7 p-90 -72.14 -6.78 45.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 70.5 110.921 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.808 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -77.22 150.96 35.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 74.549999999999997 111.097 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' A' ' 91' ' ' PRO . . . 64.9 47.44 2.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 74.129999999999995 111.071 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 75.1 mt -146.33 66.67 11.35 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.592 0.71 . . . . 71.219999999999999 110.917 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 150.97 68.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.713 2.276 . . . . 71.209999999999994 112.319 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.06 16.64 1.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 32.520000000000003 110.797 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.1 p -141.96 152.41 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.25 111.136 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.555 ' O ' HD12 ' A' ' 171' ' ' LEU . . . -94.29 113.71 25.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 111.13 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 16.1 p -150.83 174.94 12.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 110.897 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -144.95 167.0 23.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.47 . . . . 72.150000000000006 110.789 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.694 HD13 ' N ' ' A' ' 74' ' ' GLN . 2.0 tm? -122.38 135.8 54.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 44.520000000000003 110.941 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.694 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -107.69 135.76 48.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 72.219999999999999 110.932 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 57.8 m -128.69 140.33 51.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 61.420000000000002 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -112.39 157.03 21.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 54.509999999999998 111.08 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.63 ' HD3' HD11 ' A' ' 82' ' ' LEU . 5.8 ptm180 -162.58 125.8 2.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 74.430000000000007 110.904 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.0 t0 55.74 28.63 12.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 72.329999999999998 110.93 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.43 18.0 79.5 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.654 -0.784 . . . . 72.140000000000001 112.464 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.576 HD12 ' NH1' ' A' ' 77' ' ' ARG . 31.5 mt -110.69 108.5 58.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.577 0.704 . . . . 75.239999999999995 110.925 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 54.1 Cg_endo -69.69 89.7 0.52 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.722 2.282 . . . . 71.230000000000004 112.371 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.63 HD11 ' HD3' ' A' ' 77' ' ' ARG . 20.1 mt -66.53 159.46 73.4 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.552 0.691 . . . . 62.039999999999999 110.918 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 119.98 6.83 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.648 2.232 . . . . 63.340000000000003 112.345 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.58 147.99 43.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 21.0 111.108 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -148.17 137.66 22.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 75.340000000000003 110.9 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.83 109.45 2.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 61.530000000000001 112.47 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.0 mt -78.13 71.27 4.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.868 0.366 . . . . 72.209999999999994 110.912 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -111.74 6.75 19.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 63.210000000000001 110.954 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -19.07 63.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 65.040000000000006 110.861 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -139.67 154.56 71.26 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.633 0.73 . . . . 72.5 110.894 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.603 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 53.9 Cg_endo -69.77 -29.22 24.15 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.788 2.325 . . . . 41.020000000000003 112.32 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.609 ' HB3' HG22 ' A' ' 118' ' ' VAL . 11.6 p90 -148.8 179.29 7.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 74.299999999999997 110.887 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -150.44 110.51 4.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 110.953 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.528 HD13 ' SG ' ' A' ' 101' ' ' CYS . 0.4 OUTLIER -89.2 143.34 26.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.162 -0.472 . . . . 72.5 110.94 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -127.21 111.79 14.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 72.219999999999999 110.888 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -170.41 -160.12 18.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 74.129999999999995 112.469 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.23 0.81 21.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 52.109999999999999 110.9 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.458 ' HB3' HG22 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -85.51 156.48 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 34.140000000000001 110.874 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -21.34 57.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.129999999999995 110.847 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 98' ' ' SER . 15.4 m -70.15 -28.71 36.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.406 . . . . 74.239999999999995 111.116 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.528 ' SG ' HD13 ' A' ' 94' ' ' LEU . 91.6 m -65.78 159.86 24.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 64.230000000000004 110.889 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -75.71 -18.8 59.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 65.129999999999995 110.813 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -138.13 107.83 6.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 62.340000000000003 111.014 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 p -100.48 108.05 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 63.43 111.118 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.63 -169.18 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 71.099999999999994 110.957 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.14 107.47 7.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.876 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.563 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -154.13 148.65 19.47 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.549 0.69 . . . . 65.400000000000006 110.884 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -18.32 37.27 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.714 2.276 . . . . 71.040000000000006 112.342 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 p -102.46 -23.85 13.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 62.509999999999998 110.857 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.563 HD12 ' HB2' ' A' ' 107' ' ' HIS . 44.5 mt -77.09 108.14 9.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.501 . . . . 64.219999999999999 111.158 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.2 m -87.53 169.71 11.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 73.340000000000003 110.837 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -47.37 -36.56 9.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 61.210000000000001 110.849 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.794 HG11 ' CD2' ' A' ' 57' ' ' TYR . 1.7 m -141.47 80.39 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 72.450000000000003 111.159 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.68 ' CD2' HG22 ' A' ' 137' ' ' VAL . 2.0 t60 -65.73 -56.64 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 72.439999999999998 110.825 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.406 ' CB ' HD21 ' A' ' 128' ' ' LEU . . . -166.88 161.41 15.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 75.549999999999997 111.099 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.33 131.15 40.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 70.209999999999994 111.135 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.4 142.49 37.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 53.009999999999998 110.95 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.609 HG22 ' HB3' ' A' ' 92' ' ' PHE . 13.8 t -132.9 136.32 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 74.540000000000006 111.203 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.88 92.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 44.450000000000003 110.821 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -61.06 108.53 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 74.299999999999997 110.848 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.63 -7.4 61.19 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 33.409999999999997 112.508 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -89.66 -51.98 2.75 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.719 -0.753 . . . . 22.109999999999999 112.448 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -95.38 -3.11 47.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 74.400000000000006 110.94 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 61.66 33.1 18.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.857 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 49.5 m -139.22 158.71 43.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 64.049999999999997 110.935 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -82.35 127.42 33.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 75.439999999999998 110.89 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 79.5 t -109.49 110.34 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 74.299999999999997 111.137 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.406 HD21 ' CB ' ' A' ' 115' ' ' ALA . 8.8 tt -100.84 126.15 47.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 53.030000000000001 110.869 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 26.5 mtm -117.19 125.91 51.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 110.9 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -79.73 130.8 35.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 71.140000000000001 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.463 ' N ' HD22 ' A' ' 131' ' ' LEU . 1.2 mm? -92.55 17.85 9.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 71.239999999999995 110.884 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 102.51 58.67 0.77 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 65.019999999999996 112.469 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 64.1 p -53.17 136.82 35.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.952 0.406 . . . . 75.230000000000004 110.84 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.2 m -68.51 -29.46 68.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 64.439999999999998 111.17 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.15 -56.66 2.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 75.510000000000005 110.922 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 141.97 121.46 1.7 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 63.210000000000001 112.545 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.68 HG22 ' CD2' ' A' ' 114' ' ' HIS . 1.8 t -87.37 142.79 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 71.439999999999998 111.161 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 0.8 OUTLIER -101.13 134.43 44.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 75.010000000000005 110.869 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.706 HD13 ' HB2' ' A' ' 140' ' ' ASN . 3.2 tm? -117.97 122.7 43.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 110.861 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.706 ' HB2' HD13 ' A' ' 139' ' ' LEU . 1.3 m-80 56.83 23.83 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 71.439999999999998 110.9 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 89.5 11.22 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.685 -0.769 . . . . 71.430000000000007 112.51 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.64 136.47 24.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.809 0.338 . . . . 54.32 110.887 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -65.23 145.2 56.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 74.430000000000007 110.839 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.575 HG13 HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -145.23 175.51 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 64.299999999999997 111.131 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.408 ' HB2' ' HD2' ' A' ' 148' ' ' ARG . 0.7 OUTLIER -53.24 168.4 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.934 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -105.16 178.32 4.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 75.200000000000003 110.907 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 38.4 50.94 1.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 63.340000000000003 110.824 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.565 ' HG3' HD21 ' A' ' 150' ' ' LEU . 10.9 ptm180 -143.92 156.15 58.89 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.603 0.716 . . . . 52.450000000000003 110.873 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 148' ' ' ARG . 53.9 Cg_endo -69.76 110.81 2.64 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.688 2.259 . . . . 52.420000000000002 112.352 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.575 HD22 HG13 ' A' ' 144' ' ' ILE . 13.9 mt -110.25 84.48 3.76 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.597 0.713 . . . . 74.319999999999993 110.887 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 120.69 7.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.659 2.239 . . . . 61.450000000000003 112.366 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.692 ' O ' HG21 ' A' ' 169' ' ' VAL . . . -112.28 75.47 1.68 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.551 0.691 . . . . 63.119999999999997 111.11 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 171.3 14.69 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 43.140000000000001 112.396 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.5 m -50.97 136.69 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 70.540000000000006 111.117 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 93.91 -10.83 71.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.749 -0.739 . . . . 74.129999999999995 112.496 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.57 176.71 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.895 0.378 . . . . 64.329999999999998 110.836 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.1 m -133.34 161.71 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 61.399999999999999 110.902 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 166' ' ' VAL . 3.8 mt -141.71 145.34 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 74.310000000000002 111.075 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.49 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -151.74 149.65 29.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 53.420000000000002 110.934 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.49 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 4.1 p90 -149.0 135.17 19.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 73.430000000000007 110.917 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 64.52 -143.81 47.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 23.199999999999999 112.457 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -110.29 11.37 23.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 64.409999999999997 110.931 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 94.6 p -52.42 148.88 6.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 110.817 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.0 m -91.74 5.1 51.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.517 . . . . 73.430000000000007 110.857 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.4 137.56 42.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 62.420000000000002 110.892 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 158' ' ' ILE . 24.3 t -125.65 137.21 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 63.530000000000001 111.096 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.598 ' HB3' HD11 ' A' ' 73' ' ' LEU . 5.4 m-85 -96.65 101.71 13.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 110.94 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.08 111.14 23.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 71.420000000000002 110.836 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.692 HG21 ' O ' ' A' ' 152' ' ' ALA . 3.1 t -75.52 153.68 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.519999999999996 111.138 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -160.1 153.08 21.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 61.439999999999998 110.868 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.555 HD12 ' O ' ' A' ' 70' ' ' ALA . 34.9 tp -94.54 135.07 36.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 51.25 110.87 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -75.14 178.25 47.17 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.703 -0.76 . . . . 72.140000000000001 112.475 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 167.59 23.93 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.721 2.281 . . . . 61.109999999999999 112.34 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.68 130.5 19.55 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.676 2.251 . . . . 74.310000000000002 112.406 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.3 p -104.97 25.74 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 65.25 110.817 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.1 t -84.17 115.05 22.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 63.240000000000002 110.863 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 94.8 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 73.120000000000005 110.877 -179.824 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 CA-C-O 121.384 0.435 . . . . 74.439999999999998 112.432 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 152.08 69.07 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.735 2.29 . . . . 73.099999999999994 112.315 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -154.56 161.0 41.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 73.030000000000001 110.857 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.9 m -97.1 155.16 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 111.106 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.24 138.3 54.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 61.140000000000001 111.141 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.8 p -56.44 150.87 14.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 55.049999999999997 110.825 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.7 p -76.55 -19.11 58.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 73.319999999999993 111.129 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.8 20.31 13.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 62.299999999999997 112.497 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.2 mt -60.67 122.43 14.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 71.540000000000006 110.934 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 tp -127.58 152.49 47.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 53.5 110.969 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.2 p -75.04 179.72 4.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 54.43 110.816 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.92 149.08 9.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 75.049999999999997 110.91 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.87 164.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 63.43 111.124 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.55 144.1 54.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.219999999999999 111.109 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.22 145.72 26.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 64.230000000000004 111.077 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 14' ' ' VAL . 2.6 p -60.34 96.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 63.0 111.103 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -108.16 120.64 42.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 73.329999999999998 110.863 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -127.53 152.82 47.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 64.129999999999995 110.844 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.47 171.84 12.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 64.010000000000005 111.1 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.78 148.45 47.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 73.25 111.023 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -115.54 115.54 26.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 73.450000000000003 110.881 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.5 mp -80.54 121.54 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 71.239999999999995 111.157 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.68 175.88 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 51.25 111.08 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -131.9 157.55 77.9 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.551 0.691 . . . . 62.32 110.935 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 167.66 23.67 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.699 2.266 . . . . 71.140000000000001 112.394 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 167.89 23.25 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.613 2.208 . . . . 75.340000000000003 112.354 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 167.74 23.51 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.756 2.304 . . . . 73.420000000000002 112.377 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.86 -173.84 0.81 Allowed 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.709 2.273 . . . . 75.420000000000002 112.298 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.48 102.57 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 74.329999999999998 110.872 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.9 m -53.03 167.77 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 74.430000000000007 111.148 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 75.2 t -77.82 143.62 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 75.519999999999996 111.127 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -66.96 166.63 13.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.151 -0.477 . . . . 72.340000000000003 110.879 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -64.86 162.04 17.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 61.229999999999997 110.926 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.95 176.88 4.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 63.329999999999998 111.134 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.14 -27.95 54.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 52.049999999999997 110.872 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.93 -16.4 55.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 111.063 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.63 -38.67 14.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 75.329999999999998 111.158 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -5.72 47.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 70.219999999999999 110.901 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -112.95 -40.43 3.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 72.129999999999995 110.933 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.3 153.15 40.58 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.657 0.741 . . . . 75.530000000000001 110.908 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 151.19 68.83 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.21 . . . . 72.530000000000001 112.338 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.69 ' HG3' HD12 ' A' ' 43' ' ' ILE . 8.9 mt-30 -69.62 172.02 8.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 75.209999999999994 110.877 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.813 ' CD2' HG23 ' A' ' 42' ' ' ILE . 19.7 p-80 -64.05 -43.94 93.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 75.340000000000003 110.871 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.813 HG23 ' CD2' ' A' ' 41' ' ' HIS . 1.1 pp -72.5 -32.49 41.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 72.219999999999999 111.121 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.69 HD12 ' HG3' ' A' ' 40' ' ' GLN . 63.0 mt -79.34 -26.71 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 63.109999999999999 111.1 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.2 -18.16 40.94 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.766 -0.731 . . . . 71.030000000000001 112.446 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.7 t -107.58 -26.48 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 75.349999999999994 111.122 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 42' ' ' ILE . 78.5 p -59.8 153.75 19.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 71.109999999999999 111.146 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.57 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -79.2 160.06 71.55 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.669 0.747 . . . . 73.430000000000007 110.874 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -38.75 7.37 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.673 2.249 . . . . 61.25 112.378 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.16 -14.74 35.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 71.049999999999997 111.148 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -83.5 -56.75 3.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 53.140000000000001 110.942 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.6 OUTLIER -61.29 -28.85 69.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 75.109999999999999 110.959 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.593 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.3 t30 -73.77 -43.95 57.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 75.340000000000003 110.881 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.681 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -58.24 -25.16 61.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 72.019999999999996 111.124 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -92.6 -18.69 22.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.281 -0.418 . . . . 54.409999999999997 110.93 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -28.68 45.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 74.519999999999996 111.145 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.53 3.73 17.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 64.319999999999993 110.884 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.767 ' CD2' HG11 ' A' ' 113' ' ' VAL . 42.7 m-85 -126.55 -56.11 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 62.439999999999998 110.917 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HE2' HD22 ' A' ' 94' ' ' LEU . 28.2 p90 -146.79 147.59 31.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 72.349999999999994 110.819 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -99.36 152.85 19.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 63.219999999999999 110.858 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 3.6 m -95.57 107.07 30.92 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.655 0.74 . . . . 31.239999999999998 110.844 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.82 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 54.1 Cg_endo -69.73 162.32 42.51 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.697 2.265 . . . . 53.329999999999998 112.353 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.88 -37.76 8.45 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.672 2.248 . . . . 74.439999999999998 112.288 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.495 ' HA ' HD12 ' A' ' 66' ' ' LEU . 33.6 p-90 -71.67 -7.33 47.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 74.239999999999995 110.971 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.82 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -75.46 148.33 39.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 65.299999999999997 111.107 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.748 ' HB2' ' HB3' ' A' ' 91' ' ' PRO . . . 64.15 38.34 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 73.200000000000003 111.121 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 63' ' ' TRP . 94.7 mt -135.9 67.29 63.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.586 0.707 . . . . 71.409999999999997 110.901 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 151.46 69.24 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.68 2.253 . . . . 70.140000000000001 112.414 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.4 12.67 2.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 72.120000000000005 110.813 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.29 150.69 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 70.109999999999999 111.123 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.623 ' O ' HD12 ' A' ' 171' ' ' LEU . . . -87.39 117.37 26.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 22.329999999999998 111.073 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.4 p -151.06 167.23 28.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 64.329999999999998 110.899 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -137.62 168.0 20.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 72.420000000000002 110.84 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 74' ' ' GLN . 2.7 tm? -123.12 136.31 54.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 72.209999999999994 110.882 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.68 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -110.92 133.27 53.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 74.349999999999994 110.905 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.6 m -123.43 137.63 54.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 72.400000000000006 110.804 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.523 HG23 ' NE2' ' A' ' 74' ' ' GLN . 39.8 p -105.5 149.69 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 74.439999999999998 111.154 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.446 ' HD3' HD11 ' A' ' 82' ' ' LEU . 6.8 ptm180 -149.09 117.57 6.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 74.219999999999999 110.898 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 54.01 36.13 23.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 71.450000000000003 110.872 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.19 19.61 79.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.748 -0.739 . . . . 64.040000000000006 112.463 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 62.3 mt -110.58 108.49 58.2 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.58 0.705 . . . . 72.299999999999997 110.88 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 53.7 Cg_endo -69.65 92.23 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.728 2.285 . . . . 75.120000000000005 112.364 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.446 HD11 ' HD3' ' A' ' 77' ' ' ARG . 20.2 mt -71.02 159.2 86.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.609 0.719 . . . . 53.509999999999998 110.914 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 118.5 5.72 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.628 2.218 . . . . 73.120000000000005 112.379 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.54 146.33 52.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 32.240000000000002 111.061 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 mt -143.13 137.84 29.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 73.340000000000003 110.956 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -60.18 99.53 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 61.039999999999999 112.514 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.5 mt -75.48 71.24 2.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.823 0.344 . . . . 72.019999999999996 110.881 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -111.46 6.12 20.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 65.040000000000006 110.822 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -20.09 63.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 63.030000000000001 110.832 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -137.03 155.71 76.06 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.646 0.736 . . . . 74.329999999999998 110.893 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.748 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 53.1 Cg_endo -69.75 -30.77 21.79 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.645 2.23 . . . . 74.230000000000004 112.386 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.582 ' HB3' HG22 ' A' ' 118' ' ' VAL . 3.7 p90 -159.29 179.4 9.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 61.549999999999997 110.893 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -149.48 122.72 8.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 73.340000000000003 110.904 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.619 HD21 HG12 ' A' ' 113' ' ' VAL . 25.8 tp -96.07 129.13 43.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 72.450000000000003 110.911 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -110.53 113.63 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 110.881 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.48 -157.45 10.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.693 -0.765 . . . . 40.240000000000002 112.455 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.0 -1.86 12.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.743 0.306 . . . . 73.540000000000006 110.864 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.46 166.91 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 51.240000000000002 110.864 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.44 -10.85 57.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 73.120000000000005 110.92 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.681 HG11 ' HB1' ' A' ' 53' ' ' ALA . 16.8 m -92.75 -6.81 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 70.450000000000003 111.145 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.588 ' HA ' HD23 ' A' ' 94' ' ' LEU . 11.4 p -76.48 160.55 29.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 64.420000000000002 110.897 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.24 -0.13 57.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 110.807 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -155.89 106.13 2.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 74.129999999999995 110.944 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 104' ' ' VAL . 3.0 p -97.48 109.62 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.066 -0.516 . . . . 75.420000000000002 111.194 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.656 HD13 HD13 ' A' ' 110' ' ' ILE . 0.6 OUTLIER -110.59 -169.24 1.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 62.340000000000003 110.953 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -132.17 106.96 8.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 72.519999999999996 110.917 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.476 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -164.83 143.57 5.55 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 110.87 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -13.04 34.17 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 2.257 . . . . 70.349999999999994 112.287 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.9 p -99.48 -27.97 13.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.29 -0.414 . . . . 64.120000000000005 110.871 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.656 HD13 HD13 ' A' ' 105' ' ' LEU . 58.7 mt -75.07 112.94 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 75.420000000000002 111.132 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.3 m -93.87 170.52 9.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 74.120000000000005 110.91 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.85 -36.26 3.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 42.039999999999999 110.845 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.767 HG11 ' CD2' ' A' ' 57' ' ' TYR . 2.7 m -142.6 78.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 72.140000000000001 111.124 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.546 ' CD2' HG12 ' A' ' 137' ' ' VAL . 3.9 t60 -65.52 -55.7 16.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.868 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -168.78 153.58 5.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.264 -0.425 . . . . 71.030000000000001 111.108 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.475 ' HB ' HD13 ' A' ' 94' ' ' LEU . 6.7 p -131.96 135.57 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.148 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 126' ' ' PHE . 3.0 pp -108.56 140.05 42.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 74.25 110.874 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 92' ' ' PHE . 15.3 t -129.47 137.31 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 63.43 111.118 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.78 90.43 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 65.439999999999998 110.928 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -60.13 108.13 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 74.120000000000005 110.893 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.58 -8.24 59.63 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 63.229999999999997 112.461 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -90.02 -49.92 3.19 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.811 -0.709 . . . . 73.109999999999999 112.475 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -94.18 -5.43 47.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.76 0.314 . . . . 71.530000000000001 110.866 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.23 18.54 11.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 71.409999999999997 110.857 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 8.7 p -127.33 164.81 20.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 70.329999999999998 110.911 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.493 ' CD2' HD13 ' A' ' 117' ' ' LEU . 60.4 m-85 -87.24 127.12 35.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 61.109999999999999 110.891 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.47 110.02 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 74.299999999999997 111.191 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 128' ' ' LEU . 6.7 tt -101.72 121.46 42.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 60.399999999999999 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.1 mtt -115.72 133.01 56.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 63.119999999999997 110.805 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.64 132.58 34.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 73.540000000000006 110.893 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.454 ' N ' HD22 ' A' ' 131' ' ' LEU . 2.9 mm? -75.67 -8.73 57.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 74.420000000000002 110.937 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 122.21 47.24 0.28 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.739 -0.743 . . . . 54.329999999999998 112.435 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.7 t -61.26 130.97 48.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 52.420000000000002 110.89 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.1 t -55.73 -24.68 36.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 42.039999999999999 111.173 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -100.43 -50.0 4.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 62.109999999999999 110.886 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 105.12 144.52 12.81 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.755 -0.736 . . . . 53.420000000000002 112.581 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 114' ' ' HIS . 1.9 m -88.62 172.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 64.109999999999999 111.134 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 3.6 mtmt -112.19 133.18 54.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 74.310000000000002 110.887 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.711 HD13 ' HB2' ' A' ' 140' ' ' ASN . 3.1 tm? -113.65 124.46 52.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.323 -0.399 . . . . 75.400000000000006 110.886 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.711 ' HB2' HD13 ' A' ' 139' ' ' LEU . 1.0 OUTLIER 62.19 21.2 12.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 74.219999999999999 110.914 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.9 25.39 41.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 43.509999999999998 112.5 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.563 ' O ' HG23 ' A' ' 144' ' ' ILE . 30.3 m120 -145.03 121.23 10.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.806 0.336 . . . . 74.340000000000003 110.948 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.9 135.97 35.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 75.310000000000002 110.836 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.697 HD11 HD13 ' A' ' 150' ' ' LEU . 32.9 pt -140.26 -173.21 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 64.540000000000006 111.105 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.24 -170.26 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 74.010000000000005 110.951 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.37 173.84 10.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 110.892 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.29 42.47 21.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 110.901 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.726 ' HG3' HD21 ' A' ' 150' ' ' LEU . 2.5 ptm85 -147.99 159.44 40.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.6 0.714 . . . . 71.140000000000001 110.886 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 112.73 3.17 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.719 2.28 . . . . 71.299999999999997 112.322 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.726 HD21 ' HG3' ' A' ' 148' ' ' ARG . 5.4 mt -114.61 83.77 9.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 73.219999999999999 110.901 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 124.81 11.42 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.608 2.205 . . . . 54.340000000000003 112.316 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -118.54 80.14 16.51 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.598 0.713 . . . . 71.099999999999994 111.035 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -175.87 1.31 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.755 2.303 . . . . 73.099999999999994 112.269 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.2 m -65.84 144.5 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 63.5 111.126 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.36 -11.83 64.54 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.754 -0.736 . . . . 51.299999999999997 112.471 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.68 174.68 6.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 61.219999999999999 110.827 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 53.5 m -126.18 164.88 19.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 74.430000000000007 110.884 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.4 mt -142.87 148.37 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 111.12 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.466 ' NE2' ' H ' ' A' ' 160' ' ' PHE . 0.0 OUTLIER -151.76 154.52 36.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 40.049999999999997 110.863 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.466 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 2.5 p90 -148.53 136.82 21.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 61.240000000000002 110.824 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.21 -151.45 45.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 54.130000000000003 112.479 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -103.38 10.62 37.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 53.43 110.82 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.54 160.39 5.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 70.319999999999993 110.916 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 21.7 t -91.48 -31.35 16.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 71.040000000000006 110.865 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -53.41 152.47 4.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 74.430000000000007 110.891 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.26 130.96 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 75.120000000000005 111.067 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -97.85 102.9 14.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 75.109999999999999 110.916 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.4 tppm? -103.47 110.17 22.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 73.400000000000006 110.963 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.71 153.04 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 75.239999999999995 111.188 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -160.71 147.65 15.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.219999999999999 110.96 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.623 HD12 ' O ' ' A' ' 70' ' ' ALA . 31.6 tp -80.45 136.97 36.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 55.039999999999999 110.911 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -59.41 177.19 2.63 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.775 -0.726 . . . . 52.310000000000002 112.51 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.81 23.41 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.656 2.238 . . . . 75.209999999999994 112.335 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -24.25 29.73 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.597 2.198 . . . . 73.439999999999998 112.399 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.9 t -88.51 55.16 3.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 63.109999999999999 110.923 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.48 137.6 57.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.51 . . . . 74.040000000000006 110.852 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 62.439999999999998 110.927 -179.824 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 CA-C-O 121.475 0.486 . . . . 42.409999999999997 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 143.26 50.45 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.664 2.243 . . . . 51.130000000000003 112.378 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -175.27 154.86 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 73.129999999999995 110.881 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.6 148.27 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 71.230000000000004 111.079 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.3 p -134.54 101.73 5.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 111.122 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.8 p -159.91 133.79 7.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.292 -0.413 . . . . 71.439999999999998 110.9 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.651 HG23 ' H ' ' A' ' 7' ' ' LEU . 10.9 t -116.89 -19.02 10.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 73.120000000000005 111.161 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.19 20.99 74.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 74.120000000000005 112.486 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.651 ' H ' HG23 ' A' ' 5' ' ' THR . 68.2 tp -51.87 154.36 2.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.887 0.375 . . . . 70.540000000000006 110.855 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.8 tp -125.2 167.87 14.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 72.329999999999998 110.923 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.65 176.22 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 72.230000000000004 110.838 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.8 ptt85 -110.3 148.5 31.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 54.409999999999997 110.871 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.85 150.77 10.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 63.420000000000002 111.121 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.51 160.93 0.54 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 73.319999999999993 111.053 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.87 168.99 11.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 64.329999999999998 111.16 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 14' ' ' VAL . 3.5 p -115.5 113.33 43.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 55.039999999999999 111.152 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -154.46 166.87 31.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 60.109999999999999 110.894 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.97 163.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 64.400000000000006 110.881 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.87 174.26 10.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.438 . . . . 63.329999999999998 111.109 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.94 152.07 3.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 70.329999999999998 111.136 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.17 101.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 74.349999999999994 110.924 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 20' ' ' ILE . 4.4 mp -60.3 134.4 25.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 73.519999999999996 111.13 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.84 -178.86 0.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 111.147 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -53.63 110.04 1.83 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 71.25 110.913 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 168.18 22.43 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.715 2.277 . . . . 64.420000000000002 112.294 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 168.39 21.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 73.439999999999998 112.323 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.4 Cg_endo -69.74 112.2 3.01 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.671 2.247 . . . . 72.420000000000002 112.349 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 54.0 Cg_endo -69.73 -169.5 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.731 2.287 . . . . 75.439999999999998 112.315 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.24 150.61 27.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 62.219999999999999 110.905 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -47.95 140.86 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 70.409999999999997 111.215 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.53 151.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 63.520000000000003 111.106 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.88 169.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.499 . . . . 70.25 110.872 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.9 mt -54.24 176.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 73.439999999999998 110.975 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.35 168.52 3.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 53.240000000000002 111.151 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -57.19 -60.79 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 72.420000000000002 110.866 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.449 ' HA ' ' HG2' ' A' ' 37' ' ' GLN . . . -64.37 -14.63 57.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 64.319999999999993 111.156 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.03 -30.61 21.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 52.240000000000002 111.105 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -92.95 -23.7 18.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 73.150000000000006 110.918 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HG2' ' HA ' ' A' ' 34' ' ' ALA . 1.1 pt20 -105.78 35.17 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.838 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.844 ' H ' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -42.69 158.63 0.22 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.597 0.713 . . . . 62.409999999999997 110.907 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 38' ' ' LEU . 53.9 Cg_endo -69.78 96.14 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.7 2.267 . . . . 61.140000000000001 112.356 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.426 HE21 HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -51.56 172.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.323 -0.399 . . . . 73.400000000000006 110.976 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.473 ' CE1' HG23 ' A' ' 42' ' ' ILE . 8.5 p80 -46.21 -50.63 15.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 74.340000000000003 110.841 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.74 ' O ' HG23 ' A' ' 46' ' ' THR . 0.9 OUTLIER -51.25 -39.49 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 73.310000000000002 111.119 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.488 HG23 HD12 ' A' ' 51' ' ' LEU . 8.2 mt -80.95 -28.84 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 64.099999999999994 111.096 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.53 -10.01 52.52 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.711 -0.757 . . . . 72.5 112.484 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.32 -26.24 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.889 0.376 . . . . 63.340000000000003 111.149 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 42' ' ' ILE . 23.2 p -54.45 153.68 5.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 73.450000000000003 111.095 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.542 ' O ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -67.4 160.16 73.49 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.563 0.697 . . . . 74.340000000000003 110.905 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -36.84 10.11 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.716 2.278 . . . . 71.150000000000006 112.37 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.16 -18.16 27.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.089 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -83.29 -59.8 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 62.329999999999998 110.911 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -53.9 -29.61 42.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.3 -0.409 . . . . 73.340000000000003 110.855 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.585 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.5 t30 -73.53 -44.2 58.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 63.140000000000001 110.896 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.643 ' HB1' ' CG1' ' A' ' 100' ' ' VAL . . . -53.74 -26.98 25.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 72.129999999999995 111.099 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.402 HE22 HD12 ' A' ' 94' ' ' LEU . 11.0 mm-40 -93.66 -21.81 19.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 71.549999999999997 110.935 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.716 HG22 HE22 ' A' ' 59' ' ' GLN . 0.3 OUTLIER -83.74 -13.16 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 70.450000000000003 111.077 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 t -82.99 0.82 42.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 70.129999999999995 110.915 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.705 ' CD2' HG11 ' A' ' 113' ' ' VAL . 27.0 m-85 -129.38 -53.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 73.430000000000007 110.888 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -134.61 148.59 50.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 64.450000000000003 110.926 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.716 HE22 HG22 ' A' ' 55' ' ' VAL . 8.9 mm-40 -100.99 152.62 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 64.019999999999996 110.914 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 21.6 t -101.5 102.67 22.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.546 0.688 . . . . 71.319999999999993 110.893 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.792 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 53.7 Cg_endo -69.71 165.43 30.92 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.71 2.273 . . . . 54.039999999999999 112.38 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -38.86 7.13 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.733 2.289 . . . . 63.0 112.323 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.473 ' CZ2' ' HG3' ' A' ' 61' ' ' PRO . 40.3 p-90 -71.79 -6.51 42.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 62.140000000000001 110.939 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.792 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -79.07 149.55 32.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 62.450000000000003 111.13 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 91' ' ' PRO . . . 63.98 30.89 14.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 70.120000000000005 111.115 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 63' ' ' TRP . 71.2 mt -127.68 67.56 72.95 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.626 0.727 . . . . 61.329999999999998 110.945 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 151.27 69.16 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.623 2.216 . . . . 70.409999999999997 112.4 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.9 m -135.69 8.19 3.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 74.109999999999999 110.838 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -141.06 151.3 20.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 73.439999999999998 111.113 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.61 119.04 27.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 44.130000000000003 111.075 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.6 p -151.17 178.18 9.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 74.019999999999996 110.955 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -148.63 167.34 25.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 64.019999999999996 110.869 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.712 HD13 ' N ' ' A' ' 74' ' ' GLN . 1.6 tm? -121.58 135.94 54.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 72.349999999999994 110.879 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.712 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -111.24 135.71 51.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 71.420000000000002 110.904 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.6 m -127.13 140.56 52.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 64.439999999999998 110.906 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.447 HG23 ' NE2' ' A' ' 74' ' ' GLN . 17.7 p -111.34 153.98 25.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 111.183 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -155.17 121.41 5.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.305 -0.407 . . . . 64.019999999999996 110.852 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.1 t0 54.38 35.12 22.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 64.120000000000005 110.806 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.08 19.89 79.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 64.430000000000007 112.531 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 24.1 mt -110.33 108.64 58.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.645 0.736 . . . . 74.299999999999997 110.853 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 54.5 Cg_endo -69.7 92.46 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.642 2.228 . . . . 73.140000000000001 112.424 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.4 mt -71.44 159.24 86.12 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.668 0.747 . . . . 64.219999999999999 110.952 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 123.52 10.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.722 2.281 . . . . 75.0 112.313 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.65 149.43 49.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 72.129999999999995 111.174 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 mt -147.05 136.9 23.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 55.399999999999999 110.794 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.91 100.28 0.2 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.649 -0.786 . . . . 70.230000000000004 112.491 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.5 mt -78.69 70.8 5.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 73.310000000000002 110.912 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -111.92 6.08 19.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 53.329999999999998 110.8 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.1 mmt85 -69.21 -19.55 63.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 63.140000000000001 110.929 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.06 157.01 79.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.678 0.751 . . . . 72.329999999999998 110.845 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.545 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 53.3 Cg_endo -69.74 -28.49 25.27 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.702 2.268 . . . . 62.229999999999997 112.395 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.64 ' HB3' HG22 ' A' ' 118' ' ' VAL . 18.7 p90 -159.7 176.58 11.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 62.039999999999999 110.942 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -142.61 122.68 13.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.956 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.551 HD13 ' SG ' ' A' ' 101' ' ' CYS . 0.7 OUTLIER -89.98 152.59 21.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 71.209999999999994 110.932 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -139.8 106.0 5.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 71.549999999999997 110.901 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -164.22 -145.13 4.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.746 -0.74 . . . . 44.549999999999997 112.452 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.14 -1.25 11.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.748 0.309 . . . . 74.439999999999998 110.854 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -83.9 159.11 21.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 73.099999999999994 110.904 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -21.39 52.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 110.917 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.643 ' CG1' ' HB1' ' A' ' 53' ' ' ALA . 15.8 m -71.41 -22.95 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 71.209999999999994 111.147 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.551 ' SG ' HD13 ' A' ' 94' ' ' LEU . 99.6 m -68.91 164.57 21.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 72.519999999999996 110.932 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -85.27 -19.98 30.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.206 -0.452 . . . . 73.519999999999996 110.83 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -132.9 108.49 8.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 73.319999999999993 110.914 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.0 t -96.08 107.57 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 75.299999999999997 111.118 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.533 HD13 HD13 ' A' ' 110' ' ' ILE . 0.3 OUTLIER -112.93 -170.51 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 71.230000000000004 110.934 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.4 107.24 5.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 71.230000000000004 110.922 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.49 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -159.85 147.56 13.01 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.657 0.742 . . . . 72.450000000000003 110.857 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -15.48 37.13 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.662 2.241 . . . . 65.340000000000003 112.312 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 p -99.18 -27.33 13.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 63.219999999999999 110.825 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.533 HD13 HD13 ' A' ' 105' ' ' LEU . 59.5 mt -76.35 115.75 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 72.420000000000002 111.101 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.5 m -95.9 169.84 9.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 72.329999999999998 110.842 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.0 m -45.87 -35.63 4.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 74.239999999999995 110.844 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.705 HG11 ' CD2' ' A' ' 57' ' ' TYR . 1.7 m -143.01 78.0 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 73.299999999999997 111.099 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -65.53 -61.2 2.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 73.420000000000002 110.876 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.47 167.42 29.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 62.109999999999999 111.051 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.8 p -148.73 140.87 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 65.109999999999999 111.093 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 126' ' ' PHE . 3.1 pp -114.73 141.9 47.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 74.140000000000001 110.912 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.64 HG22 ' HB3' ' A' ' 92' ' ' PHE . 16.1 t -128.56 136.77 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 75.530000000000001 111.126 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.76 88.52 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 70.030000000000001 110.914 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -58.42 108.06 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 71.239999999999995 110.816 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.88 -5.31 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.756 -0.735 . . . . 74.519999999999996 112.503 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -88.48 -49.32 3.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 62.100000000000001 112.533 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -101.82 -4.31 26.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 62.329999999999998 110.886 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 64.26 28.38 13.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 110.809 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 33.4 m -134.33 138.2 44.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 44.210000000000001 110.9 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 117' ' ' LEU . 55.6 m-85 -64.41 127.32 30.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 74.439999999999998 110.87 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.6 t -105.72 109.29 27.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 75.340000000000003 111.086 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.444 HD13 HG21 ' A' ' 158' ' ' ILE . 6.3 tt -102.09 131.62 48.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 75.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 16.4 mtp -130.96 137.96 49.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.881 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.94 129.0 40.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.28 -0.418 . . . . 73.129999999999995 110.892 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.696 HD13 HG23 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -64.86 -14.69 60.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 64.219999999999999 110.985 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.5 ' N ' HD23 ' A' ' 131' ' ' LEU . . . 113.58 49.15 0.56 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 54.0 112.493 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.6 t -55.57 175.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.931 0.396 . . . . 74.430000000000007 110.854 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.13 -23.83 19.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 70.5 111.103 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -85.31 -73.27 0.45 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 73.219999999999999 110.878 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 141.65 127.89 2.3 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 41.009999999999998 112.479 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.02 145.96 6.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.906 0.384 . . . . 52.409999999999997 111.072 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 1.5 mtmm -99.59 148.72 24.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 74.150000000000006 110.901 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.7 HD13 ' HB2' ' A' ' 140' ' ' ASN . 3.1 tm? -130.95 122.64 27.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 74.120000000000005 110.978 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.7 ' HB2' HD13 ' A' ' 139' ' ' LEU . 1.1 m-80 61.0 21.9 12.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 54.310000000000002 110.889 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.54 21.85 42.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.794 -0.717 . . . . 63.439999999999998 112.489 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 144' ' ' ILE . 29.1 m-20 -144.89 125.87 14.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 52.439999999999998 110.898 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -60.17 135.03 57.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 74.010000000000005 110.833 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.488 HG23 ' O ' ' A' ' 142' ' ' ASN . 0.0 OUTLIER -141.69 176.08 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 72.349999999999994 111.137 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -57.97 -176.47 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 75.140000000000001 110.872 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.33 174.55 7.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 74.209999999999994 110.855 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 52.79 45.92 27.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 72.120000000000005 110.835 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.746 ' HG3' HD21 ' A' ' 150' ' ' LEU . 3.4 ptp180 -144.99 159.02 51.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.571 0.7 . . . . 70.409999999999997 110.918 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 102.47 1.03 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.704 2.269 . . . . 73.010000000000005 112.383 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.746 HD21 ' HG3' ' A' ' 148' ' ' ARG . 3.4 mt -109.88 83.76 3.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.581 0.705 . . . . 60.310000000000002 110.897 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 130.61 19.56 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.625 2.217 . . . . 73.230000000000004 112.339 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -119.05 79.88 18.28 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.54 0.686 . . . . 71.329999999999998 111.069 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -179.2 2.75 Favored 'Trans proline' 0 N--CA 1.466 -0.128 0 C-N-CA 122.748 2.299 . . . . 54.030000000000001 112.295 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.413 HG21 ' HB2' ' A' ' 171' ' ' LEU . 11.0 m -64.44 144.9 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.18 -0.464 . . . . 74.319999999999993 111.139 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.62 -10.24 68.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.769 -0.729 . . . . 75.400000000000006 112.426 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.69 -178.67 4.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.892 0.377 . . . . 61.219999999999999 110.832 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 52.8 m -132.99 165.73 24.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 61.420000000000002 110.895 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.444 HG21 HD13 ' A' ' 128' ' ' LEU . 6.8 mt -143.35 151.06 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 74.239999999999995 111.081 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.423 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -151.97 157.69 42.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.019999999999996 110.943 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -153.73 134.65 13.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 72.420000000000002 110.938 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.22 -153.59 42.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 73.219999999999999 112.471 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -101.33 18.09 20.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.351 . . . . 73.109999999999999 110.803 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.0 p -64.83 158.82 24.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 74.409999999999997 110.953 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.8 p -91.31 -33.29 15.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 54.350000000000001 110.861 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -53.12 154.7 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.209999999999994 110.87 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.7 t -145.38 131.13 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.464 . . . . 74.5 111.111 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.466 ' HB3' HD11 ' A' ' 73' ' ' LEU . 5.3 m-85 -98.46 103.12 15.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 74.409999999999997 110.939 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -104.93 110.49 22.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 51.43 110.873 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.92 153.88 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 75.340000000000003 111.151 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.66 145.92 14.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 72.200000000000003 110.894 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.413 ' HB2' HG21 ' A' ' 154' ' ' VAL . 7.6 tt -89.5 136.03 33.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 71.010000000000005 110.889 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.22 172.26 19.49 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.738 -0.744 . . . . 62.140000000000001 112.456 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.67 167.63 23.76 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.629 2.219 . . . . 64.239999999999995 112.378 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 -24.79 29.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.635 2.223 . . . . 71.329999999999998 112.384 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 m -90.11 81.18 6.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 75.040000000000006 110.805 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.3 m -52.07 -30.61 26.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.509 . . . . 52.549999999999997 110.861 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 63.350000000000001 110.816 -179.757 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.403 0 CA-C-O 121.422 0.456 . . . . 74.420000000000002 112.483 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 120.83 7.55 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.667 2.245 . . . . 71.140000000000001 112.346 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -138.4 149.33 45.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 74.409999999999997 110.976 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.3 t -98.42 138.39 23.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 53.530000000000001 111.103 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 t -125.74 140.05 53.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 53.530000000000001 111.167 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 p -107.51 164.49 12.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 71.549999999999997 110.797 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m -93.84 -19.12 21.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.115 -0.493 . . . . 51.240000000000002 111.183 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.85 20.96 79.07 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.746 -0.74 . . . . 74.450000000000003 112.573 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.7 mt -55.92 117.5 3.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 62.340000000000003 110.9 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 tp -142.56 157.2 44.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 110.945 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.3 t -155.87 136.13 13.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 74.530000000000001 110.946 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.96 133.16 31.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 72.230000000000004 110.888 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.9 t -124.04 125.6 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.540000000000006 111.156 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.92 153.5 28.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.340000000000003 111.139 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -124.97 109.75 13.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 74.239999999999995 111.126 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.5 t -118.96 105.57 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 54.109999999999999 111.153 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -129.16 110.55 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 74.420000000000002 110.907 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -126.4 155.7 41.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 75.049999999999997 110.933 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.85 148.47 30.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 63.420000000000002 111.138 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.91 145.22 8.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 111.11 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -119.26 101.99 8.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 74.109999999999999 110.885 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 20' ' ' ILE . 3.5 mp -80.53 99.2 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 73.510000000000005 111.103 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.05 156.62 48.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 63.25 111.153 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -130.32 86.67 53.03 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.59 0.709 . . . . 64.530000000000001 110.893 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 167.65 23.79 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.712 2.274 . . . . 62.299999999999997 112.374 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 167.78 23.41 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.718 2.278 . . . . 65.340000000000003 112.293 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 167.64 23.85 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.757 2.305 . . . . 71.519999999999996 112.294 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -170.98 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.716 2.277 . . . . 55.409999999999997 112.313 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.56 142.55 49.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 70.239999999999995 110.908 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 m -90.2 171.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 51.299999999999997 111.107 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.8 t -145.02 146.63 19.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 73.230000000000004 111.118 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -95.78 161.01 14.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 61.25 110.89 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.8 mt -118.12 174.77 6.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.239999999999995 110.891 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.603 ' OG1' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -88.76 175.47 7.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 62.119999999999997 111.055 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -72.2 -41.51 66.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 51.409999999999997 110.822 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.97 -20.65 34.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 61.020000000000003 111.05 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.603 ' HB2' ' OG1' ' A' ' 32' ' ' THR . . . -54.92 -27.36 42.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 44.140000000000001 111.176 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -20.87 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 72.420000000000002 110.814 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -73.04 -52.0 16.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 62.43 110.868 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.84 85.76 4.27 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.549 0.69 . . . . 61.020000000000003 110.945 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 155.26 66.25 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.241 . . . . 72.109999999999999 112.336 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.69 ' HG3' HD12 ' A' ' 43' ' ' ILE . 8.5 mt-30 -67.52 172.52 4.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 75.400000000000006 110.907 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -65.28 -47.28 77.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 73.129999999999995 110.868 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.695 ' O ' HG23 ' A' ' 46' ' ' THR . 1.6 pp -70.05 -32.5 51.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 64.409999999999997 111.132 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.69 HD12 ' HG3' ' A' ' 40' ' ' GLN . 61.6 mt -79.41 -27.36 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 71.530000000000001 111.109 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.83 -14.34 60.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.786 -0.721 . . . . 63.200000000000003 112.517 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.93 -25.83 3.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.945 0.403 . . . . 73.510000000000005 111.139 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 42' ' ' ILE . 48.4 p -58.86 153.56 16.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 71.420000000000002 111.154 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.746 ' O ' HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -83.06 159.72 61.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.535 0.684 . . . . 74.439999999999998 110.876 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -38.73 7.39 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.672 2.248 . . . . 71.200000000000003 112.315 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.27 -14.65 32.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 111.187 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.64 -59.18 2.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 110.88 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.932 HD13 ' N ' ' A' ' 52' ' ' ASN . 0.0 OUTLIER -63.11 -16.29 59.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 74.219999999999999 110.927 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.932 ' N ' HD13 ' A' ' 51' ' ' LEU . 4.0 t30 -81.35 -48.18 12.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 61.240000000000002 110.946 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.815 ' HB1' HG12 ' A' ' 100' ' ' VAL . . . -56.78 -24.47 50.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 65.030000000000001 111.146 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.83 -17.18 25.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.223 -0.444 . . . . 73.530000000000001 110.906 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -64.57 -15.45 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 73.040000000000006 111.177 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.9 t -90.12 -2.74 58.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 63.229999999999997 110.885 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.772 ' CD2' HG21 ' A' ' 113' ' ' VAL . 23.8 m-85 -126.86 -57.42 1.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 75.150000000000006 110.959 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.581 ' CE1' HD11 ' A' ' 131' ' ' LEU . 58.1 m-85 -139.58 142.55 37.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 73.140000000000001 110.839 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -114.41 118.08 32.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 75.109999999999999 110.954 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.5 p -49.98 108.45 1.0 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.626 0.727 . . . . 74.200000000000003 110.862 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.779 ' HG2' ' HB2' ' A' ' 64' ' ' ALA . 53.3 Cg_endo -69.77 168.93 20.15 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.708 2.272 . . . . 53.210000000000001 112.344 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -38.02 8.49 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.621 2.214 . . . . 63.520000000000003 112.4 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.455 ' HA ' HD12 ' A' ' 66' ' ' LEU . 32.7 p-90 -75.36 -5.62 45.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 73.439999999999998 110.896 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.779 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . . . -74.3 147.42 42.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 45.109999999999999 111.082 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.487 ' CB ' HG21 ' A' ' 42' ' ' ILE . . . 64.98 48.51 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 51.119999999999997 111.044 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 63' ' ' TRP . 85.5 mt -146.25 66.67 11.44 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.628 0.727 . . . . 63.210000000000001 110.927 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 151.3 69.11 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.243 . . . . 72.439999999999998 112.352 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.59 -4.3 8.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 110.802 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 p -143.09 147.9 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 74.510000000000005 111.188 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.557 ' O ' HD12 ' A' ' 171' ' ' LEU . . . -81.03 126.55 31.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 72.219999999999999 111.143 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.2 p -151.0 176.07 11.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 63.140000000000001 110.87 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -143.69 167.53 22.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 74.519999999999996 110.839 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.698 HD13 ' N ' ' A' ' 74' ' ' GLN . 2.2 tm? -121.73 135.97 54.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 52.240000000000002 110.894 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.698 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -111.54 135.03 52.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 75.109999999999999 110.918 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 14.5 p -125.04 134.87 52.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 73.310000000000002 110.902 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.538 HG23 ' NE2' ' A' ' 74' ' ' GLN . 34.4 p -99.85 155.15 17.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 53.32 111.105 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.419 ' CD ' HD11 ' A' ' 82' ' ' LEU . 6.6 ptm180 -156.9 115.05 3.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 75.209999999999994 110.839 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.3 t70 53.87 37.92 27.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 63.340000000000003 110.892 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.14 78.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.696 -0.764 . . . . 70.420000000000002 112.496 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 16.7 mt -110.99 108.57 57.54 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.663 0.744 . . . . 62.240000000000002 110.916 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 80' ' ' LEU . 53.1 Cg_endo -69.83 91.2 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.671 2.247 . . . . 41.439999999999998 112.358 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.419 HD11 ' CD ' ' A' ' 77' ' ' ARG . 20.3 mt -66.88 159.35 76.19 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 75.25 110.91 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 117.99 5.41 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 122.689 2.259 . . . . 53.439999999999998 112.39 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.63 147.51 52.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.442 . . . . 73.510000000000005 111.084 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.9 mt -147.89 144.17 27.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 71.25 110.886 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.89 101.65 0.28 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 71.109999999999999 112.49 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 69.0 mt -75.49 70.55 2.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 74.129999999999995 110.939 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -111.96 6.13 19.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 110.854 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -19.03 63.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 110.856 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -137.51 156.29 74.99 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.672 0.749 . . . . 70.310000000000002 110.863 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.401 ' HB3' HD13 ' A' ' 42' ' ' ILE . 53.8 Cg_endo -69.66 -25.92 28.55 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.671 2.247 . . . . 70.230000000000004 112.354 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.648 ' HB3' HG22 ' A' ' 118' ' ' VAL . 35.2 p90 -164.98 172.39 12.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 72.329999999999998 110.856 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -138.46 112.05 8.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.113 -0.494 . . . . 73.239999999999995 110.877 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.665 HD22 ' HA ' ' A' ' 101' ' ' CYS . 5.5 tt -91.95 140.34 29.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 73.540000000000006 110.96 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.401 ' N ' HD23 ' A' ' 94' ' ' LEU . 18.4 m-85 -122.72 119.2 29.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.886 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.76 -157.71 12.54 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.731 . . . . 73.540000000000006 112.487 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.65 -11.93 13.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.826 0.346 . . . . 63.299999999999997 110.882 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 100' ' ' VAL . 32.8 t -75.47 167.69 21.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 54.149999999999999 110.846 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 -16.73 55.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 75.129999999999995 110.896 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.815 HG12 ' HB1' ' A' ' 53' ' ' ALA . 17.1 m -76.35 -24.01 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 64.230000000000004 111.141 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.665 ' HA ' HD22 ' A' ' 94' ' ' LEU . 7.5 p -62.62 156.47 23.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 110.867 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.56 -0.16 57.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.430000000000007 110.809 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.19 106.24 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 71.140000000000001 110.92 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.97 108.58 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 73.230000000000004 111.131 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.717 HD13 HD13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -109.99 -176.55 3.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 75.5 110.93 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -131.76 106.56 8.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 110.869 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.486 ' HB2' HD12 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -164.95 145.29 6.01 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.618 0.723 . . . . 72.430000000000007 110.847 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -16.93 37.72 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.695 2.263 . . . . 74.329999999999998 112.322 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 p -96.25 -26.83 15.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 62.439999999999998 110.92 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.717 HD13 HD13 ' A' ' 105' ' ' LEU . 55.3 mt -74.14 110.1 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.509 . . . . 74.530000000000001 111.139 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.3 m -92.63 171.37 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.181 -0.463 . . . . 74.200000000000003 110.853 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -40.0 -44.77 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 42.43 110.863 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.772 HG21 ' CD2' ' A' ' 57' ' ' TYR . 26.0 t -138.24 81.54 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 73.209999999999994 111.128 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.613 ' CD2' HG22 ' A' ' 137' ' ' VAL . 2.3 t60 -64.85 -47.05 79.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 75.430000000000007 110.872 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -175.1 171.57 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 72.400000000000006 111.09 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 p -152.03 134.66 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 75.409999999999997 111.152 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.467 HD12 ' CD2' ' A' ' 126' ' ' PHE . 0.7 OUTLIER -107.34 138.2 43.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 71.109999999999999 110.928 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' A' ' 92' ' ' PHE . 17.0 t -129.61 138.32 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 65.310000000000002 111.178 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.69 98.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.9 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -72.29 104.48 3.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 72.239999999999995 110.841 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.63 -5.34 68.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.803 -0.713 . . . . 74.099999999999994 112.456 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.89 -40.91 6.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.792 -0.718 . . . . 74.239999999999995 112.441 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.55 5.41 16.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.837 0.351 . . . . 71.129999999999995 110.92 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? 51.84 57.54 6.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 52.43 110.878 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 24.2 p -167.85 138.07 2.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 75.030000000000001 110.852 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.467 ' CD2' HD12 ' A' ' 117' ' ' LEU . 67.7 m-85 -64.7 131.07 45.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 75.530000000000001 110.908 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.8 t -112.26 111.61 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 75.150000000000006 111.133 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.6 tt -100.62 125.75 47.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 75.239999999999995 110.923 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.0 mtt -116.93 132.43 56.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 61.229999999999997 110.845 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -84.52 132.41 34.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 74.319999999999993 110.862 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.654 ' CD2' HG12 ' A' ' 113' ' ' VAL . 3.8 mm? -73.35 -15.29 61.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 75.109999999999999 110.836 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.62 43.96 0.93 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.774 -0.727 . . . . 72.209999999999994 112.488 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.9 t -52.01 168.55 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 40.119999999999997 110.875 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.23 -21.08 33.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 111.116 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -92.76 -75.3 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 110.899 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 147.97 142.58 3.68 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.714 -0.755 . . . . 74.140000000000001 112.462 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.613 HG22 ' CD2' ' A' ' 114' ' ' HIS . 16.0 t -102.1 143.12 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.925 0.393 . . . . 71.049999999999997 111.12 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 159' ' ' GLN . 4.6 mtmm -101.83 147.93 25.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 62.43 110.924 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.562 HD13 ' HB3' ' A' ' 150' ' ' LEU . 6.8 tp -135.83 135.87 40.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.915 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.39 22.24 6.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.164 -0.471 . . . . 64.230000000000004 110.859 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.93 21.47 57.38 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 62.530000000000001 112.483 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -145.8 132.82 20.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.763 0.316 . . . . 74.129999999999995 110.892 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -64.13 135.47 56.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 64.530000000000001 110.874 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.454 HD13 ' H ' ' A' ' 144' ' ' ILE . 0.0 OUTLIER -140.39 177.77 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.140000000000001 111.121 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -171.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.040000000000006 110.884 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 172.71 12.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 74.450000000000003 110.923 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 58.49 41.22 23.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.540000000000006 110.882 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.76 ' HG3' HD21 ' A' ' 150' ' ' LEU . 7.7 ptm180 -147.59 158.67 42.9 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.573 0.701 . . . . 64.099999999999994 110.905 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 107.06 1.77 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.678 2.252 . . . . 72.409999999999997 112.343 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.76 HD21 ' HG3' ' A' ' 148' ' ' ARG . 4.7 mt -111.84 83.88 5.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.597 0.713 . . . . 51.409999999999997 110.902 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 135.99 31.9 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.718 2.278 . . . . 73.230000000000004 112.344 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.422 ' O ' HG21 ' A' ' 169' ' ' VAL . . . -132.32 79.99 64.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.57 0.7 . . . . 74.120000000000005 111.096 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 -178.36 2.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.67 2.247 . . . . 65.140000000000001 112.38 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 13.5 m -54.08 143.08 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 73.150000000000006 111.074 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.94 -11.22 65.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 74.5 112.519 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.5 m -96.5 174.34 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.966 0.413 . . . . 74.120000000000005 110.789 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.2 m -130.05 163.86 25.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 74.329999999999998 110.877 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.9 mt -142.12 145.18 24.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.072 -0.513 . . . . 73.340000000000003 111.155 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -151.93 148.82 28.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 63.100000000000001 111.003 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.403 ' H ' ' NE2' ' A' ' 159' ' ' GLN . 4.4 p90 -148.37 140.84 24.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 73.010000000000005 110.884 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 64.17 -145.5 49.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 61.130000000000003 112.473 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -113.61 14.43 18.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.901 0.382 . . . . 74.329999999999998 110.869 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.76 160.86 11.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 61.210000000000001 110.88 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 61.9 m -91.32 -32.92 15.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 64.209999999999994 110.881 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.72 152.45 9.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 64.409999999999997 110.848 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.9 t -144.84 132.41 16.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 71.019999999999996 111.17 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -95.41 103.25 15.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 74.299999999999997 110.871 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 7.3 tptp -105.29 110.38 22.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 71.239999999999995 110.913 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 152' ' ' ALA . 2.9 t -78.66 153.2 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 111.116 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -160.76 150.87 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 63.039999999999999 110.893 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 70' ' ' ALA . 16.1 tp -89.74 139.16 30.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 64.5 110.906 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -91.53 173.33 36.93 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 33.530000000000001 112.451 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 167.76 23.52 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.676 2.251 . . . . 74.099999999999994 112.382 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 117.82 5.31 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.729 2.286 . . . . 51.299999999999997 112.343 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.6 t -52.12 156.65 1.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 64.450000000000003 110.894 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.6 t -53.53 -45.39 69.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 53.530000000000001 110.86 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 75.129999999999995 110.834 -179.784 . . . . . . . . 0 0 . 1 stop_ save_